id	sid	tid	token	lemma	pos
fnp-5347	1	1	neuropathology	neuropathology	NOUN
fnp-5347	1	2	and	and	CCONJ
fnp-5347	1	3	epilepsy	epilepsy	ADJ
fnp-5347	1	4	surgery	surgery	NOUN
fnp-5347	1	5	–	–	PUNCT
fnp-5347	1	6	2024	2024	NUM
fnp-5347	1	7	update	update	NOUN
fnp-5347	1	8	feel	feel	VERB
fnp-5347	1	9	free	free	ADJ
fnp-5347	1	10	to	to	PART
fnp-5347	1	11	add	add	VERB
fnp-5347	1	12	comments	comment	NOUN
fnp-5347	1	13	by	by	ADP
fnp-5347	1	14	clicking	click	VERB
fnp-5347	1	15	these	these	DET
fnp-5347	1	16	icons	icon	NOUN
fnp-5347	1	17	on	on	ADP
fnp-5347	1	18	the	the	DET
fnp-5347	1	19	sidebar	sidebar	NOUN
fnp-5347	1	20	free	free	ADJ
fnp-5347	1	21	neuropathology	neuropathology	NOUN
fnp-5347	1	22	5:8	5:8	NUM
fnp-5347	1	23	(	(	PUNCT
fnp-5347	1	24	2024	2024	NUM
fnp-5347	1	25	)	)	PUNCT
fnp-5347	1	26	review	review	VERB
fnp-5347	1	27	neuropathology	neuropathology	NOUN
fnp-5347	1	28	and	and	CCONJ
fnp-5347	1	29	epilepsy	epilepsy	VERB
fnp-5347	1	30	surgery	surgery	NOUN
fnp-5347	1	31	–	–	PUNCT
fnp-5347	1	32	2024	2024	NUM
fnp-5347	1	33	update	update	NOUN
fnp-5347	1	34	ingmar	ingmar	PROPN
fnp-5347	1	35	blümcke	blümcke	PROPN
fnp-5347	1	36	department	department	PROPN
fnp-5347	1	37	of	of	ADP
fnp-5347	1	38	neuropathology	neuropathology	NOUN
fnp-5347	1	39	,	,	PUNCT
fnp-5347	1	40	university	university	NOUN
fnp-5347	1	41	hospital	hospital	NOUN
fnp-5347	1	42	erlangen	erlangen	PROPN
fnp-5347	1	43	,	,	PUNCT
fnp-5347	1	44	germany	germany	PROPN
fnp-5347	1	45	corresponding	corresponding	ADJ
fnp-5347	1	46	author	author	NOUN
fnp-5347	1	47	:	:	PUNCT
fnp-5347	1	48	ingmar	ingmar	PROPN
fnp-5347	1	49	blümcke	blümcke	PROPN
fnp-5347	1	50	·	·	PUNCT
fnp-5347	1	51	department	department	NOUN
fnp-5347	1	52	of	of	ADP
fnp-5347	1	53	neuropathology	neuropathology	NOUN
fnp-5347	1	54	·	·	PUNCT
fnp-5347	1	55	university	university	NOUN
fnp-5347	1	56	hospital	hospital	NOUN
fnp-5347	1	57	erlangen	erlangen	X
fnp-5347	1	58	·	·	PUNCT
fnp-5347	1	59	schwabachanlage	schwabachanlage	VERB
fnp-5347	1	60	6	6	NUM
fnp-5347	1	61	·	·	PUNCT
fnp-5347	1	62	erlangen	erlangen	PROPN
fnp-5347	1	63	·	·	PUNCT
fnp-5347	1	64	germany	germany	PROPN
fnp-5347	1	65	bluemcke@uk-erlangen.de	bluemcke@uk-erlangen.de	PROPN
fnp-5347	1	66	submitted	submit	VERB
fnp-5347	1	67	:	:	PUNCT
fnp-5347	1	68	05	05	NUM
fnp-5347	1	69	february	february	PROPN
fnp-5347	1	70	2024	2024	NUM
fnp-5347	1	71	accepted	accept	VERB
fnp-5347	1	72	:	:	PUNCT
fnp-5347	1	73	11	11	NUM
fnp-5347	1	74	march	march	NOUN
fnp-5347	1	75	2024	2024	NUM
fnp-5347	1	76	copyedited	copyedit	VERB
fnp-5347	1	77	by	by	ADP
fnp-5347	1	78	:	:	PUNCT
fnp-5347	1	79	joão	joão	PROPN
fnp-5347	1	80	gama	gama	PROPN
fnp-5347	1	81	published	publish	VERB
fnp-5347	1	82	:	:	PUNCT
fnp-5347	1	83	22	22	NUM
fnp-5347	1	84	march	march	NOUN
fnp-5347	1	85	2024	2024	NUM
fnp-5347	1	86	https://doi.org/10.17879/freeneuropathology-2024-5347	https://doi.org/10.17879/freeneuropathology-2024-5347	ADJ
fnp-5347	1	87	keywords	keyword	NOUN
fnp-5347	1	88	:	:	PUNCT
fnp-5347	1	89	brain	brain	NOUN
fnp-5347	1	90	,	,	PUNCT
fnp-5347	1	91	histopathology	histopathology	NOUN
fnp-5347	1	92	,	,	PUNCT
fnp-5347	1	93	seizure	seizure	NOUN
fnp-5347	1	94	,	,	PUNCT
fnp-5347	1	95	hippocampus	hippocampus	NOUN
fnp-5347	1	96	,	,	PUNCT
fnp-5347	1	97	neocortex	neocortex	NOUN
fnp-5347	1	98	,	,	PUNCT
fnp-5347	1	99	dysplasia	dysplasia	NOUN
fnp-5347	1	100	,	,	PUNCT
fnp-5347	1	101	tumor	tumor	NOUN
fnp-5347	1	102	abstract	abstract	ADJ
fnp-5347	1	103	neuropathology	neuropathology	NOUN
fnp-5347	1	104	-	-	PUNCT
fnp-5347	1	105	based	base	VERB
fnp-5347	1	106	studies	study	NOUN
fnp-5347	1	107	in	in	ADP
fnp-5347	1	108	neurosurgically	neurosurgically	ADV
fnp-5347	1	109	resected	resect	VERB
fnp-5347	1	110	brain	brain	NOUN
fnp-5347	1	111	tissue	tissue	NOUN
fnp-5347	1	112	obtained	obtain	VERB
fnp-5347	1	113	from	from	ADP
fnp-5347	1	114	carefully	carefully	ADV
fnp-5347	1	115	examined	examine	VERB
fnp-5347	1	116	patients	patient	NOUN
fnp-5347	1	117	with	with	ADP
fnp-5347	1	118	focal	focal	ADJ
fnp-5347	1	119	epilepsies	epilepsy	NOUN
fnp-5347	1	120	remain	remain	VERB
fnp-5347	1	121	a	a	DET
fnp-5347	1	122	treasure	treasure	NOUN
fnp-5347	1	123	box	box	NOUN
fnp-5347	1	124	for	for	ADP
fnp-5347	1	125	excellent	excellent	ADJ
fnp-5347	1	126	insights	insight	NOUN
fnp-5347	1	127	into	into	ADP
fnp-5347	1	128	human	human	ADJ
fnp-5347	1	129	neuroscience	neuroscience	NOUN
fnp-5347	1	130	,	,	PUNCT
fnp-5347	1	131	including	include	VERB
fnp-5347	1	132	avenues	avenue	NOUN
fnp-5347	1	133	to	to	PART
fnp-5347	1	134	better	well	ADV
fnp-5347	1	135	understand	understand	VERB
fnp-5347	1	136	the	the	DET
fnp-5347	1	137	neurobiology	neurobiology	NOUN
fnp-5347	1	138	of	of	ADP
fnp-5347	1	139	human	human	ADJ
fnp-5347	1	140	brain	brain	NOUN
fnp-5347	1	141	organization	organization	NOUN
fnp-5347	1	142	and	and	CCONJ
fnp-5347	1	143	neuronal	neuronal	ADJ
fnp-5347	1	144	hyperexcitability	hyperexcitability	NOUN
fnp-5347	1	145	at	at	ADP
fnp-5347	1	146	the	the	DET
fnp-5347	1	147	cellular	cellular	ADJ
fnp-5347	1	148	level	level	NOUN
fnp-5347	1	149	including	include	VERB
fnp-5347	1	150	glio	glio	ADJ
fnp-5347	1	151	-	-	PUNCT
fnp-5347	1	152	neuronal	neuronal	ADJ
fnp-5347	1	153	interaction	interaction	NOUN
fnp-5347	1	154	.	.	PUNCT
fnp-5347	2	1	it	it	PRON
fnp-5347	2	2	also	also	ADV
fnp-5347	2	3	allows	allow	VERB
fnp-5347	2	4	to	to	PART
fnp-5347	2	5	translate	translate	VERB
fnp-5347	2	6	results	result	NOUN
fnp-5347	2	7	from	from	ADP
fnp-5347	2	8	animal	animal	NOUN
fnp-5347	2	9	models	model	NOUN
fnp-5347	2	10	in	in	ADP
fnp-5347	2	11	order	order	NOUN
fnp-5347	2	12	to	to	PART
fnp-5347	2	13	develop	develop	VERB
fnp-5347	2	14	personalized	personalized	ADJ
fnp-5347	2	15	treatment	treatment	NOUN
fnp-5347	2	16	strategies	strategy	NOUN
fnp-5347	2	17	in	in	ADP
fnp-5347	2	18	the	the	DET
fnp-5347	2	19	near	near	ADJ
fnp-5347	2	20	future	future	NOUN
fnp-5347	2	21	.	.	PUNCT
fnp-5347	3	1	a	a	DET
fnp-5347	3	2	nice	nice	ADJ
fnp-5347	3	3	example	example	NOUN
fnp-5347	3	4	of	of	ADP
fnp-5347	3	5	this	this	PRON
fnp-5347	3	6	is	be	AUX
fnp-5347	3	7	the	the	DET
fnp-5347	3	8	discovery	discovery	NOUN
fnp-5347	3	9	of	of	ADP
fnp-5347	3	10	a	a	DET
fnp-5347	3	11	new	new	ADJ
fnp-5347	3	12	disease	disease	NOUN
fnp-5347	3	13	entity	entity	NOUN
fnp-5347	3	14	in	in	ADP
fnp-5347	3	15	2017	2017	NUM
fnp-5347	3	16	,	,	PUNCT
fnp-5347	3	17	termed	term	VERB
fnp-5347	3	18	mild	mild	ADJ
fnp-5347	3	19	malformation	malformation	NOUN
fnp-5347	3	20	of	of	ADP
fnp-5347	3	21	cortical	cortical	ADJ
fnp-5347	3	22	development	development	NOUN
fnp-5347	3	23	with	with	ADP
fnp-5347	3	24	oligodendroglial	oligodendroglial	ADJ
fnp-5347	3	25	hyperplasia	hyperplasia	NOUN
fnp-5347	3	26	in	in	ADP
fnp-5347	3	27	epilepsy	epilepsy	NOUN
fnp-5347	3	28	or	or	CCONJ
fnp-5347	3	29	moghe	moghe	VERB
fnp-5347	3	30	,	,	PUNCT
fnp-5347	3	31	in	in	ADP
fnp-5347	3	32	the	the	DET
fnp-5347	3	33	frontal	frontal	ADJ
fnp-5347	3	34	lobe	lobe	NOUN
fnp-5347	3	35	of	of	ADP
fnp-5347	3	36	young	young	ADJ
fnp-5347	3	37	children	child	NOUN
fnp-5347	3	38	with	with	ADP
fnp-5347	3	39	intractable	intractable	ADJ
fnp-5347	3	40	seizures	seizure	NOUN
fnp-5347	3	41	.	.	PUNCT
fnp-5347	4	1	in	in	ADP
fnp-5347	4	2	2021	2021	NUM
fnp-5347	4	3	,	,	PUNCT
fnp-5347	4	4	a	a	DET
fnp-5347	4	5	brain	brain	NOUN
fnp-5347	4	6	somatic	somatic	ADJ
fnp-5347	4	7	missense	missense	NOUN
fnp-5347	4	8	mutation	mutation	NOUN
fnp-5347	4	9	of	of	ADP
fnp-5347	4	10	the	the	DET
fnp-5347	4	11	galactose	galactose	ADJ
fnp-5347	4	12	transporter	transporter	NOUN
fnp-5347	4	13	slc35a2	slc35a2	ADV
fnp-5347	4	14	leading	lead	VERB
fnp-5347	4	15	to	to	ADP
fnp-5347	4	16	altered	alter	VERB
fnp-5347	4	17	glycosylation	glycosylation	NOUN
fnp-5347	4	18	of	of	ADP
fnp-5347	4	19	lipoproteins	lipoprotein	NOUN
fnp-5347	4	20	in	in	ADP
fnp-5347	4	21	the	the	DET
fnp-5347	4	22	golgi	golgi	NOUN
fnp-5347	4	23	apparatus	apparatus	NOUN
fnp-5347	4	24	was	be	AUX
fnp-5347	4	25	detected	detect	VERB
fnp-5347	4	26	in	in	ADP
fnp-5347	4	27	50	50	NUM
fnp-5347	4	28	 	 	SPACE
fnp-5347	4	29	%	%	NOUN
fnp-5347	4	30	of	of	ADP
fnp-5347	4	31	moghe	moghe	ADJ
fnp-5347	4	32	samples	sample	NOUN
fnp-5347	4	33	.	.	PUNCT
fnp-5347	5	1	in	in	ADP
fnp-5347	5	2	2023	2023	NUM
fnp-5347	5	3	,	,	PUNCT
fnp-5347	5	4	the	the	DET
fnp-5347	5	5	first	first	ADJ
fnp-5347	5	6	clinical	clinical	ADJ
fnp-5347	5	7	trial	trial	NOUN
fnp-5347	5	8	evaluated	evaluate	VERB
fnp-5347	5	9	galactose	galactose	ADJ
fnp-5347	5	10	supplementation	supplementation	NOUN
fnp-5347	5	11	in	in	ADP
fnp-5347	5	12	patients	patient	NOUN
fnp-5347	5	13	with	with	ADP
fnp-5347	5	14	histopathologically	histopathologically	ADV
fnp-5347	5	15	confirmed	confirm	VERB
fnp-5347	5	16	moghe	moghe	NOUN
fnp-5347	5	17	carrying	carry	VERB
fnp-5347	5	18	brain	brain	NOUN
fnp-5347	5	19	somatic	somatic	ADJ
fnp-5347	5	20	slc35a2	slc35a2	NOUN
fnp-5347	5	21	mutations	mutation	NOUN
fnp-5347	5	22	that	that	PRON
fnp-5347	5	23	were	be	AUX
fnp-5347	5	24	not	not	PART
fnp-5347	5	25	seizure	seizure	VERB
fnp-5347	5	26	free	free	ADJ
fnp-5347	5	27	after	after	ADP
fnp-5347	5	28	surgery	surgery	NOUN
fnp-5347	5	29	.	.	PUNCT
fnp-5347	6	1	the	the	DET
fnp-5347	6	2	promising	promising	ADJ
fnp-5347	6	3	results	result	NOUN
fnp-5347	6	4	of	of	ADP
fnp-5347	6	5	this	this	DET
fnp-5347	6	6	pilot	pilot	NOUN
fnp-5347	6	7	trial	trial	NOUN
fnp-5347	6	8	are	be	AUX
fnp-5347	6	9	an	an	DET
fnp-5347	6	10	example	example	NOUN
fnp-5347	6	11	of	of	ADP
fnp-5347	6	12	personalized	personalized	ADJ
fnp-5347	6	13	medicine	medicine	NOUN
fnp-5347	6	14	in	in	ADP
fnp-5347	6	15	the	the	DET
fnp-5347	6	16	arena	arena	NOUN
fnp-5347	6	17	of	of	ADP
fnp-5347	6	18	epileptology	epileptology	NOUN
fnp-5347	6	19	.	.	PUNCT
fnp-5347	7	1	besides	besides	SCONJ
fnp-5347	7	2	this	this	PRON
fnp-5347	7	3	,	,	PUNCT
fnp-5347	7	4	neuropathological	neuropathological	ADJ
fnp-5347	7	5	studies	study	NOUN
fnp-5347	7	6	of	of	ADP
fnp-5347	7	7	epilepsy	epilepsy	NOUN
fnp-5347	7	8	samples	sample	NOUN
fnp-5347	7	9	have	have	AUX
fnp-5347	7	10	revealed	reveal	VERB
fnp-5347	7	11	many	many	ADJ
fnp-5347	7	12	other	other	ADJ
fnp-5347	7	13	fascinating	fascinating	ADJ
fnp-5347	7	14	results	result	NOUN
fnp-5347	7	15	for	for	ADP
fnp-5347	7	16	the	the	DET
fnp-5347	7	17	main	main	ADJ
fnp-5347	7	18	disease	disease	NOUN
fnp-5347	7	19	categories	category	NOUN
fnp-5347	7	20	in	in	ADP
fnp-5347	7	21	focal	focal	ADJ
fnp-5347	7	22	epilepsies	epilepsy	NOUN
fnp-5347	7	23	,	,	PUNCT
fnp-5347	7	24	such	such	ADJ
fnp-5347	7	25	as	as	ADP
fnp-5347	7	26	the	the	DET
fnp-5347	7	27	first	first	ADJ
fnp-5347	7	28	deep	deep	ADV
fnp-5347	7	29	-	-	PUNCT
fnp-5347	7	30	learning	learn	VERB
fnp-5347	7	31	based	base	VERB
fnp-5347	7	32	classifier	classifier	NOUN
fnp-5347	7	33	for	for	ADP
fnp-5347	7	34	focal	focal	ADJ
fnp-5347	7	35	cortical	cortical	ADJ
fnp-5347	7	36	dysplasia	dysplasia	NOUN
fnp-5347	7	37	,	,	PUNCT
fnp-5347	7	38	or	or	CCONJ
fnp-5347	7	39	the	the	DET
fnp-5347	7	40	genomic	genomic	ADJ
fnp-5347	7	41	landscape	landscape	NOUN
fnp-5347	7	42	of	of	ADP
fnp-5347	7	43	cortical	cortical	ADJ
fnp-5347	7	44	malformations	malformation	NOUN
fnp-5347	7	45	showing	show	VERB
fnp-5347	7	46	new	new	ADJ
fnp-5347	7	47	candidate	candidate	NOUN
fnp-5347	7	48	genes	gene	NOUN
fnp-5347	7	49	such	such	ADJ
fnp-5347	7	50	as	as	ADP
fnp-5347	7	51	ptpn11	ptpn11	NOUN
fnp-5347	7	52	,	,	PUNCT
fnp-5347	7	53	which	which	PRON
fnp-5347	7	54	is	be	AUX
fnp-5347	7	55	associated	associate	VERB
fnp-5347	7	56	with	with	ADP
fnp-5347	7	57	ganglioglioma	ganglioglioma	ADJ
fnp-5347	7	58	and	and	CCONJ
fnp-5347	7	59	adverse	adverse	ADJ
fnp-5347	7	60	clinical	clinical	ADJ
fnp-5347	7	61	outcome	outcome	NOUN
fnp-5347	7	62	.	.	PUNCT
fnp-5347	8	1	this	this	DET
fnp-5347	8	2	update	update	NOUN
fnp-5347	8	3	will	will	AUX
fnp-5347	8	4	also	also	ADV
fnp-5347	8	5	ask	ask	VERB
fnp-5347	8	6	why	why	SCONJ
fnp-5347	8	7	common	common	ADJ
fnp-5347	8	8	pathogenic	pathogenic	ADJ
fnp-5347	8	9	variants	variant	NOUN
fnp-5347	8	10	accumulate	accumulate	VERB
fnp-5347	8	11	in	in	ADP
fnp-5347	8	12	certain	certain	ADJ
fnp-5347	8	13	brain	brain	NOUN
fnp-5347	8	14	regions	region	NOUN
fnp-5347	8	15	,	,	PUNCT
fnp-5347	8	16	e.g.	e.g.	ADV
fnp-5347	8	17	,	,	PUNCT
fnp-5347	8	18	mtor	mtor	PROPN
fnp-5347	8	19	in	in	ADP
fnp-5347	8	20	the	the	DET
fnp-5347	8	21	frontal	frontal	ADJ
fnp-5347	8	22	lobe	lobe	NOUN
fnp-5347	8	23	,	,	PUNCT
fnp-5347	8	24	and	and	CCONJ
fnp-5347	8	25	braf	braf	NOUN
fnp-5347	8	26	in	in	ADP
fnp-5347	8	27	the	the	DET
fnp-5347	8	28	temporal	temporal	ADJ
fnp-5347	8	29	lobe	lobe	NOUN
fnp-5347	8	30	.	.	PUNCT
fnp-5347	9	1	finally	finally	ADV
fnp-5347	9	2	,	,	PUNCT
fnp-5347	9	3	i	i	PRON
fnp-5347	9	4	will	will	AUX
fnp-5347	9	5	highlight	highlight	VERB
fnp-5347	9	6	the	the	DET
fnp-5347	9	7	ongoing	ongoing	ADJ
fnp-5347	9	8	discussion	discussion	NOUN
fnp-5347	9	9	addressing	address	VERB
fnp-5347	9	10	commonalities	commonality	NOUN
fnp-5347	9	11	between	between	ADP
fnp-5347	9	12	temporal	temporal	ADJ
fnp-5347	9	13	lobe	lobe	NOUN
fnp-5347	9	14	epilepsy	epilepsy	PROPN
fnp-5347	9	15	and	and	CCONJ
fnp-5347	9	16	alzheimer	alzheimer	PROPN
fnp-5347	9	17	's	's	PART
fnp-5347	9	18	disease	disease	NOUN
fnp-5347	9	19	,	,	PUNCT
fnp-5347	9	20	the	the	DET
fnp-5347	9	21	impact	impact	NOUN
fnp-5347	9	22	of	of	ADP
fnp-5347	9	23	adult	adult	NOUN
fnp-5347	9	24	neurogenesis	neurogenesis	NOUN
fnp-5347	9	25	and	and	CCONJ
fnp-5347	9	26	gliogenesis	gliogenesis	NOUN
fnp-5347	9	27	for	for	ADP
fnp-5347	9	28	the	the	DET
fnp-5347	9	29	initiation	initiation	NOUN
fnp-5347	9	30	and	and	CCONJ
fnp-5347	9	31	progression	progression	NOUN
fnp-5347	9	32	of	of	ADP
fnp-5347	9	33	temporal	temporal	ADJ
fnp-5347	9	34	lobe	lobe	ADJ
fnp-5347	9	35	seizures	seizure	NOUN
fnp-5347	9	36	in	in	ADP
fnp-5347	9	37	the	the	DET
fnp-5347	9	38	human	human	ADJ
fnp-5347	9	39	brain	brain	NOUN
fnp-5347	9	40	as	as	ADV
fnp-5347	9	41	well	well	ADV
fnp-5347	9	42	as	as	ADP
fnp-5347	9	43	the	the	DET
fnp-5347	9	44	immunopathogenesis	immunopathogenesis	NOUN
fnp-5347	9	45	of	of	ADP
fnp-5347	9	46	glutamic	glutamic	ADJ
fnp-5347	9	47	acid	acid	NOUN
fnp-5347	9	48	decarboxylase	decarboxylase	NOUN
fnp-5347	9	49	antibody	antibody	NOUN
fnp-5347	9	50	associated	associate	VERB
fnp-5347	9	51	temporal	temporal	ADJ
fnp-5347	9	52	lobe	lobe	NOUN
fnp-5347	9	53	epilepsy	epilepsy	NOUN
fnp-5347	9	54	as	as	ADP
fnp-5347	9	55	a	a	DET
fnp-5347	9	56	meaningful	meaningful	ADJ
fnp-5347	9	57	disease	disease	NOUN
fnp-5347	9	58	entity	entity	NOUN
fnp-5347	9	59	.	.	PUNCT
fnp-5347	10	1	this	this	DET
fnp-5347	10	2	review	review	NOUN
fnp-5347	10	3	will	will	AUX
fnp-5347	10	4	update	update	VERB
fnp-5347	10	5	the	the	DET
fnp-5347	10	6	reader	reader	NOUN
fnp-5347	10	7	on	on	ADP
fnp-5347	10	8	some	some	PRON
fnp-5347	10	9	of	of	ADP
fnp-5347	10	10	these	these	DET
fnp-5347	10	11	fascinating	fascinating	ADJ
fnp-5347	10	12	publications	publication	NOUN
fnp-5347	10	13	from	from	ADP
fnp-5347	10	14	2022	2022	NUM
fnp-5347	10	15	and	and	CCONJ
fnp-5347	10	16	2023	2023	NUM
fnp-5347	10	17	which	which	PRON
fnp-5347	10	18	were	be	AUX
fnp-5347	10	19	selected	select	VERB
fnp-5347	10	20	carefully	carefully	ADV
fnp-5347	10	21	,	,	PUNCT
fnp-5347	10	22	yet	yet	CCONJ
fnp-5347	10	23	subjectively	subjectively	ADV
fnp-5347	10	24	,	,	PUNCT
fnp-5347	10	25	by	by	ADP
fnp-5347	10	26	the	the	DET
fnp-5347	10	27	author	author	NOUN
fnp-5347	10	28	.	.	PUNCT
fnp-5347	11	1	introduction	introduction	NOUN
fnp-5347	11	2	this	this	DET
fnp-5347	11	3	review	review	NOUN
fnp-5347	11	4	is	be	AUX
fnp-5347	11	5	a	a	DET
fnp-5347	11	6	continuation	continuation	NOUN
fnp-5347	11	7	of	of	ADP
fnp-5347	11	8	my	my	PRON
fnp-5347	11	9	2022	2022	NUM
fnp-5347	11	10	update	update	NOUN
fnp-5347	11	11	of	of	ADP
fnp-5347	11	12	interesting	interesting	ADJ
fnp-5347	11	13	research	research	NOUN
fnp-5347	11	14	papers	paper	NOUN
fnp-5347	11	15	and	and	CCONJ
fnp-5347	11	16	topics	topic	NOUN
fnp-5347	11	17	covering	cover	VERB
fnp-5347	11	18	the	the	DET
fnp-5347	11	19	search	search	NOUN
fnp-5347	11	20	terms	term	NOUN
fnp-5347	11	21	"	"	PUNCT
fnp-5347	11	22	neuropathology	neuropathology	NOUN
fnp-5347	11	23	"	"	PUNCT
fnp-5347	11	24	and	and	CCONJ
fnp-5347	11	25	"	"	PUNCT
fnp-5347	11	26	epilepsy	epilepsy	ADJ
fnp-5347	11	27	surgery	surgery	NOUN
fnp-5347	11	28	"	"	PUNCT
fnp-5347	11	29	from	from	ADP
fnp-5347	11	30	2021	2021	NUM
fnp-5347	11	31	[	[	X
fnp-5347	11	32	9	9	NUM
fnp-5347	11	33	]	]	PUNCT
fnp-5347	11	34	,	,	PUNCT
fnp-5347	11	35	now	now	ADV
fnp-5347	11	36	discussing	discuss	VERB
fnp-5347	11	37	the	the	DET
fnp-5347	11	38	10	10	NUM
fnp-5347	11	39	most	most	ADV
fnp-5347	11	40	interesting	interesting	ADJ
fnp-5347	11	41	topics	topic	NOUN
fnp-5347	11	42	and/or	and/or	CCONJ
fnp-5347	11	43	papers	paper	NOUN
fnp-5347	11	44	published	publish	VERB
fnp-5347	11	45	in	in	ADP
fnp-5347	11	46	2022	2022	NUM
fnp-5347	11	47	and	and	CCONJ
fnp-5347	11	48	2023	2023	NUM
fnp-5347	11	49	.	.	PUNCT
fnp-5347	12	1	these	these	DET
fnp-5347	12	2	search	search	NOUN
fnp-5347	12	3	terms	term	NOUN
fnp-5347	12	4	produced	produce	VERB
fnp-5347	12	5	about	about	ADP
fnp-5347	12	6	150	150	NUM
fnp-5347	12	7	hits	hit	NOUN
fnp-5347	12	8	in	in	ADP
fnp-5347	12	9	pubmed	pubmed	PROPN
fnp-5347	12	10	in	in	ADP
fnp-5347	12	11	each	each	DET
fnp-5347	12	12	year	year	NOUN
fnp-5347	12	13	.	.	PUNCT
fnp-5347	13	1	the	the	DET
fnp-5347	13	2	'	'	PUNCT
fnp-5347	13	3	subjective	subjective	ADJ
fnp-5347	13	4	'	'	PUNCT
fnp-5347	13	5	selection	selection	NOUN
fnp-5347	13	6	by	by	ADP
fnp-5347	13	7	the	the	DET
fnp-5347	13	8	author	author	NOUN
fnp-5347	13	9	is	be	AUX
fnp-5347	13	10	not	not	PART
fnp-5347	13	11	an	an	DET
fnp-5347	13	12	attempt	attempt	NOUN
fnp-5347	13	13	at	at	ADP
fnp-5347	13	14	including	include	VERB
fnp-5347	13	15	all	all	DET
fnp-5347	13	16	published	publish	VERB
fnp-5347	13	17	papers	paper	NOUN
fnp-5347	13	18	or	or	CCONJ
fnp-5347	13	19	topics	topic	NOUN
fnp-5347	13	20	of	of	ADP
fnp-5347	13	21	the	the	DET
fnp-5347	13	22	field	field	NOUN
fnp-5347	13	23	and	and	CCONJ
fnp-5347	13	24	over	over	ADP
fnp-5347	13	25	this	this	DET
fnp-5347	13	26	time	time	NOUN
fnp-5347	13	27	period	period	NOUN
fnp-5347	13	28	.	.	PUNCT
fnp-5347	14	1	rather	rather	ADV
fnp-5347	14	2	,	,	PUNCT
fnp-5347	14	3	i	i	PRON
fnp-5347	14	4	hope	hope	VERB
fnp-5347	14	5	to	to	PART
fnp-5347	14	6	highlight	highlight	VERB
fnp-5347	14	7	active	active	ADJ
fnp-5347	14	8	areas	area	NOUN
fnp-5347	14	9	of	of	ADP
fnp-5347	14	10	clinical	clinical	ADJ
fnp-5347	14	11	and	and	CCONJ
fnp-5347	14	12	basic	basic	ADJ
fnp-5347	14	13	research	research	NOUN
fnp-5347	14	14	with	with	ADP
fnp-5347	14	15	the	the	DET
fnp-5347	14	16	potential	potential	NOUN
fnp-5347	14	17	to	to	PART
fnp-5347	14	18	advance	advance	VERB
fnp-5347	14	19	our	our	PRON
fnp-5347	14	20	concepts	concept	NOUN
fnp-5347	14	21	and	and	CCONJ
fnp-5347	14	22	understanding	understanding	NOUN
fnp-5347	14	23	of	of	ADP
fnp-5347	14	24	disease	disease	NOUN
fnp-5347	14	25	pathomechanisms	pathomechanism	NOUN
fnp-5347	14	26	,	,	PUNCT
fnp-5347	14	27	e.g.	e.g.	ADV
fnp-5347	14	28	how	how	SCONJ
fnp-5347	14	29	does	do	AUX
fnp-5347	14	30	a	a	DET
fnp-5347	14	31	given	give	VERB
fnp-5347	14	32	'	'	PUNCT
fnp-5347	14	33	molecular	molecular	ADJ
fnp-5347	14	34	'	'	PUNCT
fnp-5347	14	35	pathomechanism	pathomechanism	NOUN
fnp-5347	14	36	translate	translate	VERB
fnp-5347	14	37	into	into	ADP
fnp-5347	14	38	a	a	DET
fnp-5347	14	39	lesional	lesional	ADJ
fnp-5347	14	40	and	and	CCONJ
fnp-5347	14	41	epileptic	epileptic	ADJ
fnp-5347	14	42	phenotype	phenotype	NOUN
fnp-5347	14	43	.	.	PUNCT
fnp-5347	15	1	i	i	PRON
fnp-5347	15	2	will	will	AUX
fnp-5347	15	3	start	start	VERB
fnp-5347	15	4	with	with	ADP
fnp-5347	15	5	last	last	ADJ
fnp-5347	15	6	year	year	NOUN
fnp-5347	15	7	's	's	PART
fnp-5347	15	8	"	"	PUNCT
fnp-5347	15	9	missing	missing	ADJ
fnp-5347	15	10	topic	topic	NOUN
fnp-5347	15	11	"	"	PUNCT
fnp-5347	15	12	,	,	PUNCT
fnp-5347	15	13	i.e.	i.e.	X
fnp-5347	15	14	,	,	PUNCT
fnp-5347	15	15	the	the	DET
fnp-5347	15	16	lack	lack	NOUN
fnp-5347	15	17	of	of	ADP
fnp-5347	15	18	published	publish	VERB
fnp-5347	15	19	articles	article	NOUN
fnp-5347	15	20	using	use	VERB
fnp-5347	15	21	artificial	artificial	ADJ
fnp-5347	15	22	intelligence	intelligence	NOUN
fnp-5347	15	23	(	(	PUNCT
fnp-5347	15	24	ai	ai	NOUN
fnp-5347	15	25	)	)	PUNCT
fnp-5347	15	26	based	base	VERB
fnp-5347	15	27	algorithms	algorithm	NOUN
fnp-5347	15	28	to	to	PART
fnp-5347	15	29	support	support	VERB
fnp-5347	15	30	or	or	CCONJ
fnp-5347	15	31	supplement	supplement	VERB
fnp-5347	15	32	histopathology	histopathology	NOUN
fnp-5347	15	33	diagnosis	diagnosis	NOUN
fnp-5347	15	34	of	of	ADP
fnp-5347	15	35	epilepsy	epilepsy	NOUN
fnp-5347	15	36	-	-	PUNCT
fnp-5347	15	37	associated	associate	VERB
fnp-5347	15	38	brain	brain	NOUN
fnp-5347	15	39	lesions	lesion	NOUN
fnp-5347	15	40	.	.	PUNCT
fnp-5347	16	1	this	this	DET
fnp-5347	16	2	chapter	chapter	NOUN
fnp-5347	16	3	will	will	AUX
fnp-5347	16	4	also	also	ADV
fnp-5347	16	5	enlighten	enlighten	VERB
fnp-5347	16	6	the	the	DET
fnp-5347	16	7	discussion	discussion	NOUN
fnp-5347	16	8	about	about	ADP
fnp-5347	16	9	the	the	DET
fnp-5347	16	10	substitution	substitution	NOUN
fnp-5347	16	11	of	of	ADP
fnp-5347	16	12	histopathologists	histopathologist	NOUN
fnp-5347	16	13	by	by	ADP
fnp-5347	16	14	ai	ai	ADJ
fnp-5347	16	15	-	-	PUNCT
fnp-5347	16	16	driven	drive	VERB
fnp-5347	16	17	technology	technology	NOUN
fnp-5347	16	18	as	as	ADV
fnp-5347	16	19	well	well	ADV
fnp-5347	16	20	as	as	ADP
fnp-5347	16	21	ongoing	ongoing	ADJ
fnp-5347	16	22	technical	technical	ADJ
fnp-5347	16	23	obstacles	obstacle	NOUN
fnp-5347	16	24	to	to	PART
fnp-5347	16	25	successfully	successfully	ADV
fnp-5347	16	26	develop	develop	VERB
fnp-5347	16	27	the	the	DET
fnp-5347	16	28	field	field	NOUN
fnp-5347	16	29	by	by	ADP
fnp-5347	16	30	histopathology	histopathology	NOUN
fnp-5347	16	31	experts	expert	NOUN
fnp-5347	16	32	rather	rather	ADV
fnp-5347	16	33	than	than	ADP
fnp-5347	16	34	by	by	ADP
fnp-5347	16	35	industry	industry	NOUN
fnp-5347	16	36	-	-	PUNCT
fnp-5347	16	37	driven	drive	VERB
fnp-5347	16	38	incentives	incentive	NOUN
fnp-5347	16	39	.	.	PUNCT
fnp-5347	17	1	the	the	DET
fnp-5347	17	2	first	first	ADJ
fnp-5347	17	3	update	update	NOUN
fnp-5347	17	4	to	to	ADP
fnp-5347	17	5	the	the	DET
fnp-5347	17	6	internationally	internationally	ADV
fnp-5347	17	7	renowned	renowned	ADJ
fnp-5347	17	8	fcd	fcd	ADJ
fnp-5347	17	9	classification	classification	NOUN
fnp-5347	17	10	scheme	scheme	NOUN
fnp-5347	17	11	,	,	PUNCT
fnp-5347	17	12	originally	originally	ADV
fnp-5347	17	13	published	publish	VERB
fnp-5347	17	14	in	in	ADP
fnp-5347	17	15	2011	2011	NUM
fnp-5347	17	16	under	under	ADP
fnp-5347	17	17	the	the	DET
fnp-5347	17	18	direction	direction	NOUN
fnp-5347	17	19	of	of	ADP
fnp-5347	17	20	the	the	DET
fnp-5347	17	21	international	international	ADJ
fnp-5347	17	22	league	league	NOUN
fnp-5347	17	23	against	against	ADP
fnp-5347	17	24	epilepsy	epilepsy	NOUN
fnp-5347	17	25	(	(	PUNCT
fnp-5347	17	26	ilae	ilae	NOUN
fnp-5347	17	27	)	)	PUNCT
fnp-5347	17	28	and	and	CCONJ
fnp-5347	17	29	since	since	SCONJ
fnp-5347	17	30	then	then	ADV
fnp-5347	17	31	applied	apply	VERB
fnp-5347	17	32	in	in	ADP
fnp-5347	17	33	epilepsy	epilepsy	ADJ
fnp-5347	17	34	surgery	surgery	NOUN
fnp-5347	17	35	units	unit	NOUN
fnp-5347	17	36	around	around	ADP
fnp-5347	17	37	the	the	DET
fnp-5347	17	38	world	world	NOUN
fnp-5347	17	39	as	as	ADV
fnp-5347	17	40	well	well	ADV
fnp-5347	17	41	as	as	ADP
fnp-5347	17	42	in	in	ADP
fnp-5347	17	43	research	research	NOUN
fnp-5347	17	44	studies	study	NOUN
fnp-5347	17	45	(	(	PUNCT
fnp-5347	17	46	cumulative	cumulative	ADJ
fnp-5347	17	47	citation	citation	NOUN
fnp-5347	17	48	index	index	NOUN
fnp-5347	17	49	of	of	ADP
fnp-5347	17	50	>	>	X
fnp-5347	17	51	 	 	SPACE
fnp-5347	17	52	1,199	1,199	NUM
fnp-5347	17	53	in	in	ADP
fnp-5347	17	54	the	the	DET
fnp-5347	17	55	clarivate	clarivate	NOUN
fnp-5347	17	56	web	web	NOUN
fnp-5347	17	57	-	-	PUNCT
fnp-5347	17	58	of	of	ADP
fnp-5347	17	59	-	-	PUNCT
fnp-5347	17	60	science	science	NOUN
fnp-5347	17	61	database	database	NOUN
fnp-5347	17	62	as	as	ADP
fnp-5347	17	63	of	of	ADP
fnp-5347	17	64	january	january	PROPN
fnp-5347	17	65	2024	2024	NUM
fnp-5347	17	66	)	)	PUNCT
fnp-5347	17	67	,	,	PUNCT
fnp-5347	17	68	represents	represent	VERB
fnp-5347	17	69	probably	probably	ADV
fnp-5347	17	70	one	one	NUM
fnp-5347	17	71	of	of	ADP
fnp-5347	17	72	the	the	DET
fnp-5347	17	73	most	most	ADV
fnp-5347	17	74	important	important	ADJ
fnp-5347	17	75	papers	paper	NOUN
fnp-5347	17	76	published	publish	VERB
fnp-5347	17	77	in	in	ADP
fnp-5347	17	78	the	the	DET
fnp-5347	17	79	time	time	NOUN
fnp-5347	17	80	period	period	NOUN
fnp-5347	17	81	under	under	ADP
fnp-5347	17	82	review	review	NOUN
fnp-5347	17	83	.	.	PUNCT
fnp-5347	18	1	the	the	DET
fnp-5347	18	2	updated	update	VERB
fnp-5347	18	3	fcd	fcd	ADJ
fnp-5347	18	4	classification	classification	NOUN
fnp-5347	18	5	has	have	AUX
fnp-5347	18	6	been	be	AUX
fnp-5347	18	7	already	already	ADV
fnp-5347	18	8	previewed	preview	VERB
fnp-5347	18	9	in	in	ADP
fnp-5347	18	10	my	my	PRON
fnp-5347	18	11	2022	2022	NUM
fnp-5347	18	12	update	update	NOUN
fnp-5347	18	13	,	,	PUNCT
fnp-5347	18	14	however	however	ADV
fnp-5347	18	15	[	[	X
fnp-5347	18	16	9	9	NUM
fnp-5347	18	17	]	]	PUNCT
fnp-5347	18	18	.	.	PUNCT
fnp-5347	19	1	the	the	DET
fnp-5347	19	2	2022	2022	NUM
fnp-5347	19	3	update	update	NOUN
fnp-5347	19	4	emphasized	emphasize	VERB
fnp-5347	19	5	the	the	DET
fnp-5347	19	6	impact	impact	NOUN
fnp-5347	19	7	of	of	ADP
fnp-5347	19	8	brain	brain	NOUN
fnp-5347	19	9	somatic	somatic	ADJ
fnp-5347	19	10	mutations	mutation	NOUN
fnp-5347	19	11	in	in	ADP
fnp-5347	19	12	lesional	lesional	ADJ
fnp-5347	19	13	epilepsies	epilepsy	NOUN
fnp-5347	19	14	such	such	ADJ
fnp-5347	19	15	as	as	ADP
fnp-5347	19	16	focal	focal	ADJ
fnp-5347	19	17	cortical	cortical	ADJ
fnp-5347	19	18	dysplasia	dysplasia	NOUN
fnp-5347	19	19	(	(	PUNCT
fnp-5347	19	20	fcd	fcd	PROPN
fnp-5347	19	21	)	)	PUNCT
fnp-5347	19	22	.	.	PUNCT
fnp-5347	20	1	three	three	NUM
fnp-5347	20	2	international	international	ADJ
fnp-5347	20	3	and	and	CCONJ
fnp-5347	20	4	collaborative	collaborative	ADJ
fnp-5347	20	5	research	research	NOUN
fnp-5347	20	6	teams	team	NOUN
fnp-5347	20	7	studied	study	VERB
fnp-5347	20	8	a	a	DET
fnp-5347	20	9	series	series	NOUN
fnp-5347	20	10	of	of	ADP
fnp-5347	20	11	807	807	NUM
fnp-5347	20	12	human	human	ADJ
fnp-5347	20	13	brain	brain	NOUN
fnp-5347	20	14	tissues	tissue	NOUN
fnp-5347	20	15	to	to	PART
fnp-5347	20	16	unravel	unravel	VERB
fnp-5347	20	17	the	the	DET
fnp-5347	20	18	genomic	genomic	ADJ
fnp-5347	20	19	landscape	landscape	NOUN
fnp-5347	20	20	of	of	ADP
fnp-5347	20	21	focal	focal	ADJ
fnp-5347	20	22	(	(	PUNCT
fnp-5347	20	23	lesional	lesional	ADJ
fnp-5347	20	24	)	)	PUNCT
fnp-5347	20	25	epilepsies	epilepsy	NOUN
fnp-5347	20	26	,	,	PUNCT
fnp-5347	20	27	which	which	PRON
fnp-5347	20	28	will	will	AUX
fnp-5347	20	29	be	be	AUX
fnp-5347	20	30	subsumed	subsume	VERB
fnp-5347	20	31	under	under	ADP
fnp-5347	20	32	item	item	NOUN
fnp-5347	20	33	#	#	SYM
fnp-5347	20	34	2	2	NUM
fnp-5347	20	35	.	.	PUNCT
fnp-5347	21	1	these	these	DET
fnp-5347	21	2	studies	study	NOUN
fnp-5347	21	3	independently	independently	ADV
fnp-5347	21	4	identified	identify	VERB
fnp-5347	21	5	new	new	ADJ
fnp-5347	21	6	epilepsy	epilepsy	NOUN
fnp-5347	21	7	-	-	PUNCT
fnp-5347	21	8	related	relate	VERB
fnp-5347	21	9	candidate	candidate	NOUN
fnp-5347	21	10	genes	gene	NOUN
fnp-5347	21	11	,	,	PUNCT
fnp-5347	21	12	such	such	ADJ
fnp-5347	21	13	as	as	ADP
fnp-5347	21	14	ptpn11	ptpn11	NOUN
fnp-5347	21	15	,	,	PUNCT
fnp-5347	21	16	which	which	PRON
fnp-5347	21	17	belongs	belong	VERB
fnp-5347	21	18	to	to	ADP
fnp-5347	21	19	the	the	DET
fnp-5347	21	20	map	map	NOUN
fnp-5347	21	21	-	-	PUNCT
fnp-5347	21	22	kinase	kinase	NOUN
fnp-5347	21	23	signaling	signal	VERB
fnp-5347	21	24	pathway	pathway	NOUN
fnp-5347	21	25	and	and	CCONJ
fnp-5347	21	26	is	be	AUX
fnp-5347	21	27	well	well	ADV
fnp-5347	21	28	known	know	VERB
fnp-5347	21	29	from	from	ADP
fnp-5347	21	30	noonan	noonan	PROPN
fnp-5347	21	31	syndrome	syndrome	PROPN
fnp-5347	21	32	,	,	PUNCT
fnp-5347	21	33	a	a	DET
fnp-5347	21	34	common	common	ADJ
fnp-5347	21	35	rasopathy	rasopathy	NOUN
fnp-5347	21	36	in	in	ADP
fnp-5347	21	37	children	child	NOUN
fnp-5347	21	38	characterized	characterize	VERB
fnp-5347	21	39	by	by	ADP
fnp-5347	21	40	short	short	ADJ
fnp-5347	21	41	height	height	NOUN
fnp-5347	21	42	,	,	PUNCT
fnp-5347	21	43	congenital	congenital	ADJ
fnp-5347	21	44	heart	heart	NOUN
fnp-5347	21	45	disease	disease	NOUN
fnp-5347	21	46	and	and	CCONJ
fnp-5347	21	47	often	often	ADV
fnp-5347	21	48	epilepsy	epilepsy	VERB
fnp-5347	21	49	,	,	PUNCT
fnp-5347	21	50	amongst	amongst	ADP
fnp-5347	21	51	many	many	ADJ
fnp-5347	21	52	other	other	ADJ
fnp-5347	21	53	clinical	clinical	ADJ
fnp-5347	21	54	features	feature	NOUN
fnp-5347	21	55	.	.	PUNCT
fnp-5347	22	1	interestingly	interestingly	ADV
fnp-5347	22	2	,	,	PUNCT
fnp-5347	22	3	ptpn11	ptpn11	NOUN
fnp-5347	22	4	variants	variant	NOUN
fnp-5347	22	5	are	be	AUX
fnp-5347	22	6	most	most	ADV
fnp-5347	22	7	commonly	commonly	ADV
fnp-5347	22	8	detectable	detectable	ADJ
fnp-5347	22	9	in	in	ADP
fnp-5347	22	10	temporal	temporal	ADJ
fnp-5347	22	11	lobe	lobe	NOUN
fnp-5347	22	12	epilepsy	epilepsy	NOUN
fnp-5347	22	13	(	(	PUNCT
fnp-5347	22	14	item	item	NOUN
fnp-5347	22	15	#	#	SYM
fnp-5347	22	16	3	3	NUM
fnp-5347	22	17	)	)	PUNCT
fnp-5347	22	18	and	and	CCONJ
fnp-5347	22	19	ganglioglioma	ganglioglioma	ADJ
fnp-5347	22	20	(	(	PUNCT
fnp-5347	22	21	gg	gg	PROPN
fnp-5347	22	22	)	)	PUNCT
fnp-5347	22	23	with	with	ADP
fnp-5347	22	24	adverse	adverse	ADJ
fnp-5347	22	25	clinical	clinical	ADJ
fnp-5347	22	26	outcome	outcome	NOUN
fnp-5347	22	27	,	,	PUNCT
fnp-5347	22	28	respectively	respectively	ADV
fnp-5347	22	29	(	(	PUNCT
fnp-5347	22	30	item	item	NOUN
fnp-5347	22	31	#	#	SYM
fnp-5347	22	32	6	6	NUM
fnp-5347	22	33	)	)	PUNCT
fnp-5347	22	34	.	.	PUNCT
fnp-5347	23	1	the	the	DET
fnp-5347	23	2	fcd	fcd	ADJ
fnp-5347	23	3	update	update	NOUN
fnp-5347	23	4	from	from	ADP
fnp-5347	23	5	2022	2022	NUM
fnp-5347	23	6	also	also	ADV
fnp-5347	23	7	introduced	introduce	VERB
fnp-5347	23	8	a	a	DET
fnp-5347	23	9	new	new	ADJ
fnp-5347	23	10	disease	disease	NOUN
fnp-5347	23	11	entity	entity	NOUN
fnp-5347	23	12	,	,	PUNCT
fnp-5347	23	13	i.e.	i.e.	X
fnp-5347	23	14	moghe	moghe	NOUN
fnp-5347	23	15	,	,	PUNCT
fnp-5347	23	16	which	which	PRON
fnp-5347	23	17	was	be	AUX
fnp-5347	23	18	a	a	DET
fnp-5347	23	19	topic	topic	NOUN
fnp-5347	23	20	of	of	ADP
fnp-5347	23	21	ongoing	ongoing	ADJ
fnp-5347	23	22	research	research	NOUN
fnp-5347	23	23	in	in	ADP
fnp-5347	23	24	2022	2022	NUM
fnp-5347	23	25	and	and	CCONJ
fnp-5347	23	26	2023	2023	NUM
fnp-5347	23	27	.	.	PUNCT
fnp-5347	24	1	herein	herein	NOUN
fnp-5347	24	2	,	,	PUNCT
fnp-5347	24	3	i	i	PRON
fnp-5347	24	4	will	will	AUX
fnp-5347	24	5	review	review	VERB
fnp-5347	24	6	the	the	DET
fnp-5347	24	7	clinical	clinical	ADJ
fnp-5347	24	8	,	,	PUNCT
fnp-5347	24	9	genetic	genetic	ADJ
fnp-5347	24	10	and	and	CCONJ
fnp-5347	24	11	histopathological	histopathological	ADJ
fnp-5347	24	12	assessments	assessment	NOUN
fnp-5347	24	13	in	in	ADP
fnp-5347	24	14	a	a	DET
fnp-5347	24	15	large	large	ADJ
fnp-5347	24	16	,	,	PUNCT
fnp-5347	24	17	international	international	ADJ
fnp-5347	24	18	cohort	cohort	NOUN
fnp-5347	24	19	of	of	ADP
fnp-5347	24	20	47	47	NUM
fnp-5347	24	21	patients	patient	NOUN
fnp-5347	24	22	with	with	ADP
fnp-5347	24	23	moghe	moghe	ADJ
fnp-5347	24	24	and	and	CCONJ
fnp-5347	24	25	slc35a2	slc35a2	NOUN
fnp-5347	24	26	mutations	mutation	NOUN
fnp-5347	24	27	(	(	PUNCT
fnp-5347	24	28	item	item	NOUN
fnp-5347	24	29	#	#	SYM
fnp-5347	24	30	4	4	NUM
fnp-5347	24	31	)	)	PUNCT
fnp-5347	24	32	.	.	PUNCT
fnp-5347	25	1	a	a	DET
fnp-5347	25	2	first	first	ADJ
fnp-5347	25	3	trial	trial	NOUN
fnp-5347	25	4	assessing	assess	VERB
fnp-5347	25	5	d	d	PROPN
fnp-5347	25	6	-	-	PUNCT
fnp-5347	25	7	galactose	galactose	ADJ
fnp-5347	25	8	supplementation	supplementation	NOUN
fnp-5347	25	9	in	in	ADP
fnp-5347	25	10	moghe	moghe	ADJ
fnp-5347	25	11	patients	patient	NOUN
fnp-5347	25	12	with	with	ADP
fnp-5347	25	13	slc35a2	slc35a2	NOUN
fnp-5347	25	14	mutations	mutation	NOUN
fnp-5347	25	15	not	not	PART
fnp-5347	25	16	being	be	AUX
fnp-5347	25	17	seizure	seizure	VERB
fnp-5347	25	18	free	free	ADJ
fnp-5347	25	19	after	after	ADP
fnp-5347	25	20	surgery	surgery	NOUN
fnp-5347	25	21	is	be	AUX
fnp-5347	25	22	the	the	DET
fnp-5347	25	23	consequential	consequential	ADJ
fnp-5347	25	24	next	next	ADJ
fnp-5347	25	25	important	important	ADJ
fnp-5347	25	26	step	step	NOUN
fnp-5347	25	27	in	in	ADP
fnp-5347	25	28	the	the	DET
fnp-5347	25	29	translation	translation	NOUN
fnp-5347	25	30	of	of	ADP
fnp-5347	25	31	our	our	PRON
fnp-5347	25	32	tissue	tissue	NOUN
fnp-5347	25	33	research	research	NOUN
fnp-5347	25	34	towards	towards	ADP
fnp-5347	25	35	the	the	DET
fnp-5347	25	36	implementation	implementation	NOUN
fnp-5347	25	37	of	of	ADP
fnp-5347	25	38	personalized	personalized	ADJ
fnp-5347	25	39	medicine	medicine	NOUN
fnp-5347	25	40	and	and	CCONJ
fnp-5347	25	41	will	will	AUX
fnp-5347	25	42	be	be	AUX
fnp-5347	25	43	covered	cover	VERB
fnp-5347	25	44	in	in	ADP
fnp-5347	25	45	the	the	DET
fnp-5347	25	46	same	same	ADJ
fnp-5347	25	47	chapter	chapter	NOUN
fnp-5347	25	48	.	.	PUNCT
fnp-5347	26	1	the	the	DET
fnp-5347	26	2	frequent	frequent	ADJ
fnp-5347	26	3	localization	localization	NOUN
fnp-5347	26	4	of	of	ADP
fnp-5347	26	5	fcd	fcd	ADJ
fnp-5347	26	6	ilae	ilae	NOUN
fnp-5347	26	7	type	type	NOUN
fnp-5347	26	8	2	2	NUM
fnp-5347	26	9	in	in	ADP
fnp-5347	26	10	the	the	DET
fnp-5347	26	11	frontal	frontal	ADJ
fnp-5347	26	12	lobe	lobe	NOUN
fnp-5347	26	13	and	and	CCONJ
fnp-5347	26	14	of	of	ADP
fnp-5347	26	15	leat	leat	NOUN
fnp-5347	26	16	in	in	ADP
fnp-5347	26	17	the	the	DET
fnp-5347	26	18	temporal	temporal	ADJ
fnp-5347	26	19	lobe	lobe	NOUN
fnp-5347	26	20	is	be	AUX
fnp-5347	26	21	another	another	DET
fnp-5347	26	22	question	question	NOUN
fnp-5347	26	23	not	not	PART
fnp-5347	26	24	yet	yet	ADV
fnp-5347	26	25	fully	fully	ADV
fnp-5347	26	26	understood	understand	VERB
fnp-5347	26	27	in	in	ADP
fnp-5347	26	28	the	the	DET
fnp-5347	26	29	current	current	ADJ
fnp-5347	26	30	literature	literature	NOUN
fnp-5347	26	31	.	.	PUNCT
fnp-5347	27	1	however	however	ADV
fnp-5347	27	2	,	,	PUNCT
fnp-5347	27	3	a	a	DET
fnp-5347	27	4	recent	recent	ADJ
fnp-5347	27	5	brain	brain	NOUN
fnp-5347	27	6	article	article	NOUN
fnp-5347	27	7	tackled	tackle	VERB
fnp-5347	27	8	this	this	DET
fnp-5347	27	9	question	question	NOUN
fnp-5347	27	10	and	and	CCONJ
fnp-5347	27	11	delivered	deliver	VERB
fnp-5347	27	12	a	a	DET
fnp-5347	27	13	fascinating	fascinating	ADJ
fnp-5347	27	14	hypothesis	hypothesis	NOUN
fnp-5347	27	15	supported	support	VERB
fnp-5347	27	16	by	by	ADP
fnp-5347	27	17	the	the	DET
fnp-5347	27	18	allan	allan	PROPN
fnp-5347	27	19	brain	brain	PROPN
fnp-5347	27	20	atlas	atlas	PROPN
fnp-5347	27	21	describing	describe	VERB
fnp-5347	27	22	region	region	NOUN
fnp-5347	27	23	-	-	PUNCT
fnp-5347	27	24	specific	specific	ADJ
fnp-5347	27	25	expression	expression	NOUN
fnp-5347	27	26	patterns	pattern	NOUN
fnp-5347	27	27	of	of	ADP
fnp-5347	27	28	the	the	DET
fnp-5347	27	29	mtor	mtor	NOUN
fnp-5347	27	30	protein	protein	NOUN
fnp-5347	27	31	to	to	PART
fnp-5347	27	32	explain	explain	VERB
fnp-5347	27	33	the	the	DET
fnp-5347	27	34	impact	impact	NOUN
fnp-5347	27	35	of	of	ADP
fnp-5347	27	36	either	either	PRON
fnp-5347	27	37	loss	loss	NOUN
fnp-5347	27	38	-	-	PUNCT
fnp-5347	27	39	of	of	ADP
fnp-5347	27	40	-	-	PUNCT
fnp-5347	27	41	function	function	NOUN
fnp-5347	27	42	or	or	CCONJ
fnp-5347	27	43	activating	activate	VERB
fnp-5347	27	44	gene	gene	NOUN
fnp-5347	27	45	mutations	mutation	NOUN
fnp-5347	27	46	in	in	ADP
fnp-5347	27	47	their	their	PRON
fnp-5347	27	48	associated	associated	ADJ
fnp-5347	27	49	signaling	signal	VERB
fnp-5347	27	50	pathways	pathway	NOUN
fnp-5347	27	51	(	(	PUNCT
fnp-5347	27	52	see	see	AUX
fnp-5347	27	53	also	also	ADV
fnp-5347	27	54	item	item	VERB
fnp-5347	27	55	#	#	SYM
fnp-5347	27	56	3	3	NUM
fnp-5347	27	57	)	)	PUNCT
fnp-5347	27	58	.	.	PUNCT
fnp-5347	28	1	temporal	temporal	ADJ
fnp-5347	28	2	lobe	lobe	PROPN
fnp-5347	28	3	epilepsy	epilepsy	NOUN
fnp-5347	28	4	remains	remain	VERB
fnp-5347	28	5	the	the	DET
fnp-5347	28	6	most	most	ADV
fnp-5347	28	7	common	common	ADJ
fnp-5347	28	8	form	form	NOUN
fnp-5347	28	9	of	of	ADP
fnp-5347	28	10	focal	focal	ADJ
fnp-5347	28	11	epilepsy	epilepsy	NOUN
fnp-5347	28	12	in	in	ADP
fnp-5347	28	13	adults	adult	NOUN
fnp-5347	28	14	and	and	CCONJ
fnp-5347	28	15	thus	thus	ADV
fnp-5347	28	16	raises	raise	VERB
fnp-5347	28	17	continuous	continuous	ADJ
fnp-5347	28	18	interest	interest	NOUN
fnp-5347	28	19	.	.	PUNCT
fnp-5347	29	1	in	in	ADP
fnp-5347	29	2	the	the	DET
fnp-5347	29	3	last	last	ADJ
fnp-5347	29	4	four	four	NUM
fnp-5347	29	5	chapters	chapter	NOUN
fnp-5347	29	6	,	,	PUNCT
fnp-5347	29	7	i	i	PRON
fnp-5347	29	8	will	will	AUX
fnp-5347	29	9	discuss	discuss	VERB
fnp-5347	29	10	a	a	DET
fnp-5347	29	11	series	series	NOUN
fnp-5347	29	12	of	of	ADP
fnp-5347	29	13	publications	publication	NOUN
fnp-5347	29	14	reporting	report	VERB
fnp-5347	29	15	expression	expression	NOUN
fnp-5347	29	16	of	of	ADP
fnp-5347	29	17	hyperphosphorylated	hyperphosphorylated	ADJ
fnp-5347	29	18	tau	tau	PROPN
fnp-5347	29	19	in	in	ADP
fnp-5347	29	20	the	the	DET
fnp-5347	29	21	epileptic	epileptic	ADJ
fnp-5347	29	22	condition	condition	NOUN
fnp-5347	29	23	as	as	ADP
fnp-5347	29	24	compared	compare	VERB
fnp-5347	29	25	to	to	ADP
fnp-5347	29	26	neurodegenerative	neurodegenerative	ADJ
fnp-5347	29	27	disorders	disorder	NOUN
fnp-5347	29	28	(	(	PUNCT
fnp-5347	29	29	chapter	chapter	NOUN
fnp-5347	29	30	#	#	SYM
fnp-5347	29	31	7	7	NUM
fnp-5347	29	32	)	)	PUNCT
fnp-5347	29	33	.	.	PUNCT
fnp-5347	30	1	the	the	DET
fnp-5347	30	2	impact	impact	NOUN
fnp-5347	30	3	of	of	ADP
fnp-5347	30	4	altered	altered	ADJ
fnp-5347	30	5	neurogenesis	neurogenesis	NOUN
fnp-5347	30	6	and	and	CCONJ
fnp-5347	30	7	gliogenesis	gliogenesis	NOUN
fnp-5347	30	8	in	in	ADP
fnp-5347	30	9	the	the	DET
fnp-5347	30	10	dentate	dentate	ADJ
fnp-5347	30	11	gyrus	gyrus	NOUN
fnp-5347	30	12	of	of	ADP
fnp-5347	30	13	the	the	DET
fnp-5347	30	14	human	human	ADJ
fnp-5347	30	15	hippocampus	hippocampus	NOUN
fnp-5347	30	16	represents	represent	VERB
fnp-5347	30	17	another	another	DET
fnp-5347	30	18	hot	hot	ADJ
fnp-5347	30	19	topic	topic	NOUN
fnp-5347	30	20	(	(	PUNCT
fnp-5347	30	21	#	#	SYM
fnp-5347	30	22	8)	8)	NUM
fnp-5347	30	23	as	as	SCONJ
fnp-5347	30	24	will	will	AUX
fnp-5347	30	25	the	the	DET
fnp-5347	30	26	impact	impact	NOUN
fnp-5347	30	27	of	of	ADP
fnp-5347	30	28	hippocampal	hippocampal	ADJ
fnp-5347	30	29	innate	innate	ADJ
fnp-5347	30	30	inflammatory	inflammatory	ADJ
fnp-5347	30	31	gliosis	gliosis	NOUN
fnp-5347	30	32	(	(	PUNCT
fnp-5347	30	33	#	#	SYM
fnp-5347	30	34	9	9	NUM
fnp-5347	30	35	)	)	PUNCT
fnp-5347	30	36	.	.	PUNCT
fnp-5347	31	1	these	these	DET
fnp-5347	31	2	papers	paper	NOUN
fnp-5347	31	3	may	may	AUX
fnp-5347	31	4	redirect	redirect	VERB
fnp-5347	31	5	our	our	PRON
fnp-5347	31	6	research	research	NOUN
fnp-5347	31	7	focus	focus	NOUN
fnp-5347	31	8	and	and	CCONJ
fnp-5347	31	9	interest	interest	NOUN
fnp-5347	31	10	on	on	ADP
fnp-5347	31	11	glial	glial	ADJ
fnp-5347	31	12	cells	cell	NOUN
fnp-5347	31	13	as	as	ADP
fnp-5347	31	14	important	important	ADJ
fnp-5347	31	15	modulators	modulator	NOUN
fnp-5347	31	16	if	if	SCONJ
fnp-5347	31	17	not	not	PART
fnp-5347	31	18	initiators	initiator	NOUN
fnp-5347	31	19	of	of	ADP
fnp-5347	31	20	epileptogenesis	epileptogenesis	NOUN
fnp-5347	31	21	in	in	ADP
fnp-5347	31	22	the	the	DET
fnp-5347	31	23	temporal	temporal	ADJ
fnp-5347	31	24	lobe	lobe	NOUN
fnp-5347	31	25	.	.	PUNCT
fnp-5347	32	1	my	my	PRON
fnp-5347	32	2	final	final	ADJ
fnp-5347	32	3	topic	topic	NOUN
fnp-5347	32	4	addresses	address	VERB
fnp-5347	32	5	neuroinflammation	neuroinflammation	NOUN
fnp-5347	32	6	and	and	CCONJ
fnp-5347	32	7	autoimmunity	autoimmunity	NOUN
fnp-5347	32	8	.	.	PUNCT
fnp-5347	33	1	the	the	DET
fnp-5347	33	2	lymphocytic	lymphocytic	ADJ
fnp-5347	33	3	and	and	CCONJ
fnp-5347	33	4	microglial	microglial	ADJ
fnp-5347	33	5	response	response	NOUN
fnp-5347	33	6	to	to	ADP
fnp-5347	33	7	inflammatory	inflammatory	ADJ
fnp-5347	33	8	pathomechanisms	pathomechanism	NOUN
fnp-5347	33	9	will	will	AUX
fnp-5347	33	10	always	always	ADV
fnp-5347	33	11	remain	remain	VERB
fnp-5347	33	12	an	an	DET
fnp-5347	33	13	important	important	ADJ
fnp-5347	33	14	topic	topic	NOUN
fnp-5347	33	15	in	in	ADP
fnp-5347	33	16	the	the	DET
fnp-5347	33	17	realm	realm	NOUN
fnp-5347	33	18	of	of	ADP
fnp-5347	33	19	focal	focal	ADJ
fnp-5347	33	20	epilepsy	epilepsy	NOUN
fnp-5347	33	21	,	,	PUNCT
fnp-5347	33	22	and	and	CCONJ
fnp-5347	33	23	i	i	PRON
fnp-5347	33	24	do	do	AUX
fnp-5347	33	25	hope	hope	VERB
fnp-5347	33	26	that	that	SCONJ
fnp-5347	33	27	my	my	PRON
fnp-5347	33	28	update	update	NOUN
fnp-5347	33	29	will	will	AUX
fnp-5347	33	30	stimulate	stimulate	VERB
fnp-5347	33	31	the	the	DET
fnp-5347	33	32	readers	reader	NOUN
fnp-5347	33	33	'	'	PART
fnp-5347	33	34	interest	interest	NOUN
fnp-5347	33	35	in	in	ADP
fnp-5347	33	36	this	this	DET
fnp-5347	33	37	field	field	NOUN
fnp-5347	33	38	.	.	PUNCT
fnp-5347	34	1	table	table	NOUN
fnp-5347	34	2	1	1	NUM
fnp-5347	34	3	:	:	PUNCT
fnp-5347	34	4	top	top	ADJ
fnp-5347	34	5	10	10	NUM
fnp-5347	34	6	publications	publication	NOUN
fnp-5347	34	7	and	and	CCONJ
fnp-5347	34	8	topics	topic	NOUN
fnp-5347	34	9	to	to	PART
fnp-5347	34	10	be	be	AUX
fnp-5347	34	11	discussed	discuss	VERB
fnp-5347	34	12	in	in	ADP
fnp-5347	34	13	this	this	DET
fnp-5347	34	14	update	update	NOUN
fnp-5347	34	15	topic	topic	NOUN
fnp-5347	34	16	title	title	NOUN
fnp-5347	34	17	major	major	ADJ
fnp-5347	34	18	reference(s	reference(s	NOUN
fnp-5347	34	19	)	)	PUNCT
fnp-5347	34	20	#	#	SYM
fnp-5347	34	21	1	1	NUM
fnp-5347	34	22	ai	ai	NOUN
fnp-5347	34	23	-	-	PUNCT
fnp-5347	34	24	based	base	VERB
fnp-5347	34	25	classification	classification	NOUN
fnp-5347	34	26	of	of	ADP
fnp-5347	34	27	focal	focal	ADJ
fnp-5347	34	28	cortical	cortical	ADJ
fnp-5347	34	29	dysplasia	dysplasia	NOUN
fnp-5347	34	30	(	(	PUNCT
fnp-5347	34	31	fcd	fcd	PROPN
fnp-5347	34	32	)	)	PUNCT
fnp-5347	35	1	[	[	X
fnp-5347	35	2	43	43	NUM
fnp-5347	35	3	]	]	X
fnp-5347	36	1	[	[	X
fnp-5347	36	2	24	24	NUM
fnp-5347	36	3	]	]	PUNCT
fnp-5347	36	4	#	#	SYM
fnp-5347	36	5	2	2	NUM
fnp-5347	36	6	the	the	DET
fnp-5347	36	7	genomic	genomic	ADJ
fnp-5347	36	8	landscape	landscape	NOUN
fnp-5347	36	9	of	of	ADP
fnp-5347	36	10	epileptogenic	epileptogenic	ADJ
fnp-5347	36	11	brain	brain	NOUN
fnp-5347	36	12	lesions	lesion	NOUN
fnp-5347	36	13	[	[	X
fnp-5347	36	14	30	30	NUM
fnp-5347	36	15	]	]	X
fnp-5347	37	1	[	[	X
fnp-5347	37	2	13	13	NUM
fnp-5347	37	3	]	]	X
fnp-5347	37	4	[	[	X
fnp-5347	37	5	7	7	X
fnp-5347	37	6	]	]	SYM
fnp-5347	37	7	#	#	SYM
fnp-5347	37	8	3	3	NUM
fnp-5347	37	9	a	a	DET
fnp-5347	37	10	new	new	ADJ
fnp-5347	37	11	hypothesis	hypothesis	NOUN
fnp-5347	37	12	about	about	ADP
fnp-5347	37	13	regional	regional	ADJ
fnp-5347	37	14	mtor	mtor	NOUN
fnp-5347	37	15	gene	gene	NOUN
fnp-5347	37	16	variant	variant	ADJ
fnp-5347	37	17	accumulation	accumulation	NOUN
fnp-5347	37	18	in	in	ADP
fnp-5347	37	19	the	the	DET
fnp-5347	37	20	frontal	frontal	ADJ
fnp-5347	37	21	lobe	lobe	NOUN
fnp-5347	37	22	and	and	CCONJ
fnp-5347	37	23	map	map	NOUN
fnp-5347	37	24	-	-	PUNCT
fnp-5347	37	25	kinase	kinase	ADJ
fnp-5347	37	26	gene	gene	NOUN
fnp-5347	37	27	variant	variant	NOUN
fnp-5347	37	28	accumulation	accumulation	NOUN
fnp-5347	37	29	in	in	ADP
fnp-5347	37	30	the	the	DET
fnp-5347	37	31	temporal	temporal	ADJ
fnp-5347	37	32	lobe	lobe	NOUN
fnp-5347	37	33	[	[	X
fnp-5347	37	34	26	26	NUM
fnp-5347	37	35	]	]	X
fnp-5347	38	1	[	[	X
fnp-5347	38	2	31	31	NUM
fnp-5347	38	3	]	]	SYM
fnp-5347	38	4	#	#	SYM
fnp-5347	38	5	4	4	NUM
fnp-5347	38	6	new	new	ADJ
fnp-5347	38	7	disease	disease	NOUN
fnp-5347	38	8	entities	entity	NOUN
fnp-5347	38	9	:	:	PUNCT
fnp-5347	38	10	i.	i.	PROPN
fnp-5347	38	11	moghe	moghe	NOUN
fnp-5347	39	1	[	[	X
fnp-5347	39	2	6	6	NUM
fnp-5347	39	3	]	]	PUNCT
fnp-5347	39	4	[	[	X
fnp-5347	39	5	1	1	NUM
fnp-5347	39	6	]	]	PUNCT
fnp-5347	39	7	#	#	SYM
fnp-5347	39	8	5	5	NUM
fnp-5347	39	9	new	new	ADJ
fnp-5347	39	10	disease	disease	NOUN
fnp-5347	39	11	entities	entity	NOUN
fnp-5347	39	12	:	:	PUNCT
fnp-5347	39	13	ii	ii	X
fnp-5347	39	14	.	.	PUNCT
fnp-5347	40	1	encephaloceles	encephalocele	NOUN
fnp-5347	41	1	[	[	X
fnp-5347	41	2	16	16	NUM
fnp-5347	41	3	]	]	X
fnp-5347	42	1	[	[	X
fnp-5347	42	2	4	4	NUM
fnp-5347	42	3	]	]	SYM
fnp-5347	42	4	#	#	SYM
fnp-5347	42	5	6	6	NUM
fnp-5347	42	6	what	what	PRON
fnp-5347	42	7	did	do	AUX
fnp-5347	42	8	we	we	PRON
fnp-5347	42	9	learn	learn	VERB
fnp-5347	42	10	in	in	ADP
fnp-5347	42	11	2022	2022	NUM
fnp-5347	42	12	and	and	CCONJ
fnp-5347	42	13	2023	2023	NUM
fnp-5347	42	14	about	about	ADP
fnp-5347	42	15	low	low	ADJ
fnp-5347	42	16	-	-	PUNCT
fnp-5347	42	17	grade	grade	NOUN
fnp-5347	42	18	,	,	PUNCT
fnp-5347	42	19	epilepsy	epilepsy	NOUN
fnp-5347	42	20	-	-	PUNCT
fnp-5347	42	21	associated	associate	VERB
fnp-5347	42	22	brain	brain	NOUN
fnp-5347	42	23	tumors	tumor	NOUN
fnp-5347	42	24	(	(	PUNCT
fnp-5347	42	25	leat	leat	NOUN
fnp-5347	42	26	)	)	PUNCT
fnp-5347	43	1	[	[	X
fnp-5347	43	2	21	21	NUM
fnp-5347	43	3	]	]	X
fnp-5347	44	1	[	[	X
fnp-5347	44	2	40	40	NUM
fnp-5347	44	3	]	]	PUNCT
fnp-5347	44	4	[	[	X
fnp-5347	44	5	35	35	NUM
fnp-5347	44	6	]	]	SYM
fnp-5347	44	7	#	#	SYM
fnp-5347	44	8	7	7	NUM
fnp-5347	44	9	tauopathies	tauopathie	NOUN
fnp-5347	44	10	in	in	ADP
fnp-5347	44	11	mesial	mesial	ADJ
fnp-5347	44	12	temporal	temporal	ADJ
fnp-5347	44	13	lobe	lobe	NOUN
fnp-5347	44	14	epilepsy	epilepsy	NOUN
fnp-5347	44	15	(	(	PUNCT
fnp-5347	44	16	mtle	mtle	NOUN
fnp-5347	44	17	)	)	PUNCT
fnp-5347	45	1	[	[	X
fnp-5347	45	2	46	46	NUM
fnp-5347	45	3	]	]	X
fnp-5347	46	1	[	[	X
fnp-5347	46	2	14	14	NUM
fnp-5347	46	3	]	]	X
fnp-5347	47	1	[	[	X
fnp-5347	47	2	3	3	NUM
fnp-5347	47	3	]	]	SYM
fnp-5347	47	4	#	#	SYM
fnp-5347	47	5	8	8	NUM
fnp-5347	47	6	'	'	NUM
fnp-5347	47	7	hippocampal	hippocampal	ADJ
fnp-5347	47	8	innate	innate	ADJ
fnp-5347	47	9	inflammatory	inflammatory	ADJ
fnp-5347	47	10	gliosis	gliosis	NOUN
fnp-5347	47	11	only	only	ADV
fnp-5347	47	12	'	'	PUNCT
fnp-5347	47	13	in	in	ADP
fnp-5347	47	14	pharmacoresistant	pharmacoresistant	ADJ
fnp-5347	47	15	temporal	temporal	ADJ
fnp-5347	47	16	lobe	lobe	NOUN
fnp-5347	47	17	epilepsy	epilepsy	NOUN
fnp-5347	47	18	(	(	PUNCT
fnp-5347	47	19	tle	tle	ADJ
fnp-5347	47	20	)	)	PUNCT
fnp-5347	48	1	[	[	X
fnp-5347	48	2	19	19	NUM
fnp-5347	48	3	]	]	SYM
fnp-5347	48	4	#	#	SYM
fnp-5347	48	5	9	9	NUM
fnp-5347	48	6	altered	alter	VERB
fnp-5347	48	7	adult	adult	NOUN
fnp-5347	48	8	neurogenesis	neurogenesis	NOUN
fnp-5347	48	9	and	and	CCONJ
fnp-5347	48	10	gliogenesis	gliogenesis	NOUN
fnp-5347	48	11	in	in	ADP
fnp-5347	48	12	patients	patient	NOUN
fnp-5347	48	13	with	with	ADP
fnp-5347	48	14	mesial	mesial	ADJ
fnp-5347	48	15	tle	tle	NOUN
fnp-5347	48	16	[	[	X
fnp-5347	48	17	2	2	NUM
fnp-5347	48	18	]	]	SYM
fnp-5347	48	19	#	#	SYM
fnp-5347	48	20	10	10	NUM
fnp-5347	48	21	autoimmune	autoimmune	ADJ
fnp-5347	48	22	encephalitis	encephalitis	NOUN
fnp-5347	48	23	and	and	CCONJ
fnp-5347	48	24	new	new	ADJ
fnp-5347	48	25	-	-	PUNCT
fnp-5347	48	26	onset	onset	NOUN
fnp-5347	48	27	refractory	refractory	NOUN
fnp-5347	48	28	status	status	NOUN
fnp-5347	48	29	epilepticus	epilepticus	NOUN
fnp-5347	48	30	(	(	PUNCT
fnp-5347	48	31	norse	norse	PROPN
fnp-5347	48	32	)	)	PUNCT
fnp-5347	49	1	[	[	X
fnp-5347	49	2	41	41	NUM
fnp-5347	49	3	]	]	X
fnp-5347	50	1	[	[	X
fnp-5347	50	2	8	8	NUM
fnp-5347	50	3	]	]	X
fnp-5347	50	4	[	[	X
fnp-5347	50	5	20	20	NUM
fnp-5347	50	6	]	]	PUNCT
fnp-5347	50	7	topic	topic	NOUN
fnp-5347	50	8	1	1	NUM
fnp-5347	50	9	:	:	PUNCT
fnp-5347	50	10	which	which	DET
fnp-5347	50	11	topic	topic	NOUN
fnp-5347	50	12	was	be	AUX
fnp-5347	50	13	missing	miss	VERB
fnp-5347	50	14	in	in	ADP
fnp-5347	50	15	the	the	DET
fnp-5347	50	16	2022	2022	NUM
fnp-5347	50	17	update	update	NOUN
fnp-5347	50	18	?	?	PUNCT
fnp-5347	51	1	ai	ai	VERB
fnp-5347	51	2	-	-	PUNCT
fnp-5347	51	3	supplemented	supplement	VERB
fnp-5347	51	4	applications	application	NOUN
fnp-5347	51	5	for	for	ADP
fnp-5347	51	6	routine	routine	ADJ
fnp-5347	51	7	histopathology	histopathology	NOUN
fnp-5347	51	8	review	review	NOUN
fnp-5347	51	9	and	and	CCONJ
fnp-5347	51	10	diagnosis	diagnosis	NOUN
fnp-5347	51	11	may	may	AUX
fnp-5347	51	12	be	be	AUX
fnp-5347	51	13	seen	see	VERB
fnp-5347	51	14	as	as	ADP
fnp-5347	51	15	the	the	DET
fnp-5347	51	16	next	next	ADJ
fnp-5347	51	17	era	era	NOUN
fnp-5347	51	18	in	in	ADP
fnp-5347	51	19	neuropathology	neuropathology	NOUN
fnp-5347	51	20	.	.	PUNCT
fnp-5347	52	1	however	however	ADV
fnp-5347	52	2	,	,	PUNCT
fnp-5347	52	3	ai	ai	INTJ
fnp-5347	52	4	has	have	AUX
fnp-5347	52	5	not	not	PART
fnp-5347	52	6	been	be	AUX
fnp-5347	52	7	used	use	VERB
fnp-5347	52	8	in	in	ADP
fnp-5347	52	9	the	the	DET
fnp-5347	52	10	arena	arena	NOUN
fnp-5347	52	11	of	of	ADP
fnp-5347	52	12	epilepsy	epilepsy	NOUN
fnp-5347	52	13	surgery	surgery	NOUN
fnp-5347	52	14	yet	yet	ADV
fnp-5347	52	15	and	and	CCONJ
fnp-5347	52	16	this	this	PRON
fnp-5347	52	17	was	be	AUX
fnp-5347	52	18	identified	identify	VERB
fnp-5347	52	19	as	as	ADP
fnp-5347	52	20	a	a	DET
fnp-5347	52	21	missing	miss	VERB
fnp-5347	52	22	topic	topic	NOUN
fnp-5347	52	23	in	in	ADP
fnp-5347	52	24	my	my	PRON
fnp-5347	52	25	2022	2022	NUM
fnp-5347	52	26	update	update	NOUN
fnp-5347	52	27	review	review	NOUN
fnp-5347	52	28	article	article	NOUN
fnp-5347	52	29	[	[	X
fnp-5347	52	30	9	9	NUM
fnp-5347	52	31	]	]	PUNCT
fnp-5347	52	32	.	.	PUNCT
fnp-5347	53	1	such	such	DET
fnp-5347	53	2	a	a	DET
fnp-5347	53	3	deep	deep	ADV
fnp-5347	53	4	-	-	PUNCT
fnp-5347	53	5	learning	learn	VERB
fnp-5347	53	6	based	base	VERB
fnp-5347	53	7	classifier	classifier	NOUN
fnp-5347	53	8	for	for	ADP
fnp-5347	53	9	fcd	fcd	NOUN
fnp-5347	53	10	was	be	AUX
fnp-5347	53	11	published	publish	VERB
fnp-5347	53	12	in	in	ADP
fnp-5347	53	13	2023	2023	NUM
fnp-5347	53	14	[	[	X
fnp-5347	53	15	43	43	NUM
fnp-5347	53	16	]	]	PUNCT
fnp-5347	53	17	and	and	CCONJ
fnp-5347	53	18	claimed	claim	VERB
fnp-5347	53	19	to	to	PART
fnp-5347	53	20	recognize	recognize	VERB
fnp-5347	53	21	most	most	ADJ
fnp-5347	53	22	of	of	ADP
fnp-5347	53	23	the	the	DET
fnp-5347	53	24	diagnostic	diagnostic	ADJ
fnp-5347	53	25	entities	entity	NOUN
fnp-5347	53	26	defined	define	VERB
fnp-5347	53	27	in	in	ADP
fnp-5347	53	28	the	the	DET
fnp-5347	53	29	2022	2022	NUM
fnp-5347	53	30	fcd	fcd	ADJ
fnp-5347	53	31	classification	classification	NOUN
fnp-5347	53	32	update	update	NOUN
fnp-5347	53	33	[	[	X
fnp-5347	53	34	33	33	NUM
fnp-5347	53	35	]	]	PUNCT
fnp-5347	53	36	.	.	PUNCT
fnp-5347	54	1	the	the	DET
fnp-5347	54	2	resnet18	resnet18	NOUN
fnp-5347	54	3	deep	deep	ADV
fnp-5347	54	4	-	-	PUNCT
fnp-5347	54	5	learning	learn	VERB
fnp-5347	54	6	algorithm	algorithm	NOUN
fnp-5347	54	7	was	be	AUX
fnp-5347	54	8	trained	train	VERB
fnp-5347	54	9	with	with	ADP
fnp-5347	54	10	extraordinarily	extraordinarily	ADV
fnp-5347	54	11	large	large	ADJ
fnp-5347	54	12	1000	1000	NUM
fnp-5347	54	13	 	 	SPACE
fnp-5347	54	14	x	x	NOUN
fnp-5347	54	15	 	 	SPACE
fnp-5347	54	16	1000	1000	NUM
fnp-5347	54	17	 	 	SPACE
fnp-5347	54	18	µm	µm	ADP
fnp-5347	54	19	digital	digital	ADJ
fnp-5347	54	20	tiles	tile	NOUN
fnp-5347	54	21	automatically	automatically	ADV
fnp-5347	54	22	extracted	extract	VERB
fnp-5347	54	23	from	from	ADP
fnp-5347	54	24	whole	whole	ADJ
fnp-5347	54	25	slide	slide	NOUN
fnp-5347	54	26	images	image	NOUN
fnp-5347	54	27	(	(	PUNCT
fnp-5347	54	28	wsi	wsi	NOUN
fnp-5347	54	29	)	)	PUNCT
fnp-5347	54	30	of	of	ADP
fnp-5347	54	31	414	414	NUM
fnp-5347	54	32	manually	manually	ADV
fnp-5347	54	33	annotated	annotate	VERB
fnp-5347	54	34	,	,	PUNCT
fnp-5347	54	35	h&e	h&e	PROPN
fnp-5347	54	36	stained	stain	VERB
fnp-5347	54	37	of	of	ADP
fnp-5347	54	38	fcd1a	fcd1a	PROPN
fnp-5347	54	39	,	,	PUNCT
fnp-5347	54	40	fcd2a	fcd2a	PROPN
fnp-5347	54	41	,	,	PUNCT
fnp-5347	54	42	fcd2b	fcd2b	PROPN
fnp-5347	54	43	,	,	PUNCT
fnp-5347	54	44	mmcd	mmcd	NOUN
fnp-5347	54	45	and	and	CCONJ
fnp-5347	54	46	moghe	moghe	VERB
fnp-5347	54	47	samples	sample	NOUN
fnp-5347	54	48	(	(	PUNCT
fnp-5347	54	49	figure	figure	NOUN
fnp-5347	54	50	1	1	NUM
fnp-5347	54	51	)	)	PUNCT
fnp-5347	54	52	.	.	PUNCT
fnp-5347	55	1	these	these	PRON
fnp-5347	55	2	were	be	AUX
fnp-5347	55	3	similarly	similarly	ADV
fnp-5347	55	4	processed	process	VERB
fnp-5347	55	5	to	to	ADP
fnp-5347	55	6	a	a	DET
fnp-5347	55	7	series	series	NOUN
fnp-5347	55	8	of	of	ADP
fnp-5347	55	9	198	198	NUM
fnp-5347	55	10	postmortem	postmortem	NOUN
fnp-5347	55	11	tissue	tissue	NOUN
fnp-5347	55	12	blocks	block	NOUN
fnp-5347	55	13	from	from	ADP
fnp-5347	55	14	59	59	NUM
fnp-5347	55	15	patients	patient	NOUN
fnp-5347	55	16	without	without	ADP
fnp-5347	55	17	neurological	neurological	ADJ
fnp-5347	55	18	disorders	disorder	NOUN
fnp-5347	55	19	including	include	VERB
fnp-5347	55	20	homotypic	homotypic	ADJ
fnp-5347	55	21	frontal	frontal	ADJ
fnp-5347	55	22	,	,	PUNCT
fnp-5347	55	23	temporal	temporal	ADJ
fnp-5347	55	24	and	and	CCONJ
fnp-5347	55	25	occipital	occipital	ADJ
fnp-5347	55	26	areas	area	NOUN
fnp-5347	55	27	and	and	CCONJ
fnp-5347	55	28	heterotypic	heterotypic	NOUN
fnp-5347	55	29	brodmann	brodmann	NOUN
fnp-5347	55	30	areas	area	NOUN
fnp-5347	55	31	4	4	NUM
fnp-5347	55	32	and	and	CCONJ
fnp-5347	55	33	17	17	NUM
fnp-5347	55	34	,	,	PUNCT
fnp-5347	55	35	entorhinal	entorhinal	ADJ
fnp-5347	55	36	cortex	cortex	NOUN
fnp-5347	55	37	and	and	CCONJ
fnp-5347	55	38	dentate	dentate	ADJ
fnp-5347	55	39	gyrus	gyru	NOUN
fnp-5347	55	40	.	.	PUNCT
fnp-5347	56	1	overall	overall	ADV
fnp-5347	56	2	,	,	PUNCT
fnp-5347	56	3	the	the	DET
fnp-5347	56	4	algorithm	algorithm	NOUN
fnp-5347	56	5	's	's	PART
fnp-5347	56	6	accuracy	accuracy	NOUN
fnp-5347	56	7	was	be	AUX
fnp-5347	56	8	specified	specify	VERB
fnp-5347	56	9	as	as	ADP
fnp-5347	56	10	98.8	98.8	NUM
fnp-5347	56	11	 	 	SPACE
fnp-5347	56	12	%	%	NOUN
fnp-5347	56	13	(	(	PUNCT
fnp-5347	56	14	f1	f1	NOUN
fnp-5347	56	15	score	score	NOUN
fnp-5347	56	16	 	 	SPACE
fnp-5347	56	17	=	=	NOUN
fnp-5347	56	18	 	 	SPACE
fnp-5347	56	19	0.82	0.82	NUM
fnp-5347	56	20	)	)	PUNCT
fnp-5347	56	21	in	in	ADP
fnp-5347	56	22	detecting	detect	VERB
fnp-5347	56	23	25	25	NUM
fnp-5347	56	24	different	different	ADJ
fnp-5347	56	25	anatomical	anatomical	ADJ
fnp-5347	56	26	regions	region	NOUN
fnp-5347	56	27	and	and	CCONJ
fnp-5347	56	28	fcd	fcd	ADJ
fnp-5347	56	29	categories	category	NOUN
fnp-5347	56	30	.	.	PUNCT
fnp-5347	57	1	the	the	DET
fnp-5347	57	2	classifier	classifier	NOUN
fnp-5347	57	3	was	be	AUX
fnp-5347	57	4	also	also	ADV
fnp-5347	57	5	made	make	VERB
fnp-5347	57	6	temporarily	temporarily	ADV
fnp-5347	57	7	available	available	ADJ
fnp-5347	57	8	as	as	ADP
fnp-5347	57	9	an	an	DET
fnp-5347	57	10	open	open	ADJ
fnp-5347	57	11	access	access	NOUN
fnp-5347	57	12	web	web	NOUN
fnp-5347	57	13	application	application	NOUN
fnp-5347	57	14	.	.	PUNCT
fnp-5347	58	1	figure	figure	NOUN
fnp-5347	58	2	1	1	NUM
fnp-5347	58	3	:	:	PUNCT
fnp-5347	58	4	evaluation	evaluation	NOUN
fnp-5347	58	5	and	and	CCONJ
fnp-5347	58	6	visualization	visualization	NOUN
fnp-5347	58	7	of	of	ADP
fnp-5347	58	8	a	a	DET
fnp-5347	58	9	complete	complete	ADJ
fnp-5347	58	10	wsi	wsi	NOUN
fnp-5347	58	11	slide	slide	NOUN
fnp-5347	58	12	obtained	obtain	VERB
fnp-5347	58	13	from	from	ADP
fnp-5347	58	14	epilepsy	epilepsy	ADJ
fnp-5347	58	15	surgery	surgery	NOUN
fnp-5347	58	16	figure	figure	NOUN
fnp-5347	58	17	1	1	NUM
fnp-5347	58	18	.	.	PUNCT
fnp-5347	59	1	a	a	X
fnp-5347	59	2	:	:	PUNCT
fnp-5347	59	3	this	this	PRON
fnp-5347	59	4	is	be	AUX
fnp-5347	59	5	an	an	DET
fnp-5347	59	6	example	example	NOUN
fnp-5347	59	7	of	of	ADP
fnp-5347	59	8	the	the	DET
fnp-5347	59	9	dl	dl	PROPN
fnp-5347	59	10	-	-	PUNCT
fnp-5347	59	11	based	base	VERB
fnp-5347	59	12	fcd	fcd	ADJ
fnp-5347	59	13	classifier	classifier	NOUN
fnp-5347	59	14	output	output	NOUN
fnp-5347	59	15	as	as	SCONJ
fnp-5347	59	16	published	publish	VERB
fnp-5347	59	17	by	by	ADP
fnp-5347	59	18	vorndran	vorndran	NOUN
fnp-5347	59	19	et	et	PROPN
fnp-5347	59	20	al	al	PROPN
fnp-5347	59	21	.	.	PUNCT
fnp-5347	60	1	a	a	DET
fnp-5347	60	2	digital	digital	ADJ
fnp-5347	60	3	slide	slide	NOUN
fnp-5347	60	4	(	(	PUNCT
fnp-5347	60	5	visible	visible	ADJ
fnp-5347	60	6	in	in	ADP
fnp-5347	60	7	grey	grey	NOUN
fnp-5347	60	8	in	in	ADP
fnp-5347	60	9	the	the	DET
fnp-5347	60	10	background	background	NOUN
fnp-5347	60	11	)	)	PUNCT
fnp-5347	60	12	was	be	AUX
fnp-5347	60	13	automatically	automatically	ADV
fnp-5347	60	14	segmented	segment	VERB
fnp-5347	60	15	into	into	ADP
fnp-5347	60	16	a	a	DET
fnp-5347	60	17	grid	grid	NOUN
fnp-5347	60	18	of	of	ADP
fnp-5347	60	19	tiles	tile	NOUN
fnp-5347	60	20	each	each	PRON
fnp-5347	60	21	measuring	measure	VERB
fnp-5347	60	22	1000	1000	NUM
fnp-5347	60	23	 	 	SPACE
fnp-5347	60	24	x	x	NOUN
fnp-5347	60	25	 	 	SPACE
fnp-5347	60	26	1000	1000	NUM
fnp-5347	60	27	 	 	SPACE
fnp-5347	60	28	µm	µm	NOUN
fnp-5347	60	29	.	.	PUNCT
fnp-5347	61	1	all	all	DET
fnp-5347	61	2	tiles	tile	NOUN
fnp-5347	61	3	reaching	reach	VERB
fnp-5347	61	4	the	the	DET
fnp-5347	61	5	predefined	predefine	VERB
fnp-5347	61	6	confidence	confidence	NOUN
fnp-5347	61	7	threshold	threshold	NOUN
fnp-5347	61	8	(	(	PUNCT
fnp-5347	61	9	herein	herein	NOUN
fnp-5347	61	10	 	 	SPACE
fnp-5347	61	11	=	=	NOUN
fnp-5347	61	12	 	 	SPACE
fnp-5347	61	13	>	>	X
fnp-5347	61	14	 	 	SPACE
fnp-5347	61	15	0.9	0.9	NUM
fnp-5347	61	16	)	)	PUNCT
fnp-5347	61	17	can	can	AUX
fnp-5347	61	18	be	be	AUX
fnp-5347	61	19	visualized	visualize	VERB
fnp-5347	61	20	by	by	ADP
fnp-5347	61	21	a	a	DET
fnp-5347	61	22	color	color	NOUN
fnp-5347	61	23	-	-	PUNCT
fnp-5347	61	24	index	index	NOUN
fnp-5347	61	25	map	map	NOUN
fnp-5347	61	26	,	,	PUNCT
fnp-5347	61	27	e.g.	e.g.	ADV
fnp-5347	61	28	,	,	PUNCT
fnp-5347	61	29	purple	purple	ADJ
fnp-5347	61	30	or	or	CCONJ
fnp-5347	61	31	yellow	yellow	ADJ
fnp-5347	61	32	.	.	PUNCT
fnp-5347	62	1	summary	summary	NOUN
fnp-5347	62	2	values	value	NOUN
fnp-5347	62	3	were	be	AUX
fnp-5347	62	4	also	also	ADV
fnp-5347	62	5	given	give	VERB
fnp-5347	62	6	on	on	ADP
fnp-5347	62	7	the	the	DET
fnp-5347	62	8	upper	upper	ADJ
fnp-5347	62	9	left	left	ADJ
fnp-5347	62	10	corner	corner	NOUN
fnp-5347	62	11	of	of	ADP
fnp-5347	62	12	the	the	DET
fnp-5347	62	13	output	output	NOUN
fnp-5347	62	14	screen	screen	NOUN
fnp-5347	62	15	.	.	PUNCT
fnp-5347	63	1	b	b	X
fnp-5347	63	2	:	:	PUNCT
fnp-5347	63	3	a	a	DET
fnp-5347	63	4	blurring	blur	VERB
fnp-5347	63	5	image	image	NOUN
fnp-5347	63	6	filter	filter	NOUN
fnp-5347	63	7	is	be	AUX
fnp-5347	63	8	applied	apply	VERB
fnp-5347	63	9	for	for	ADP
fnp-5347	63	10	the	the	DET
fnp-5347	63	11	final	final	ADJ
fnp-5347	63	12	output	output	NOUN
fnp-5347	63	13	image	image	NOUN
fnp-5347	63	14	hiding	hide	VERB
fnp-5347	63	15	all	all	DET
fnp-5347	63	16	information	information	NOUN
fnp-5347	63	17	shown	show	VERB
fnp-5347	63	18	in	in	ADP
fnp-5347	63	19	a.	a.	NOUN
fnp-5347	63	20	please	please	INTJ
fnp-5347	63	21	note	note	VERB
fnp-5347	63	22	that	that	SCONJ
fnp-5347	63	23	the	the	DET
fnp-5347	63	24	user	user	NOUN
fnp-5347	63	25	can	can	AUX
fnp-5347	63	26	choose	choose	VERB
fnp-5347	63	27	which	which	PRON
fnp-5347	63	28	of	of	ADP
fnp-5347	63	29	the	the	DET
fnp-5347	63	30	available	available	ADJ
fnp-5347	63	31	and	and	CCONJ
fnp-5347	63	32	trained	train	VERB
fnp-5347	63	33	fcd	fcd	ADJ
fnp-5347	63	34	categories	category	NOUN
fnp-5347	63	35	should	should	AUX
fnp-5347	63	36	be	be	AUX
fnp-5347	63	37	displayed	display	VERB
fnp-5347	63	38	.	.	PUNCT
fnp-5347	64	1	in	in	ADP
fnp-5347	64	2	this	this	DET
fnp-5347	64	3	example	example	NOUN
fnp-5347	64	4	,	,	PUNCT
fnp-5347	64	5	it	it	PRON
fnp-5347	64	6	is	be	AUX
fnp-5347	64	7	only	only	ADV
fnp-5347	64	8	fcd1a	fcd1a	PROPN
fnp-5347	64	9	and	and	CCONJ
fnp-5347	64	10	white	white	ADJ
fnp-5347	64	11	matter	matter	NOUN
fnp-5347	64	12	(	(	PUNCT
fnp-5347	64	13	wm	wm	PROPN
fnp-5347	64	14	)	)	PUNCT
fnp-5347	64	15	.	.	PUNCT
fnp-5347	65	1	the	the	DET
fnp-5347	65	2	sample	sample	NOUN
fnp-5347	65	3	was	be	AUX
fnp-5347	65	4	taken	take	VERB
fnp-5347	65	5	from	from	ADP
fnp-5347	65	6	a	a	DET
fnp-5347	65	7	patient	patient	NOUN
fnp-5347	65	8	with	with	ADP
fnp-5347	65	9	histopathologically	histopathologically	ADV
fnp-5347	65	10	classified	classified	ADJ
fnp-5347	65	11	fcd1a	fcd1a	PROPN
fnp-5347	66	1	[	[	X
fnp-5347	66	2	22	22	NUM
fnp-5347	66	3	]	]	PUNCT
fnp-5347	66	4	.	.	PUNCT
fnp-5347	67	1	c	c	X
fnp-5347	67	2	:	:	PUNCT
fnp-5347	67	3	a	a	DET
fnp-5347	67	4	validation	validation	NOUN
fnp-5347	67	5	case	case	NOUN
fnp-5347	67	6	example	example	NOUN
fnp-5347	67	7	of	of	ADP
fnp-5347	67	8	a	a	DET
fnp-5347	67	9	wsi	wsi	NOUN
fnp-5347	67	10	obtained	obtain	VERB
fnp-5347	67	11	from	from	ADP
fnp-5347	67	12	a	a	DET
fnp-5347	67	13	patient	patient	NOUN
fnp-5347	67	14	with	with	ADP
fnp-5347	67	15	histopathologically	histopathologically	ADV
fnp-5347	67	16	confirmed	confirm	VERB
fnp-5347	67	17	fcd2b	fcd2b	PROPN
fnp-5347	67	18	and	and	CCONJ
fnp-5347	67	19	genetically	genetically	ADV
fnp-5347	67	20	confirmed	confirm	VERB
fnp-5347	67	21	pathogenic	pathogenic	ADJ
fnp-5347	67	22	mtor	mtor	NOUN
fnp-5347	67	23	mosaicism	mosaicism	NOUN
fnp-5347	67	24	.	.	PUNCT
fnp-5347	68	1	the	the	DET
fnp-5347	68	2	lesion	lesion	NOUN
fnp-5347	68	3	was	be	AUX
fnp-5347	68	4	detected	detect	VERB
fnp-5347	68	5	and	and	CCONJ
fnp-5347	68	6	colored	color	VERB
fnp-5347	68	7	in	in	ADP
fnp-5347	68	8	dark	dark	ADJ
fnp-5347	68	9	blue	blue	NOUN
fnp-5347	68	10	for	for	ADP
fnp-5347	68	11	areas	area	NOUN
fnp-5347	68	12	classified	classify	VERB
fnp-5347	68	13	as	as	ADP
fnp-5347	68	14	fcd2b	fcd2b	PROPN
fnp-5347	68	15	,	,	PUNCT
fnp-5347	68	16	light	light	ADJ
fnp-5347	68	17	blue	blue	NOUN
fnp-5347	68	18	for	for	ADP
fnp-5347	68	19	neocortex	neocortex	NOUN
fnp-5347	68	20	associated	associate	VERB
fnp-5347	68	21	with	with	ADP
fnp-5347	68	22	fcd2b	fcd2b	PROPN
fnp-5347	68	23	,	,	PUNCT
fnp-5347	68	24	yellow	yellow	ADJ
fnp-5347	68	25	for	for	ADP
fnp-5347	68	26	white	white	ADJ
fnp-5347	68	27	matter	matter	NOUN
fnp-5347	68	28	associated	associate	VERB
fnp-5347	68	29	with	with	ADP
fnp-5347	68	30	fcd2b	fcd2b	PROPN
fnp-5347	68	31	.	.	PUNCT
fnp-5347	69	1	however	however	ADV
fnp-5347	69	2	,	,	PUNCT
fnp-5347	69	3	there	there	PRON
fnp-5347	69	4	were	be	VERB
fnp-5347	69	5	also	also	ADV
fnp-5347	69	6	areas	area	NOUN
fnp-5347	69	7	recognized	recognize	VERB
fnp-5347	69	8	by	by	ADP
fnp-5347	69	9	the	the	DET
fnp-5347	69	10	algorithm	algorithm	NOUN
fnp-5347	69	11	as	as	ADP
fnp-5347	69	12	fcd2a	fcd2a	PROPN
fnp-5347	69	13	(	(	PUNCT
fnp-5347	69	14	x	x	SYM
fnp-5347	69	15	light	light	ADJ
fnp-5347	69	16	purple	purple	NOUN
fnp-5347	69	17	)	)	PUNCT
fnp-5347	69	18	and	and	CCONJ
fnp-5347	69	19	moghe	moghe	NOUN
fnp-5347	69	20	(	(	PUNCT
fnp-5347	69	21	y	y	NOUN
fnp-5347	69	22	pink	pink	ADJ
fnp-5347	69	23	)	)	PUNCT
fnp-5347	69	24	.	.	PUNCT
fnp-5347	70	1	the	the	DET
fnp-5347	70	2	algorithm	algorithm	NOUN
fnp-5347	70	3	's	's	PART
fnp-5347	70	4	confidence	confidence	NOUN
fnp-5347	70	5	score	score	NOUN
fnp-5347	70	6	for	for	ADP
fnp-5347	70	7	these	these	DET
fnp-5347	70	8	regions	region	NOUN
fnp-5347	70	9	was	be	AUX
fnp-5347	70	10	low	low	ADJ
fnp-5347	70	11	,	,	PUNCT
fnp-5347	70	12	however	however	ADV
fnp-5347	70	13	(	(	PUNCT
fnp-5347	70	14	<	<	X
fnp-5347	70	15	 	 	SPACE
fnp-5347	70	16	0.415	0.415	NUM
fnp-5347	70	17	,	,	PUNCT
fnp-5347	70	18	0.562	0.562	NUM
fnp-5347	70	19	,	,	PUNCT
fnp-5347	70	20	respectively	respectively	ADV
fnp-5347	70	21	)	)	PUNCT
fnp-5347	70	22	.	.	PUNCT
fnp-5347	71	1	such	such	ADJ
fnp-5347	71	2	regions	region	NOUN
fnp-5347	71	3	should	should	AUX
fnp-5347	71	4	then	then	ADV
fnp-5347	71	5	be	be	AUX
fnp-5347	71	6	reviewed	review	VERB
fnp-5347	71	7	at	at	ADP
fnp-5347	71	8	the	the	DET
fnp-5347	71	9	light	light	ADJ
fnp-5347	71	10	microscope	microscope	NOUN
fnp-5347	71	11	by	by	ADP
fnp-5347	71	12	the	the	DET
fnp-5347	71	13	responsible	responsible	ADJ
fnp-5347	71	14	histopathologist	histopathologist	NOUN
fnp-5347	71	15	.	.	PUNCT
fnp-5347	72	1	in	in	ADP
fnp-5347	72	2	this	this	DET
fnp-5347	72	3	case	case	NOUN
fnp-5347	72	4	,	,	PUNCT
fnp-5347	72	5	moghe	moghe	NOUN
fnp-5347	72	6	(	(	PUNCT
fnp-5347	72	7	y	y	NOUN
fnp-5347	72	8	)	)	PUNCT
fnp-5347	72	9	was	be	AUX
fnp-5347	72	10	not	not	PART
fnp-5347	72	11	confirmed	confirm	VERB
fnp-5347	72	12	histopathologically	histopathologically	ADV
fnp-5347	72	13	by	by	ADP
fnp-5347	72	14	the	the	DET
fnp-5347	72	15	authors	author	NOUN
fnp-5347	72	16	.	.	PUNCT
fnp-5347	73	1	d	d	X
fnp-5347	73	2	:	:	PUNCT
fnp-5347	73	3	a	a	DET
fnp-5347	73	4	validation	validation	NOUN
fnp-5347	73	5	case	case	NOUN
fnp-5347	73	6	example	example	NOUN
fnp-5347	73	7	of	of	ADP
fnp-5347	73	8	a	a	DET
fnp-5347	73	9	wsi	wsi	NOUN
fnp-5347	73	10	obtained	obtain	VERB
fnp-5347	73	11	from	from	ADP
fnp-5347	73	12	a	a	DET
fnp-5347	73	13	patient	patient	NOUN
fnp-5347	73	14	with	with	ADP
fnp-5347	73	15	histopathologically	histopathologically	ADV
fnp-5347	73	16	confirmed	confirm	VERB
fnp-5347	73	17	moghe	moghe	NOUN
fnp-5347	73	18	with	with	ADP
fnp-5347	73	19	slc35a2	slc35a2	NOUN
fnp-5347	73	20	mutation	mutation	NOUN
fnp-5347	73	21	.	.	PUNCT
fnp-5347	74	1	z	z	NOUN
fnp-5347	74	2	points	point	VERB
fnp-5347	74	3	to	to	ADP
fnp-5347	74	4	a	a	DET
fnp-5347	74	5	region	region	NOUN
fnp-5347	74	6	with	with	ADP
fnp-5347	74	7	fcd1a	fcd1a	PROPN
fnp-5347	74	8	as	as	SCONJ
fnp-5347	74	9	confirmed	confirm	VERB
fnp-5347	74	10	by	by	ADP
fnp-5347	74	11	the	the	DET
fnp-5347	74	12	authors	author	NOUN
fnp-5347	74	13	.	.	PUNCT
fnp-5347	75	1	modified	modify	VERB
fnp-5347	75	2	from	from	ADP
fnp-5347	75	3	[	[	X
fnp-5347	75	4	43	43	NUM
fnp-5347	75	5	]	]	PUNCT
fnp-5347	75	6	with	with	ADP
fnp-5347	75	7	permission	permission	NOUN
fnp-5347	75	8	from	from	ADP
fnp-5347	75	9	the	the	DET
fnp-5347	75	10	author	author	NOUN
fnp-5347	75	11	.	.	PUNCT
fnp-5347	76	1	such	such	ADJ
fnp-5347	76	2	digital	digital	ADJ
fnp-5347	76	3	slide	slide	NOUN
fnp-5347	76	4	suite	suite	NOUN
fnp-5347	76	5	projects	project	NOUN
fnp-5347	76	6	will	will	AUX
fnp-5347	76	7	pave	pave	VERB
fnp-5347	76	8	the	the	DET
fnp-5347	76	9	way	way	NOUN
fnp-5347	76	10	towards	towards	ADP
fnp-5347	76	11	ai	ai	VERB
fnp-5347	76	12	-	-	PUNCT
fnp-5347	76	13	supported	support	VERB
fnp-5347	76	14	histopathology	histopathology	NOUN
fnp-5347	76	15	diagnosis	diagnosis	NOUN
fnp-5347	76	16	in	in	ADP
fnp-5347	76	17	years	year	NOUN
fnp-5347	76	18	to	to	PART
fnp-5347	76	19	come	come	VERB
fnp-5347	76	20	pending	pende	VERB
fnp-5347	76	21	the	the	DET
fnp-5347	76	22	clarification	clarification	NOUN
fnp-5347	76	23	and	and	CCONJ
fnp-5347	76	24	resolution	resolution	NOUN
fnp-5347	76	25	of	of	ADP
fnp-5347	76	26	ongoing	ongoing	ADJ
fnp-5347	76	27	obstacles	obstacle	NOUN
fnp-5347	76	28	in	in	ADP
fnp-5347	76	29	the	the	DET
fnp-5347	76	30	field	field	NOUN
fnp-5347	76	31	of	of	ADP
fnp-5347	76	32	whole	whole	ADJ
fnp-5347	76	33	slide	slide	NOUN
fnp-5347	76	34	imaging	imaging	NOUN
fnp-5347	76	35	(	(	PUNCT
fnp-5347	76	36	wsi	wsi	PROPN
fnp-5347	76	37	)	)	PUNCT
fnp-5347	76	38	.	.	PUNCT
fnp-5347	77	1	firstly	firstly	ADV
fnp-5347	77	2	,	,	PUNCT
fnp-5347	77	3	many	many	ADJ
fnp-5347	77	4	parts	part	NOUN
fnp-5347	77	5	of	of	ADP
fnp-5347	77	6	the	the	DET
fnp-5347	77	7	world	world	NOUN
fnp-5347	77	8	may	may	AUX
fnp-5347	77	9	not	not	PART
fnp-5347	77	10	have	have	VERB
fnp-5347	77	11	access	access	NOUN
fnp-5347	77	12	to	to	ADP
fnp-5347	77	13	a	a	DET
fnp-5347	77	14	fast	fast	ADJ
fnp-5347	77	15	enough	enough	ADJ
fnp-5347	77	16	internet	internet	NOUN
fnp-5347	77	17	to	to	PART
fnp-5347	77	18	upload	upload	VERB
fnp-5347	77	19	such	such	ADJ
fnp-5347	77	20	large	large	ADJ
fnp-5347	77	21	digital	digital	ADJ
fnp-5347	77	22	wsi	wsi	NOUN
fnp-5347	77	23	files	file	NOUN
fnp-5347	77	24	,	,	PUNCT
fnp-5347	77	25	which	which	PRON
fnp-5347	77	26	can	can	AUX
fnp-5347	77	27	easily	easily	ADV
fnp-5347	77	28	exceed	exceed	VERB
fnp-5347	77	29	multiple	multiple	ADJ
fnp-5347	77	30	gbyte	gbyte	NOUN
fnp-5347	77	31	(	(	PUNCT
fnp-5347	77	32	the	the	DET
fnp-5347	77	33	range	range	NOUN
fnp-5347	77	34	was	be	AUX
fnp-5347	77	35	described	describe	VERB
fnp-5347	77	36	as	as	ADP
fnp-5347	77	37	0.47	0.47	NUM
fnp-5347	77	38	-	-	SYM
fnp-5347	77	39	5.72	5.72	NUM
fnp-5347	77	40	gbyte	gbyte	NOUN
fnp-5347	77	41	per	per	ADP
fnp-5347	77	42	wsi	wsi	NOUN
fnp-5347	77	43	in	in	ADP
fnp-5347	77	44	the	the	DET
fnp-5347	77	45	current	current	ADJ
fnp-5347	77	46	study	study	NOUN
fnp-5347	77	47	)	)	PUNCT
fnp-5347	77	48	.	.	PUNCT
fnp-5347	78	1	secondly	secondly	ADV
fnp-5347	78	2	,	,	PUNCT
fnp-5347	78	3	a	a	DET
fnp-5347	78	4	uniform	uniform	ADJ
fnp-5347	78	5	laboratory	laboratory	NOUN
fnp-5347	78	6	standard	standard	NOUN
fnp-5347	78	7	of	of	ADP
fnp-5347	78	8	section	section	NOUN
fnp-5347	78	9	thickness	thickness	NOUN
fnp-5347	78	10	in	in	ADP
fnp-5347	78	11	the	the	DET
fnp-5347	78	12	range	range	NOUN
fnp-5347	78	13	of	of	ADP
fnp-5347	78	14	4	4	NUM
fnp-5347	78	15	-	-	SYM
fnp-5347	78	16	5	5	NUM
fnp-5347	78	17	 	 	SPACE
fnp-5347	78	18	µm	µm	NOUN
fnp-5347	78	19	and	and	CCONJ
fnp-5347	78	20	standardized	standardized	ADJ
fnp-5347	78	21	h&e	h&e	PROPN
fnp-5347	78	22	staining	stain	VERB
fnp-5347	78	23	protocols	protocol	NOUN
fnp-5347	78	24	must	must	AUX
fnp-5347	78	25	be	be	AUX
fnp-5347	78	26	applied	apply	VERB
fnp-5347	78	27	to	to	PART
fnp-5347	78	28	be	be	AUX
fnp-5347	78	29	compatible	compatible	ADJ
fnp-5347	78	30	with	with	ADP
fnp-5347	78	31	the	the	DET
fnp-5347	78	32	trained	train	VERB
fnp-5347	78	33	dataset	dataset	NOUN
fnp-5347	78	34	of	of	ADP
fnp-5347	78	35	the	the	DET
fnp-5347	78	36	ai	ai	NOUN
fnp-5347	78	37	algorithm	algorithm	NOUN
fnp-5347	78	38	.	.	PUNCT
fnp-5347	79	1	thirdly	thirdly	ADV
fnp-5347	79	2	and	and	CCONJ
fnp-5347	79	3	unfortunately	unfortunately	ADV
fnp-5347	79	4	most	most	ADV
fnp-5347	79	5	challenging	challenging	ADJ
fnp-5347	79	6	,	,	PUNCT
fnp-5347	79	7	vendors	vendor	NOUN
fnp-5347	79	8	of	of	ADP
fnp-5347	79	9	different	different	ADJ
fnp-5347	79	10	wsi	wsi	NOUN
fnp-5347	79	11	scanners	scanner	NOUN
fnp-5347	79	12	implement	implement	VERB
fnp-5347	79	13	their	their	PRON
fnp-5347	79	14	unique	unique	ADJ
fnp-5347	79	15	file	file	NOUN
fnp-5347	79	16	formats	format	NOUN
fnp-5347	79	17	[	[	X
fnp-5347	79	18	27	27	NUM
fnp-5347	79	19	]	]	PUNCT
fnp-5347	79	20	.	.	PUNCT
fnp-5347	80	1	there	there	PRON
fnp-5347	80	2	are	be	VERB
fnp-5347	80	3	open	open	ADJ
fnp-5347	80	4	access	access	NOUN
fnp-5347	80	5	wsi	wsi	NOUN
fnp-5347	80	6	reading	reading	NOUN
fnp-5347	80	7	applications	application	NOUN
fnp-5347	80	8	such	such	ADJ
fnp-5347	80	9	as	as	ADP
fnp-5347	80	10	open.slide	open.slide	NOUN
fnp-5347	80	11	which	which	PRON
fnp-5347	80	12	can	can	AUX
fnp-5347	80	13	help	help	VERB
fnp-5347	80	14	to	to	PART
fnp-5347	80	15	read	read	VERB
fnp-5347	80	16	and	and	CCONJ
fnp-5347	80	17	import	import	VERB
fnp-5347	80	18	different	different	ADJ
fnp-5347	80	19	formats	format	NOUN
fnp-5347	80	20	into	into	ADP
fnp-5347	80	21	an	an	DET
fnp-5347	80	22	ai	ai	NOUN
fnp-5347	80	23	algorithm	algorithm	NOUN
fnp-5347	80	24	.	.	PUNCT
fnp-5347	81	1	however	however	ADV
fnp-5347	81	2	,	,	PUNCT
fnp-5347	81	3	any	any	DET
fnp-5347	81	4	technical	technical	ADJ
fnp-5347	81	5	update	update	NOUN
fnp-5347	81	6	of	of	ADP
fnp-5347	81	7	the	the	DET
fnp-5347	81	8	file	file	NOUN
fnp-5347	81	9	format	format	NOUN
fnp-5347	81	10	or	or	CCONJ
fnp-5347	81	11	reading	read	VERB
fnp-5347	81	12	header	header	NOUN
fnp-5347	81	13	by	by	ADP
fnp-5347	81	14	the	the	DET
fnp-5347	81	15	vendor	vendor	NOUN
fnp-5347	81	16	requires	require	VERB
fnp-5347	81	17	prompt	prompt	ADJ
fnp-5347	81	18	adaptation	adaptation	NOUN
fnp-5347	81	19	by	by	ADP
fnp-5347	81	20	software	software	NOUN
fnp-5347	81	21	stewards	steward	NOUN
fnp-5347	81	22	for	for	ADP
fnp-5347	81	23	any	any	DET
fnp-5347	81	24	independent	independent	ADJ
fnp-5347	81	25	application	application	NOUN
fnp-5347	81	26	.	.	PUNCT
fnp-5347	82	1	a	a	DET
fnp-5347	82	2	solution	solution	NOUN
fnp-5347	82	3	to	to	ADP
fnp-5347	82	4	this	this	DET
fnp-5347	82	5	problem	problem	NOUN
fnp-5347	82	6	would	would	AUX
fnp-5347	82	7	be	be	AUX
fnp-5347	82	8	the	the	DET
fnp-5347	82	9	use	use	NOUN
fnp-5347	82	10	of	of	ADP
fnp-5347	82	11	internationally	internationally	ADV
fnp-5347	82	12	defined	define	VERB
fnp-5347	82	13	dicom	dicom	NOUN
fnp-5347	82	14	standards	standard	NOUN
fnp-5347	82	15	,	,	PUNCT
fnp-5347	82	16	which	which	PRON
fnp-5347	82	17	already	already	ADV
fnp-5347	82	18	exists	exist	VERB
fnp-5347	82	19	for	for	ADP
fnp-5347	82	20	wsi	wsi	NOUN
fnp-5347	83	1	[	[	X
fnp-5347	83	2	27	27	NUM
fnp-5347	83	3	]	]	PUNCT
fnp-5347	83	4	.	.	PUNCT
fnp-5347	84	1	however	however	ADV
fnp-5347	84	2	,	,	PUNCT
fnp-5347	84	3	this	this	PRON
fnp-5347	84	4	has	have	AUX
fnp-5347	84	5	not	not	PART
fnp-5347	84	6	been	be	AUX
fnp-5347	84	7	implemented	implement	VERB
fnp-5347	84	8	by	by	ADP
fnp-5347	84	9	wsi	wsi	PROPN
fnp-5347	84	10	vendors	vendor	NOUN
fnp-5347	84	11	with	with	ADP
fnp-5347	84	12	the	the	DET
fnp-5347	84	13	intention	intention	NOUN
fnp-5347	84	14	to	to	PART
fnp-5347	84	15	control	control	VERB
fnp-5347	84	16	ai	ai	VERB
fnp-5347	84	17	based	base	VERB
fnp-5347	84	18	histopathology	histopathology	NOUN
fnp-5347	84	19	slide	slide	NOUN
fnp-5347	84	20	suits	suit	NOUN
fnp-5347	84	21	as	as	ADP
fnp-5347	84	22	a	a	DET
fnp-5347	84	23	walled	walled	ADJ
fnp-5347	84	24	garden	garden	NOUN
fnp-5347	84	25	laboratory	laboratory	NOUN
fnp-5347	84	26	solution	solution	NOUN
fnp-5347	84	27	wherein	wherein	SCONJ
fnp-5347	84	28	the	the	DET
fnp-5347	84	29	wsi	wsi	NOUN
fnp-5347	84	30	equipment	equipment	NOUN
fnp-5347	84	31	and	and	CCONJ
fnp-5347	84	32	laboratory	laboratory	NOUN
fnp-5347	84	33	software	software	NOUN
fnp-5347	84	34	must	must	AUX
fnp-5347	84	35	be	be	AUX
fnp-5347	84	36	purchased	purchase	VERB
fnp-5347	84	37	from	from	ADP
fnp-5347	84	38	the	the	DET
fnp-5347	84	39	same	same	ADJ
fnp-5347	84	40	company	company	NOUN
fnp-5347	84	41	.	.	PUNCT
fnp-5347	85	1	in	in	ADP
fnp-5347	85	2	contrast	contrast	NOUN
fnp-5347	85	3	,	,	PUNCT
fnp-5347	85	4	these	these	DET
fnp-5347	85	5	applications	application	NOUN
fnp-5347	85	6	should	should	AUX
fnp-5347	85	7	be	be	AUX
fnp-5347	85	8	openly	openly	ADV
fnp-5347	85	9	available	available	ADJ
fnp-5347	85	10	for	for	ADP
fnp-5347	85	11	research	research	NOUN
fnp-5347	85	12	and	and	CCONJ
fnp-5347	85	13	managed	manage	VERB
fnp-5347	85	14	by	by	ADP
fnp-5347	85	15	experts	expert	NOUN
fnp-5347	85	16	in	in	ADP
fnp-5347	85	17	the	the	DET
fnp-5347	85	18	field	field	NOUN
fnp-5347	85	19	to	to	PART
fnp-5347	85	20	allow	allow	VERB
fnp-5347	85	21	broad	broad	ADJ
fnp-5347	85	22	access	access	NOUN
fnp-5347	85	23	to	to	ADP
fnp-5347	85	24	this	this	DET
fnp-5347	85	25	technology	technology	NOUN
fnp-5347	85	26	irrespective	irrespective	ADV
fnp-5347	85	27	of	of	ADP
fnp-5347	85	28	any	any	DET
fnp-5347	85	29	country	country	NOUN
fnp-5347	85	30	's	's	PART
fnp-5347	85	31	or	or	CCONJ
fnp-5347	85	32	researcher	researcher	NOUN
fnp-5347	85	33	's	's	PART
fnp-5347	85	34	socio	socio	NOUN
fnp-5347	85	35	-	-	PUNCT
fnp-5347	85	36	economic	economic	ADJ
fnp-5347	85	37	background	background	NOUN
fnp-5347	85	38	.	.	PUNCT
fnp-5347	86	1	another	another	DET
fnp-5347	86	2	open	open	ADJ
fnp-5347	86	3	question	question	NOUN
fnp-5347	86	4	remains	remain	VERB
fnp-5347	86	5	,	,	PUNCT
fnp-5347	86	6	if	if	SCONJ
fnp-5347	86	7	ai	ai	VERB
fnp-5347	86	8	-	-	PUNCT
fnp-5347	86	9	based	base	VERB
fnp-5347	86	10	histopathology	histopathology	NOUN
fnp-5347	86	11	classifier	classifier	NOUN
fnp-5347	86	12	will	will	AUX
fnp-5347	86	13	replace	replace	VERB
fnp-5347	86	14	the	the	DET
fnp-5347	86	15	pathology	pathology	NOUN
fnp-5347	86	16	expert	expert	NOUN
fnp-5347	86	17	in	in	ADP
fnp-5347	86	18	the	the	DET
fnp-5347	86	19	near	near	ADJ
fnp-5347	86	20	future	future	NOUN
fnp-5347	86	21	.	.	PUNCT
fnp-5347	87	1	my	my	PRON
fnp-5347	87	2	personal	personal	ADJ
fnp-5347	87	3	belief	belief	NOUN
fnp-5347	87	4	is	be	AUX
fnp-5347	87	5	that	that	SCONJ
fnp-5347	87	6	ai	ai	VERB
fnp-5347	87	7	will	will	AUX
fnp-5347	87	8	not	not	PART
fnp-5347	87	9	replace	replace	VERB
fnp-5347	87	10	the	the	DET
fnp-5347	87	11	physician	physician	NOUN
fnp-5347	87	12	as	as	ADP
fnp-5347	87	13	the	the	DET
fnp-5347	87	14	legal	legal	ADJ
fnp-5347	87	15	accountability	accountability	NOUN
fnp-5347	87	16	of	of	ADP
fnp-5347	87	17	a	a	DET
fnp-5347	87	18	signed	sign	VERB
fnp-5347	87	19	pathology	pathology	NOUN
fnp-5347	87	20	report	report	NOUN
fnp-5347	87	21	for	for	ADP
fnp-5347	87	22	clinical	clinical	ADJ
fnp-5347	87	23	patient	patient	NOUN
fnp-5347	87	24	management	management	NOUN
fnp-5347	87	25	remains	remain	VERB
fnp-5347	87	26	so	so	ADV
fnp-5347	87	27	high	high	ADJ
fnp-5347	87	28	.	.	PUNCT
fnp-5347	88	1	instead	instead	ADV
fnp-5347	88	2	,	,	PUNCT
fnp-5347	88	3	such	such	ADJ
fnp-5347	88	4	tools	tool	NOUN
fnp-5347	88	5	should	should	AUX
fnp-5347	88	6	help	help	VERB
fnp-5347	88	7	to	to	PART
fnp-5347	88	8	prescreen	prescreen	VERB
fnp-5347	88	9	routine	routine	ADJ
fnp-5347	88	10	cases	case	NOUN
fnp-5347	88	11	.	.	PUNCT
fnp-5347	89	1	the	the	DET
fnp-5347	89	2	application	application	NOUN
fnp-5347	89	3	may	may	AUX
fnp-5347	89	4	then	then	ADV
fnp-5347	89	5	suggest	suggest	VERB
fnp-5347	89	6	a	a	DET
fnp-5347	89	7	preselection	preselection	NOUN
fnp-5347	89	8	of	of	ADP
fnp-5347	89	9	regions	region	NOUN
fnp-5347	89	10	of	of	ADP
fnp-5347	89	11	interest	interest	NOUN
fnp-5347	89	12	,	,	PUNCT
fnp-5347	89	13	pending	pende	VERB
fnp-5347	89	14	on	on	ADP
fnp-5347	89	15	an	an	DET
fnp-5347	89	16	individually	individually	ADV
fnp-5347	89	17	chosen	choose	VERB
fnp-5347	89	18	level	level	NOUN
fnp-5347	89	19	of	of	ADP
fnp-5347	89	20	the	the	DET
fnp-5347	89	21	algorithm	algorithm	NOUN
fnp-5347	89	22	's	's	PART
fnp-5347	89	23	detection	detection	NOUN
fnp-5347	89	24	sensitivity	sensitivity	NOUN
fnp-5347	89	25	and	and	CCONJ
fnp-5347	89	26	which	which	PRON
fnp-5347	89	27	can	can	AUX
fnp-5347	89	28	be	be	AUX
fnp-5347	89	29	adapted	adapt	VERB
fnp-5347	89	30	by	by	ADP
fnp-5347	89	31	each	each	DET
fnp-5347	89	32	reviewer	reviewer	NOUN
fnp-5347	89	33	(	(	PUNCT
fnp-5347	89	34	see	see	VERB
fnp-5347	89	35	figure	figure	NOUN
fnp-5347	89	36	2	2	NUM
fnp-5347	89	37	)	)	PUNCT
fnp-5347	89	38	.	.	PUNCT
fnp-5347	90	1	each	each	DET
fnp-5347	90	2	reviewer	reviewer	NOUN
fnp-5347	90	3	must	must	AUX
fnp-5347	90	4	also	also	ADV
fnp-5347	90	5	determine	determine	VERB
fnp-5347	90	6	if	if	SCONJ
fnp-5347	90	7	technical	technical	ADJ
fnp-5347	90	8	pitfalls	pitfall	NOUN
fnp-5347	90	9	have	have	AUX
fnp-5347	90	10	compromised	compromise	VERB
fnp-5347	90	11	the	the	DET
fnp-5347	90	12	results	result	NOUN
fnp-5347	90	13	,	,	PUNCT
fnp-5347	90	14	e.g.	e.g.	ADV
fnp-5347	90	15	,	,	PUNCT
fnp-5347	90	16	wrinkles	wrinkle	NOUN
fnp-5347	90	17	,	,	PUNCT
fnp-5347	90	18	dust	dust	NOUN
fnp-5347	90	19	particles	particle	NOUN
fnp-5347	90	20	or	or	CCONJ
fnp-5347	90	21	other	other	ADJ
fnp-5347	90	22	coloring	coloring	NOUN
fnp-5347	90	23	errors	error	NOUN
fnp-5347	90	24	,	,	PUNCT
fnp-5347	90	25	etc	etc	X
fnp-5347	90	26	.	.	X
fnp-5347	91	1	these	these	DET
fnp-5347	91	2	decisions	decision	NOUN
fnp-5347	91	3	will	will	AUX
fnp-5347	91	4	always	always	ADV
fnp-5347	91	5	remain	remain	VERB
fnp-5347	91	6	with	with	ADP
fnp-5347	91	7	the	the	DET
fnp-5347	91	8	responsible	responsible	ADJ
fnp-5347	91	9	physician	physician	NOUN
fnp-5347	91	10	and	and	CCONJ
fnp-5347	91	11	can	can	AUX
fnp-5347	91	12	not	not	PART
fnp-5347	91	13	be	be	AUX
fnp-5347	91	14	replaced	replace	VERB
fnp-5347	91	15	easily	easily	ADV
fnp-5347	91	16	by	by	ADP
fnp-5347	91	17	any	any	DET
fnp-5347	91	18	ai	ai	NOUN
fnp-5347	91	19	.	.	PUNCT
fnp-5347	92	1	however	however	ADV
fnp-5347	92	2	,	,	PUNCT
fnp-5347	92	3	this	this	DET
fnp-5347	92	4	discussion	discussion	NOUN
fnp-5347	92	5	will	will	AUX
fnp-5347	92	6	be	be	AUX
fnp-5347	92	7	ongoing	ongoing	ADJ
fnp-5347	92	8	in	in	ADP
fnp-5347	92	9	the	the	DET
fnp-5347	92	10	community	community	NOUN
fnp-5347	92	11	and	and	CCONJ
fnp-5347	92	12	my	my	PRON
fnp-5347	92	13	hope	hope	NOUN
fnp-5347	92	14	is	be	AUX
fnp-5347	92	15	that	that	SCONJ
fnp-5347	92	16	many	many	ADJ
fnp-5347	92	17	world	world	NOUN
fnp-5347	92	18	renowned	renowned	ADJ
fnp-5347	92	19	experts	expert	NOUN
fnp-5347	92	20	will	will	AUX
fnp-5347	92	21	share	share	VERB
fnp-5347	92	22	their	their	PRON
fnp-5347	92	23	expertise	expertise	NOUN
fnp-5347	92	24	in	in	ADP
fnp-5347	92	25	ai	ai	ADV
fnp-5347	92	26	-	-	PUNCT
fnp-5347	92	27	based	base	VERB
fnp-5347	92	28	slide	slide	NOUN
fnp-5347	92	29	suites	suite	NOUN
fnp-5347	92	30	and	and	CCONJ
fnp-5347	92	31	classifier	classifier	NOUN
fnp-5347	92	32	tools	tool	NOUN
fnp-5347	92	33	and	and	CCONJ
fnp-5347	92	34	which	which	PRON
fnp-5347	92	35	can	can	AUX
fnp-5347	92	36	be	be	AUX
fnp-5347	92	37	used	use	VERB
fnp-5347	92	38	open	open	ADJ
fnp-5347	92	39	access	access	NOUN
fnp-5347	92	40	around	around	ADP
fnp-5347	92	41	the	the	DET
fnp-5347	92	42	world	world	NOUN
fnp-5347	92	43	,	,	PUNCT
fnp-5347	92	44	in	in	ADP
fnp-5347	92	45	particular	particular	ADJ
fnp-5347	92	46	in	in	ADP
fnp-5347	92	47	those	those	DET
fnp-5347	92	48	regions	region	NOUN
fnp-5347	92	49	where	where	SCONJ
fnp-5347	92	50	training	training	NOUN
fnp-5347	92	51	and	and	CCONJ
fnp-5347	92	52	experience	experience	NOUN
fnp-5347	92	53	in	in	ADP
fnp-5347	92	54	less	less	ADV
fnp-5347	92	55	broadly	broadly	ADV
fnp-5347	92	56	available	available	ADJ
fnp-5347	92	57	.	.	PUNCT
fnp-5347	93	1	figure	figure	NOUN
fnp-5347	93	2	2	2	NUM
fnp-5347	93	3	:	:	PUNCT
fnp-5347	93	4	new	new	ADJ
fnp-5347	93	5	genotype	genotype	NOUN
fnp-5347	93	6	-	-	PUNCT
fnp-5347	93	7	phenotype	phenotype	NOUN
fnp-5347	93	8	associations	association	NOUN
fnp-5347	93	9	in	in	ADP
fnp-5347	93	10	epileptogenic	epileptogenic	ADJ
fnp-5347	93	11	brain	brain	NOUN
fnp-5347	93	12	lesions	lesion	NOUN
fnp-5347	93	13	figure	figure	NOUN
fnp-5347	93	14	2	2	NUM
fnp-5347	93	15	.	.	PUNCT
fnp-5347	94	1	a	a	X
fnp-5347	94	2	-	-	PUNCT
fnp-5347	94	3	b	b	NOUN
fnp-5347	94	4	:	:	PUNCT
fnp-5347	94	5	two	two	NUM
fnp-5347	94	6	patients	patient	NOUN
fnp-5347	94	7	with	with	ADP
fnp-5347	94	8	a	a	DET
fnp-5347	94	9	complex	complex	ADJ
fnp-5347	94	10	malformation	malformation	NOUN
fnp-5347	94	11	of	of	ADP
fnp-5347	94	12	cortical	cortical	ADJ
fnp-5347	94	13	development	development	NOUN
fnp-5347	94	14	including	include	VERB
fnp-5347	94	15	heterotopias	heterotopia	NOUN
fnp-5347	94	16	(	(	PUNCT
fnp-5347	94	17	a	a	NOUN
fnp-5347	94	18	)	)	PUNCT
fnp-5347	94	19	and	and	CCONJ
fnp-5347	94	20	polymicrogyria	polymicrogyria	NOUN
fnp-5347	94	21	(	(	PUNCT
fnp-5347	94	22	b	b	NOUN
fnp-5347	94	23	)	)	PUNCT
fnp-5347	94	24	revealed	reveal	VERB
fnp-5347	94	25	brain	brain	NOUN
fnp-5347	94	26	somatic	somatic	ADJ
fnp-5347	94	27	mutations	mutation	NOUN
fnp-5347	94	28	in	in	ADP
fnp-5347	94	29	nras	nras	PROPN
fnp-5347	94	30	.	.	PUNCT
fnp-5347	95	1	c	c	X
fnp-5347	95	2	:	:	PUNCT
fnp-5347	95	3	a	a	DET
fnp-5347	95	4	novel	novel	ADJ
fnp-5347	95	5	association	association	NOUN
fnp-5347	95	6	was	be	AUX
fnp-5347	95	7	shown	show	VERB
fnp-5347	95	8	in	in	ADP
fnp-5347	95	9	another	another	DET
fnp-5347	95	10	patient	patient	NOUN
fnp-5347	95	11	for	for	ADP
fnp-5347	95	12	a	a	DET
fnp-5347	95	13	large	large	ADJ
fnp-5347	95	14	chromosomal	chromosomal	ADJ
fnp-5347	95	15	1q	1q	ADJ
fnp-5347	95	16	duplication	duplication	NOUN
fnp-5347	95	17	that	that	PRON
fnp-5347	95	18	included	include	VERB
fnp-5347	95	19	akt3	akt3	NOUN
fnp-5347	95	20	and	and	CCONJ
fnp-5347	95	21	type	type	NOUN
fnp-5347	95	22	fcd2a	fcd2a	VERB
fnp-5347	95	23	with	with	ADP
fnp-5347	95	24	hyaline	hyaline	ADJ
fnp-5347	95	25	astrocytic	astrocytic	ADJ
fnp-5347	95	26	inclusions	inclusion	NOUN
fnp-5347	95	27	.	.	PUNCT
fnp-5347	96	1	figure	figure	NOUN
fnp-5347	96	2	modified	modify	VERB
fnp-5347	96	3	from	from	ADP
fnp-5347	96	4	open	open	ADJ
fnp-5347	96	5	-	-	PUNCT
fnp-5347	96	6	access	access	NOUN
fnp-5347	96	7	paper	paper	NOUN
fnp-5347	96	8	published	publish	VERB
fnp-5347	96	9	under	under	ADP
fnp-5347	96	10	a	a	DET
fnp-5347	96	11	creative	creative	ADJ
fnp-5347	96	12	commons	common	NOUN
fnp-5347	96	13	license	license	NOUN
fnp-5347	97	1	[	[	X
fnp-5347	97	2	30	30	NUM
fnp-5347	97	3	]	]	PUNCT
fnp-5347	97	4	,	,	PUNCT
fnp-5347	97	5	with	with	ADP
fnp-5347	97	6	permission	permission	NOUN
fnp-5347	97	7	from	from	ADP
fnp-5347	97	8	the	the	DET
fnp-5347	97	9	authors	author	NOUN
fnp-5347	97	10	.	.	PUNCT
fnp-5347	98	1	just	just	ADV
fnp-5347	98	2	to	to	PART
fnp-5347	98	3	mention	mention	VERB
fnp-5347	98	4	in	in	ADP
fnp-5347	98	5	this	this	DET
fnp-5347	98	6	chapter	chapter	NOUN
fnp-5347	98	7	that	that	PRON
fnp-5347	98	8	machine	machine	NOUN
fnp-5347	98	9	learning	learning	NOUN
fnp-5347	98	10	and	and	CCONJ
fnp-5347	98	11	ai	ai	VERB
fnp-5347	98	12	tools	tool	NOUN
fnp-5347	98	13	were	be	AUX
fnp-5347	98	14	recognized	recognize	VERB
fnp-5347	98	15	and	and	CCONJ
fnp-5347	98	16	increasingly	increasingly	ADV
fnp-5347	98	17	published	publish	VERB
fnp-5347	98	18	already	already	ADV
fnp-5347	98	19	in	in	ADP
fnp-5347	98	20	the	the	DET
fnp-5347	98	21	arena	arena	NOUN
fnp-5347	98	22	of	of	ADP
fnp-5347	98	23	epileptology	epileptology	NOUN
fnp-5347	99	1	[	[	X
fnp-5347	99	2	25	25	NUM
fnp-5347	99	3	]	]	PUNCT
fnp-5347	99	4	,	,	PUNCT
fnp-5347	99	5	e.g.	e.g.	ADV
fnp-5347	99	6	,	,	PUNCT
fnp-5347	99	7	when	when	SCONJ
fnp-5347	99	8	virtual	virtual	ADJ
fnp-5347	99	9	digital	digital	ADJ
fnp-5347	99	10	brain	brain	NOUN
fnp-5347	99	11	models	model	NOUN
fnp-5347	99	12	can	can	AUX
fnp-5347	99	13	help	help	VERB
fnp-5347	99	14	to	to	PART
fnp-5347	99	15	map	map	VERB
fnp-5347	99	16	a	a	DET
fnp-5347	99	17	brain	brain	NOUN
fnp-5347	99	18	network	network	NOUN
fnp-5347	99	19	in	in	ADP
fnp-5347	99	20	a	a	DET
fnp-5347	99	21	given	give	VERB
fnp-5347	99	22	patient	patient	NOUN
fnp-5347	99	23	with	with	ADP
fnp-5347	99	24	epilepsy	epilepsy	NOUN
fnp-5347	99	25	[	[	X
fnp-5347	99	26	24	24	NUM
fnp-5347	99	27	]	]	PUNCT
fnp-5347	99	28	,	,	PUNCT
fnp-5347	99	29	when	when	SCONJ
fnp-5347	99	30	neuroimaging	neuroimage	VERB
fnp-5347	99	31	algorithms	algorithm	NOUN
fnp-5347	99	32	help	help	VERB
fnp-5347	99	33	to	to	PART
fnp-5347	99	34	better	well	ADV
fnp-5347	99	35	identify	identify	VERB
fnp-5347	99	36	structural	structural	ADJ
fnp-5347	99	37	brain	brain	NOUN
fnp-5347	99	38	lesions	lesion	NOUN
fnp-5347	99	39	[	[	X
fnp-5347	99	40	44	44	NUM
fnp-5347	99	41	]	]	PUNCT
fnp-5347	99	42	,	,	PUNCT
fnp-5347	99	43	or	or	CCONJ
fnp-5347	99	44	when	when	SCONJ
fnp-5347	99	45	predicting	predict	VERB
fnp-5347	99	46	seizure	seizure	NOUN
fnp-5347	99	47	outcome	outcome	NOUN
fnp-5347	99	48	after	after	ADP
fnp-5347	99	49	epilepsy	epilepsy	NOUN
fnp-5347	99	50	surgery	surgery	NOUN
fnp-5347	99	51	in	in	ADP
fnp-5347	99	52	order	order	NOUN
fnp-5347	99	53	to	to	PART
fnp-5347	99	54	avoid	avoid	VERB
fnp-5347	99	55	unnecessary	unnecessary	ADJ
fnp-5347	99	56	invasive	invasive	ADJ
fnp-5347	99	57	diagnostic	diagnostic	ADJ
fnp-5347	99	58	procedures	procedure	NOUN
fnp-5347	99	59	for	for	ADP
fnp-5347	99	60	the	the	DET
fnp-5347	99	61	patient	patient	NOUN
fnp-5347	99	62	[	[	X
fnp-5347	99	63	17	17	NUM
fnp-5347	99	64	]	]	PUNCT
fnp-5347	99	65	.	.	PUNCT
fnp-5347	100	1	notwithstanding	notwithstanding	ADV
fnp-5347	100	2	,	,	PUNCT
fnp-5347	100	3	the	the	DET
fnp-5347	100	4	histopathology	histopathology	NOUN
fnp-5347	100	5	diagnosis	diagnosis	NOUN
fnp-5347	100	6	often	often	ADV
fnp-5347	100	7	remains	remain	VERB
fnp-5347	100	8	an	an	DET
fnp-5347	100	9	important	important	ADJ
fnp-5347	100	10	predictor	predictor	NOUN
fnp-5347	100	11	in	in	ADP
fnp-5347	100	12	many	many	ADJ
fnp-5347	100	13	of	of	ADP
fnp-5347	100	14	these	these	DET
fnp-5347	100	15	ai	ai	NOUN
fnp-5347	100	16	-	-	PUNCT
fnp-5347	100	17	based	base	VERB
fnp-5347	100	18	applications	application	NOUN
fnp-5347	100	19	.	.	PUNCT
fnp-5347	101	1	topic	topic	NOUN
fnp-5347	101	2	2	2	NUM
fnp-5347	101	3	:	:	PUNCT
fnp-5347	101	4	deciphering	decipher	VERB
fnp-5347	101	5	the	the	DET
fnp-5347	101	6	genomic	genomic	ADJ
fnp-5347	101	7	landscape	landscape	NOUN
fnp-5347	101	8	of	of	ADP
fnp-5347	101	9	epileptogenic	epileptogenic	ADJ
fnp-5347	101	10	brain	brain	NOUN
fnp-5347	101	11	lesions	lesion	NOUN
fnp-5347	101	12	the	the	DET
fnp-5347	101	13	search	search	NOUN
fnp-5347	101	14	for	for	ADP
fnp-5347	101	15	genetic	genetic	ADJ
fnp-5347	101	16	factors	factor	NOUN
fnp-5347	101	17	in	in	ADP
fnp-5347	101	18	lesional	lesional	ADJ
fnp-5347	101	19	focal	focal	ADJ
fnp-5347	101	20	epilepsies	epilepsy	NOUN
fnp-5347	101	21	is	be	AUX
fnp-5347	101	22	ongoing	ongoing	ADJ
fnp-5347	101	23	and	and	CCONJ
fnp-5347	101	24	pushed	push	VERB
fnp-5347	101	25	our	our	PRON
fnp-5347	101	26	knowledge	knowledge	NOUN
fnp-5347	101	27	of	of	ADP
fnp-5347	101	28	brain	brain	NOUN
fnp-5347	101	29	somatic	somatic	ADJ
fnp-5347	101	30	mutations	mutation	NOUN
fnp-5347	101	31	,	,	PUNCT
fnp-5347	101	32	chromosomal	chromosomal	ADJ
fnp-5347	101	33	aberrations	aberration	NOUN
fnp-5347	101	34	and	and	CCONJ
fnp-5347	101	35	epigenetic	epigenetic	ADJ
fnp-5347	101	36	factors	factor	NOUN
fnp-5347	101	37	to	to	ADP
fnp-5347	101	38	a	a	DET
fnp-5347	101	39	next	next	ADJ
fnp-5347	101	40	level	level	NOUN
fnp-5347	101	41	.	.	PUNCT
fnp-5347	102	1	i	i	PRON
fnp-5347	102	2	will	will	AUX
fnp-5347	102	3	review	review	VERB
fnp-5347	102	4	herein	herein	VERB
fnp-5347	102	5	a	a	DET
fnp-5347	102	6	series	series	NOUN
fnp-5347	102	7	of	of	ADP
fnp-5347	102	8	three	three	NUM
fnp-5347	102	9	publications	publication	NOUN
fnp-5347	102	10	from	from	ADP
fnp-5347	102	11	2022	2022	NUM
fnp-5347	102	12	and	and	CCONJ
fnp-5347	102	13	2023	2023	NUM
fnp-5347	102	14	which	which	PRON
fnp-5347	102	15	comprehensively	comprehensively	ADV
fnp-5347	102	16	study	study	VERB
fnp-5347	102	17	brain	brain	NOUN
fnp-5347	102	18	tissues	tissue	NOUN
fnp-5347	102	19	obtained	obtain	VERB
fnp-5347	102	20	from	from	ADP
fnp-5347	102	21	a	a	DET
fnp-5347	102	22	total	total	NOUN
fnp-5347	102	23	of	of	ADP
fnp-5347	102	24	807	807	NUM
fnp-5347	102	25	patients	patient	NOUN
fnp-5347	102	26	using	use	VERB
fnp-5347	102	27	different	different	ADJ
fnp-5347	102	28	bioinformatic	bioinformatic	ADJ
fnp-5347	102	29	approaches	approach	NOUN
fnp-5347	102	30	.	.	PUNCT
fnp-5347	103	1	chung	chung	PROPN
fnp-5347	103	2	et	et	PROPN
fnp-5347	103	3	al	al	PROPN
fnp-5347	103	4	.	.	PROPN
fnp-5347	103	5	reported	report	VERB
fnp-5347	103	6	a	a	DET
fnp-5347	103	7	multidisciplinary	multidisciplinary	ADJ
fnp-5347	103	8	team	team	NOUN
fnp-5347	103	9	effort	effort	NOUN
fnp-5347	103	10	including	include	VERB
fnp-5347	103	11	the	the	DET
fnp-5347	103	12	fcd	fcd	PROPN
fnp-5347	103	13	neurogenetics	neurogenetic	NOUN
fnp-5347	103	14	consortium	consortium	PROPN
fnp-5347	103	15	and	and	CCONJ
fnp-5347	103	16	the	the	DET
fnp-5347	103	17	brain	brain	NOUN
fnp-5347	103	18	somatic	somatic	ADJ
fnp-5347	103	19	mosaicism	mosaicism	NOUN
fnp-5347	103	20	network	network	NOUN
fnp-5347	103	21	[	[	X
fnp-5347	103	22	13	13	NUM
fnp-5347	103	23	]	]	PUNCT
fnp-5347	103	24	.	.	PUNCT
fnp-5347	104	1	they	they	PRON
fnp-5347	104	2	retrieved	retrieve	VERB
fnp-5347	104	3	283	283	NUM
fnp-5347	104	4	resected	resect	VERB
fnp-5347	104	5	brain	brain	NOUN
fnp-5347	104	6	samples	sample	NOUN
fnp-5347	104	7	of	of	ADP
fnp-5347	104	8	patients	patient	NOUN
fnp-5347	104	9	with	with	ADP
fnp-5347	104	10	clinically	clinically	ADV
fnp-5347	104	11	and/or	and/or	CCONJ
fnp-5347	104	12	histopathologically	histopathologically	ADV
fnp-5347	104	13	validated	validate	VERB
fnp-5347	104	14	malformations	malformation	NOUN
fnp-5347	104	15	of	of	ADP
fnp-5347	104	16	cortical	cortical	ADJ
fnp-5347	104	17	development	development	NOUN
fnp-5347	104	18	(	(	PUNCT
fnp-5347	104	19	mcd	mcd	NOUN
fnp-5347	104	20	)	)	PUNCT
fnp-5347	104	21	and	and	CCONJ
fnp-5347	104	22	identified	identify	VERB
fnp-5347	104	23	a	a	DET
fnp-5347	104	24	total	total	NOUN
fnp-5347	104	25	of	of	ADP
fnp-5347	104	26	69	69	NUM
fnp-5347	104	27	mutated	mutate	VERB
fnp-5347	104	28	candidate	candidate	NOUN
fnp-5347	104	29	genes	gene	NOUN
fnp-5347	104	30	.	.	PUNCT
fnp-5347	105	1	they	they	PRON
fnp-5347	105	2	had	have	VERB
fnp-5347	105	3	access	access	NOUN
fnp-5347	105	4	to	to	ADP
fnp-5347	105	5	whole	whole	ADJ
fnp-5347	105	6	exome	exome	NOUN
fnp-5347	105	7	sequencing	sequence	VERB
fnp-5347	105	8	and	and	CCONJ
fnp-5347	105	9	targeted	target	VERB
fnp-5347	105	10	-	-	PUNCT
fnp-5347	105	11	amplicon	amplicon	NOUN
fnp-5347	105	12	sequencing	sequencing	NOUN
fnp-5347	105	13	platforms	platform	NOUN
fnp-5347	105	14	,	,	PUNCT
fnp-5347	105	15	and	and	CCONJ
fnp-5347	105	16	included	include	VERB
fnp-5347	105	17	in	in	ADP
fnp-5347	105	18	utero	utero	ADJ
fnp-5347	105	19	electroporation	electroporation	NOUN
fnp-5347	105	20	of	of	ADP
fnp-5347	105	21	the	the	DET
fnp-5347	105	22	developing	develop	VERB
fnp-5347	105	23	mouse	mouse	NOUN
fnp-5347	105	24	brain	brain	NOUN
fnp-5347	105	25	to	to	PART
fnp-5347	105	26	test	test	VERB
fnp-5347	105	27	the	the	DET
fnp-5347	105	28	effect	effect	NOUN
fnp-5347	105	29	of	of	ADP
fnp-5347	105	30	their	their	PRON
fnp-5347	105	31	newly	newly	ADV
fnp-5347	105	32	discovered	discover	VERB
fnp-5347	105	33	genetic	genetic	ADJ
fnp-5347	105	34	variants	variant	NOUN
fnp-5347	105	35	.	.	PUNCT
fnp-5347	106	1	finally	finally	ADV
fnp-5347	106	2	,	,	PUNCT
fnp-5347	106	3	single	single	ADJ
fnp-5347	106	4	-	-	PUNCT
fnp-5347	106	5	nucleus	nucleus	NOUN
fnp-5347	106	6	rna	rna	NOUN
fnp-5347	106	7	sequencing	sequencing	NOUN
fnp-5347	106	8	was	be	AUX
fnp-5347	106	9	employed	employ	VERB
fnp-5347	106	10	to	to	PART
fnp-5347	106	11	learn	learn	VERB
fnp-5347	106	12	about	about	ADP
fnp-5347	106	13	the	the	DET
fnp-5347	106	14	spatial	spatial	ADJ
fnp-5347	106	15	gene	gene	NOUN
fnp-5347	106	16	expression	expression	NOUN
fnp-5347	106	17	patterns	pattern	NOUN
fnp-5347	106	18	and	and	CCONJ
fnp-5347	106	19	enriched	enriched	ADJ
fnp-5347	106	20	cell	cell	NOUN
fnp-5347	106	21	populations	population	NOUN
fnp-5347	106	22	which	which	PRON
fnp-5347	106	23	may	may	AUX
fnp-5347	106	24	help	help	VERB
fnp-5347	106	25	to	to	PART
fnp-5347	106	26	better	well	ADV
fnp-5347	106	27	understand	understand	VERB
fnp-5347	106	28	the	the	DET
fnp-5347	106	29	underlying	underlie	VERB
fnp-5347	106	30	pathomechanisms	pathomechanism	NOUN
fnp-5347	106	31	of	of	ADP
fnp-5347	106	32	mcd	mcd	NOUN
fnp-5347	106	33	.	.	PUNCT
fnp-5347	107	1	the	the	DET
fnp-5347	107	2	most	most	ADV
fnp-5347	107	3	commonly	commonly	ADV
fnp-5347	107	4	affected	affect	VERB
fnp-5347	107	5	genes	gene	NOUN
fnp-5347	107	6	were	be	AUX
fnp-5347	107	7	,	,	PUNCT
fnp-5347	107	8	however	however	ADV
fnp-5347	107	9	,	,	PUNCT
fnp-5347	107	10	the	the	DET
fnp-5347	107	11	already	already	ADV
fnp-5347	107	12	well	well	ADV
fnp-5347	107	13	-	-	PUNCT
fnp-5347	107	14	known	know	VERB
fnp-5347	107	15	candidates	candidate	NOUN
fnp-5347	107	16	mtor	mtor	NOUN
fnp-5347	107	17	,	,	PUNCT
fnp-5347	107	18	pik3ca	pik3ca	NOUN
fnp-5347	107	19	,	,	PUNCT
fnp-5347	107	20	slc35a2	slc35a2	NOUN
fnp-5347	107	21	,	,	PUNCT
fnp-5347	107	22	tsc2	tsc2	NOUN
fnp-5347	107	23	,	,	PUNCT
fnp-5347	107	24	akt3	akt3	NOUN
fnp-5347	107	25	and	and	CCONJ
fnp-5347	107	26	braf	braf	NOUN
fnp-5347	107	27	.	.	PUNCT
fnp-5347	108	1	cheung	cheung	PROPN
fnp-5347	108	2	et	et	PROPN
fnp-5347	108	3	al	al	PROPN
fnp-5347	108	4	.	.	PROPN
fnp-5347	108	5	comprehensively	comprehensively	ADV
fnp-5347	108	6	studied	study	VERB
fnp-5347	108	7	their	their	PRON
fnp-5347	108	8	dataset	dataset	NOUN
fnp-5347	108	9	from	from	ADP
fnp-5347	108	10	various	various	ADJ
fnp-5347	108	11	angles	angle	NOUN
fnp-5347	108	12	.	.	PUNCT
fnp-5347	109	1	firstly	firstly	ADV
fnp-5347	109	2	,	,	PUNCT
fnp-5347	109	3	their	their	PRON
fnp-5347	109	4	analysis	analysis	NOUN
fnp-5347	109	5	of	of	ADP
fnp-5347	109	6	genes	gene	NOUN
fnp-5347	109	7	mutated	mutate	VERB
fnp-5347	109	8	in	in	ADP
fnp-5347	109	9	mcd	mcd	NOUN
fnp-5347	109	10	highlighted	highlight	VERB
fnp-5347	109	11	four	four	NUM
fnp-5347	109	12	affected	affected	ADJ
fnp-5347	109	13	gene	gene	NOUN
fnp-5347	109	14	networks	network	NOUN
fnp-5347	109	15	.	.	PUNCT
fnp-5347	110	1	the	the	DET
fnp-5347	110	2	largest	large	ADJ
fnp-5347	110	3	and	and	CCONJ
fnp-5347	110	4	most	most	ADV
fnp-5347	110	5	prominent	prominent	ADJ
fnp-5347	110	6	cluster	cluster	NOUN
fnp-5347	110	7	pointed	point	VERB
fnp-5347	110	8	to	to	ADP
fnp-5347	110	9	the	the	DET
fnp-5347	110	10	well	well	ADV
fnp-5347	110	11	-	-	PUNCT
fnp-5347	110	12	known	know	VERB
fnp-5347	110	13	mtor	mtor	NOUN
fnp-5347	110	14	-	-	PUNCT
fnp-5347	110	15	map	map	NOUN
fnp-5347	110	16	kinase	kinase	PROPN
fnp-5347	110	17	pathway	pathway	NOUN
fnp-5347	110	18	,	,	PUNCT
fnp-5347	110	19	in	in	ADP
fnp-5347	110	20	addition	addition	NOUN
fnp-5347	110	21	to	to	ADP
fnp-5347	110	22	a	a	DET
fnp-5347	110	23	calcium	calcium	NOUN
fnp-5347	110	24	dynamics	dynamic	NOUN
fnp-5347	110	25	cluster	cluster	NOUN
fnp-5347	110	26	,	,	PUNCT
fnp-5347	110	27	a	a	DET
fnp-5347	110	28	synapse	synapse	NOUN
fnp-5347	110	29	cluster	cluster	NOUN
fnp-5347	110	30	and	and	CCONJ
fnp-5347	110	31	a	a	DET
fnp-5347	110	32	cluster	cluster	NOUN
fnp-5347	110	33	aligned	align	VERB
fnp-5347	110	34	to	to	ADP
fnp-5347	110	35	gene	gene	NOUN
fnp-5347	110	36	expression	expression	NOUN
fnp-5347	110	37	.	.	PUNCT
fnp-5347	111	1	then	then	ADV
fnp-5347	111	2	,	,	PUNCT
fnp-5347	111	3	the	the	DET
fnp-5347	111	4	newly	newly	ADV
fnp-5347	111	5	identified	identify	VERB
fnp-5347	111	6	gene	gene	NOUN
fnp-5347	111	7	variants	variant	NOUN
fnp-5347	111	8	of	of	ADP
fnp-5347	111	9	praga	praga	NOUN
fnp-5347	111	10	,	,	PUNCT
fnp-5347	111	11	grin2c	grin2c	NOUN
fnp-5347	111	12	and	and	CCONJ
fnp-5347	111	13	klhl22	klhl22	PROPN
fnp-5347	111	14	were	be	AUX
fnp-5347	111	15	electroporated	electroporate	VERB
fnp-5347	111	16	into	into	ADP
fnp-5347	111	17	the	the	DET
fnp-5347	111	18	developing	develop	VERB
fnp-5347	111	19	mouse	mouse	NOUN
fnp-5347	111	20	brain	brain	NOUN
fnp-5347	111	21	and	and	CCONJ
fnp-5347	111	22	revealed	reveal	VERB
fnp-5347	111	23	functional	functional	ADJ
fnp-5347	111	24	(	(	PUNCT
fnp-5347	111	25	migration	migration	NOUN
fnp-5347	111	26	)	)	PUNCT
fnp-5347	111	27	defects	defect	NOUN
fnp-5347	111	28	resembling	resemble	VERB
fnp-5347	111	29	that	that	PRON
fnp-5347	111	30	of	of	ADP
fnp-5347	111	31	a	a	DET
fnp-5347	111	32	cortical	cortical	ADJ
fnp-5347	111	33	malformation	malformation	NOUN
fnp-5347	111	34	.	.	PUNCT
fnp-5347	112	1	thirdly	thirdly	ADV
fnp-5347	112	2	,	,	PUNCT
fnp-5347	112	3	their	their	PRON
fnp-5347	112	4	genotype	genotype	NOUN
fnp-5347	112	5	-	-	PUNCT
fnp-5347	112	6	phenotype	phenotype	NOUN
fnp-5347	112	7	correlation	correlation	NOUN
fnp-5347	112	8	highlighted	highlight	VERB
fnp-5347	112	9	an	an	DET
fnp-5347	112	10	association	association	NOUN
fnp-5347	112	11	of	of	ADP
fnp-5347	112	12	fcd	fcd	ADJ
fnp-5347	112	13	ilae	ilae	NOUN
fnp-5347	112	14	type	type	NOUN
fnp-5347	112	15	2b	2b	NOUN
fnp-5347	112	16	and	and	CCONJ
fnp-5347	112	17	2a	2a	NUM
fnp-5347	112	18	with	with	ADP
fnp-5347	112	19	mtor	mtor	PROPN
fnp-5347	112	20	rather	rather	ADV
fnp-5347	112	21	than	than	ADP
fnp-5347	112	22	map	map	NOUN
fnp-5347	112	23	-	-	PUNCT
fnp-5347	112	24	kinase	kinase	ADJ
fnp-5347	112	25	pathways	pathway	NOUN
fnp-5347	112	26	.	.	PUNCT
fnp-5347	113	1	this	this	DET
fnp-5347	113	2	association	association	NOUN
fnp-5347	113	3	has	have	AUX
fnp-5347	113	4	been	be	AUX
fnp-5347	113	5	now	now	ADV
fnp-5347	113	6	consistently	consistently	ADV
fnp-5347	113	7	reported	report	VERB
fnp-5347	113	8	[	[	X
fnp-5347	113	9	23	23	NUM
fnp-5347	113	10	]	]	PUNCT
fnp-5347	113	11	and	and	CCONJ
fnp-5347	113	12	will	will	AUX
fnp-5347	113	13	be	be	AUX
fnp-5347	113	14	further	far	ADV
fnp-5347	113	15	discussed	discuss	VERB
fnp-5347	113	16	in	in	ADP
fnp-5347	113	17	the	the	DET
fnp-5347	113	18	chapter	chapter	NOUN
fnp-5347	113	19	below	below	ADV
fnp-5347	113	20	.	.	PUNCT
fnp-5347	114	1	finally	finally	ADV
fnp-5347	114	2	,	,	PUNCT
fnp-5347	114	3	they	they	PRON
fnp-5347	114	4	studied	study	VERB
fnp-5347	114	5	single	single	ADJ
fnp-5347	114	6	-	-	PUNCT
fnp-5347	114	7	nucleus	nucleus	NOUN
fnp-5347	114	8	spatial	spatial	ADJ
fnp-5347	114	9	transcriptomics	transcriptomic	NOUN
fnp-5347	114	10	of	of	ADP
fnp-5347	114	11	mutated	mutate	VERB
fnp-5347	114	12	genes	gene	NOUN
fnp-5347	114	13	obtained	obtain	VERB
fnp-5347	114	14	from	from	ADP
fnp-5347	114	15	patient	patient	ADJ
fnp-5347	114	16	samples	sample	NOUN
fnp-5347	114	17	versus	versus	ADP
fnp-5347	114	18	controls	control	NOUN
fnp-5347	114	19	,	,	PUNCT
fnp-5347	114	20	which	which	PRON
fnp-5347	114	21	indicated	indicate	VERB
fnp-5347	114	22	a	a	DET
fnp-5347	114	23	critical	critical	ADJ
fnp-5347	114	24	role	role	NOUN
fnp-5347	114	25	in	in	ADP
fnp-5347	114	26	excitatory	excitatory	ADJ
fnp-5347	114	27	neurogenic	neurogenic	ADJ
fnp-5347	114	28	cell	cell	NOUN
fnp-5347	114	29	pools	pool	NOUN
fnp-5347	114	30	during	during	ADP
fnp-5347	114	31	brain	brain	NOUN
fnp-5347	114	32	development	development	NOUN
fnp-5347	114	33	,	,	PUNCT
fnp-5347	114	34	and	and	CCONJ
fnp-5347	114	35	further	far	ADV
fnp-5347	114	36	supported	support	VERB
fnp-5347	114	37	the	the	DET
fnp-5347	114	38	neurobiological	neurobiological	ADJ
fnp-5347	114	39	basis	basis	NOUN
fnp-5347	114	40	for	for	ADP
fnp-5347	114	41	enhanced	enhanced	ADJ
fnp-5347	114	42	neuronal	neuronal	ADJ
fnp-5347	114	43	hyperexcitability	hyperexcitability	NOUN
fnp-5347	114	44	in	in	ADP
fnp-5347	114	45	the	the	DET
fnp-5347	114	46	epileptogenic	epileptogenic	ADJ
fnp-5347	114	47	brain	brain	NOUN
fnp-5347	114	48	.	.	PUNCT
fnp-5347	115	1	of	of	ADP
fnp-5347	115	2	note	note	NOUN
fnp-5347	115	3	,	,	PUNCT
fnp-5347	115	4	all	all	DET
fnp-5347	115	5	slc35a2	slc35a2	ADV
fnp-5347	115	6	mutated	mutate	VERB
fnp-5347	115	7	cases	case	NOUN
fnp-5347	115	8	were	be	AUX
fnp-5347	115	9	histopathologically	histopathologically	ADV
fnp-5347	115	10	classified	classify	VERB
fnp-5347	115	11	as	as	ADP
fnp-5347	115	12	fcd	fcd	NOUN
fnp-5347	115	13	1	1	NUM
fnp-5347	115	14	and	and	CCONJ
fnp-5347	115	15	the	the	DET
fnp-5347	115	16	braf	braf	NOUN
fnp-5347	115	17	cases	case	NOUN
fnp-5347	115	18	as	as	ADP
fnp-5347	115	19	fcd	fcd	NOUN
fnp-5347	115	20	3	3	NUM
fnp-5347	115	21	.	.	PUNCT
fnp-5347	116	1	this	this	PRON
fnp-5347	116	2	is	be	AUX
fnp-5347	116	3	likely	likely	ADJ
fnp-5347	116	4	a	a	DET
fnp-5347	116	5	histopathology	histopathology	NOUN
fnp-5347	116	6	-	-	PUNCT
fnp-5347	116	7	disagreement	disagreement	NOUN
fnp-5347	116	8	error	error	NOUN
fnp-5347	116	9	frequently	frequently	ADV
fnp-5347	116	10	encountered	encounter	VERB
fnp-5347	116	11	in	in	ADP
fnp-5347	116	12	the	the	DET
fnp-5347	116	13	histopathology	histopathology	NOUN
fnp-5347	116	14	work	work	NOUN
fnp-5347	116	15	-	-	PUNCT
fnp-5347	116	16	up	up	NOUN
fnp-5347	116	17	of	of	ADP
fnp-5347	116	18	epilepsy	epilepsy	ADJ
fnp-5347	116	19	surgery	surgery	NOUN
fnp-5347	116	20	tissue	tissue	NOUN
fnp-5347	116	21	samples	sample	NOUN
fnp-5347	116	22	and	and	CCONJ
fnp-5347	116	23	this	this	DET
fnp-5347	116	24	discussion	discussion	NOUN
fnp-5347	116	25	will	will	AUX
fnp-5347	116	26	be	be	AUX
fnp-5347	116	27	continued	continue	VERB
fnp-5347	116	28	below	below	ADV
fnp-5347	116	29	.	.	PUNCT
fnp-5347	117	1	in	in	ADP
fnp-5347	117	2	fact	fact	NOUN
fnp-5347	117	3	,	,	PUNCT
fnp-5347	117	4	re	re	VERB
fnp-5347	117	5	-	-	NOUN
fnp-5347	117	6	review	review	NOUN
fnp-5347	117	7	of	of	ADP
fnp-5347	117	8	published	publish	VERB
fnp-5347	117	9	cases	case	NOUN
fnp-5347	117	10	carrying	carry	VERB
fnp-5347	117	11	a	a	DET
fnp-5347	117	12	slc35a2	slc35a2	NOUN
fnp-5347	117	13	gene	gene	NOUN
fnp-5347	117	14	mutation	mutation	NOUN
fnp-5347	117	15	were	be	AUX
fnp-5347	117	16	frequently	frequently	ADV
fnp-5347	117	17	re	re	VERB
fnp-5347	117	18	-	-	VERB
fnp-5347	117	19	classified	classified	ADJ
fnp-5347	117	20	as	as	ADP
fnp-5347	117	21	moghe	moghe	NOUN
fnp-5347	117	22	[	[	X
fnp-5347	117	23	6	6	NUM
fnp-5347	117	24	,	,	PUNCT
fnp-5347	117	25	10	10	NUM
fnp-5347	117	26	,	,	PUNCT
fnp-5347	117	27	12	12	NUM
fnp-5347	117	28	]	]	PUNCT
fnp-5347	117	29	.	.	PUNCT
fnp-5347	118	1	the	the	DET
fnp-5347	118	2	braf	braf	NOUN
fnp-5347	118	3	mutations	mutation	NOUN
fnp-5347	118	4	described	describe	VERB
fnp-5347	118	5	by	by	ADP
fnp-5347	118	6	cheung	cheung	PROPN
fnp-5347	118	7	and	and	CCONJ
fnp-5347	118	8	colleagues	colleague	NOUN
fnp-5347	118	9	most	most	ADV
fnp-5347	118	10	likely	likely	ADV
fnp-5347	118	11	represents	represent	VERB
fnp-5347	118	12	ganglioglioma	ganglioglioma	ADJ
fnp-5347	118	13	tumor	tumor	NOUN
fnp-5347	118	14	cell	cell	NOUN
fnp-5347	118	15	infiltration	infiltration	NOUN
fnp-5347	118	16	into	into	ADP
fnp-5347	118	17	surrounding	surround	VERB
fnp-5347	118	18	brain	brain	NOUN
fnp-5347	118	19	tissue	tissue	NOUN
fnp-5347	118	20	,	,	PUNCT
fnp-5347	118	21	which	which	PRON
fnp-5347	118	22	is	be	AUX
fnp-5347	118	23	often	often	ADV
fnp-5347	118	24	regarded	regard	VERB
fnp-5347	118	25	as	as	ADP
fnp-5347	118	26	an	an	DET
fnp-5347	118	27	associated	associated	ADJ
fnp-5347	118	28	fcd	fcd	NOUN
fnp-5347	118	29	ilae	ilae	NOUN
fnp-5347	118	30	type	type	NOUN
fnp-5347	118	31	3b	3b	NOUN
fnp-5347	118	32	.	.	PUNCT
fnp-5347	119	1	as	as	ADP
fnp-5347	119	2	another	another	DET
fnp-5347	119	3	example	example	NOUN
fnp-5347	119	4	for	for	ADP
fnp-5347	119	5	disagreement	disagreement	NOUN
fnp-5347	119	6	in	in	ADP
fnp-5347	119	7	histopathology	histopathology	NOUN
fnp-5347	119	8	diagnosis	diagnosis	NOUN
fnp-5347	119	9	,	,	PUNCT
fnp-5347	119	10	however	however	ADV
fnp-5347	119	11	,	,	PUNCT
fnp-5347	119	12	a	a	DET
fnp-5347	119	13	recently	recently	ADV
fnp-5347	119	14	published	publish	VERB
fnp-5347	119	15	paper	paper	NOUN
fnp-5347	119	16	claimed	claim	VERB
fnp-5347	119	17	a	a	DET
fnp-5347	119	18	new	new	ADJ
fnp-5347	119	19	diagnostic	diagnostic	ADJ
fnp-5347	119	20	entity	entity	NOUN
fnp-5347	119	21	with	with	ADP
fnp-5347	119	22	braf	braf	NOUN
fnp-5347	119	23	mutated	mutate	VERB
fnp-5347	119	24	cells	cell	NOUN
fnp-5347	119	25	invading	invade	VERB
fnp-5347	119	26	/	/	SYM
fnp-5347	119	27	infiltrating	infiltrate	VERB
fnp-5347	119	28	the	the	DET
fnp-5347	119	29	hippocampus	hippocampus	NOUN
fnp-5347	119	30	[	[	X
fnp-5347	119	31	29	29	NUM
fnp-5347	119	32	]	]	PUNCT
fnp-5347	119	33	.	.	PUNCT
fnp-5347	120	1	such	such	ADJ
fnp-5347	120	2	cases	case	NOUN
fnp-5347	120	3	have	have	AUX
fnp-5347	120	4	been	be	AUX
fnp-5347	120	5	seen	see	VERB
fnp-5347	120	6	also	also	ADV
fnp-5347	120	7	in	in	ADP
fnp-5347	120	8	our	our	PRON
fnp-5347	120	9	routine	routine	ADJ
fnp-5347	120	10	practice	practice	NOUN
fnp-5347	120	11	but	but	CCONJ
fnp-5347	120	12	regarded	regard	VERB
fnp-5347	120	13	rather	rather	ADV
fnp-5347	120	14	as	as	ADP
fnp-5347	120	15	remnants	remnant	NOUN
fnp-5347	120	16	of	of	ADP
fnp-5347	120	17	a	a	DET
fnp-5347	120	18	ganglioglioma	ganglioglioma	NOUN
fnp-5347	120	19	infiltrating	infiltrate	VERB
fnp-5347	120	20	the	the	DET
fnp-5347	120	21	hippocampus	hippocampus	NOUN
fnp-5347	120	22	.	.	PUNCT
fnp-5347	121	1	cheung	cheung	PROPN
fnp-5347	121	2	and	and	CCONJ
fnp-5347	121	3	coworkers	coworker	NOUN
fnp-5347	121	4	also	also	ADV
fnp-5347	121	5	briefly	briefly	ADV
fnp-5347	121	6	mention	mention	VERB
fnp-5347	121	7	ptpn11	ptpn11	NOUN
fnp-5347	121	8	as	as	ADP
fnp-5347	121	9	new	new	ADJ
fnp-5347	121	10	lesional	lesional	ADJ
fnp-5347	121	11	epilepsy	epilepsy	NOUN
fnp-5347	121	12	gene	gene	NOUN
fnp-5347	121	13	.	.	PUNCT
fnp-5347	122	1	two	two	NUM
fnp-5347	122	2	other	other	ADJ
fnp-5347	122	3	studies	study	NOUN
fnp-5347	122	4	have	have	AUX
fnp-5347	122	5	made	make	VERB
fnp-5347	122	6	the	the	DET
fnp-5347	122	7	same	same	ADJ
fnp-5347	122	8	observation	observation	NOUN
fnp-5347	122	9	but	but	CCONJ
fnp-5347	122	10	at	at	ADP
fnp-5347	122	11	a	a	DET
fnp-5347	122	12	much	much	ADV
fnp-5347	122	13	larger	large	ADJ
fnp-5347	122	14	frequency	frequency	NOUN
fnp-5347	122	15	of	of	ADP
fnp-5347	122	16	affected	affect	VERB
fnp-5347	122	17	samples	sample	NOUN
fnp-5347	122	18	and	and	CCONJ
fnp-5347	122	19	diagnostic	diagnostic	ADJ
fnp-5347	122	20	emphasis	emphasis	NOUN
fnp-5347	122	21	.	.	PUNCT
fnp-5347	123	1	in	in	ADP
fnp-5347	123	2	the	the	DET
fnp-5347	123	3	second	second	ADJ
fnp-5347	123	4	paper	paper	NOUN
fnp-5347	123	5	,	,	PUNCT
fnp-5347	123	6	lópez	lópez	NOUN
fnp-5347	123	7	-	-	PUNCT
fnp-5347	123	8	rivera	rivera	PROPN
fnp-5347	123	9	and	and	CCONJ
fnp-5347	123	10	coworkers	coworker	NOUN
fnp-5347	123	11	examined	examine	VERB
fnp-5347	123	12	a	a	DET
fnp-5347	123	13	total	total	NOUN
fnp-5347	123	14	of	of	ADP
fnp-5347	123	15	474	474	NUM
fnp-5347	123	16	new	new	ADJ
fnp-5347	123	17	samples	sample	NOUN
fnp-5347	123	18	not	not	PART
fnp-5347	123	19	previously	previously	ADV
fnp-5347	123	20	reported	report	VERB
fnp-5347	123	21	in	in	ADP
fnp-5347	123	22	other	other	ADJ
fnp-5347	123	23	studies	study	NOUN
fnp-5347	123	24	[	[	X
fnp-5347	123	25	30	30	NUM
fnp-5347	123	26	]	]	PUNCT
fnp-5347	123	27	.	.	PUNCT
fnp-5347	124	1	the	the	DET
fnp-5347	124	2	surgical	surgical	ADJ
fnp-5347	124	3	tissues	tissue	NOUN
fnp-5347	124	4	were	be	AUX
fnp-5347	124	5	selected	select	VERB
fnp-5347	124	6	from	from	ADP
fnp-5347	124	7	four	four	NUM
fnp-5347	124	8	different	different	ADJ
fnp-5347	124	9	centers	center	NOUN
fnp-5347	124	10	in	in	ADP
fnp-5347	124	11	germany	germany	PROPN
fnp-5347	124	12	and	and	CCONJ
fnp-5347	124	13	the	the	DET
fnp-5347	124	14	us	us	PROPN
fnp-5347	124	15	.	.	PUNCT
fnp-5347	125	1	histopathology	histopathology	NOUN
fnp-5347	125	2	diagnosis	diagnosis	NOUN
fnp-5347	125	3	covering	cover	VERB
fnp-5347	125	4	the	the	DET
fnp-5347	125	5	spectrum	spectrum	NOUN
fnp-5347	125	6	of	of	ADP
fnp-5347	125	7	mcd	mcd	PROPN
fnp-5347	125	8	(	(	PUNCT
fnp-5347	125	9	n	n	CCONJ
fnp-5347	125	10	 	 	SPACE
fnp-5347	125	11	=	=	NOUN
fnp-5347	125	12	 	 	SPACE
fnp-5347	125	13	223	223	NUM
fnp-5347	125	14	)	)	PUNCT
fnp-5347	125	15	,	,	PUNCT
fnp-5347	125	16	leat	leat	NOUN
fnp-5347	125	17	(	(	PUNCT
fnp-5347	125	18	n	n	CCONJ
fnp-5347	125	19	 	 	SPACE
fnp-5347	125	20	=	=	NOUN
fnp-5347	125	21	 	 	SPACE
fnp-5347	125	22	154	154	NUM
fnp-5347	125	23	)	)	PUNCT
fnp-5347	125	24	and	and	CCONJ
fnp-5347	125	25	hippocampal	hippocampal	ADJ
fnp-5347	125	26	sclerosis	sclerosis	NOUN
fnp-5347	125	27	(	(	PUNCT
fnp-5347	125	28	n	n	CCONJ
fnp-5347	125	29	 	 	SPACE
fnp-5347	125	30	=	=	NOUN
fnp-5347	125	31	 	 	SPACE
fnp-5347	125	32	97	97	NUM
fnp-5347	125	33	)	)	PUNCT
fnp-5347	125	34	were	be	AUX
fnp-5347	125	35	included	include	VERB
fnp-5347	125	36	.	.	PUNCT
fnp-5347	126	1	they	they	PRON
fnp-5347	126	2	reported	report	VERB
fnp-5347	126	3	nineteen	nineteen	NUM
fnp-5347	126	4	genes	gene	NOUN
fnp-5347	126	5	of	of	ADP
fnp-5347	126	6	interest	interest	NOUN
fnp-5347	126	7	and	and	CCONJ
fnp-5347	126	8	reported	report	VERB
fnp-5347	126	9	153	153	NUM
fnp-5347	126	10	samples	sample	NOUN
fnp-5347	126	11	carrying	carry	VERB
fnp-5347	126	12	at	at	ADP
fnp-5347	126	13	least	least	ADV
fnp-5347	126	14	one	one	NUM
fnp-5347	126	15	single	single	ADJ
fnp-5347	126	16	nucleotide	nucleotide	ADJ
fnp-5347	126	17	variant	variant	NOUN
fnp-5347	126	18	,	,	PUNCT
fnp-5347	126	19	copy	copy	VERB
fnp-5347	126	20	number	number	NOUN
fnp-5347	126	21	variant	variant	NOUN
fnp-5347	126	22	or	or	CCONJ
fnp-5347	126	23	loss	loss	NOUN
fnp-5347	126	24	of	of	ADP
fnp-5347	126	25	heterozygosity	heterozygosity	NOUN
fnp-5347	126	26	affecting	affect	VERB
fnp-5347	126	27	31.4	31.4	NUM
fnp-5347	126	28	 	 	SPACE
fnp-5347	126	29	%	%	NOUN
fnp-5347	126	30	of	of	ADP
fnp-5347	126	31	the	the	DET
fnp-5347	126	32	entire	entire	ADJ
fnp-5347	126	33	cohort	cohort	NOUN
fnp-5347	126	34	,	,	PUNCT
fnp-5347	126	35	7.2	7.2	NUM
fnp-5347	126	36	 	 	SPACE
fnp-5347	126	37	%	%	NOUN
fnp-5347	126	38	of	of	ADP
fnp-5347	126	39	hs	hs	PROPN
fnp-5347	126	40	,	,	PUNCT
fnp-5347	126	41	31.8	31.8	NUM
fnp-5347	126	42	 	 	SPACE
fnp-5347	126	43	%	%	NOUN
fnp-5347	126	44	of	of	ADP
fnp-5347	126	45	mcd	mcd	NOUN
fnp-5347	126	46	and	and	CCONJ
fnp-5347	126	47	51.9	51.9	NUM
fnp-5347	126	48	 	 	SPACE
fnp-5347	126	49	%	%	NOUN
fnp-5347	126	50	of	of	ADP
fnp-5347	126	51	leat	leat	NOUN
fnp-5347	126	52	.	.	PUNCT
fnp-5347	127	1	these	these	DET
fnp-5347	127	2	numbers	number	NOUN
fnp-5347	127	3	remain	remain	VERB
fnp-5347	127	4	low	low	ADJ
fnp-5347	127	5	despite	despite	SCONJ
fnp-5347	127	6	their	their	PRON
fnp-5347	127	7	effort	effort	NOUN
fnp-5347	127	8	to	to	PART
fnp-5347	127	9	use	use	VERB
fnp-5347	127	10	deep	deep	ADJ
fnp-5347	127	11	sequencing	sequencing	NOUN
fnp-5347	127	12	rates	rate	NOUN
fnp-5347	127	13	at	at	ADP
fnp-5347	127	14	a	a	DET
fnp-5347	127	15	mean	mean	ADJ
fnp-5347	127	16	depth	depth	NOUN
fnp-5347	127	17	of	of	ADP
fnp-5347	127	18	>	>	X
fnp-5347	127	19	 	 	SPACE
fnp-5347	127	20	350	350	NUM
fnp-5347	127	21	 	 	SPACE
fnp-5347	127	22	x.	x.	NOUN
fnp-5347	127	23	a	a	DET
fnp-5347	127	24	novel	novel	ADJ
fnp-5347	127	25	association	association	NOUN
fnp-5347	127	26	was	be	AUX
fnp-5347	127	27	histopathologically	histopathologically	ADV
fnp-5347	127	28	established	establish	VERB
fnp-5347	127	29	for	for	ADP
fnp-5347	127	30	ptpn11	ptpn11	NOUN
fnp-5347	127	31	with	with	ADP
fnp-5347	127	32	low	low	ADJ
fnp-5347	127	33	-	-	PUNCT
fnp-5347	127	34	grade	grade	NOUN
fnp-5347	127	35	epilepsy	epilepsy	NOUN
fnp-5347	127	36	-	-	PUNCT
fnp-5347	127	37	associated	associate	VERB
fnp-5347	127	38	brain	brain	NOUN
fnp-5347	127	39	tumors	tumor	NOUN
fnp-5347	127	40	(	(	PUNCT
fnp-5347	127	41	ganglioglioma	ganglioglioma	NOUN
fnp-5347	127	42	)	)	PUNCT
fnp-5347	127	43	,	,	PUNCT
fnp-5347	127	44	nras	nras	PROPN
fnp-5347	127	45	with	with	ADP
fnp-5347	127	46	a	a	DET
fnp-5347	127	47	complex	complex	ADJ
fnp-5347	127	48	mcd	mcd	NOUN
fnp-5347	127	49	including	include	VERB
fnp-5347	127	50	polymicrogyria	polymicrogyria	NOUN
fnp-5347	127	51	,	,	PUNCT
fnp-5347	127	52	and	and	CCONJ
fnp-5347	127	53	akt3	akt3	NOUN
fnp-5347	127	54	with	with	ADP
fnp-5347	127	55	fcd	fcd	PROPN
fnp-5347	127	56	2a	2a	NUM
fnp-5347	127	57	and	and	CCONJ
fnp-5347	127	58	hyaline	hyaline	ADJ
fnp-5347	127	59	astrocytic	astrocytic	ADJ
fnp-5347	127	60	inclusions	inclusion	NOUN
fnp-5347	127	61	(	(	PUNCT
fnp-5347	127	62	figure	figure	NOUN
fnp-5347	127	63	2	2	NUM
fnp-5347	127	64	)	)	PUNCT
fnp-5347	127	65	.	.	PUNCT
fnp-5347	128	1	in	in	ADP
fnp-5347	128	2	addition	addition	NOUN
fnp-5347	128	3	,	,	PUNCT
fnp-5347	128	4	chromosomal	chromosomal	ADJ
fnp-5347	128	5	losses	loss	NOUN
fnp-5347	128	6	for	for	ADP
fnp-5347	128	7	germline	germline	NOUN
fnp-5347	128	8	variants	variant	NOUN
fnp-5347	128	9	recognized	recognize	VERB
fnp-5347	128	10	for	for	ADP
fnp-5347	128	11	tsc2	tsc2	NOUN
fnp-5347	128	12	,	,	PUNCT
fnp-5347	128	13	depdc5	depdc5	PROPN
fnp-5347	128	14	and	and	CCONJ
fnp-5347	128	15	pten	pten	VERB
fnp-5347	128	16	were	be	AUX
fnp-5347	128	17	most	most	ADV
fnp-5347	128	18	compatible	compatible	ADJ
fnp-5347	128	19	with	with	ADP
fnp-5347	128	20	the	the	DET
fnp-5347	128	21	previously	previously	ADV
fnp-5347	128	22	proposed	propose	VERB
fnp-5347	128	23	second	second	ADJ
fnp-5347	128	24	hit	hit	VERB
fnp-5347	128	25	hypothesis	hypothesis	NOUN
fnp-5347	128	26	to	to	PART
fnp-5347	128	27	also	also	ADV
fnp-5347	128	28	play	play	VERB
fnp-5347	128	29	a	a	DET
fnp-5347	128	30	role	role	NOUN
fnp-5347	128	31	in	in	ADP
fnp-5347	128	32	the	the	DET
fnp-5347	128	33	etiopathology	etiopathology	NOUN
fnp-5347	128	34	of	of	ADP
fnp-5347	128	35	mcd	mcd	NOUN
fnp-5347	128	36	[	[	X
fnp-5347	128	37	36	36	NUM
fnp-5347	128	38	]	]	PUNCT
fnp-5347	128	39	.	.	PUNCT
fnp-5347	129	1	the	the	DET
fnp-5347	129	2	authors	author	NOUN
fnp-5347	129	3	then	then	ADV
fnp-5347	129	4	concluded	conclude	VERB
fnp-5347	129	5	to	to	PART
fnp-5347	129	6	design	design	VERB
fnp-5347	129	7	mcd	mcd	NOUN
fnp-5347	129	8	-	-	PUNCT
fnp-5347	129	9	specific	specific	ADJ
fnp-5347	129	10	panels	panel	NOUN
fnp-5347	129	11	for	for	ADP
fnp-5347	129	12	clinical	clinical	ADJ
fnp-5347	129	13	routine	routine	ADJ
fnp-5347	129	14	testing	testing	NOUN
fnp-5347	129	15	of	of	ADP
fnp-5347	129	16	surgical	surgical	ADJ
fnp-5347	129	17	samples	sample	NOUN
fnp-5347	129	18	to	to	PART
fnp-5347	129	19	support	support	VERB
fnp-5347	129	20	clinical	clinical	ADJ
fnp-5347	129	21	diagnosis	diagnosis	NOUN
fnp-5347	129	22	but	but	CCONJ
fnp-5347	129	23	also	also	ADV
fnp-5347	129	24	enable	enable	VERB
fnp-5347	129	25	targeted	targeted	ADJ
fnp-5347	129	26	treatment	treatment	NOUN
fnp-5347	129	27	in	in	ADP
fnp-5347	129	28	those	those	DET
fnp-5347	129	29	patients	patient	NOUN
fnp-5347	129	30	that	that	PRON
fnp-5347	129	31	failed	fail	VERB
fnp-5347	129	32	successful	successful	ADJ
fnp-5347	129	33	postsurgical	postsurgical	ADJ
fnp-5347	129	34	seizure	seizure	NOUN
fnp-5347	129	35	control	control	NOUN
fnp-5347	129	36	.	.	PUNCT
fnp-5347	130	1	a	a	DET
fnp-5347	130	2	third	third	ADJ
fnp-5347	130	3	,	,	PUNCT
fnp-5347	130	4	smaller	small	ADJ
fnp-5347	130	5	study	study	NOUN
fnp-5347	130	6	from	from	ADP
fnp-5347	130	7	the	the	DET
fnp-5347	130	8	us	us	PROPN
fnp-5347	130	9	enrolled	enrol	VERB
fnp-5347	130	10	surgical	surgical	ADJ
fnp-5347	130	11	brain	brain	NOUN
fnp-5347	130	12	tissue	tissue	NOUN
fnp-5347	130	13	samples	sample	NOUN
fnp-5347	130	14	obtained	obtain	VERB
fnp-5347	130	15	from	from	ADP
fnp-5347	130	16	50	50	NUM
fnp-5347	130	17	children	child	NOUN
fnp-5347	130	18	and	and	CCONJ
fnp-5347	130	19	used	use	VERB
fnp-5347	130	20	whole	whole	ADJ
fnp-5347	130	21	exome	exome	NOUN
fnp-5347	130	22	and	and	CCONJ
fnp-5347	130	23	rna	rna	NOUN
fnp-5347	130	24	sequencing	sequence	VERB
fnp-5347	130	25	[	[	X
fnp-5347	130	26	7	7	NUM
fnp-5347	130	27	]	]	PUNCT
fnp-5347	130	28	.	.	PUNCT
fnp-5347	131	1	overall	overall	ADJ
fnp-5347	131	2	,	,	PUNCT
fnp-5347	131	3	56	56	NUM
fnp-5347	131	4	 	 	SPACE
fnp-5347	131	5	%	%	NOUN
fnp-5347	131	6	of	of	ADP
fnp-5347	131	7	their	their	PRON
fnp-5347	131	8	patients	patient	NOUN
fnp-5347	131	9	could	could	AUX
fnp-5347	131	10	be	be	AUX
fnp-5347	131	11	explained	explain	VERB
fnp-5347	131	12	by	by	ADP
fnp-5347	131	13	genetic	genetic	ADJ
fnp-5347	131	14	findings	finding	NOUN
fnp-5347	131	15	,	,	PUNCT
fnp-5347	131	16	including	include	VERB
fnp-5347	131	17	the	the	DET
fnp-5347	131	18	slc35a2	slc35a2	NOUN
fnp-5347	131	19	gene	gene	NOUN
fnp-5347	131	20	and	and	CCONJ
fnp-5347	131	21	mtor	mtor	NOUN
fnp-5347	131	22	pathway	pathway	NOUN
fnp-5347	131	23	genes	gene	NOUN
fnp-5347	131	24	in	in	ADP
fnp-5347	131	25	mcd	mcd	NOUN
fnp-5347	131	26	,	,	PUNCT
fnp-5347	131	27	and	and	CCONJ
fnp-5347	131	28	map	map	NOUN
fnp-5347	131	29	-	-	PUNCT
fnp-5347	131	30	kinase	kinase	NOUN
fnp-5347	131	31	pathway	pathway	NOUN
fnp-5347	131	32	genes	gene	NOUN
fnp-5347	131	33	in	in	ADP
fnp-5347	131	34	tumors	tumor	NOUN
fnp-5347	131	35	.	.	PUNCT
fnp-5347	132	1	amongst	amongst	ADP
fnp-5347	132	2	the	the	DET
fnp-5347	132	3	map	map	NOUN
fnp-5347	132	4	-	-	PUNCT
fnp-5347	132	5	kinase	kinase	NOUN
fnp-5347	132	6	pathway	pathway	NOUN
fnp-5347	132	7	genes	gene	NOUN
fnp-5347	132	8	,	,	PUNCT
fnp-5347	132	9	the	the	DET
fnp-5347	132	10	authors	author	NOUN
fnp-5347	132	11	were	be	AUX
fnp-5347	132	12	the	the	DET
fnp-5347	132	13	first	first	ADJ
fnp-5347	132	14	to	to	PART
fnp-5347	132	15	report	report	VERB
fnp-5347	132	16	ptpn11	ptpn11	NOUN
fnp-5347	132	17	,	,	PUNCT
fnp-5347	132	18	which	which	PRON
fnp-5347	132	19	was	be	AUX
fnp-5347	132	20	detected	detect	VERB
fnp-5347	132	21	in	in	ADP
fnp-5347	132	22	two	two	NUM
fnp-5347	132	23	samples	sample	NOUN
fnp-5347	132	24	including	include	VERB
fnp-5347	132	25	fcd	fcd	ADJ
fnp-5347	132	26	iiia	iiia	NOUN
fnp-5347	132	27	and	and	CCONJ
fnp-5347	132	28	iiid	iiid	VERB
fnp-5347	132	29	.	.	PUNCT
fnp-5347	133	1	they	they	PRON
fnp-5347	133	2	also	also	ADV
fnp-5347	133	3	reported	report	VERB
fnp-5347	133	4	slc35a2	slc35a2	NOUN
fnp-5347	133	5	genotypes	genotype	NOUN
fnp-5347	133	6	in	in	ADP
fnp-5347	133	7	two	two	NUM
fnp-5347	133	8	patients	patient	NOUN
fnp-5347	133	9	with	with	ADP
fnp-5347	133	10	the	the	DET
fnp-5347	133	11	histopathology	histopathology	NOUN
fnp-5347	133	12	diagnosis	diagnosis	NOUN
fnp-5347	133	13	of	of	ADP
fnp-5347	133	14	fcd	fcd	PROPN
fnp-5347	133	15	ic	ic	NUM
fnp-5347	133	16	,	,	PUNCT
fnp-5347	133	17	but	but	CCONJ
fnp-5347	133	18	these	these	DET
fnp-5347	133	19	histopathology	histopathology	NOUN
fnp-5347	133	20	phenotype	phenotype	NOUN
fnp-5347	133	21	-	-	PUNCT
fnp-5347	133	22	genotype	genotype	NOUN
fnp-5347	133	23	correlations	correlation	NOUN
fnp-5347	133	24	may	may	AUX
fnp-5347	133	25	not	not	PART
fnp-5347	133	26	stand	stand	VERB
fnp-5347	133	27	an	an	DET
fnp-5347	133	28	independent	independent	ADJ
fnp-5347	133	29	second	second	ADJ
fnp-5347	133	30	review	review	NOUN
fnp-5347	133	31	.	.	PUNCT
fnp-5347	134	1	as	as	SCONJ
fnp-5347	134	2	mentioned	mention	VERB
fnp-5347	134	3	above	above	ADV
fnp-5347	134	4	,	,	PUNCT
fnp-5347	134	5	an	an	DET
fnp-5347	134	6	independent	independent	ADJ
fnp-5347	134	7	re	re	NOUN
fnp-5347	134	8	-	-	NOUN
fnp-5347	134	9	review	review	NOUN
fnp-5347	134	10	of	of	ADP
fnp-5347	134	11	previously	previously	ADV
fnp-5347	134	12	published	publish	VERB
fnp-5347	134	13	slc35a2	slc35a2	NOUN
fnp-5347	134	14	altered	alter	VERB
fnp-5347	134	15	samples	sample	NOUN
fnp-5347	134	16	identified	identify	VERB
fnp-5347	134	17	the	the	DET
fnp-5347	134	18	'	'	PUNCT
fnp-5347	134	19	new	new	ADJ
fnp-5347	134	20	disease	disease	NOUN
fnp-5347	134	21	entity	entity	NOUN
fnp-5347	134	22	'	'	PUNCT
fnp-5347	134	23	of	of	ADP
fnp-5347	134	24	moghe	moghe	NOUN
fnp-5347	134	25	to	to	PART
fnp-5347	134	26	be	be	AUX
fnp-5347	134	27	the	the	DET
fnp-5347	134	28	underlying	underlie	VERB
fnp-5347	134	29	pathology	pathology	NOUN
fnp-5347	134	30	rather	rather	ADV
fnp-5347	134	31	than	than	ADP
fnp-5347	134	32	any	any	DET
fnp-5347	134	33	fcd	fcd	NOUN
fnp-5347	134	34	or	or	CCONJ
fnp-5347	134	35	mmcd	mmcd	VERB
fnp-5347	134	36	subtypes	subtype	NOUN
fnp-5347	134	37	[	[	X
fnp-5347	134	38	6	6	NUM
fnp-5347	134	39	,	,	PUNCT
fnp-5347	134	40	12	12	NUM
fnp-5347	134	41	]	]	PUNCT
fnp-5347	134	42	.	.	PUNCT
fnp-5347	135	1	the	the	DET
fnp-5347	135	2	same	same	ADJ
fnp-5347	135	3	conclusion	conclusion	NOUN
fnp-5347	135	4	is	be	AUX
fnp-5347	135	5	drawn	draw	VERB
fnp-5347	135	6	from	from	ADP
fnp-5347	135	7	the	the	DET
fnp-5347	135	8	paper	paper	NOUN
fnp-5347	135	9	of	of	ADP
fnp-5347	135	10	carmen	carman	NOUN
fnp-5347	135	11	barba	barba	PROPN
fnp-5347	135	12	reviewing	review	VERB
fnp-5347	135	13	47	47	NUM
fnp-5347	135	14	patients	patient	NOUN
fnp-5347	135	15	with	with	ADP
fnp-5347	135	16	moghe	moghe	NOUN
fnp-5347	135	17	as	as	SCONJ
fnp-5347	135	18	discussed	discuss	VERB
fnp-5347	135	19	below	below	ADV
fnp-5347	135	20	(	(	PUNCT
fnp-5347	135	21	#	#	SYM
fnp-5347	135	22	4	4	NUM
fnp-5347	135	23	)	)	PUNCT
fnp-5347	135	24	.	.	PUNCT
fnp-5347	136	1	topic	topic	NOUN
fnp-5347	136	2	3	3	NUM
fnp-5347	136	3	:	:	PUNCT
fnp-5347	136	4	a	a	DET
fnp-5347	136	5	new	new	ADJ
fnp-5347	136	6	hypothesis	hypothesis	NOUN
fnp-5347	136	7	about	about	ADP
fnp-5347	136	8	regional	regional	ADJ
fnp-5347	136	9	mtor	mtor	NOUN
fnp-5347	136	10	gene	gene	NOUN
fnp-5347	136	11	variant	variant	ADJ
fnp-5347	136	12	accumulation	accumulation	NOUN
fnp-5347	136	13	in	in	ADP
fnp-5347	136	14	the	the	DET
fnp-5347	136	15	frontal	frontal	ADJ
fnp-5347	136	16	lobe	lobe	NOUN
fnp-5347	136	17	and	and	CCONJ
fnp-5347	136	18	map	map	NOUN
fnp-5347	136	19	-	-	PUNCT
fnp-5347	136	20	kinase	kinase	ADJ
fnp-5347	136	21	gene	gene	NOUN
fnp-5347	136	22	variant	variant	NOUN
fnp-5347	136	23	accumulation	accumulation	NOUN
fnp-5347	136	24	in	in	ADP
fnp-5347	136	25	the	the	DET
fnp-5347	136	26	temporal	temporal	ADJ
fnp-5347	136	27	lobe	lobe	VERB
fnp-5347	136	28	the	the	DET
fnp-5347	136	29	genomic	genomic	ADJ
fnp-5347	136	30	landscape	landscape	NOUN
fnp-5347	136	31	of	of	ADP
fnp-5347	136	32	focal	focal	ADJ
fnp-5347	136	33	lesional	lesional	ADJ
fnp-5347	136	34	epilepsy	epilepsy	NOUN
fnp-5347	136	35	gets	get	AUX
fnp-5347	136	36	better	well	ADV
fnp-5347	136	37	recognized	recognize	VERB
fnp-5347	136	38	as	as	SCONJ
fnp-5347	136	39	large	large	ADJ
fnp-5347	136	40	enough	enough	ADJ
fnp-5347	136	41	patient	patient	ADJ
fnp-5347	136	42	series	series	NOUN
fnp-5347	136	43	are	be	AUX
fnp-5347	136	44	examined	examine	VERB
fnp-5347	136	45	.	.	PUNCT
fnp-5347	137	1	however	however	ADV
fnp-5347	137	2	,	,	PUNCT
fnp-5347	137	3	it	it	PRON
fnp-5347	137	4	remained	remain	VERB
fnp-5347	137	5	a	a	DET
fnp-5347	137	6	hitherto	hitherto	NOUN
fnp-5347	137	7	open	open	ADJ
fnp-5347	137	8	question	question	NOUN
fnp-5347	137	9	why	why	SCONJ
fnp-5347	137	10	some	some	DET
fnp-5347	137	11	lesions	lesion	NOUN
fnp-5347	137	12	and	and	CCONJ
fnp-5347	137	13	their	their	PRON
fnp-5347	137	14	associated	associated	ADJ
fnp-5347	137	15	genetic	genetic	ADJ
fnp-5347	137	16	alterations	alteration	NOUN
fnp-5347	137	17	occur	occur	VERB
fnp-5347	137	18	overwhelmingly	overwhelmingly	ADV
fnp-5347	137	19	frequent	frequent	ADJ
fnp-5347	137	20	in	in	ADP
fnp-5347	137	21	certain	certain	ADJ
fnp-5347	137	22	brain	brain	NOUN
fnp-5347	137	23	localizations	localization	NOUN
fnp-5347	137	24	.	.	PUNCT
fnp-5347	138	1	as	as	ADP
fnp-5347	138	2	a	a	DET
fnp-5347	138	3	prominent	prominent	ADJ
fnp-5347	138	4	example	example	NOUN
fnp-5347	138	5	,	,	PUNCT
fnp-5347	138	6	fcd	fcd	ADJ
fnp-5347	138	7	ilae	ilae	NOUN
fnp-5347	138	8	type	type	NOUN
fnp-5347	138	9	2	2	NUM
fnp-5347	138	10	lesions	lesion	NOUN
fnp-5347	138	11	carry	carry	AUX
fnp-5347	138	12	constitutively	constitutively	ADV
fnp-5347	138	13	activating	activate	VERB
fnp-5347	138	14	mtor	mtor	PROPN
fnp-5347	138	15	pathway	pathway	NOUN
fnp-5347	138	16	gene	gene	NOUN
fnp-5347	138	17	variants	variant	NOUN
fnp-5347	138	18	and	and	CCONJ
fnp-5347	138	19	occur	occur	VERB
fnp-5347	138	20	most	most	ADV
fnp-5347	138	21	frequently	frequently	ADV
fnp-5347	138	22	in	in	ADP
fnp-5347	138	23	the	the	DET
fnp-5347	138	24	frontal	frontal	ADJ
fnp-5347	138	25	lobe	lobe	NOUN
fnp-5347	138	26	,	,	PUNCT
fnp-5347	138	27	same	same	ADJ
fnp-5347	138	28	as	as	SCONJ
fnp-5347	138	29	do	do	AUX
fnp-5347	138	30	slc35a2	slc35a2	ADV
fnp-5347	138	31	altered	alter	VERB
fnp-5347	138	32	moghe	moghe	NOUN
fnp-5347	138	33	.	.	PUNCT
fnp-5347	139	1	in	in	ADP
fnp-5347	139	2	contrast	contrast	NOUN
fnp-5347	139	3	,	,	PUNCT
fnp-5347	139	4	gg	gg	NOUN
fnp-5347	139	5	and	and	CCONJ
fnp-5347	139	6	other	other	ADJ
fnp-5347	139	7	low	low	ADJ
fnp-5347	139	8	-	-	PUNCT
fnp-5347	139	9	grade	grade	NOUN
fnp-5347	139	10	epilepsy	epilepsy	NOUN
fnp-5347	139	11	associated	associated	ADJ
fnp-5347	139	12	brain	brain	NOUN
fnp-5347	139	13	tumors	tumor	NOUN
fnp-5347	139	14	(	(	PUNCT
fnp-5347	139	15	leat	leat	NOUN
fnp-5347	139	16	)	)	PUNCT
fnp-5347	139	17	overwhelmingly	overwhelmingly	ADV
fnp-5347	139	18	often	often	ADV
fnp-5347	139	19	carry	carry	VERB
fnp-5347	139	20	activating	activate	VERB
fnp-5347	139	21	map	map	NOUN
fnp-5347	139	22	-	-	PUNCT
fnp-5347	139	23	ras	ras	NOUN
fnp-5347	139	24	-	-	ADJ
fnp-5347	139	25	raf	raf	ADJ
fnp-5347	139	26	kinase	kinase	NOUN
fnp-5347	139	27	signaling	signal	VERB
fnp-5347	139	28	pathway	pathway	NOUN
fnp-5347	139	29	gene	gene	NOUN
fnp-5347	139	30	variants	variant	NOUN
fnp-5347	139	31	(	(	PUNCT
fnp-5347	139	32	e.g.	e.g.	ADV
fnp-5347	139	33	,	,	PUNCT
fnp-5347	139	34	braf	braf	NOUN
fnp-5347	139	35	or	or	CCONJ
fnp-5347	139	36	ptpn11	ptpn11	NOUN
fnp-5347	139	37	)	)	PUNCT
fnp-5347	139	38	and	and	CCONJ
fnp-5347	139	39	occur	occur	VERB
fnp-5347	139	40	predominantly	predominantly	ADV
fnp-5347	139	41	in	in	ADP
fnp-5347	139	42	the	the	DET
fnp-5347	139	43	temporal	temporal	ADJ
fnp-5347	139	44	lobe	lobe	NOUN
fnp-5347	139	45	.	.	PUNCT
fnp-5347	140	1	a	a	DET
fnp-5347	140	2	recent	recent	ADJ
fnp-5347	140	3	brain	brain	NOUN
fnp-5347	140	4	publication	publication	NOUN
fnp-5347	140	5	from	from	ADP
fnp-5347	140	6	macdonald	macdonald	PROPN
fnp-5347	140	7	-	-	PUNCT
fnp-5347	140	8	laurs	laur	NOUN
fnp-5347	140	9	and	and	CCONJ
fnp-5347	140	10	coworkers	coworker	NOUN
fnp-5347	140	11	offered	offer	VERB
fnp-5347	140	12	an	an	DET
fnp-5347	140	13	intriguing	intriguing	ADJ
fnp-5347	140	14	answer	answer	NOUN
fnp-5347	140	15	to	to	ADP
fnp-5347	140	16	that	that	DET
fnp-5347	140	17	question	question	NOUN
fnp-5347	140	18	[	[	X
fnp-5347	140	19	31	31	NUM
fnp-5347	140	20	]	]	PUNCT
fnp-5347	140	21	.	.	PUNCT
fnp-5347	141	1	by	by	ADP
fnp-5347	141	2	studying	study	VERB
fnp-5347	141	3	the	the	DET
fnp-5347	141	4	clinical	clinical	ADJ
fnp-5347	141	5	,	,	PUNCT
fnp-5347	141	6	pathologic	pathologic	ADJ
fnp-5347	141	7	and	and	CCONJ
fnp-5347	141	8	genetic	genetic	ADJ
fnp-5347	141	9	landscape	landscape	NOUN
fnp-5347	141	10	of	of	ADP
fnp-5347	141	11	their	their	PRON
fnp-5347	141	12	cohort	cohort	NOUN
fnp-5347	141	13	of	of	ADP
fnp-5347	141	14	85	85	NUM
fnp-5347	141	15	patients	patient	NOUN
fnp-5347	141	16	with	with	ADP
fnp-5347	141	17	fcd	fcd	NOUN
fnp-5347	141	18	at	at	ADP
fnp-5347	141	19	the	the	DET
fnp-5347	141	20	bottom	bottom	NOUN
fnp-5347	141	21	-	-	PUNCT
fnp-5347	141	22	of	of	ADP
fnp-5347	141	23	-	-	PUNCT
fnp-5347	141	24	sulcus	sulcus	NOUN
fnp-5347	141	25	(	(	PUNCT
fnp-5347	141	26	bosd	bosd	PROPN
fnp-5347	141	27	)	)	PUNCT
fnp-5347	141	28	,	,	PUNCT
fnp-5347	141	29	which	which	PRON
fnp-5347	141	30	is	be	AUX
fnp-5347	141	31	a	a	DET
fnp-5347	141	32	peculiar	peculiar	ADJ
fnp-5347	141	33	fcd	fcd	ADJ
fnp-5347	141	34	type	type	NOUN
fnp-5347	141	35	2	2	NUM
fnp-5347	141	36	variant	variant	NOUN
fnp-5347	141	37	specifically	specifically	ADV
fnp-5347	141	38	highlighted	highlight	VERB
fnp-5347	141	39	also	also	ADV
fnp-5347	141	40	in	in	ADP
fnp-5347	141	41	the	the	DET
fnp-5347	141	42	international	international	ADJ
fnp-5347	141	43	fcd	fcd	ADJ
fnp-5347	141	44	classification	classification	NOUN
fnp-5347	141	45	update	update	NOUN
fnp-5347	141	46	of	of	ADP
fnp-5347	141	47	2022	2022	NUM
fnp-5347	141	48	,	,	PUNCT
fnp-5347	141	49	they	they	PRON
fnp-5347	141	50	reported	report	VERB
fnp-5347	141	51	that	that	SCONJ
fnp-5347	141	52	62	62	NUM
fnp-5347	141	53	 	 	SPACE
fnp-5347	141	54	%	%	NOUN
fnp-5347	141	55	of	of	ADP
fnp-5347	141	56	their	their	PRON
fnp-5347	141	57	cohort	cohort	NOUN
fnp-5347	141	58	presented	present	VERB
fnp-5347	141	59	in	in	ADP
fnp-5347	141	60	the	the	DET
fnp-5347	141	61	frontal	frontal	ADJ
fnp-5347	141	62	lobe	lobe	NOUN
fnp-5347	141	63	,	,	PUNCT
fnp-5347	141	64	18	18	NUM
fnp-5347	141	65	 	 	SPACE
fnp-5347	141	66	%	%	NOUN
fnp-5347	141	67	in	in	ADP
fnp-5347	141	68	the	the	DET
fnp-5347	141	69	parietal	parietal	ADJ
fnp-5347	141	70	lobe	lobe	NOUN
fnp-5347	141	71	,	,	PUNCT
fnp-5347	141	72	and	and	CCONJ
fnp-5347	141	73	14	14	NUM
fnp-5347	141	74	 	 	SPACE
fnp-5347	141	75	%	%	NOUN
fnp-5347	141	76	in	in	ADP
fnp-5347	141	77	the	the	DET
fnp-5347	141	78	insula	insula	NOUN
fnp-5347	141	79	,	,	PUNCT
fnp-5347	141	80	whereas	whereas	SCONJ
fnp-5347	141	81	the	the	DET
fnp-5347	141	82	temporal	temporal	ADJ
fnp-5347	141	83	and	and	CCONJ
fnp-5347	141	84	occipital	occipital	NOUN
fnp-5347	141	85	lobes	lobe	NOUN
fnp-5347	141	86	were	be	AUX
fnp-5347	141	87	rarely	rarely	ADV
fnp-5347	141	88	affected	affect	VERB
fnp-5347	141	89	(	(	PUNCT
fnp-5347	141	90	5	5	NUM
fnp-5347	141	91	 	 	SPACE
fnp-5347	141	92	%	%	NOUN
fnp-5347	141	93	and	and	CCONJ
fnp-5347	141	94	1	1	NUM
fnp-5347	141	95	 	 	SPACE
fnp-5347	141	96	%	%	NOUN
fnp-5347	141	97	,	,	PUNCT
fnp-5347	141	98	respectively	respectively	ADV
fnp-5347	141	99	)	)	PUNCT
fnp-5347	141	100	.	.	PUNCT
fnp-5347	142	1	only	only	ADV
fnp-5347	142	2	pathogenic	pathogenic	ADJ
fnp-5347	142	3	mtor	mtor	NOUN
fnp-5347	142	4	pathway	pathway	NOUN
fnp-5347	142	5	gene	gene	NOUN
fnp-5347	142	6	variants	variant	NOUN
fnp-5347	142	7	were	be	AUX
fnp-5347	142	8	detected	detect	VERB
fnp-5347	142	9	and	and	CCONJ
fnp-5347	142	10	occurred	occur	VERB
fnp-5347	142	11	in	in	ADP
fnp-5347	142	12	60	60	NUM
fnp-5347	142	13	 	 	SPACE
fnp-5347	142	14	%	%	NOUN
fnp-5347	142	15	of	of	ADP
fnp-5347	142	16	their	their	PRON
fnp-5347	142	17	patient	patient	ADJ
fnp-5347	142	18	cohort	cohort	NOUN
fnp-5347	142	19	.	.	PUNCT
fnp-5347	143	1	then	then	ADV
fnp-5347	143	2	,	,	PUNCT
fnp-5347	143	3	they	they	PRON
fnp-5347	143	4	compared	compare	VERB
fnp-5347	143	5	the	the	DET
fnp-5347	143	6	regional	regional	ADJ
fnp-5347	143	7	frequency	frequency	NOUN
fnp-5347	143	8	of	of	ADP
fnp-5347	143	9	the	the	DET
fnp-5347	143	10	bosd	bosd	NOUN
fnp-5347	143	11	with	with	ADP
fnp-5347	143	12	the	the	DET
fnp-5347	143	13	mtor	mtor	NOUN
fnp-5347	143	14	protein	protein	NOUN
fnp-5347	143	15	expression	expression	NOUN
fnp-5347	143	16	pattern	pattern	NOUN
fnp-5347	143	17	published	publish	VERB
fnp-5347	143	18	in	in	ADP
fnp-5347	143	19	the	the	DET
fnp-5347	143	20	open	open	ADJ
fnp-5347	143	21	access	access	NOUN
fnp-5347	143	22	online	online	PROPN
fnp-5347	143	23	allen	allen	PROPN
fnp-5347	143	24	human	human	PROPN
fnp-5347	143	25	brain	brain	PROPN
fnp-5347	143	26	atlas	atlas	PROPN
fnp-5347	143	27	(	(	PUNCT
fnp-5347	143	28	figure	figure	NOUN
fnp-5347	143	29	3	3	NUM
fnp-5347	143	30	)	)	PUNCT
fnp-5347	143	31	.	.	PUNCT
fnp-5347	144	1	intriguingly	intriguingly	ADV
fnp-5347	144	2	,	,	PUNCT
fnp-5347	144	3	mtor	mtor	PROPN
fnp-5347	144	4	is	be	AUX
fnp-5347	144	5	less	less	ADV
fnp-5347	144	6	dominantly	dominantly	ADV
fnp-5347	144	7	expressed	express	VERB
fnp-5347	144	8	in	in	ADP
fnp-5347	144	9	the	the	DET
fnp-5347	144	10	frontal	frontal	ADJ
fnp-5347	144	11	lobe	lobe	NOUN
fnp-5347	144	12	compared	compare	VERB
fnp-5347	144	13	to	to	ADP
fnp-5347	144	14	temporal	temporal	ADJ
fnp-5347	144	15	or	or	CCONJ
fnp-5347	144	16	occipital	occipital	NOUN
fnp-5347	144	17	lobes	lobe	NOUN
fnp-5347	144	18	suggesting	suggest	VERB
fnp-5347	144	19	that	that	SCONJ
fnp-5347	144	20	a	a	DET
fnp-5347	144	21	gain	gain	NOUN
fnp-5347	144	22	-	-	PUNCT
fnp-5347	144	23	of	of	ADP
fnp-5347	144	24	-	-	PUNCT
fnp-5347	144	25	function	function	NOUN
fnp-5347	144	26	alteration	alteration	NOUN
fnp-5347	144	27	of	of	ADP
fnp-5347	144	28	mtor	mtor	NOUN
fnp-5347	144	29	signaling	signal	VERB
fnp-5347	144	30	,	,	PUNCT
fnp-5347	144	31	e.g.	e.g.	ADV
fnp-5347	144	32	,	,	PUNCT
fnp-5347	144	33	mtor	mtor	NOUN
fnp-5347	144	34	activating	activate	VERB
fnp-5347	144	35	mutations	mutation	NOUN
fnp-5347	144	36	or	or	CCONJ
fnp-5347	144	37	inactivating	inactivate	VERB
fnp-5347	144	38	depdc5	depdc5	PROPN
fnp-5347	144	39	mutations	mutation	NOUN
fnp-5347	144	40	/	/	SYM
fnp-5347	144	41	losses	loss	NOUN
fnp-5347	144	42	,	,	PUNCT
fnp-5347	144	43	would	would	AUX
fnp-5347	144	44	have	have	AUX
fnp-5347	144	45	had	have	VERB
fnp-5347	144	46	a	a	DET
fnp-5347	144	47	much	much	ADV
fnp-5347	144	48	higher	high	ADJ
fnp-5347	144	49	impact	impact	NOUN
fnp-5347	144	50	in	in	ADP
fnp-5347	144	51	the	the	DET
fnp-5347	144	52	frontal	frontal	ADJ
fnp-5347	144	53	lobe	lobe	NOUN
fnp-5347	144	54	where	where	SCONJ
fnp-5347	144	55	these	these	DET
fnp-5347	144	56	genes	gene	NOUN
fnp-5347	144	57	are	be	AUX
fnp-5347	144	58	not	not	PART
fnp-5347	144	59	naturally	naturally	ADV
fnp-5347	144	60	highly	highly	ADV
fnp-5347	144	61	expressed	express	VERB
fnp-5347	144	62	.	.	PUNCT
fnp-5347	145	1	notwithstanding	notwithstanding	ADV
fnp-5347	145	2	,	,	PUNCT
fnp-5347	145	3	this	this	DET
fnp-5347	145	4	hypothesis	hypothesis	NOUN
fnp-5347	145	5	needs	need	VERB
fnp-5347	145	6	to	to	PART
fnp-5347	145	7	be	be	AUX
fnp-5347	145	8	studied	study	VERB
fnp-5347	145	9	further	far	ADV
fnp-5347	145	10	.	.	PUNCT
fnp-5347	146	1	an	an	DET
fnp-5347	146	2	intriguing	intriguing	ADJ
fnp-5347	146	3	study	study	NOUN
fnp-5347	146	4	would	would	AUX
fnp-5347	146	5	be	be	AUX
fnp-5347	146	6	to	to	PART
fnp-5347	146	7	search	search	VERB
fnp-5347	146	8	for	for	ADP
fnp-5347	146	9	pathogenic	pathogenic	ADJ
fnp-5347	146	10	mutations	mutation	NOUN
fnp-5347	146	11	in	in	ADP
fnp-5347	146	12	mtor	mtor	NOUN
fnp-5347	146	13	or	or	CCONJ
fnp-5347	146	14	map	map	NOUN
fnp-5347	146	15	-	-	PUNCT
fnp-5347	146	16	kinase	kinase	NOUN
fnp-5347	146	17	pathway	pathway	NOUN
fnp-5347	146	18	genes	gene	NOUN
fnp-5347	146	19	in	in	ADP
fnp-5347	146	20	other	other	ADJ
fnp-5347	146	21	brain	brain	NOUN
fnp-5347	146	22	regions	region	NOUN
fnp-5347	146	23	not	not	PART
fnp-5347	146	24	affected	affect	VERB
fnp-5347	146	25	by	by	ADP
fnp-5347	146	26	a	a	DET
fnp-5347	146	27	pathology	pathology	NOUN
fnp-5347	146	28	lesion	lesion	NOUN
fnp-5347	146	29	of	of	ADP
fnp-5347	146	30	the	the	DET
fnp-5347	146	31	same	same	ADJ
fnp-5347	146	32	patients	patient	NOUN
fnp-5347	146	33	or	or	CCONJ
fnp-5347	146	34	in	in	ADP
fnp-5347	146	35	the	the	DET
fnp-5347	146	36	general	general	ADJ
fnp-5347	146	37	population	population	NOUN
fnp-5347	146	38	.	.	PUNCT
fnp-5347	147	1	if	if	SCONJ
fnp-5347	147	2	one	one	PRON
fnp-5347	147	3	can	can	AUX
fnp-5347	147	4	prove	prove	VERB
fnp-5347	147	5	their	their	PRON
fnp-5347	147	6	presence	presence	NOUN
fnp-5347	147	7	it	it	PRON
fnp-5347	147	8	could	could	AUX
fnp-5347	147	9	well	well	ADV
fnp-5347	147	10	support	support	VERB
fnp-5347	147	11	the	the	DET
fnp-5347	147	12	functional	functional	ADJ
fnp-5347	147	13	impact	impact	NOUN
fnp-5347	147	14	in	in	ADP
fnp-5347	147	15	generating	generate	VERB
fnp-5347	147	16	a	a	DET
fnp-5347	147	17	structural	structural	ADJ
fnp-5347	147	18	lesion	lesion	NOUN
fnp-5347	147	19	only	only	ADV
fnp-5347	147	20	when	when	SCONJ
fnp-5347	147	21	their	their	PRON
fnp-5347	147	22	signal	signal	NOUN
fnp-5347	147	23	gets	get	VERB
fnp-5347	147	24	abnormally	abnormally	ADV
fnp-5347	147	25	high	high	ADJ
fnp-5347	147	26	during	during	ADP
fnp-5347	147	27	the	the	DET
fnp-5347	147	28	neurodevelopmental	neurodevelopmental	ADJ
fnp-5347	147	29	process	process	NOUN
fnp-5347	147	30	.	.	PUNCT
fnp-5347	148	1	figure	figure	VERB
fnp-5347	148	2	3	3	NUM
fnp-5347	148	3	:	:	PUNCT
fnp-5347	148	4	brain	brain	NOUN
fnp-5347	148	5	expression	expression	NOUN
fnp-5347	148	6	of	of	ADP
fnp-5347	148	7	mtor	mtor	PROPN
fnp-5347	148	8	suggests	suggest	VERB
fnp-5347	148	9	regional	regional	ADJ
fnp-5347	148	10	vulnerability	vulnerability	NOUN
fnp-5347	148	11	for	for	ADP
fnp-5347	148	12	fcd	fcd	ADJ
fnp-5347	148	13	2	2	NUM
fnp-5347	148	14	figure	figure	NOUN
fnp-5347	148	15	3	3	NUM
fnp-5347	148	16	.	.	PUNCT
fnp-5347	148	17	schaefer	schaefer	NOUN
fnp-5347	148	18	parcellation	parcellation	NOUN
fnp-5347	148	19	of	of	ADP
fnp-5347	148	20	the	the	DET
fnp-5347	148	21	lateral	lateral	ADJ
fnp-5347	148	22	and	and	CCONJ
fnp-5347	148	23	medial	medial	ADJ
fnp-5347	148	24	surface	surface	NOUN
fnp-5347	148	25	of	of	ADP
fnp-5347	148	26	the	the	DET
fnp-5347	148	27	left	left	ADJ
fnp-5347	148	28	hemisphere	hemisphere	ADV
fnp-5347	148	29	showing	show	VERB
fnp-5347	148	30	(	(	PUNCT
fnp-5347	148	31	a	a	X
fnp-5347	148	32	)	)	PUNCT
fnp-5347	148	33	the	the	DET
fnp-5347	148	34	number	number	NOUN
fnp-5347	148	35	of	of	ADP
fnp-5347	148	36	bottom	bottom	ADJ
fnp-5347	148	37	-	-	PUNCT
fnp-5347	148	38	of	of	ADP
fnp-5347	148	39	-	-	PUNCT
fnp-5347	148	40	sulcus	sulcus	NOUN
fnp-5347	148	41	-	-	PUNCT
fnp-5347	148	42	dysplasia	dysplasia	NOUN
fnp-5347	148	43	(	(	PUNCT
fnp-5347	148	44	bosd	bosd	ADJ
fnp-5347	148	45	)	)	PUNCT
fnp-5347	148	46	with	with	ADP
fnp-5347	148	47	at	at	ADV
fnp-5347	148	48	least	least	ADV
fnp-5347	148	49	10	10	NUM
fnp-5347	148	50	 	 	SPACE
fnp-5347	148	51	%	%	NOUN
fnp-5347	148	52	overlap	overlap	NOUN
fnp-5347	148	53	with	with	ADP
fnp-5347	148	54	each	each	DET
fnp-5347	148	55	parcel	parcel	NOUN
fnp-5347	148	56	,	,	PUNCT
fnp-5347	148	57	and	and	CCONJ
fnp-5347	148	58	(	(	PUNCT
fnp-5347	148	59	b	b	NOUN
fnp-5347	148	60	)	)	PUNCT
fnp-5347	148	61	relative	relative	ADJ
fnp-5347	148	62	mtor	mtor	NOUN
fnp-5347	148	63	expression	expression	NOUN
fnp-5347	148	64	from	from	ADP
fnp-5347	148	65	the	the	DET
fnp-5347	148	66	allen	allen	PROPN
fnp-5347	148	67	human	human	PROPN
fnp-5347	148	68	brain	brain	PROPN
fnp-5347	148	69	atlas	atlas	PROPN
fnp-5347	148	70	.	.	PUNCT
fnp-5347	149	1	note	note	VERB
fnp-5347	149	2	that	that	SCONJ
fnp-5347	149	3	privileged	privileged	ADJ
fnp-5347	149	4	regions	region	NOUN
fnp-5347	149	5	of	of	ADP
fnp-5347	149	6	bold	bold	ADJ
fnp-5347	149	7	associated	associate	VERB
fnp-5347	149	8	with	with	ADP
fnp-5347	149	9	low	low	ADJ
fnp-5347	149	10	expression	expression	NOUN
fnp-5347	149	11	of	of	ADP
fnp-5347	149	12	mtor	mtor	PROPN
fnp-5347	149	13	.	.	PUNCT
fnp-5347	150	1	figure	figure	NOUN
fnp-5347	150	2	modified	modify	VERB
fnp-5347	150	3	from	from	ADP
fnp-5347	150	4	open	open	ADJ
fnp-5347	150	5	-	-	PUNCT
fnp-5347	150	6	access	access	NOUN
fnp-5347	150	7	paper	paper	NOUN
fnp-5347	150	8	published	publish	VERB
fnp-5347	150	9	under	under	ADP
fnp-5347	150	10	a	a	DET
fnp-5347	150	11	creative	creative	ADJ
fnp-5347	150	12	commons	common	NOUN
fnp-5347	150	13	license	license	NOUN
fnp-5347	151	1	[	[	X
fnp-5347	151	2	31	31	NUM
fnp-5347	151	3	]	]	PUNCT
fnp-5347	151	4	,	,	PUNCT
fnp-5347	151	5	with	with	ADP
fnp-5347	151	6	permission	permission	NOUN
fnp-5347	151	7	from	from	ADP
fnp-5347	151	8	the	the	DET
fnp-5347	151	9	authors	author	NOUN
fnp-5347	151	10	.	.	PUNCT
fnp-5347	152	1	a	a	DET
fnp-5347	152	2	same	same	ADJ
fnp-5347	152	3	regional	regional	ADJ
fnp-5347	152	4	accumulation	accumulation	NOUN
fnp-5347	152	5	of	of	ADP
fnp-5347	152	6	activating	activate	VERB
fnp-5347	152	7	mutations	mutation	NOUN
fnp-5347	152	8	of	of	ADP
fnp-5347	152	9	the	the	DET
fnp-5347	152	10	map	map	NOUN
fnp-5347	152	11	-	-	PUNCT
fnp-5347	152	12	kinase	kinase	NOUN
fnp-5347	152	13	pathway	pathway	NOUN
fnp-5347	152	14	,	,	PUNCT
fnp-5347	152	15	such	such	ADJ
fnp-5347	152	16	braf	braf	NOUN
fnp-5347	152	17	or	or	CCONJ
fnp-5347	152	18	ptpn11	ptpn11	NOUN
fnp-5347	152	19	have	have	AUX
fnp-5347	152	20	been	be	AUX
fnp-5347	152	21	identified	identify	VERB
fnp-5347	152	22	in	in	ADP
fnp-5347	152	23	the	the	DET
fnp-5347	152	24	temporal	temporal	ADJ
fnp-5347	152	25	lobe	lobe	NOUN
fnp-5347	152	26	,	,	PUNCT
fnp-5347	152	27	as	as	SCONJ
fnp-5347	152	28	recently	recently	ADV
fnp-5347	152	29	published	publish	VERB
fnp-5347	152	30	by	by	ADP
fnp-5347	152	31	khoshkhoo	khoshkhoo	NOUN
fnp-5347	152	32	and	and	CCONJ
fnp-5347	152	33	coworkers	coworker	NOUN
fnp-5347	152	34	[	[	X
fnp-5347	152	35	26	26	NUM
fnp-5347	152	36	]	]	PUNCT
fnp-5347	152	37	.	.	PUNCT
fnp-5347	153	1	they	they	PRON
fnp-5347	153	2	studied	study	VERB
fnp-5347	153	3	105	105	NUM
fnp-5347	153	4	individuals	individual	NOUN
fnp-5347	153	5	with	with	ADP
fnp-5347	153	6	mesial	mesial	ADJ
fnp-5347	153	7	temporal	temporal	ADJ
fnp-5347	153	8	lobe	lobe	NOUN
fnp-5347	153	9	epilepsy	epilepsy	NOUN
fnp-5347	153	10	(	(	PUNCT
fnp-5347	153	11	mtle	mtle	NOUN
fnp-5347	153	12	)	)	PUNCT
fnp-5347	153	13	compared	compare	VERB
fnp-5347	153	14	to	to	ADP
fnp-5347	153	15	30	30	NUM
fnp-5347	153	16	neurotypical	neurotypical	ADJ
fnp-5347	153	17	controls	control	NOUN
fnp-5347	153	18	.	.	PUNCT
fnp-5347	154	1	they	they	PRON
fnp-5347	154	2	detected	detect	VERB
fnp-5347	154	3	11	11	NUM
fnp-5347	154	4	pathogenic	pathogenic	ADJ
fnp-5347	154	5	somatic	somatic	ADJ
fnp-5347	154	6	variants	variant	NOUN
fnp-5347	154	7	in	in	ADP
fnp-5347	154	8	hippocampal	hippocampal	ADJ
fnp-5347	154	9	tissue	tissue	NOUN
fnp-5347	154	10	neurosurgically	neurosurgically	ADV
fnp-5347	154	11	resected	resect	VERB
fnp-5347	154	12	in	in	ADP
fnp-5347	154	13	their	their	PRON
fnp-5347	154	14	patient	patient	ADJ
fnp-5347	154	15	cohort	cohort	NOUN
fnp-5347	154	16	but	but	CCONJ
fnp-5347	154	17	none	none	NOUN
fnp-5347	154	18	in	in	ADP
fnp-5347	154	19	their	their	PRON
fnp-5347	154	20	controls	control	NOUN
fnp-5347	154	21	.	.	PUNCT
fnp-5347	155	1	these	these	DET
fnp-5347	155	2	variants	variant	NOUN
fnp-5347	155	3	included	include	VERB
fnp-5347	155	4	ptpn11	ptpn11	NOUN
fnp-5347	155	5	,	,	PUNCT
fnp-5347	155	6	sos1	sos1	PROPN
fnp-5347	155	7	,	,	PUNCT
fnp-5347	155	8	kras	kras	PROPN
fnp-5347	155	9	,	,	PUNCT
fnp-5347	155	10	braf	braf	NOUN
fnp-5347	155	11	and	and	CCONJ
fnp-5347	155	12	nf1	nf1	NOUN
fnp-5347	155	13	,	,	PUNCT
fnp-5347	155	14	all	all	PRON
fnp-5347	155	15	of	of	ADP
fnp-5347	155	16	which	which	PRON
fnp-5347	155	17	are	be	AUX
fnp-5347	155	18	predicted	predict	VERB
fnp-5347	155	19	to	to	PART
fnp-5347	155	20	constitutively	constitutively	ADV
fnp-5347	155	21	activate	activate	VERB
fnp-5347	155	22	the	the	DET
fnp-5347	155	23	map	map	NOUN
fnp-5347	155	24	-	-	PUNCT
fnp-5347	155	25	kinase	kinase	NOUN
fnp-5347	155	26	signaling	signal	VERB
fnp-5347	155	27	pathway	pathway	NOUN
fnp-5347	155	28	and	and	CCONJ
fnp-5347	155	29	which	which	PRON
fnp-5347	155	30	might	might	AUX
fnp-5347	155	31	contribute	contribute	VERB
fnp-5347	155	32	to	to	ADP
fnp-5347	155	33	the	the	DET
fnp-5347	155	34	pathogenesis	pathogenesis	NOUN
fnp-5347	155	35	of	of	ADP
fnp-5347	155	36	sporadically	sporadically	ADV
fnp-5347	155	37	occurring	occur	VERB
fnp-5347	155	38	,	,	PUNCT
fnp-5347	155	39	drug	drug	NOUN
fnp-5347	155	40	-	-	PUNCT
fnp-5347	155	41	resistant	resistant	ADJ
fnp-5347	155	42	mtle	mtle	NOUN
fnp-5347	155	43	.	.	PUNCT
fnp-5347	156	1	in	in	ADP
fnp-5347	156	2	other	other	ADJ
fnp-5347	156	3	words	word	NOUN
fnp-5347	156	4	,	,	PUNCT
fnp-5347	156	5	not	not	PART
fnp-5347	156	6	only	only	ADV
fnp-5347	156	7	map	map	NOUN
fnp-5347	156	8	-	-	PUNCT
fnp-5347	156	9	kinase	kinase	ADJ
fnp-5347	156	10	associated	associate	VERB
fnp-5347	156	11	low	low	ADJ
fnp-5347	156	12	-	-	PUNCT
fnp-5347	156	13	grade	grade	NOUN
fnp-5347	156	14	brain	brain	NOUN
fnp-5347	156	15	tumors	tumor	NOUN
fnp-5347	156	16	but	but	CCONJ
fnp-5347	156	17	also	also	ADV
fnp-5347	156	18	hippocampal	hippocampal	VERB
fnp-5347	156	19	sclerosis	sclerosis	NOUN
fnp-5347	156	20	accumulate	accumulate	VERB
fnp-5347	156	21	map	map	NOUN
fnp-5347	156	22	-	-	PUNCT
fnp-5347	156	23	kinase	kinase	NOUN
fnp-5347	156	24	activating	activate	VERB
fnp-5347	156	25	pathogens	pathogen	NOUN
fnp-5347	156	26	and	and	CCONJ
fnp-5347	156	27	may	may	AUX
fnp-5347	156	28	contribute	contribute	VERB
fnp-5347	156	29	to	to	ADP
fnp-5347	156	30	its	its	PRON
fnp-5347	156	31	high	high	ADJ
fnp-5347	156	32	epileptogenic	epileptogenic	ADJ
fnp-5347	156	33	susceptibility	susceptibility	NOUN
fnp-5347	156	34	.	.	PUNCT
fnp-5347	157	1	topic	topic	NOUN
fnp-5347	157	2	4	4	NUM
fnp-5347	157	3	:	:	PUNCT
fnp-5347	157	4	new	new	ADJ
fnp-5347	157	5	diagnostic	diagnostic	ADJ
fnp-5347	157	6	disease	disease	NOUN
fnp-5347	157	7	entities	entity	NOUN
fnp-5347	157	8	:	:	PUNCT
fnp-5347	157	9	i.	i.	NOUN
fnp-5347	157	10	moghe	moghe	VERB
fnp-5347	157	11	the	the	DET
fnp-5347	157	12	clinico	clinico	NOUN
fnp-5347	157	13	-	-	PUNCT
fnp-5347	157	14	pathologic	pathologic	ADJ
fnp-5347	157	15	diagnosis	diagnosis	NOUN
fnp-5347	157	16	of	of	ADP
fnp-5347	157	17	moghe	moghe	NOUN
fnp-5347	157	18	as	as	ADP
fnp-5347	157	19	a	a	DET
fnp-5347	157	20	new	new	ADJ
fnp-5347	157	21	disease	disease	NOUN
fnp-5347	157	22	entity	entity	NOUN
fnp-5347	157	23	in	in	ADP
fnp-5347	157	24	patients	patient	NOUN
fnp-5347	157	25	with	with	ADP
fnp-5347	157	26	focal	focal	ADJ
fnp-5347	157	27	,	,	PUNCT
fnp-5347	157	28	drug	drug	NOUN
fnp-5347	157	29	-	-	PUNCT
fnp-5347	157	30	resistant	resistant	ADJ
fnp-5347	157	31	early	early	ADJ
fnp-5347	157	32	onset	onset	NOUN
fnp-5347	157	33	(	(	PUNCT
fnp-5347	157	34	frontal	frontal	ADJ
fnp-5347	157	35	lobe	lobe	NOUN
fnp-5347	157	36	)	)	PUNCT
fnp-5347	157	37	epilepsy	epilepsy	NOUN
fnp-5347	157	38	was	be	AUX
fnp-5347	157	39	first	first	ADV
fnp-5347	157	40	described	describe	VERB
fnp-5347	157	41	in	in	ADP
fnp-5347	157	42	2017	2017	NUM
fnp-5347	158	1	[	[	SYM
fnp-5347	158	2	37	37	NUM
fnp-5347	158	3	]	]	PUNCT
fnp-5347	158	4	.	.	PUNCT
fnp-5347	159	1	since	since	SCONJ
fnp-5347	159	2	then	then	ADV
fnp-5347	159	3	,	,	PUNCT
fnp-5347	159	4	scientific	scientific	ADJ
fnp-5347	159	5	and	and	CCONJ
fnp-5347	159	6	clinical	clinical	ADJ
fnp-5347	159	7	interest	interest	NOUN
fnp-5347	159	8	has	have	AUX
fnp-5347	159	9	continuously	continuously	ADV
fnp-5347	159	10	grown	grow	VERB
fnp-5347	159	11	towards	towards	ADP
fnp-5347	159	12	a	a	DET
fnp-5347	159	13	better	well	ADJ
fnp-5347	159	14	understanding	understanding	NOUN
fnp-5347	159	15	of	of	ADP
fnp-5347	159	16	moghe	moghe	NOUN
fnp-5347	159	17	.	.	PUNCT
fnp-5347	160	1	in	in	ADP
fnp-5347	160	2	2018	2018	NUM
fnp-5347	160	3	,	,	PUNCT
fnp-5347	160	4	a	a	DET
fnp-5347	160	5	novel	novel	ADJ
fnp-5347	160	6	brain	brain	NOUN
fnp-5347	160	7	somatic	somatic	ADJ
fnp-5347	160	8	loss	loss	NOUN
fnp-5347	160	9	-	-	PUNCT
fnp-5347	160	10	of	of	ADP
fnp-5347	160	11	-	-	PUNCT
fnp-5347	160	12	function	function	NOUN
fnp-5347	160	13	mutation	mutation	NOUN
fnp-5347	160	14	of	of	ADP
fnp-5347	160	15	the	the	DET
fnp-5347	160	16	galactose	galactose	ADJ
fnp-5347	160	17	-	-	PUNCT
fnp-5347	160	18	transporter	transporter	NOUN
fnp-5347	160	19	slc35a2	slc35a2	NOUN
fnp-5347	160	20	gene	gene	NOUN
fnp-5347	160	21	was	be	AUX
fnp-5347	160	22	identified	identify	VERB
fnp-5347	160	23	in	in	ADP
fnp-5347	160	24	epilepsy	epilepsy	ADJ
fnp-5347	160	25	surgery	surgery	NOUN
fnp-5347	160	26	brain	brain	NOUN
fnp-5347	160	27	tissues	tissue	NOUN
fnp-5347	161	1	[	[	X
fnp-5347	161	2	38	38	NUM
fnp-5347	161	3	,	,	PUNCT
fnp-5347	161	4	45	45	NUM
fnp-5347	161	5	]	]	PUNCT
fnp-5347	161	6	.	.	PUNCT
fnp-5347	162	1	this	this	PRON
fnp-5347	162	2	was	be	AUX
fnp-5347	162	3	confirmed	confirm	VERB
fnp-5347	162	4	in	in	ADP
fnp-5347	162	5	2019	2019	NUM
fnp-5347	162	6	[	[	X
fnp-5347	162	7	5	5	NUM
fnp-5347	162	8	]	]	PUNCT
fnp-5347	162	9	and	and	CCONJ
fnp-5347	162	10	all	all	DET
fnp-5347	162	11	three	three	NUM
fnp-5347	162	12	publications	publication	NOUN
fnp-5347	162	13	assigned	assign	VERB
fnp-5347	162	14	the	the	DET
fnp-5347	162	15	slc35a2	slc35a2	NOUN
fnp-5347	162	16	mutation	mutation	NOUN
fnp-5347	162	17	to	to	ADP
fnp-5347	162	18	variable	variable	ADJ
fnp-5347	162	19	histopathology	histopathology	NOUN
fnp-5347	162	20	phenotypes	phenotype	NOUN
fnp-5347	162	21	,	,	PUNCT
fnp-5347	162	22	such	such	ADJ
fnp-5347	162	23	as	as	ADP
fnp-5347	162	24	mmcd	mmcd	NOUN
fnp-5347	162	25	,	,	PUNCT
fnp-5347	162	26	fcd	fcd	ADJ
fnp-5347	162	27	type	type	NOUN
fnp-5347	162	28	1	1	NUM
fnp-5347	162	29	or	or	CCONJ
fnp-5347	162	30	non	non	ADJ
fnp-5347	162	31	-	-	ADJ
fnp-5347	162	32	lesional	lesional	ADJ
fnp-5347	162	33	samples	sample	NOUN
fnp-5347	162	34	.	.	PUNCT
fnp-5347	163	1	two	two	NUM
fnp-5347	163	2	papers	paper	NOUN
fnp-5347	163	3	concluded	conclude	VERB
fnp-5347	163	4	in	in	ADP
fnp-5347	163	5	2021	2021	NUM
fnp-5347	163	6	,	,	PUNCT
fnp-5347	163	7	however	however	ADV
fnp-5347	163	8	,	,	PUNCT
fnp-5347	163	9	that	that	SCONJ
fnp-5347	163	10	the	the	DET
fnp-5347	163	11	slc35a2	slc35a2	NOUN
fnp-5347	163	12	mutation	mutation	NOUN
fnp-5347	163	13	is	be	AUX
fnp-5347	163	14	specifically	specifically	ADV
fnp-5347	163	15	associated	associate	VERB
fnp-5347	163	16	with	with	ADP
fnp-5347	163	17	moghe	moghe	NOUN
fnp-5347	163	18	and	and	CCONJ
fnp-5347	163	19	found	find	VERB
fnp-5347	163	20	in	in	ADP
fnp-5347	163	21	about	about	ADV
fnp-5347	163	22	50	50	NUM
fnp-5347	163	23	 	 	SPACE
fnp-5347	163	24	%	%	NOUN
fnp-5347	163	25	of	of	ADP
fnp-5347	163	26	reported	report	VERB
fnp-5347	163	27	patients	patient	NOUN
fnp-5347	163	28	[	[	X
fnp-5347	163	29	10	10	NUM
fnp-5347	163	30	,	,	PUNCT
fnp-5347	163	31	12	12	NUM
fnp-5347	163	32	]	]	PUNCT
fnp-5347	163	33	.	.	PUNCT
fnp-5347	164	1	this	this	DET
fnp-5347	164	2	enduring	endure	VERB
fnp-5347	164	3	uncertainty	uncertainty	NOUN
fnp-5347	164	4	stimulated	stimulate	VERB
fnp-5347	164	5	an	an	DET
fnp-5347	164	6	international	international	ADJ
fnp-5347	164	7	consortium	consortium	NOUN
fnp-5347	164	8	of	of	ADP
fnp-5347	164	9	13	13	NUM
fnp-5347	164	10	epilepsy	epilepsy	NOUN
fnp-5347	164	11	centers	center	NOUN
fnp-5347	164	12	around	around	ADP
fnp-5347	164	13	the	the	DET
fnp-5347	164	14	world	world	NOUN
fnp-5347	164	15	led	lead	VERB
fnp-5347	164	16	by	by	ADP
fnp-5347	164	17	dr	dr	PROPN
fnp-5347	164	18	.	.	PROPN
fnp-5347	164	19	barba	barba	PROPN
fnp-5347	164	20	to	to	PART
fnp-5347	164	21	review	review	VERB
fnp-5347	164	22	the	the	DET
fnp-5347	164	23	neuropathology	neuropathology	NOUN
fnp-5347	164	24	,	,	PUNCT
fnp-5347	164	25	clinical	clinical	ADJ
fnp-5347	164	26	features	feature	NOUN
fnp-5347	164	27	,	,	PUNCT
fnp-5347	164	28	and	and	CCONJ
fnp-5347	164	29	postsurgical	postsurgical	ADJ
fnp-5347	164	30	outcome	outcome	NOUN
fnp-5347	164	31	in	in	ADP
fnp-5347	164	32	a	a	DET
fnp-5347	164	33	total	total	NOUN
fnp-5347	164	34	of	of	ADP
fnp-5347	164	35	47	47	NUM
fnp-5347	164	36	patients	patient	NOUN
fnp-5347	164	37	previously	previously	ADV
fnp-5347	164	38	described	describe	VERB
fnp-5347	164	39	to	to	PART
fnp-5347	164	40	carry	carry	VERB
fnp-5347	164	41	brain	brain	NOUN
fnp-5347	164	42	somatic	somatic	ADJ
fnp-5347	164	43	slc35a2	slc35a2	NOUN
fnp-5347	164	44	mutations	mutation	NOUN
fnp-5347	164	45	[	[	X
fnp-5347	164	46	6	6	NUM
fnp-5347	164	47	]	]	PUNCT
fnp-5347	164	48	.	.	PUNCT
fnp-5347	165	1	the	the	DET
fnp-5347	165	2	microscopic	microscopic	ADJ
fnp-5347	165	3	re	re	NOUN
fnp-5347	165	4	-	-	NOUN
fnp-5347	165	5	review	review	NOUN
fnp-5347	165	6	of	of	ADP
fnp-5347	165	7	all	all	DET
fnp-5347	165	8	available	available	ADJ
fnp-5347	165	9	surgical	surgical	ADJ
fnp-5347	165	10	specimens	specimen	NOUN
fnp-5347	165	11	identified	identify	VERB
fnp-5347	165	12	moghe	moghe	NOUN
fnp-5347	165	13	in	in	ADP
fnp-5347	165	14	94	94	NUM
fnp-5347	165	15	 	 	SPACE
fnp-5347	165	16	%	%	NOUN
fnp-5347	165	17	of	of	ADP
fnp-5347	165	18	their	their	PRON
fnp-5347	165	19	patient	patient	ADJ
fnp-5347	165	20	series	series	NOUN
fnp-5347	165	21	,	,	PUNCT
fnp-5347	165	22	leaving	leave	VERB
fnp-5347	165	23	very	very	ADV
fnp-5347	165	24	limited	limited	ADJ
fnp-5347	165	25	room	room	NOUN
fnp-5347	165	26	to	to	PART
fnp-5347	165	27	assign	assign	VERB
fnp-5347	165	28	the	the	DET
fnp-5347	165	29	slc35a2	slc35a2	NOUN
fnp-5347	165	30	mutation	mutation	NOUN
fnp-5347	165	31	to	to	ADP
fnp-5347	165	32	any	any	DET
fnp-5347	165	33	other	other	ADJ
fnp-5347	165	34	disease	disease	NOUN
fnp-5347	165	35	or	or	CCONJ
fnp-5347	165	36	fcd	fcd	ADJ
fnp-5347	165	37	entity	entity	NOUN
fnp-5347	165	38	.	.	PUNCT
fnp-5347	166	1	as	as	ADP
fnp-5347	166	2	a	a	DET
fnp-5347	166	3	matter	matter	NOUN
fnp-5347	166	4	of	of	ADP
fnp-5347	166	5	fact	fact	NOUN
fnp-5347	166	6	,	,	PUNCT
fnp-5347	166	7	the	the	DET
fnp-5347	166	8	diagnosis	diagnosis	NOUN
fnp-5347	166	9	was	be	AUX
fnp-5347	166	10	inconclusive	inconclusive	ADJ
fnp-5347	166	11	in	in	ADP
fnp-5347	166	12	3	3	NUM
fnp-5347	166	13	patients	patient	NOUN
fnp-5347	166	14	because	because	SCONJ
fnp-5347	166	15	of	of	ADP
fnp-5347	166	16	insufficient	insufficient	ADJ
fnp-5347	166	17	surgical	surgical	ADJ
fnp-5347	166	18	sampling	sampling	NOUN
fnp-5347	166	19	(	(	PUNCT
fnp-5347	166	20	6	6	NUM
fnp-5347	166	21	 	 	SPACE
fnp-5347	166	22	%	%	NOUN
fnp-5347	166	23	)	)	PUNCT
fnp-5347	166	24	.	.	PUNCT
fnp-5347	167	1	twenty	twenty	NUM
fnp-5347	167	2	-	-	PUNCT
fnp-5347	167	3	nine	nine	NUM
fnp-5347	167	4	cases	case	NOUN
fnp-5347	167	5	were	be	AUX
fnp-5347	167	6	previously	previously	ADV
fnp-5347	167	7	published	publish	VERB
fnp-5347	167	8	with	with	ADP
fnp-5347	167	9	a	a	DET
fnp-5347	167	10	diagnosis	diagnosis	NOUN
fnp-5347	167	11	of	of	ADP
fnp-5347	167	12	fcd	fcd	ADJ
fnp-5347	167	13	type	type	NOUN
fnp-5347	167	14	1	1	NUM
fnp-5347	167	15	,	,	PUNCT
fnp-5347	167	16	mmcd	mmcd	NOUN
fnp-5347	167	17	or	or	CCONJ
fnp-5347	167	18	non	non	ADJ
fnp-5347	167	19	-	-	ADJ
fnp-5347	167	20	lesional	lesional	ADJ
fnp-5347	167	21	,	,	PUNCT
fnp-5347	167	22	which	which	PRON
fnp-5347	167	23	needs	need	VERB
fnp-5347	167	24	reconsideration	reconsideration	NOUN
fnp-5347	167	25	and	and	CCONJ
fnp-5347	167	26	which	which	PRON
fnp-5347	167	27	also	also	ADV
fnp-5347	167	28	highlights	highlight	VERB
fnp-5347	167	29	the	the	DET
fnp-5347	167	30	difficulty	difficulty	NOUN
fnp-5347	167	31	to	to	PART
fnp-5347	167	32	achieve	achieve	VERB
fnp-5347	167	33	agreement	agreement	NOUN
fnp-5347	167	34	in	in	ADP
fnp-5347	167	35	the	the	DET
fnp-5347	167	36	histopathological	histopathological	ADJ
fnp-5347	167	37	diagnosis	diagnosis	NOUN
fnp-5347	167	38	of	of	ADP
fnp-5347	167	39	epilepsy	epilepsy	ADJ
fnp-5347	167	40	surgery	surgery	NOUN
fnp-5347	167	41	brain	brain	NOUN
fnp-5347	167	42	samples	sample	NOUN
fnp-5347	167	43	as	as	SCONJ
fnp-5347	167	44	was	be	AUX
fnp-5347	167	45	already	already	ADV
fnp-5347	167	46	discussed	discuss	VERB
fnp-5347	167	47	above	above	ADV
fnp-5347	167	48	.	.	PUNCT
fnp-5347	168	1	interestingly	interestingly	ADV
fnp-5347	168	2	,	,	PUNCT
fnp-5347	168	3	they	they	PRON
fnp-5347	168	4	observed	observe	VERB
fnp-5347	168	5	two	two	NUM
fnp-5347	168	6	clinical	clinical	ADJ
fnp-5347	168	7	phenotypes	phenotype	NOUN
fnp-5347	168	8	of	of	ADP
fnp-5347	168	9	moghe	moghe	NOUN
fnp-5347	168	10	.	.	PUNCT
fnp-5347	169	1	the	the	DET
fnp-5347	169	2	majority	majority	NOUN
fnp-5347	169	3	of	of	ADP
fnp-5347	169	4	their	their	PRON
fnp-5347	169	5	patients	patient	NOUN
fnp-5347	169	6	(	(	PUNCT
fnp-5347	169	7	n	n	CCONJ
fnp-5347	169	8	 	 	SPACE
fnp-5347	169	9	=	=	NOUN
fnp-5347	169	10	 	 	SPACE
fnp-5347	169	11	39	39	NUM
fnp-5347	169	12	;	;	PUNCT
fnp-5347	169	13	83	83	NUM
fnp-5347	169	14	 	 	SPACE
fnp-5347	169	15	%	%	NOUN
fnp-5347	169	16	)	)	PUNCT
fnp-5347	169	17	had	have	VERB
fnp-5347	169	18	early	early	ADJ
fnp-5347	169	19	epileptic	epileptic	ADJ
fnp-5347	169	20	encephalopathy	encephalopathy	NOUN
fnp-5347	169	21	with	with	ADP
fnp-5347	169	22	a	a	DET
fnp-5347	169	23	seizure	seizure	NOUN
fnp-5347	169	24	onset	onset	NOUN
fnp-5347	169	25	range	range	NOUN
fnp-5347	169	26	from	from	ADP
fnp-5347	169	27	3	3	NUM
fnp-5347	169	28	month	month	NOUN
fnp-5347	169	29	to	to	ADP
fnp-5347	169	30	3.5	3.5	NUM
fnp-5347	169	31	years	year	NOUN
fnp-5347	169	32	and	and	CCONJ
fnp-5347	169	33	severe	severe	ADJ
fnp-5347	169	34	to	to	ADP
fnp-5347	169	35	moderate	moderate	ADJ
fnp-5347	169	36	intellectual	intellectual	ADJ
fnp-5347	169	37	disability	disability	NOUN
fnp-5347	169	38	.	.	PUNCT
fnp-5347	170	1	the	the	DET
fnp-5347	170	2	second	second	ADJ
fnp-5347	170	3	and	and	CCONJ
fnp-5347	170	4	smaller	small	ADJ
fnp-5347	170	5	cohort	cohort	NOUN
fnp-5347	170	6	of	of	ADP
fnp-5347	170	7	eight	eight	NUM
fnp-5347	170	8	patients	patient	NOUN
fnp-5347	170	9	(	(	PUNCT
fnp-5347	170	10	17	17	NUM
fnp-5347	170	11	 	 	SPACE
fnp-5347	170	12	%	%	NOUN
fnp-5347	170	13	)	)	PUNCT
fnp-5347	170	14	could	could	AUX
fnp-5347	170	15	be	be	AUX
fnp-5347	170	16	characterized	characterize	VERB
fnp-5347	170	17	as	as	ADP
fnp-5347	170	18	drug	drug	NOUN
fnp-5347	170	19	-	-	PUNCT
fnp-5347	170	20	resistant	resistant	ADJ
fnp-5347	170	21	focal	focal	ADJ
fnp-5347	170	22	epilepsy	epilepsy	NOUN
fnp-5347	170	23	of	of	ADP
fnp-5347	170	24	young	young	ADJ
fnp-5347	170	25	to	to	ADP
fnp-5347	170	26	adolescent	adolescent	ADJ
fnp-5347	170	27	(	(	PUNCT
fnp-5347	170	28	later	later	ADV
fnp-5347	170	29	)	)	PUNCT
fnp-5347	170	30	onset	onset	NOUN
fnp-5347	170	31	associated	associate	VERB
fnp-5347	170	32	with	with	ADP
fnp-5347	170	33	almost	almost	ADV
fnp-5347	170	34	normal	normal	ADJ
fnp-5347	170	35	cognitive	cognitive	ADJ
fnp-5347	170	36	function	function	NOUN
fnp-5347	170	37	.	.	PUNCT
fnp-5347	171	1	another	another	DET
fnp-5347	171	2	interesting	interesting	ADJ
fnp-5347	171	3	observation	observation	NOUN
fnp-5347	171	4	was	be	AUX
fnp-5347	171	5	the	the	DET
fnp-5347	171	6	lack	lack	NOUN
fnp-5347	171	7	of	of	ADP
fnp-5347	171	8	any	any	DET
fnp-5347	171	9	hot	hot	ADJ
fnp-5347	171	10	spot	spot	NOUN
fnp-5347	171	11	mutation	mutation	NOUN
fnp-5347	171	12	across	across	ADP
fnp-5347	171	13	the	the	DET
fnp-5347	171	14	slc35a2	slc35a2	NOUN
fnp-5347	171	15	gene	gene	NOUN
fnp-5347	171	16	(	(	PUNCT
fnp-5347	171	17	figure	figure	NOUN
fnp-5347	171	18	4	4	NUM
fnp-5347	171	19	)	)	PUNCT
fnp-5347	171	20	.	.	PUNCT
fnp-5347	172	1	all	all	DET
fnp-5347	172	2	mutations	mutation	NOUN
fnp-5347	172	3	were	be	AUX
fnp-5347	172	4	predominantly	predominantly	ADV
fnp-5347	172	5	distributed	distribute	VERB
fnp-5347	172	6	across	across	ADP
fnp-5347	172	7	the	the	DET
fnp-5347	172	8	nine	nine	NUM
fnp-5347	172	9	transmembrane	transmembrane	NOUN
fnp-5347	172	10	domains	domain	NOUN
fnp-5347	172	11	.	.	PUNCT
fnp-5347	173	1	finally	finally	ADV
fnp-5347	173	2	,	,	PUNCT
fnp-5347	173	3	there	there	PRON
fnp-5347	173	4	was	be	VERB
fnp-5347	173	5	no	no	DET
fnp-5347	173	6	association	association	NOUN
fnp-5347	173	7	between	between	ADP
fnp-5347	173	8	the	the	DET
fnp-5347	173	9	genetic	genetic	ADJ
fnp-5347	173	10	variant	variant	NOUN
fnp-5347	173	11	or	or	CCONJ
fnp-5347	173	12	variant	variant	ADJ
fnp-5347	173	13	allelic	allelic	ADJ
fnp-5347	173	14	frequency	frequency	NOUN
fnp-5347	173	15	(	(	PUNCT
fnp-5347	173	16	vaf	vaf	PROPN
fnp-5347	173	17	)	)	PUNCT
fnp-5347	173	18	,	,	PUNCT
fnp-5347	173	19	which	which	PRON
fnp-5347	173	20	ranged	range	VERB
fnp-5347	173	21	from	from	ADP
fnp-5347	173	22	1.4	1.4	NUM
fnp-5347	173	23	 	 	SPACE
fnp-5347	173	24	%	%	NOUN
fnp-5347	173	25	52.6	52.6	NUM
fnp-5347	173	26	 	 	SPACE
fnp-5347	173	27	%	%	NOUN
fnp-5347	173	28	in	in	ADP
fnp-5347	173	29	all	all	DET
fnp-5347	173	30	samples	sample	NOUN
fnp-5347	173	31	(	(	PUNCT
fnp-5347	173	32	mean	mean	NOUN
fnp-5347	173	33	vaf	vaf	PROPN
fnp-5347	173	34	 	 	SPACE
fnp-5347	173	35	=	=	NOUN
fnp-5347	173	36	 	 	SPACE
fnp-5347	173	37	17	17	NUM
fnp-5347	173	38	 	 	SPACE
fnp-5347	173	39	%	%	NOUN
fnp-5347	173	40	)	)	PUNCT
fnp-5347	173	41	,	,	PUNCT
fnp-5347	173	42	with	with	ADP
fnp-5347	173	43	the	the	DET
fnp-5347	173	44	clinical	clinical	ADJ
fnp-5347	173	45	phenotype	phenotype	NOUN
fnp-5347	173	46	or	or	CCONJ
fnp-5347	173	47	the	the	DET
fnp-5347	173	48	postsurgical	postsurgical	ADJ
fnp-5347	173	49	outcome	outcome	NOUN
fnp-5347	173	50	.	.	PUNCT
fnp-5347	174	1	indeed	indeed	ADV
fnp-5347	174	2	,	,	PUNCT
fnp-5347	174	3	seizure	seizure	VERB
fnp-5347	174	4	freedom	freedom	NOUN
fnp-5347	174	5	was	be	AUX
fnp-5347	174	6	achieved	achieve	VERB
fnp-5347	174	7	in	in	ADP
fnp-5347	174	8	30	30	NUM
fnp-5347	174	9	patients	patient	NOUN
fnp-5347	174	10	(	(	PUNCT
fnp-5347	174	11	63.8	63.8	NUM
fnp-5347	174	12	 	 	SPACE
fnp-5347	174	13	%	%	NOUN
fnp-5347	174	14	,	,	PUNCT
fnp-5347	174	15	engel	engel	PROPN
fnp-5347	174	16	class	class	PROPN
fnp-5347	174	17	i	i	PROPN
fnp-5347	174	18	)	)	PUNCT
fnp-5347	174	19	,	,	PUNCT
fnp-5347	174	20	and	and	CCONJ
fnp-5347	174	21	favorable	favorable	ADJ
fnp-5347	174	22	outcome	outcome	NOUN
fnp-5347	174	23	was	be	AUX
fnp-5347	174	24	significantly	significantly	ADV
fnp-5347	174	25	associated	associate	VERB
fnp-5347	174	26	with	with	ADP
fnp-5347	174	27	shorter	short	ADJ
fnp-5347	174	28	disease	disease	NOUN
fnp-5347	174	29	duration	duration	NOUN
fnp-5347	174	30	and	and	CCONJ
fnp-5347	174	31	complete	complete	ADJ
fnp-5347	174	32	resection	resection	NOUN
fnp-5347	174	33	.	.	PUNCT
fnp-5347	175	1	these	these	DET
fnp-5347	175	2	numbers	number	NOUN
fnp-5347	175	3	dramatically	dramatically	ADV
fnp-5347	175	4	changed	change	VERB
fnp-5347	175	5	from	from	ADP
fnp-5347	175	6	the	the	DET
fnp-5347	175	7	first	first	ADJ
fnp-5347	175	8	published	publish	VERB
fnp-5347	175	9	results	result	NOUN
fnp-5347	175	10	in	in	ADP
fnp-5347	175	11	2017	2017	NUM
fnp-5347	175	12	,	,	PUNCT
fnp-5347	175	13	where	where	SCONJ
fnp-5347	175	14	only	only	ADV
fnp-5347	175	15	33	33	NUM
fnp-5347	175	16	 	 	SPACE
fnp-5347	175	17	%	%	NOUN
fnp-5347	175	18	of	of	ADP
fnp-5347	175	19	patients	patient	NOUN
fnp-5347	175	20	were	be	AUX
fnp-5347	175	21	reported	report	VERB
fnp-5347	175	22	to	to	PART
fnp-5347	175	23	achieve	achieve	VERB
fnp-5347	175	24	postsurgical	postsurgical	ADJ
fnp-5347	175	25	seizure	seizure	NOUN
fnp-5347	175	26	control	control	NOUN
fnp-5347	175	27	.	.	PUNCT
fnp-5347	176	1	partial	partial	ADJ
fnp-5347	176	2	resection	resection	NOUN
fnp-5347	176	3	due	due	ADP
fnp-5347	176	4	to	to	ADP
fnp-5347	176	5	unknown	unknown	ADJ
fnp-5347	176	6	lesion	lesion	NOUN
fnp-5347	176	7	boundaries	boundary	NOUN
fnp-5347	176	8	were	be	AUX
fnp-5347	176	9	the	the	DET
fnp-5347	176	10	most	most	ADV
fnp-5347	176	11	likely	likely	ADJ
fnp-5347	176	12	explanation	explanation	NOUN
fnp-5347	176	13	in	in	ADP
fnp-5347	176	14	this	this	DET
fnp-5347	176	15	early	early	ADJ
fnp-5347	176	16	study	study	NOUN
fnp-5347	176	17	.	.	PUNCT
fnp-5347	177	1	the	the	DET
fnp-5347	177	2	challenge	challenge	NOUN
fnp-5347	177	3	to	to	PART
fnp-5347	177	4	anatomically	anatomically	ADV
fnp-5347	177	5	define	define	VERB
fnp-5347	177	6	moghe	moghe	NOUN
fnp-5347	177	7	's	's	PART
fnp-5347	177	8	lesion	lesion	NOUN
fnp-5347	177	9	borders	border	NOUN
fnp-5347	177	10	remains	remain	VERB
fnp-5347	177	11	actually	actually	ADV
fnp-5347	177	12	,	,	PUNCT
fnp-5347	177	13	which	which	PRON
fnp-5347	177	14	may	may	AUX
fnp-5347	177	15	open	open	VERB
fnp-5347	177	16	possible	possible	ADJ
fnp-5347	177	17	avenues	avenue	NOUN
fnp-5347	177	18	for	for	ADP
fnp-5347	177	19	preor	preor	NOUN
fnp-5347	177	20	perioperative	perioperative	ADJ
fnp-5347	177	21	online	online	ADJ
fnp-5347	177	22	sequencing	sequence	VERB
fnp-5347	177	23	methodologies	methodology	NOUN
fnp-5347	177	24	using	use	VERB
fnp-5347	177	25	the	the	DET
fnp-5347	177	26	real	real	ADJ
fnp-5347	177	27	-	-	PUNCT
fnp-5347	177	28	time	time	NOUN
fnp-5347	177	29	,	,	PUNCT
fnp-5347	177	30	direct	direct	ADJ
fnp-5347	177	31	sequencing	sequencing	NOUN
fnp-5347	177	32	technology	technology	NOUN
fnp-5347	177	33	,	,	PUNCT
fnp-5347	177	34	e.g.	e.g.	ADV
fnp-5347	177	35	see	see	VERB
fnp-5347	177	36	[	[	X
fnp-5347	177	37	42	42	NUM
fnp-5347	177	38	]	]	PUNCT
fnp-5347	177	39	,	,	PUNCT
fnp-5347	177	40	from	from	ADP
fnp-5347	177	41	intraoperative	intraoperative	ADJ
fnp-5347	177	42	specimens	specimen	NOUN
fnp-5347	177	43	or	or	CCONJ
fnp-5347	177	44	depth	depth	NOUN
fnp-5347	177	45	electrodes	electrode	NOUN
fnp-5347	177	46	obtained	obtain	VERB
fnp-5347	177	47	from	from	ADP
fnp-5347	177	48	presumptive	presumptive	ADJ
fnp-5347	177	49	lesion	lesion	NOUN
fnp-5347	177	50	borders	border	NOUN
fnp-5347	177	51	.	.	PUNCT
fnp-5347	178	1	it	it	PRON
fnp-5347	178	2	is	be	AUX
fnp-5347	178	3	yet	yet	ADV
fnp-5347	178	4	unknown	unknown	ADJ
fnp-5347	178	5	,	,	PUNCT
fnp-5347	178	6	however	however	ADV
fnp-5347	178	7	,	,	PUNCT
fnp-5347	178	8	if	if	SCONJ
fnp-5347	178	9	the	the	DET
fnp-5347	178	10	low	low	ADJ
fnp-5347	178	11	variant	variant	ADJ
fnp-5347	178	12	frequency	frequency	NOUN
fnp-5347	178	13	in	in	ADP
fnp-5347	178	14	these	these	DET
fnp-5347	178	15	lesions	lesion	NOUN
fnp-5347	178	16	and	and	CCONJ
fnp-5347	178	17	lack	lack	NOUN
fnp-5347	178	18	of	of	ADP
fnp-5347	178	19	hot	hot	ADJ
fnp-5347	178	20	spot	spot	NOUN
fnp-5347	178	21	mutations	mutation	NOUN
fnp-5347	178	22	can	can	AUX
fnp-5347	178	23	be	be	AUX
fnp-5347	178	24	resolved	resolve	VERB
fnp-5347	178	25	by	by	ADP
fnp-5347	178	26	the	the	DET
fnp-5347	178	27	technology	technology	NOUN
fnp-5347	178	28	.	.	PUNCT
fnp-5347	179	1	figure	figure	VERB
fnp-5347	179	2	4	4	NUM
fnp-5347	179	3	:	:	PUNCT
fnp-5347	179	4	membrane	membrane	NOUN
fnp-5347	179	5	topology	topology	NOUN
fnp-5347	179	6	modeling	modeling	NOUN
fnp-5347	179	7	of	of	ADP
fnp-5347	179	8	currently	currently	ADV
fnp-5347	179	9	known	know	VERB
fnp-5347	179	10	slc35a2	slc35a2	NOUN
fnp-5347	179	11	mutations	mutation	NOUN
fnp-5347	179	12	in	in	ADP
fnp-5347	179	13	moghe	moghe	ADJ
fnp-5347	179	14	figure	figure	NOUN
fnp-5347	179	15	4	4	NUM
fnp-5347	179	16	.	.	PUNCT
fnp-5347	179	17	schematic	schematic	ADJ
fnp-5347	179	18	representation	representation	NOUN
fnp-5347	179	19	of	of	ADP
fnp-5347	179	20	variants	variant	NOUN
fnp-5347	179	21	reported	report	VERB
fnp-5347	179	22	by	by	ADP
fnp-5347	179	23	[	[	X
fnp-5347	179	24	6	6	NUM
fnp-5347	179	25	]	]	PUNCT
fnp-5347	179	26	.	.	PUNCT
fnp-5347	180	1	novel	novel	ADJ
fnp-5347	180	2	variants	variant	NOUN
fnp-5347	180	3	are	be	AUX
fnp-5347	180	4	labeled	label	VERB
fnp-5347	180	5	in	in	ADP
fnp-5347	180	6	red	red	ADJ
fnp-5347	180	7	,	,	PUNCT
fnp-5347	180	8	variants	variant	NOUN
fnp-5347	180	9	already	already	ADV
fnp-5347	180	10	described	describe	VERB
fnp-5347	180	11	are	be	AUX
fnp-5347	180	12	labeled	label	VERB
fnp-5347	180	13	in	in	ADP
fnp-5347	180	14	black	black	ADJ
fnp-5347	180	15	.	.	PUNCT
fnp-5347	181	1	membrane	membrane	NOUN
fnp-5347	181	2	topology	topology	NOUN
fnp-5347	181	3	was	be	AUX
fnp-5347	181	4	predicted	predict	VERB
fnp-5347	181	5	using	use	VERB
fnp-5347	181	6	the	the	DET
fnp-5347	181	7	protter	protter	NOUN
fnp-5347	181	8	online	online	ADJ
fnp-5347	181	9	tool41	tool41	NOUN
fnp-5347	181	10	(	(	PUNCT
fnp-5347	181	11	p78381	p78381	NOUN
fnp-5347	181	12	-	-	PUNCT
fnp-5347	181	13	slc35a2_human	slc35a2_human	NOUN
fnp-5347	181	14	)	)	PUNCT
fnp-5347	181	15	.	.	PUNCT
fnp-5347	182	1	figure	figure	NOUN
fnp-5347	182	2	collected	collect	VERB
fnp-5347	182	3	from	from	ADP
fnp-5347	182	4	open	open	ADJ
fnp-5347	182	5	-	-	PUNCT
fnp-5347	182	6	access	access	NOUN
fnp-5347	182	7	paper	paper	NOUN
fnp-5347	182	8	published	publish	VERB
fnp-5347	182	9	under	under	ADP
fnp-5347	182	10	a	a	DET
fnp-5347	182	11	creative	creative	ADJ
fnp-5347	182	12	commons	common	NOUN
fnp-5347	182	13	license	license	NOUN
fnp-5347	182	14	,	,	PUNCT
fnp-5347	182	15	with	with	ADP
fnp-5347	182	16	permission	permission	NOUN
fnp-5347	182	17	from	from	ADP
fnp-5347	182	18	the	the	DET
fnp-5347	182	19	authors	author	NOUN
fnp-5347	182	20	.	.	PUNCT
fnp-5347	183	1	in	in	ADP
fnp-5347	183	2	2023	2023	NUM
fnp-5347	183	3	,	,	PUNCT
fnp-5347	183	4	another	another	DET
fnp-5347	183	5	small	small	ADJ
fnp-5347	183	6	study	study	NOUN
fnp-5347	183	7	described	describe	VERB
fnp-5347	183	8	five	five	NUM
fnp-5347	183	9	new	new	ADJ
fnp-5347	183	10	patients	patient	NOUN
fnp-5347	183	11	with	with	ADP
fnp-5347	183	12	moghe	moghe	ADJ
fnp-5347	183	13	confirming	confirm	VERB
fnp-5347	183	14	the	the	DET
fnp-5347	183	15	predominance	predominance	NOUN
fnp-5347	183	16	of	of	ADP
fnp-5347	183	17	frontal	frontal	ADJ
fnp-5347	183	18	lobe	lobe	NOUN
fnp-5347	183	19	epilepsy	epilepsy	NOUN
fnp-5347	183	20	and	and	CCONJ
fnp-5347	183	21	epileptic	epileptic	ADJ
fnp-5347	183	22	encephalopathy	encephalopathy	ADJ
fnp-5347	183	23	phenotypes	phenotype	NOUN
fnp-5347	183	24	in	in	ADP
fnp-5347	183	25	patients	patient	NOUN
fnp-5347	183	26	histopathologically	histopathologically	ADV
fnp-5347	183	27	diagnosed	diagnose	VERB
fnp-5347	183	28	as	as	ADP
fnp-5347	183	29	moghe	moghe	NOUN
fnp-5347	183	30	[	[	X
fnp-5347	183	31	18	18	NUM
fnp-5347	183	32	]	]	PUNCT
fnp-5347	183	33	.	.	PUNCT
fnp-5347	184	1	however	however	ADV
fnp-5347	184	2	,	,	PUNCT
fnp-5347	184	3	this	this	DET
fnp-5347	184	4	study	study	NOUN
fnp-5347	184	5	has	have	AUX
fnp-5347	184	6	not	not	PART
fnp-5347	184	7	applied	apply	VERB
fnp-5347	184	8	genetic	genetic	ADJ
fnp-5347	184	9	testing	testing	NOUN
fnp-5347	184	10	for	for	ADP
fnp-5347	184	11	brain	brain	NOUN
fnp-5347	184	12	somatic	somatic	ADJ
fnp-5347	184	13	mutations	mutation	NOUN
fnp-5347	184	14	.	.	PUNCT
fnp-5347	185	1	as	as	SCONJ
fnp-5347	185	2	reported	report	VERB
fnp-5347	185	3	above	above	ADV
fnp-5347	185	4	,	,	PUNCT
fnp-5347	185	5	all	all	DET
fnp-5347	185	6	patients	patient	NOUN
fnp-5347	185	7	responded	respond	VERB
fnp-5347	185	8	favorably	favorably	ADV
fnp-5347	185	9	to	to	ADP
fnp-5347	185	10	extensive	extensive	ADJ
fnp-5347	185	11	frontal	frontal	ADJ
fnp-5347	185	12	lobe	lobe	ADJ
fnp-5347	185	13	resections	resection	NOUN
fnp-5347	185	14	,	,	PUNCT
fnp-5347	185	15	despite	despite	SCONJ
fnp-5347	185	16	widespread	widespread	ADJ
fnp-5347	185	17	epileptic	epileptic	ADJ
fnp-5347	185	18	activity	activity	NOUN
fnp-5347	185	19	recorded	record	VERB
fnp-5347	185	20	by	by	ADP
fnp-5347	185	21	surface	surface	NOUN
fnp-5347	185	22	and	and	CCONJ
fnp-5347	185	23	intracranial	intracranial	ADJ
fnp-5347	185	24	eeg	eeg	PROPN
fnp-5347	185	25	preand	preand	NOUN
fnp-5347	185	26	postoperatively	postoperatively	ADV
fnp-5347	185	27	.	.	PUNCT
fnp-5347	186	1	the	the	DET
fnp-5347	186	2	authors	author	NOUN
fnp-5347	186	3	concluded	conclude	VERB
fnp-5347	186	4	,	,	PUNCT
fnp-5347	186	5	therefore	therefore	ADV
fnp-5347	186	6	,	,	PUNCT
fnp-5347	186	7	that	that	SCONJ
fnp-5347	186	8	an	an	DET
fnp-5347	186	9	epileptic	epileptic	ADJ
fnp-5347	186	10	encephalopathy	encephalopathy	ADJ
fnp-5347	186	11	phenotype	phenotype	NOUN
fnp-5347	186	12	in	in	ADP
fnp-5347	186	13	the	the	DET
fnp-5347	186	14	first	first	ADJ
fnp-5347	186	15	years	year	NOUN
fnp-5347	186	16	of	of	ADP
fnp-5347	186	17	life	life	NOUN
fnp-5347	186	18	should	should	AUX
fnp-5347	186	19	not	not	PART
fnp-5347	186	20	discourage	discourage	VERB
fnp-5347	186	21	a	a	DET
fnp-5347	186	22	surgical	surgical	ADJ
fnp-5347	186	23	treatment	treatment	NOUN
fnp-5347	186	24	option	option	NOUN
fnp-5347	186	25	.	.	PUNCT
fnp-5347	187	1	an	an	DET
fnp-5347	187	2	additional	additional	ADJ
fnp-5347	187	3	recently	recently	ADV
fnp-5347	187	4	published	publish	VERB
fnp-5347	187	5	paper	paper	NOUN
fnp-5347	187	6	from	from	ADP
fnp-5347	187	7	a	a	DET
fnp-5347	187	8	european	european	ADJ
fnp-5347	187	9	consortium	consortium	NOUN
fnp-5347	187	10	of	of	ADP
fnp-5347	187	11	epilepsy	epilepsy	ADJ
fnp-5347	187	12	surgery	surgery	NOUN
fnp-5347	187	13	centers	center	NOUN
fnp-5347	187	14	led	lead	VERB
fnp-5347	187	15	by	by	ADP
fnp-5347	187	16	dr	dr	PROPN
fnp-5347	187	17	.	.	PROPN
fnp-5347	187	18	angel	angel	PROPN
fnp-5347	187	19	aledo	aledo	PROPN
fnp-5347	187	20	-	-	PUNCT
fnp-5347	187	21	serano	serano	PROPN
fnp-5347	187	22	from	from	ADP
fnp-5347	187	23	madrid	madrid	PROPN
fnp-5347	187	24	,	,	PUNCT
fnp-5347	187	25	spain	spain	PROPN
fnp-5347	187	26	sheds	shed	VERB
fnp-5347	187	27	further	further	ADJ
fnp-5347	187	28	light	light	NOUN
fnp-5347	187	29	on	on	ADP
fnp-5347	187	30	moghe	moghe	NOUN
fnp-5347	187	31	.	.	PUNCT
fnp-5347	188	1	twelve	twelve	NUM
fnp-5347	188	2	patients	patient	NOUN
fnp-5347	188	3	with	with	ADP
fnp-5347	188	4	histopathologically	histopathologically	ADV
fnp-5347	188	5	confirmed	confirm	VERB
fnp-5347	188	6	moghe	moghe	NOUN
fnp-5347	188	7	were	be	AUX
fnp-5347	188	8	included	include	VERB
fnp-5347	188	9	in	in	ADP
fnp-5347	188	10	their	their	PRON
fnp-5347	188	11	postsurgical	postsurgical	ADJ
fnp-5347	188	12	clinical	clinical	ADJ
fnp-5347	188	13	trial	trial	NOUN
fnp-5347	188	14	attempting	attempt	VERB
fnp-5347	188	15	to	to	PART
fnp-5347	188	16	test	test	VERB
fnp-5347	188	17	the	the	DET
fnp-5347	188	18	benefit	benefit	NOUN
fnp-5347	188	19	of	of	ADP
fnp-5347	188	20	d	d	NOUN
fnp-5347	188	21	-	-	PUNCT
fnp-5347	188	22	galactose	galactose	ADJ
fnp-5347	188	23	supplementation	supplementation	NOUN
fnp-5347	188	24	when	when	SCONJ
fnp-5347	188	25	patients	patient	NOUN
fnp-5347	188	26	were	be	AUX
fnp-5347	188	27	not	not	PART
fnp-5347	188	28	seizure	seizure	VERB
fnp-5347	188	29	free	free	ADJ
fnp-5347	188	30	after	after	ADP
fnp-5347	188	31	surgery	surgery	NOUN
fnp-5347	188	32	.	.	PUNCT
fnp-5347	189	1	so	so	ADV
fnp-5347	189	2	far	far	ADV
fnp-5347	189	3	,	,	PUNCT
fnp-5347	189	4	research	research	NOUN
fnp-5347	189	5	evidence	evidence	NOUN
fnp-5347	189	6	reached	reach	VERB
fnp-5347	189	7	the	the	DET
fnp-5347	189	8	conclusion	conclusion	NOUN
fnp-5347	189	9	that	that	SCONJ
fnp-5347	189	10	at	at	ADV
fnp-5347	189	11	least	least	ADV
fnp-5347	189	12	50	50	NUM
fnp-5347	189	13	 	 	SPACE
fnp-5347	189	14	%	%	NOUN
fnp-5347	189	15	of	of	ADP
fnp-5347	189	16	moghe	moghe	NOUN
fnp-5347	189	17	patients	patient	NOUN
fnp-5347	189	18	suffer	suffer	VERB
fnp-5347	189	19	from	from	ADP
fnp-5347	189	20	a	a	DET
fnp-5347	189	21	brain	brain	NOUN
fnp-5347	189	22	somatic	somatic	ADJ
fnp-5347	189	23	loss	loss	NOUN
fnp-5347	189	24	-	-	PUNCT
fnp-5347	189	25	of	of	ADP
fnp-5347	189	26	-	-	PUNCT
fnp-5347	189	27	function	function	NOUN
fnp-5347	189	28	mutation	mutation	NOUN
fnp-5347	189	29	in	in	ADP
fnp-5347	189	30	the	the	DET
fnp-5347	189	31	galactose	galactose	ADJ
fnp-5347	189	32	transporter	transporter	NOUN
fnp-5347	189	33	gene	gene	NOUN
fnp-5347	189	34	slc35a2	slc35a2	NOUN
fnp-5347	189	35	,	,	PUNCT
fnp-5347	189	36	which	which	PRON
fnp-5347	189	37	delivers	deliver	VERB
fnp-5347	189	38	galactose	galactose	VERB
fnp-5347	189	39	into	into	ADP
fnp-5347	189	40	the	the	DET
fnp-5347	189	41	endoplasmic	endoplasmic	ADJ
fnp-5347	189	42	reticulum	reticulum	NOUN
fnp-5347	189	43	and	and	CCONJ
fnp-5347	189	44	golgi	golgi	NOUN
fnp-5347	189	45	apparatus	apparatus	NOUN
fnp-5347	189	46	,	,	PUNCT
fnp-5347	189	47	thereby	thereby	ADV
fnp-5347	189	48	glycosylating	glycosylate	VERB
fnp-5347	189	49	sphingolipids	sphingolipid	NOUN
fnp-5347	189	50	into	into	ADP
fnp-5347	189	51	functionally	functionally	ADV
fnp-5347	189	52	active	active	ADJ
fnp-5347	189	53	protein	protein	NOUN
fnp-5347	189	54	epitopes	epitope	NOUN
fnp-5347	189	55	.	.	PUNCT
fnp-5347	190	1	one	one	NUM
fnp-5347	190	2	therapeutic	therapeutic	ADJ
fnp-5347	190	3	option	option	NOUN
fnp-5347	190	4	to	to	PART
fnp-5347	190	5	circumvent	circumvent	VERB
fnp-5347	190	6	the	the	DET
fnp-5347	190	7	lack	lack	NOUN
fnp-5347	190	8	of	of	ADP
fnp-5347	190	9	slc35a2	slc35a2	NOUN
fnp-5347	190	10	protein	protein	NOUN
fnp-5347	190	11	would	would	AUX
fnp-5347	190	12	be	be	AUX
fnp-5347	190	13	to	to	PART
fnp-5347	190	14	push	push	VERB
fnp-5347	190	15	alternative	alternative	ADJ
fnp-5347	190	16	transporter	transporter	NOUN
fnp-5347	190	17	pathways	pathway	NOUN
fnp-5347	190	18	by	by	ADP
fnp-5347	190	19	offering	offer	VERB
fnp-5347	190	20	vast	vast	ADJ
fnp-5347	190	21	amounts	amount	NOUN
fnp-5347	190	22	of	of	ADP
fnp-5347	190	23	galactose	galactose	ADJ
fnp-5347	190	24	substrate	substrate	NOUN
fnp-5347	190	25	to	to	ADP
fnp-5347	190	26	the	the	DET
fnp-5347	190	27	patient	patient	NOUN
fnp-5347	190	28	.	.	PUNCT
fnp-5347	191	1	this	this	DET
fnp-5347	191	2	treatment	treatment	NOUN
fnp-5347	191	3	strategy	strategy	NOUN
fnp-5347	191	4	was	be	AUX
fnp-5347	191	5	tested	test	VERB
fnp-5347	191	6	in	in	ADP
fnp-5347	191	7	2020	2020	NUM
fnp-5347	191	8	in	in	ADP
fnp-5347	191	9	young	young	ADJ
fnp-5347	191	10	children	child	NOUN
fnp-5347	191	11	with	with	ADP
fnp-5347	191	12	the	the	DET
fnp-5347	191	13	germline	germline	NOUN
fnp-5347	191	14	variant	variant	NOUN
fnp-5347	191	15	of	of	ADP
fnp-5347	191	16	slc35a2	slc35a2	NOUN
fnp-5347	191	17	deficiency	deficiency	NOUN
fnp-5347	191	18	,	,	PUNCT
fnp-5347	191	19	i.e.	i.e.	X
fnp-5347	191	20	slc35a2	slc35a2	ADV
fnp-5347	191	21	-	-	PUNCT
fnp-5347	191	22	congenital	congenital	ADJ
fnp-5347	191	23	glycosylation	glycosylation	NOUN
fnp-5347	191	24	disorder	disorder	NOUN
fnp-5347	191	25	characterized	characterize	VERB
fnp-5347	191	26	by	by	ADP
fnp-5347	191	27	epileptic	epileptic	ADJ
fnp-5347	191	28	encephalopathy	encephalopathy	NOUN
fnp-5347	191	29	,	,	PUNCT
fnp-5347	191	30	developmental	developmental	ADJ
fnp-5347	191	31	disability	disability	NOUN
fnp-5347	191	32	,	,	PUNCT
fnp-5347	191	33	growth	growth	NOUN
fnp-5347	191	34	deficiency	deficiency	NOUN
fnp-5347	191	35	,	,	PUNCT
fnp-5347	191	36	dysmorphism	dysmorphism	NOUN
fnp-5347	191	37	as	as	ADV
fnp-5347	191	38	well	well	ADV
fnp-5347	191	39	as	as	ADP
fnp-5347	191	40	high	high	ADJ
fnp-5347	191	41	mortality	mortality	NOUN
fnp-5347	191	42	rates	rate	NOUN
fnp-5347	191	43	within	within	ADP
fnp-5347	191	44	the	the	DET
fnp-5347	191	45	first	first	ADJ
fnp-5347	191	46	years	year	NOUN
fnp-5347	191	47	of	of	ADP
fnp-5347	191	48	life	life	NOUN
fnp-5347	191	49	[	[	X
fnp-5347	191	50	47	47	NUM
fnp-5347	191	51	]	]	PUNCT
fnp-5347	191	52	.	.	PUNCT
fnp-5347	192	1	their	their	PRON
fnp-5347	192	2	hypothesis	hypothesis	NOUN
fnp-5347	192	3	was	be	AUX
fnp-5347	192	4	that	that	SCONJ
fnp-5347	192	5	galactose	galactose	ADJ
fnp-5347	192	6	supplementation	supplementation	NOUN
fnp-5347	192	7	partially	partially	ADV
fnp-5347	192	8	overcomes	overcome	VERB
fnp-5347	192	9	the	the	DET
fnp-5347	192	10	golgi	golgi	PROPN
fnp-5347	192	11	udp	udp	PROPN
fnp-5347	192	12	-	-	NOUN
fnp-5347	192	13	galactose	galactose	ADJ
fnp-5347	192	14	deficiency	deficiency	NOUN
fnp-5347	192	15	and	and	CCONJ
fnp-5347	192	16	improves	improve	VERB
fnp-5347	192	17	galactosylation	galactosylation	NOUN
fnp-5347	192	18	[	[	X
fnp-5347	192	19	47	47	NUM
fnp-5347	192	20	]	]	PUNCT
fnp-5347	192	21	.	.	PUNCT
fnp-5347	193	1	in	in	ADP
fnp-5347	193	2	addition	addition	NOUN
fnp-5347	193	3	,	,	PUNCT
fnp-5347	193	4	oral	oral	ADJ
fnp-5347	193	5	galactose	galactose	ADJ
fnp-5347	193	6	supplementation	supplementation	NOUN
fnp-5347	193	7	was	be	AUX
fnp-5347	193	8	well	well	ADV
fnp-5347	193	9	tolerated	tolerate	VERB
fnp-5347	193	10	showing	showing	NOUN
fnp-5347	193	11	promise	promise	NOUN
fnp-5347	193	12	as	as	ADP
fnp-5347	193	13	dietary	dietary	ADJ
fnp-5347	193	14	therapy	therapy	NOUN
fnp-5347	193	15	.	.	PUNCT
fnp-5347	194	1	aledo	aledo	PROPN
fnp-5347	194	2	-	-	PUNCT
fnp-5347	194	3	serano	serano	PROPN
fnp-5347	194	4	aimed	aim	VERB
fnp-5347	194	5	,	,	PUNCT
fnp-5347	194	6	therefore	therefore	ADV
fnp-5347	194	7	,	,	PUNCT
fnp-5347	194	8	to	to	PART
fnp-5347	194	9	evaluate	evaluate	VERB
fnp-5347	194	10	the	the	DET
fnp-5347	194	11	effects	effect	NOUN
fnp-5347	194	12	of	of	ADP
fnp-5347	194	13	d	d	NOUN
fnp-5347	194	14	-	-	PUNCT
fnp-5347	194	15	galactose	galactose	ADJ
fnp-5347	194	16	supplementation	supplementation	NOUN
fnp-5347	194	17	also	also	ADV
fnp-5347	194	18	in	in	ADP
fnp-5347	194	19	patients	patient	NOUN
fnp-5347	194	20	with	with	ADP
fnp-5347	194	21	histopathologically	histopathologically	ADV
fnp-5347	194	22	confirmed	confirm	VERB
fnp-5347	194	23	moghe	moghe	NOUN
fnp-5347	194	24	,	,	PUNCT
fnp-5347	194	25	with	with	ADP
fnp-5347	194	26	uncontrolled	uncontrolled	ADJ
fnp-5347	194	27	seizures	seizure	NOUN
fnp-5347	194	28	or	or	CCONJ
fnp-5347	194	29	cognitive	cognitive	ADJ
fnp-5347	194	30	impairment	impairment	NOUN
fnp-5347	194	31	and	and	CCONJ
fnp-5347	194	32	epileptiform	epileptiform	NOUN
fnp-5347	194	33	activity	activity	NOUN
fnp-5347	194	34	at	at	ADP
fnp-5347	194	35	the	the	DET
fnp-5347	194	36	eeg	eeg	NOUN
fnp-5347	194	37	after	after	ADP
fnp-5347	194	38	epilepsy	epilepsy	NOUN
fnp-5347	194	39	surgery	surgery	NOUN
fnp-5347	194	40	as	as	ADP
fnp-5347	194	41	inclusion	inclusion	NOUN
fnp-5347	194	42	criteria	criterion	NOUN
fnp-5347	194	43	to	to	ADP
fnp-5347	194	44	their	their	PRON
fnp-5347	194	45	clinical	clinical	ADJ
fnp-5347	194	46	trial	trial	NOUN
fnp-5347	194	47	(	(	PUNCT
fnp-5347	194	48	nct04833322	nct04833322	NOUN
fnp-5347	194	49	)	)	PUNCT
fnp-5347	194	50	.	.	PUNCT
fnp-5347	195	1	patients	patient	NOUN
fnp-5347	195	2	were	be	AUX
fnp-5347	195	3	orally	orally	ADV
fnp-5347	195	4	supplemented	supplement	VERB
fnp-5347	195	5	with	with	ADP
fnp-5347	195	6	d	d	NOUN
fnp-5347	195	7	-	-	PUNCT
fnp-5347	195	8	galactose	galactose	NOUN
fnp-5347	195	9	for	for	ADP
fnp-5347	195	10	6	6	NUM
fnp-5347	195	11	months	month	NOUN
fnp-5347	195	12	in	in	ADP
fnp-5347	195	13	doses	dose	NOUN
fnp-5347	195	14	up	up	ADP
fnp-5347	195	15	to	to	ADP
fnp-5347	195	16	1.5	1.5	NUM
fnp-5347	195	17	g	g	NOUN
fnp-5347	195	18	/	/	SYM
fnp-5347	195	19	kg	kg	NOUN
fnp-5347	195	20	/	/	SYM
fnp-5347	195	21	day	day	NOUN
fnp-5347	195	22	and	and	CCONJ
fnp-5347	195	23	monitored	monitor	VERB
fnp-5347	195	24	for	for	ADP
fnp-5347	195	25	seizure	seizure	NOUN
fnp-5347	195	26	frequency	frequency	NOUN
fnp-5347	195	27	including	include	VERB
fnp-5347	195	28	24	24	NUM
fnp-5347	195	29	-	-	PUNCT
fnp-5347	195	30	h	h	NOUN
fnp-5347	195	31	video	video	NOUN
fnp-5347	195	32	-	-	PUNCT
fnp-5347	195	33	eeg	eeg	NOUN
fnp-5347	195	34	recording	recording	NOUN
fnp-5347	195	35	,	,	PUNCT
fnp-5347	195	36	cognition	cognition	NOUN
fnp-5347	195	37	and	and	CCONJ
fnp-5347	195	38	behavioral	behavioral	ADJ
fnp-5347	195	39	scores	score	NOUN
fnp-5347	195	40	,	,	PUNCT
fnp-5347	195	41	before	before	ADP
fnp-5347	195	42	and	and	CCONJ
fnp-5347	195	43	six	six	NUM
fnp-5347	195	44	months	month	NOUN
fnp-5347	195	45	after	after	ADP
fnp-5347	195	46	treatment	treatment	NOUN
fnp-5347	195	47	.	.	PUNCT
fnp-5347	196	1	positive	positive	ADJ
fnp-5347	196	2	response	response	NOUN
fnp-5347	196	3	was	be	AUX
fnp-5347	196	4	defined	define	VERB
fnp-5347	196	5	by	by	ADP
fnp-5347	196	6	more	more	ADJ
fnp-5347	196	7	than	than	ADP
fnp-5347	196	8	50	50	NUM
fnp-5347	196	9	 	 	SPACE
fnp-5347	196	10	%	%	NOUN
fnp-5347	196	11	improvement	improvement	NOUN
fnp-5347	196	12	of	of	ADP
fnp-5347	196	13	seizure	seizure	NOUN
fnp-5347	196	14	frequency	frequency	NOUN
fnp-5347	196	15	and/or	and/or	CCONJ
fnp-5347	196	16	cognition	cognition	NOUN
fnp-5347	196	17	and	and	CCONJ
fnp-5347	196	18	behavior	behavior	NOUN
fnp-5347	196	19	.	.	PUNCT
fnp-5347	197	1	twelve	twelve	NUM
fnp-5347	197	2	patients	patient	NOUN
fnp-5347	197	3	aged	age	VERB
fnp-5347	197	4	5	5	NUM
fnp-5347	197	5	-	-	SYM
fnp-5347	197	6	28	28	NUM
fnp-5347	197	7	years	year	NOUN
fnp-5347	197	8	were	be	AUX
fnp-5347	197	9	included	include	VERB
fnp-5347	197	10	from	from	ADP
fnp-5347	197	11	three	three	NUM
fnp-5347	197	12	different	different	ADJ
fnp-5347	197	13	centers	center	NOUN
fnp-5347	197	14	.	.	PUNCT
fnp-5347	198	1	neurosurgical	neurosurgical	ADJ
fnp-5347	198	2	tissue	tissue	NOUN
fnp-5347	198	3	samples	sample	NOUN
fnp-5347	198	4	were	be	AUX
fnp-5347	198	5	available	available	ADJ
fnp-5347	198	6	in	in	ADP
fnp-5347	198	7	all	all	DET
fnp-5347	198	8	patients	patient	NOUN
fnp-5347	198	9	and	and	CCONJ
fnp-5347	198	10	revealed	reveal	VERB
fnp-5347	198	11	a	a	DET
fnp-5347	198	12	brain	brain	NOUN
fnp-5347	198	13	somatic	somatic	ADJ
fnp-5347	198	14	variant	variant	NOUN
fnp-5347	198	15	in	in	ADP
fnp-5347	198	16	slc35a2	slc35a2	NOUN
fnp-5347	198	17	in	in	ADP
fnp-5347	198	18	six	six	NUM
fnp-5347	198	19	patients	patient	NOUN
fnp-5347	198	20	(	(	PUNCT
fnp-5347	198	21	not	not	PART
fnp-5347	198	22	-	-	PUNCT
fnp-5347	198	23	present	present	ADJ
fnp-5347	198	24	in	in	ADP
fnp-5347	198	25	the	the	DET
fnp-5347	198	26	blood	blood	NOUN
fnp-5347	198	27	)	)	PUNCT
fnp-5347	198	28	.	.	PUNCT
fnp-5347	199	1	after	after	ADP
fnp-5347	199	2	6	6	NUM
fnp-5347	199	3	months	month	NOUN
fnp-5347	199	4	of	of	ADP
fnp-5347	199	5	supplementation	supplementation	NOUN
fnp-5347	199	6	,	,	PUNCT
fnp-5347	199	7	d	d	X
fnp-5347	199	8	-	-	PUNCT
fnp-5347	199	9	galactose	galactose	NOUN
fnp-5347	199	10	was	be	AUX
fnp-5347	199	11	well	well	ADV
fnp-5347	199	12	tolerated	tolerate	VERB
fnp-5347	199	13	with	with	ADP
fnp-5347	199	14	just	just	ADV
fnp-5347	199	15	two	two	NUM
fnp-5347	199	16	patients	patient	NOUN
fnp-5347	199	17	presenting	present	VERB
fnp-5347	199	18	abdominal	abdominal	ADJ
fnp-5347	199	19	discomfort	discomfort	NOUN
fnp-5347	199	20	,	,	PUNCT
fnp-5347	199	21	solved	solve	VERB
fnp-5347	199	22	after	after	ADP
fnp-5347	199	23	dose	dose	NOUN
fnp-5347	199	24	spacing	spacing	NOUN
fnp-5347	199	25	or	or	CCONJ
fnp-5347	199	26	reduction	reduction	NOUN
fnp-5347	199	27	.	.	PUNCT
fnp-5347	200	1	there	there	PRON
fnp-5347	200	2	was	be	VERB
fnp-5347	200	3	a	a	DET
fnp-5347	200	4	50	50	NUM
fnp-5347	200	5	 	 	SPACE
fnp-5347	200	6	%	%	NOUN
fnp-5347	200	7	reduction	reduction	NOUN
fnp-5347	200	8	or	or	CCONJ
fnp-5347	200	9	higher	high	ADJ
fnp-5347	200	10	of	of	ADP
fnp-5347	200	11	seizure	seizure	NOUN
fnp-5347	200	12	frequency	frequency	NOUN
fnp-5347	200	13	in	in	ADP
fnp-5347	200	14	3/6	3/6	NUM
fnp-5347	200	15	patients	patient	NOUN
fnp-5347	200	16	,	,	PUNCT
fnp-5347	200	17	with	with	ADP
fnp-5347	200	18	an	an	DET
fnp-5347	200	19	improvement	improvement	NOUN
fnp-5347	200	20	at	at	ADP
fnp-5347	200	21	eeg	eeg	NOUN
fnp-5347	200	22	in	in	ADP
fnp-5347	200	23	2/5	2/5	NUM
fnp-5347	200	24	patients	patient	NOUN
fnp-5347	200	25	and	and	CCONJ
fnp-5347	200	26	a	a	DET
fnp-5347	200	27	global	global	ADJ
fnp-5347	200	28	responder	responder	NOUN
fnp-5347	200	29	rate	rate	NOUN
fnp-5347	200	30	of	of	ADP
fnp-5347	200	31	6/6	6/6	NUM
fnp-5347	200	32	in	in	ADP
fnp-5347	200	33	slc35a2	slc35a2	ADV
fnp-5347	200	34	-	-	PUNCT
fnp-5347	200	35	positive	positive	ADJ
fnp-5347	200	36	patients	patient	NOUN
fnp-5347	200	37	.	.	PUNCT
fnp-5347	201	1	one	one	NUM
fnp-5347	201	2	patient	patient	NOUN
fnp-5347	201	3	became	become	VERB
fnp-5347	201	4	seizure	seizure	NOUN
fnp-5347	201	5	-	-	PUNCT
fnp-5347	201	6	free	free	ADJ
fnp-5347	201	7	.	.	PUNCT
fnp-5347	202	1	an	an	DET
fnp-5347	202	2	improvement	improvement	NOUN
fnp-5347	202	3	of	of	ADP
fnp-5347	202	4	cognitive	cognitive	ADJ
fnp-5347	202	5	/	/	SYM
fnp-5347	202	6	behavioral	behavioral	ADJ
fnp-5347	202	7	features	feature	NOUN
fnp-5347	202	8	was	be	AUX
fnp-5347	202	9	also	also	ADV
fnp-5347	202	10	observed	observe	VERB
fnp-5347	202	11	.	.	PUNCT
fnp-5347	203	1	in	in	ADP
fnp-5347	203	2	contrast	contrast	NOUN
fnp-5347	203	3	,	,	PUNCT
fnp-5347	203	4	only	only	ADV
fnp-5347	203	5	three	three	NUM
fnp-5347	203	6	out	out	ADP
fnp-5347	203	7	of	of	ADP
fnp-5347	203	8	nine	nine	NUM
fnp-5347	203	9	responders	responder	NOUN
fnp-5347	203	10	carried	carry	VERB
fnp-5347	203	11	the	the	DET
fnp-5347	203	12	slc35a2	slc35a2	PROPN
fnp-5347	203	13	wildtype	wildtype	NOUN
fnp-5347	203	14	gene	gene	NOUN
fnp-5347	203	15	and	and	CCONJ
fnp-5347	203	16	all	all	DET
fnp-5347	203	17	non	non	NOUN
fnp-5347	203	18	-	-	NOUN
fnp-5347	203	19	responders	responder	NOUN
fnp-5347	203	20	were	be	AUX
fnp-5347	203	21	slc35a2	slc35a2	ADV
fnp-5347	203	22	wildtype	wildtype	NOUN
fnp-5347	203	23	.	.	PUNCT
fnp-5347	204	1	their	their	PRON
fnp-5347	204	2	results	result	NOUN
fnp-5347	204	3	suggested	suggest	VERB
fnp-5347	204	4	that	that	SCONJ
fnp-5347	204	5	supplementation	supplementation	NOUN
fnp-5347	204	6	with	with	ADP
fnp-5347	204	7	d	d	NOUN
fnp-5347	204	8	-	-	PUNCT
fnp-5347	204	9	galactose	galactose	NOUN
fnp-5347	204	10	in	in	ADP
fnp-5347	204	11	patients	patient	NOUN
fnp-5347	204	12	with	with	ADP
fnp-5347	204	13	moghe	moghe	NOUN
fnp-5347	204	14	is	be	AUX
fnp-5347	204	15	safe	safe	ADJ
fnp-5347	204	16	and	and	CCONJ
fnp-5347	204	17	well	well	ADV
fnp-5347	204	18	tolerated	tolerate	VERB
fnp-5347	204	19	and	and	CCONJ
fnp-5347	204	20	,	,	PUNCT
fnp-5347	204	21	although	although	SCONJ
fnp-5347	204	22	the	the	DET
fnp-5347	204	23	efficacy	efficacy	NOUN
fnp-5347	204	24	data	datum	NOUN
fnp-5347	204	25	warranted	warrant	VERB
fnp-5347	204	26	larger	large	ADJ
fnp-5347	204	27	studies	study	NOUN
fnp-5347	204	28	,	,	PUNCT
fnp-5347	204	29	it	it	PRON
fnp-5347	204	30	might	might	AUX
fnp-5347	204	31	build	build	VERB
fnp-5347	204	32	a	a	DET
fnp-5347	204	33	rationale	rationale	NOUN
fnp-5347	204	34	for	for	ADP
fnp-5347	204	35	precision	precision	NOUN
fnp-5347	204	36	medicine	medicine	NOUN
fnp-5347	204	37	after	after	ADP
fnp-5347	204	38	epilepsy	epilepsy	NOUN
fnp-5347	204	39	surgery	surgery	NOUN
fnp-5347	204	40	.	.	PUNCT
fnp-5347	205	1	topic	topic	NOUN
fnp-5347	205	2	5	5	NUM
fnp-5347	205	3	:	:	PUNCT
fnp-5347	205	4	new	new	ADJ
fnp-5347	205	5	diagnostic	diagnostic	ADJ
fnp-5347	205	6	disease	disease	NOUN
fnp-5347	205	7	entities	entity	NOUN
fnp-5347	205	8	:	:	PUNCT
fnp-5347	205	9	ii	ii	X
fnp-5347	205	10	.	.	PUNCT
fnp-5347	206	1	encephaloceles	encephalocele	VERB
fnp-5347	206	2	encephaloceles	encephalocele	NOUN
fnp-5347	206	3	(	(	PUNCT
fnp-5347	206	4	enc	enc	PROPN
fnp-5347	206	5	)	)	PUNCT
fnp-5347	206	6	are	be	AUX
fnp-5347	206	7	protrusions	protrusion	NOUN
fnp-5347	206	8	of	of	ADP
fnp-5347	206	9	the	the	DET
fnp-5347	206	10	neocortex	neocortex	NOUN
fnp-5347	206	11	and	and	CCONJ
fnp-5347	206	12	its	its	PRON
fnp-5347	206	13	meninges	meninge	NOUN
fnp-5347	206	14	expanding	expand	VERB
fnp-5347	206	15	into	into	ADP
fnp-5347	206	16	the	the	DET
fnp-5347	206	17	diploic	diploic	ADJ
fnp-5347	206	18	space	space	NOUN
fnp-5347	206	19	of	of	ADP
fnp-5347	206	20	the	the	DET
fnp-5347	206	21	skull	skull	NOUN
fnp-5347	206	22	bone	bone	NOUN
fnp-5347	206	23	(	(	PUNCT
fnp-5347	206	24	figure	figure	NOUN
fnp-5347	206	25	5	5	NUM
fnp-5347	206	26	)	)	PUNCT
fnp-5347	206	27	,	,	PUNCT
fnp-5347	206	28	i.e.	i.e.	X
fnp-5347	206	29	the	the	DET
fnp-5347	206	30	medullary	medullary	ADJ
fnp-5347	206	31	cavity	cavity	NOUN
fnp-5347	206	32	,	,	PUNCT
fnp-5347	206	33	leaving	leave	VERB
fnp-5347	206	34	the	the	DET
fnp-5347	206	35	outer	outer	ADJ
fnp-5347	206	36	skull	skull	NOUN
fnp-5347	206	37	table	table	NOUN
fnp-5347	206	38	intact	intact	ADJ
fnp-5347	206	39	[	[	X
fnp-5347	206	40	4	4	NUM
fnp-5347	206	41	]	]	PUNCT
fnp-5347	206	42	.	.	PUNCT
fnp-5347	207	1	enc	enc	PROPN
fnp-5347	207	2	can	can	AUX
fnp-5347	207	3	occur	occur	VERB
fnp-5347	207	4	in	in	ADP
fnp-5347	207	5	any	any	DET
fnp-5347	207	6	location	location	NOUN
fnp-5347	207	7	,	,	PUNCT
fnp-5347	207	8	most	most	ADV
fnp-5347	207	9	commonly	commonly	ADV
fnp-5347	207	10	in	in	ADP
fnp-5347	207	11	the	the	DET
fnp-5347	207	12	frontal	frontal	ADJ
fnp-5347	207	13	or	or	CCONJ
fnp-5347	207	14	parietal	parietal	ADJ
fnp-5347	207	15	region	region	NOUN
fnp-5347	207	16	[	[	X
fnp-5347	207	17	4	4	NUM
fnp-5347	207	18	]	]	PUNCT
fnp-5347	207	19	.	.	PUNCT
fnp-5347	208	1	they	they	PRON
fnp-5347	208	2	can	can	AUX
fnp-5347	208	3	develop	develop	VERB
fnp-5347	208	4	congenitally	congenitally	ADV
fnp-5347	208	5	,	,	PUNCT
fnp-5347	208	6	as	as	SCONJ
fnp-5347	208	7	will	will	AUX
fnp-5347	208	8	be	be	AUX
fnp-5347	208	9	discussed	discuss	VERB
fnp-5347	208	10	herein	herein	NOUN
fnp-5347	208	11	,	,	PUNCT
fnp-5347	208	12	which	which	PRON
fnp-5347	208	13	needs	need	VERB
fnp-5347	208	14	to	to	PART
fnp-5347	208	15	be	be	AUX
fnp-5347	208	16	separated	separate	VERB
fnp-5347	208	17	from	from	ADP
fnp-5347	208	18	a	a	DET
fnp-5347	208	19	traumatic	traumatic	ADJ
fnp-5347	208	20	,	,	PUNCT
fnp-5347	208	21	neoplastic	neoplastic	ADJ
fnp-5347	208	22	,	,	PUNCT
fnp-5347	208	23	inflammatory	inflammatory	ADJ
fnp-5347	208	24	or	or	CCONJ
fnp-5347	208	25	iatrogenic	iatrogenic	ADJ
fnp-5347	208	26	origin	origin	NOUN
fnp-5347	208	27	.	.	PUNCT
fnp-5347	209	1	increased	increase	VERB
fnp-5347	209	2	intracranial	intracranial	ADJ
fnp-5347	209	3	hypertension	hypertension	NOUN
fnp-5347	209	4	,	,	PUNCT
fnp-5347	209	5	e.g.	e.g.	ADV
fnp-5347	209	6	,	,	PUNCT
fnp-5347	209	7	empty	empty	ADJ
fnp-5347	209	8	sella	sella	NOUN
fnp-5347	209	9	or	or	CCONJ
fnp-5347	209	10	optic	optic	ADJ
fnp-5347	209	11	nerve	nerve	NOUN
fnp-5347	209	12	sheath	sheath	NOUN
fnp-5347	209	13	dilatation	dilatation	NOUN
fnp-5347	209	14	,	,	PUNCT
fnp-5347	209	15	female	female	ADJ
fnp-5347	209	16	gender	gender	NOUN
fnp-5347	209	17	and	and	CCONJ
fnp-5347	209	18	obesity	obesity	NOUN
fnp-5347	209	19	have	have	AUX
fnp-5347	209	20	been	be	AUX
fnp-5347	209	21	repetitively	repetitively	ADV
fnp-5347	209	22	reported	report	VERB
fnp-5347	209	23	as	as	ADP
fnp-5347	209	24	risk	risk	NOUN
fnp-5347	209	25	factor	factor	NOUN
fnp-5347	209	26	for	for	ADP
fnp-5347	209	27	enc	enc	PROPN
fnp-5347	209	28	when	when	SCONJ
fnp-5347	209	29	occurring	occur	VERB
fnp-5347	209	30	without	without	ADP
fnp-5347	209	31	a	a	DET
fnp-5347	209	32	clear	clear	ADJ
fnp-5347	209	33	etiology	etiology	NOUN
fnp-5347	209	34	.	.	PUNCT
fnp-5347	210	1	in	in	ADP
fnp-5347	210	2	patients	patient	NOUN
fnp-5347	210	3	with	with	ADP
fnp-5347	210	4	drug	drug	NOUN
fnp-5347	210	5	-	-	PUNCT
fnp-5347	210	6	resistant	resistant	ADJ
fnp-5347	210	7	temporal	temporal	ADJ
fnp-5347	210	8	lobe	lobe	NOUN
fnp-5347	210	9	epilepsy	epilepsy	NOUN
fnp-5347	210	10	(	(	PUNCT
fnp-5347	210	11	tle	tle	ADJ
fnp-5347	210	12	)	)	PUNCT
fnp-5347	210	13	,	,	PUNCT
fnp-5347	210	14	enc	enc	PROPN
fnp-5347	210	15	are	be	AUX
fnp-5347	210	16	increasingly	increasingly	ADV
fnp-5347	210	17	recognized	recognize	VERB
fnp-5347	210	18	in	in	ADP
fnp-5347	210	19	the	the	DET
fnp-5347	210	20	temporo	temporo	NOUN
fnp-5347	210	21	-	-	PUNCT
fnp-5347	210	22	polar	polar	ADJ
fnp-5347	210	23	and/or	and/or	CCONJ
fnp-5347	210	24	basal	basal	ADJ
fnp-5347	210	25	region	region	NOUN
fnp-5347	210	26	of	of	ADP
fnp-5347	210	27	the	the	DET
fnp-5347	210	28	brain	brain	NOUN
fnp-5347	210	29	.	.	PUNCT
fnp-5347	211	1	these	these	PRON
fnp-5347	211	2	are	be	AUX
fnp-5347	211	3	likely	likely	ADJ
fnp-5347	211	4	congenital	congenital	ADJ
fnp-5347	211	5	enc	enc	NOUN
fnp-5347	211	6	and	and	CCONJ
fnp-5347	211	7	can	can	AUX
fnp-5347	211	8	vary	vary	VERB
fnp-5347	211	9	in	in	ADP
fnp-5347	211	10	size	size	NOUN
fnp-5347	211	11	from	from	ADP
fnp-5347	211	12	mm	mm	PROPN
fnp-5347	211	13	to	to	ADP
fnp-5347	211	14	cm	cm	NOUN
fnp-5347	211	15	,	,	PUNCT
fnp-5347	211	16	vary	vary	VERB
fnp-5347	211	17	in	in	ADP
fnp-5347	211	18	number	number	NOUN
fnp-5347	211	19	up	up	ADP
fnp-5347	211	20	to	to	ADP
fnp-5347	211	21	more	more	ADJ
fnp-5347	211	22	than	than	ADP
fnp-5347	211	23	10	10	NUM
fnp-5347	211	24	in	in	ADP
fnp-5347	211	25	a	a	DET
fnp-5347	211	26	focal	focal	ADJ
fnp-5347	211	27	region	region	NOUN
fnp-5347	211	28	and	and	CCONJ
fnp-5347	211	29	affect	affect	VERB
fnp-5347	211	30	either	either	PRON
fnp-5347	211	31	one	one	NUM
fnp-5347	211	32	or	or	CCONJ
fnp-5347	211	33	both	both	DET
fnp-5347	211	34	hemispheres	hemisphere	NOUN
fnp-5347	211	35	.	.	PUNCT
fnp-5347	212	1	very	very	ADV
fnp-5347	212	2	small	small	ADJ
fnp-5347	212	3	enc	enc	PROPN
fnp-5347	212	4	are	be	AUX
fnp-5347	212	5	often	often	ADV
fnp-5347	212	6	seen	see	VERB
fnp-5347	212	7	only	only	ADV
fnp-5347	212	8	during	during	ADP
fnp-5347	212	9	surgery	surgery	NOUN
fnp-5347	212	10	as	as	SCONJ
fnp-5347	212	11	they	they	PRON
fnp-5347	212	12	escape	escape	VERB
fnp-5347	212	13	the	the	DET
fnp-5347	212	14	current	current	ADJ
fnp-5347	212	15	resolution	resolution	NOUN
fnp-5347	212	16	scale	scale	NOUN
fnp-5347	212	17	of	of	ADP
fnp-5347	212	18	clinical	clinical	ADJ
fnp-5347	212	19	routine	routine	ADJ
fnp-5347	212	20	mri	mri	NOUN
fnp-5347	212	21	.	.	PUNCT
fnp-5347	213	1	a	a	DET
fnp-5347	213	2	recent	recent	ADJ
fnp-5347	213	3	paper	paper	NOUN
fnp-5347	213	4	from	from	ADP
fnp-5347	213	5	di	di	NOUN
fnp-5347	213	6	giacomo	giacomo	NOUN
fnp-5347	213	7	and	and	CCONJ
fnp-5347	213	8	coworkers	coworker	NOUN
fnp-5347	213	9	looked	look	VERB
fnp-5347	213	10	at	at	ADP
fnp-5347	213	11	electro	electro	NOUN
fnp-5347	213	12	-	-	PUNCT
fnp-5347	213	13	clinical	clinical	ADJ
fnp-5347	213	14	,	,	PUNCT
fnp-5347	213	15	neuroimaging	neuroimaging	NOUN
fnp-5347	213	16	and	and	CCONJ
fnp-5347	213	17	histopathology	histopathology	NOUN
fnp-5347	213	18	features	feature	NOUN
fnp-5347	213	19	of	of	ADP
fnp-5347	213	20	their	their	PRON
fnp-5347	213	21	series	series	NOUN
fnp-5347	213	22	of	of	ADP
fnp-5347	213	23	12	12	NUM
fnp-5347	213	24	patients	patient	NOUN
fnp-5347	213	25	with	with	ADP
fnp-5347	213	26	enc	enc	PROPN
fnp-5347	213	27	[	[	X
fnp-5347	213	28	16	16	NUM
fnp-5347	213	29	]	]	PUNCT
fnp-5347	213	30	.	.	PUNCT
fnp-5347	214	1	all	all	DET
fnp-5347	214	2	patients	patient	NOUN
fnp-5347	214	3	were	be	AUX
fnp-5347	214	4	retrospectively	retrospectively	ADV
fnp-5347	214	5	identified	identify	VERB
fnp-5347	214	6	by	by	ADP
fnp-5347	214	7	reviewing	review	VERB
fnp-5347	214	8	3	3	NUM
fnp-5347	214	9	t	t	NOUN
fnp-5347	214	10	mri	mri	NOUN
fnp-5347	214	11	scans	scan	NOUN
fnp-5347	214	12	.	.	PUNCT
fnp-5347	215	1	there	there	PRON
fnp-5347	215	2	were	be	VERB
fnp-5347	215	3	no	no	DET
fnp-5347	215	4	exact	exact	ADJ
fnp-5347	215	5	numbers	number	NOUN
fnp-5347	215	6	of	of	ADP
fnp-5347	215	7	enc	enc	NOUN
fnp-5347	215	8	given	give	VERB
fnp-5347	215	9	per	per	ADP
fnp-5347	215	10	patient	patient	NOUN
fnp-5347	215	11	and	and	CCONJ
fnp-5347	215	12	data	datum	NOUN
fnp-5347	215	13	from	from	ADP
fnp-5347	215	14	their	their	PRON
fnp-5347	215	15	patient	patient	ADJ
fnp-5347	215	16	table	table	NOUN
fnp-5347	215	17	suggested	suggest	VERB
fnp-5347	215	18	one	one	NUM
fnp-5347	215	19	mri	mri	NOUN
fnp-5347	215	20	-	-	PUNCT
fnp-5347	215	21	visible	visible	ADJ
fnp-5347	215	22	enc	enc	NOUN
fnp-5347	215	23	was	be	AUX
fnp-5347	215	24	present	present	ADJ
fnp-5347	215	25	in	in	ADP
fnp-5347	215	26	either	either	DET
fnp-5347	215	27	one	one	NUM
fnp-5347	215	28	(	(	PUNCT
fnp-5347	215	29	n	n	CCONJ
fnp-5347	215	30	 	 	SPACE
fnp-5347	215	31	=	=	NOUN
fnp-5347	215	32	 	 	SPACE
fnp-5347	215	33	6	6	NUM
fnp-5347	215	34	patients	patient	NOUN
fnp-5347	215	35	)	)	PUNCT
fnp-5347	215	36	or	or	CCONJ
fnp-5347	215	37	in	in	ADP
fnp-5347	215	38	both	both	DET
fnp-5347	215	39	hemispheres	hemisphere	NOUN
fnp-5347	215	40	(	(	PUNCT
fnp-5347	215	41	n	n	CCONJ
fnp-5347	215	42	 	 	SPACE
fnp-5347	215	43	=	=	NOUN
fnp-5347	215	44	 	 	SPACE
fnp-5347	215	45	6	6	NUM
fnp-5347	215	46	patients	patient	NOUN
fnp-5347	215	47	)	)	PUNCT
fnp-5347	215	48	.	.	PUNCT
fnp-5347	216	1	however	however	ADV
fnp-5347	216	2	,	,	PUNCT
fnp-5347	216	3	eight	eight	NUM
fnp-5347	216	4	patients	patient	NOUN
fnp-5347	216	5	underwent	undergo	VERB
fnp-5347	216	6	neurosurgical	neurosurgical	ADJ
fnp-5347	216	7	resection	resection	NOUN
fnp-5347	216	8	of	of	ADP
fnp-5347	216	9	only	only	ADV
fnp-5347	216	10	one	one	NUM
fnp-5347	216	11	hemisphere	hemisphere	ADV
fnp-5347	216	12	following	follow	VERB
fnp-5347	216	13	a	a	DET
fnp-5347	216	14	careful	careful	ADJ
fnp-5347	216	15	neurophysiological	neurophysiological	ADJ
fnp-5347	216	16	video	video	NOUN
fnp-5347	216	17	-	-	PUNCT
fnp-5347	216	18	eeg	eeg	NOUN
fnp-5347	216	19	assessment	assessment	NOUN
fnp-5347	216	20	of	of	ADP
fnp-5347	216	21	the	the	DET
fnp-5347	216	22	seizure	seizure	NOUN
fnp-5347	216	23	origin	origin	NOUN
fnp-5347	216	24	.	.	PUNCT
fnp-5347	217	1	all	all	DET
fnp-5347	217	2	patients	patient	NOUN
fnp-5347	217	3	were	be	AUX
fnp-5347	217	4	postoperatively	postoperatively	ADV
fnp-5347	217	5	seizure	seizure	NOUN
fnp-5347	217	6	free	free	ADJ
fnp-5347	217	7	(	(	PUNCT
fnp-5347	217	8	engel	engel	PROPN
fnp-5347	217	9	class	class	PROPN
fnp-5347	217	10	i	i	PROPN
fnp-5347	217	11	)	)	PUNCT
fnp-5347	217	12	.	.	PUNCT
fnp-5347	218	1	the	the	DET
fnp-5347	218	2	surgical	surgical	ADJ
fnp-5347	218	3	tissue	tissue	NOUN
fnp-5347	218	4	specimens	specimen	NOUN
fnp-5347	218	5	allowed	allow	VERB
fnp-5347	218	6	for	for	ADP
fnp-5347	218	7	a	a	DET
fnp-5347	218	8	systematic	systematic	ADJ
fnp-5347	218	9	histopathological	histopathological	ADJ
fnp-5347	218	10	analysis	analysis	NOUN
fnp-5347	218	11	,	,	PUNCT
fnp-5347	218	12	which	which	PRON
fnp-5347	218	13	revealed	reveal	VERB
fnp-5347	218	14	focal	focal	ADJ
fnp-5347	218	15	distortion	distortion	NOUN
fnp-5347	218	16	of	of	ADP
fnp-5347	218	17	layer	layer	NOUN
fnp-5347	218	18	i	i	PRON
fnp-5347	218	19	,	,	PUNCT
fnp-5347	218	20	white	white	ADJ
fnp-5347	218	21	matter	matter	NOUN
fnp-5347	218	22	extending	extend	VERB
fnp-5347	218	23	into	into	ADP
fnp-5347	218	24	the	the	DET
fnp-5347	218	25	neocortex	neocortex	NOUN
fnp-5347	218	26	and/or	and/or	CCONJ
fnp-5347	218	27	an	an	DET
fnp-5347	218	28	altered	altered	ADJ
fnp-5347	218	29	gyral	gyral	ADJ
fnp-5347	218	30	profile	profile	NOUN
fnp-5347	218	31	.	.	PUNCT
fnp-5347	219	1	considering	consider	VERB
fnp-5347	219	2	the	the	DET
fnp-5347	219	3	difficulty	difficulty	NOUN
fnp-5347	219	4	to	to	PART
fnp-5347	219	5	anatomically	anatomically	ADV
fnp-5347	219	6	reconstruct	reconstruct	VERB
fnp-5347	219	7	such	such	ADJ
fnp-5347	219	8	small	small	ADJ
fnp-5347	219	9	protrusions	protrusion	NOUN
fnp-5347	219	10	in	in	ADP
fnp-5347	219	11	a	a	DET
fnp-5347	219	12	surgical	surgical	ADJ
fnp-5347	219	13	sample	sample	NOUN
fnp-5347	219	14	,	,	PUNCT
fnp-5347	219	15	their	their	PRON
fnp-5347	219	16	analysis	analysis	NOUN
fnp-5347	219	17	comprehensively	comprehensively	ADV
fnp-5347	219	18	describe	describe	VERB
fnp-5347	219	19	enc	enc	NOUN
fnp-5347	219	20	as	as	ADP
fnp-5347	219	21	a	a	DET
fnp-5347	219	22	common	common	ADJ
fnp-5347	219	23	histopathology	histopathology	NOUN
fnp-5347	219	24	entity	entity	NOUN
fnp-5347	219	25	to	to	PART
fnp-5347	219	26	be	be	AUX
fnp-5347	219	27	recognized	recognize	VERB
fnp-5347	219	28	and	and	CCONJ
fnp-5347	219	29	diagnosed	diagnose	VERB
fnp-5347	219	30	within	within	ADP
fnp-5347	219	31	the	the	DET
fnp-5347	219	32	lesional	lesional	ADJ
fnp-5347	219	33	spectrum	spectrum	NOUN
fnp-5347	219	34	of	of	ADP
fnp-5347	219	35	epilepsy	epilepsy	ADJ
fnp-5347	219	36	surgery	surgery	NOUN
fnp-5347	219	37	.	.	PUNCT
fnp-5347	220	1	i	i	PRON
fnp-5347	220	2	found	find	VERB
fnp-5347	220	3	their	their	PRON
fnp-5347	220	4	description	description	NOUN
fnp-5347	220	5	of	of	ADP
fnp-5347	220	6	a	a	DET
fnp-5347	220	7	focal	focal	ADJ
fnp-5347	220	8	distortion	distortion	NOUN
fnp-5347	220	9	of	of	ADP
fnp-5347	220	10	neocortical	neocortical	ADJ
fnp-5347	220	11	layer	layer	NOUN
fnp-5347	220	12	i	i	PRON
fnp-5347	220	13	quite	quite	ADV
fnp-5347	220	14	interesting	interesting	ADJ
fnp-5347	220	15	,	,	PUNCT
fnp-5347	220	16	as	as	SCONJ
fnp-5347	220	17	it	it	PRON
fnp-5347	220	18	reliably	reliably	ADV
fnp-5347	220	19	describes	describe	VERB
fnp-5347	220	20	for	for	ADP
fnp-5347	220	21	the	the	DET
fnp-5347	220	22	first	first	ADJ
fnp-5347	220	23	time	time	NOUN
fnp-5347	220	24	a	a	DET
fnp-5347	220	25	disease	disease	NOUN
fnp-5347	220	26	condition	condition	NOUN
fnp-5347	220	27	with	with	ADP
fnp-5347	220	28	horizontally	horizontally	ADV
fnp-5347	220	29	oriented	orient	VERB
fnp-5347	220	30	cortical	cortical	ADJ
fnp-5347	220	31	layer	layer	NOUN
fnp-5347	220	32	abnormalities	abnormality	NOUN
fnp-5347	220	33	compatible	compatible	ADJ
fnp-5347	220	34	with	with	ADP
fnp-5347	220	35	fcd	fcd	ADJ
fnp-5347	220	36	ilae	ilae	NOUN
fnp-5347	220	37	type	type	NOUN
fnp-5347	220	38	1b	1b	NUM
fnp-5347	220	39	.	.	PUNCT
fnp-5347	221	1	the	the	DET
fnp-5347	221	2	fcd	fcd	ADJ
fnp-5347	221	3	1b	1b	NUM
fnp-5347	221	4	subtype	subtype	NOUN
fnp-5347	221	5	is	be	AUX
fnp-5347	221	6	neither	neither	CCONJ
fnp-5347	221	7	well	well	ADV
fnp-5347	221	8	studied	study	VERB
fnp-5347	221	9	nor	nor	CCONJ
fnp-5347	221	10	characterized	characterize	VERB
fnp-5347	221	11	yet	yet	ADV
fnp-5347	221	12	and	and	CCONJ
fnp-5347	221	13	some	some	DET
fnp-5347	221	14	people	people	NOUN
fnp-5347	221	15	even	even	ADV
fnp-5347	221	16	question	question	VERB
fnp-5347	221	17	their	their	PRON
fnp-5347	221	18	existence	existence	NOUN
fnp-5347	221	19	due	due	ADP
fnp-5347	221	20	to	to	ADP
fnp-5347	221	21	the	the	DET
fnp-5347	221	22	lack	lack	NOUN
fnp-5347	221	23	of	of	ADP
fnp-5347	221	24	a	a	DET
fnp-5347	221	25	characteristic	characteristic	ADJ
fnp-5347	221	26	and	and	CCONJ
fnp-5347	221	27	consistent	consistent	ADJ
fnp-5347	221	28	clinico	clinico	ADJ
fnp-5347	221	29	-	-	PUNCT
fnp-5347	221	30	pathological	pathological	ADJ
fnp-5347	221	31	phenotype	phenotype	NOUN
fnp-5347	221	32	.	.	PUNCT
fnp-5347	222	1	nevertheless	nevertheless	ADV
fnp-5347	222	2	,	,	PUNCT
fnp-5347	222	3	the	the	DET
fnp-5347	222	4	authors	author	NOUN
fnp-5347	222	5	did	do	AUX
fnp-5347	222	6	not	not	PART
fnp-5347	222	7	claim	claim	VERB
fnp-5347	222	8	such	such	DET
fnp-5347	222	9	a	a	DET
fnp-5347	222	10	fcd	fcd	ADJ
fnp-5347	222	11	classification	classification	NOUN
fnp-5347	222	12	and	and	CCONJ
fnp-5347	222	13	we	we	PRON
fnp-5347	222	14	need	need	VERB
fnp-5347	222	15	to	to	PART
fnp-5347	222	16	await	await	VERB
fnp-5347	222	17	further	further	ADJ
fnp-5347	222	18	studies	study	NOUN
fnp-5347	222	19	to	to	PART
fnp-5347	222	20	better	well	ADV
fnp-5347	222	21	understand	understand	VERB
fnp-5347	222	22	its	its	PRON
fnp-5347	222	23	likely	likely	ADJ
fnp-5347	222	24	neurodevelopmental	neurodevelopmental	ADJ
fnp-5347	222	25	origin	origin	NOUN
fnp-5347	222	26	and	and	CCONJ
fnp-5347	222	27	pathogenesis	pathogenesis	NOUN
fnp-5347	222	28	.	.	PUNCT
fnp-5347	223	1	a	a	DET
fnp-5347	223	2	genetic	genetic	ADJ
fnp-5347	223	3	or	or	CCONJ
fnp-5347	223	4	epigenetic	epigenetic	ADJ
fnp-5347	223	5	characterization	characterization	NOUN
fnp-5347	223	6	would	would	AUX
fnp-5347	223	7	also	also	ADV
fnp-5347	223	8	be	be	AUX
fnp-5347	223	9	helpful	helpful	ADJ
fnp-5347	223	10	to	to	PART
fnp-5347	223	11	assess	assess	VERB
fnp-5347	223	12	their	their	PRON
fnp-5347	223	13	origin	origin	NOUN
fnp-5347	223	14	and	and	CCONJ
fnp-5347	223	15	specificity	specificity	NOUN
fnp-5347	223	16	as	as	ADP
fnp-5347	223	17	new	new	ADJ
fnp-5347	223	18	disease	disease	NOUN
fnp-5347	223	19	entity	entity	NOUN
fnp-5347	223	20	.	.	PUNCT
fnp-5347	224	1	notwithstanding	notwithstanding	ADP
fnp-5347	224	2	,	,	PUNCT
fnp-5347	224	3	the	the	DET
fnp-5347	224	4	clinical	clinical	ADJ
fnp-5347	224	5	history	history	NOUN
fnp-5347	224	6	available	available	ADJ
fnp-5347	224	7	in	in	ADP
fnp-5347	224	8	their	their	PRON
fnp-5347	224	9	presented	present	VERB
fnp-5347	224	10	patient	patient	ADJ
fnp-5347	224	11	cohort	cohort	NOUN
fnp-5347	224	12	may	may	AUX
fnp-5347	224	13	add	add	VERB
fnp-5347	224	14	to	to	ADP
fnp-5347	224	15	the	the	DET
fnp-5347	224	16	disease	disease	NOUN
fnp-5347	224	17	description	description	NOUN
fnp-5347	224	18	as	as	ADP
fnp-5347	224	19	a	a	DET
fnp-5347	224	20	majority	majority	NOUN
fnp-5347	224	21	revealed	reveal	VERB
fnp-5347	224	22	mri	mri	ADJ
fnp-5347	224	23	positive	positive	ADJ
fnp-5347	224	24	intracranial	intracranial	ADJ
fnp-5347	224	25	hypertension	hypertension	NOUN
fnp-5347	224	26	(	(	PUNCT
fnp-5347	224	27	9	9	NUM
fnp-5347	224	28	out	out	ADP
fnp-5347	224	29	of	of	ADP
fnp-5347	224	30	12	12	NUM
fnp-5347	224	31	patients	patient	NOUN
fnp-5347	224	32	)	)	PUNCT
fnp-5347	224	33	,	,	PUNCT
fnp-5347	224	34	later	later	ADV
fnp-5347	224	35	onset	onset	NOUN
fnp-5347	224	36	of	of	ADP
fnp-5347	224	37	seizures	seizure	NOUN
fnp-5347	224	38	compared	compare	VERB
fnp-5347	224	39	to	to	ADP
fnp-5347	224	40	a	a	DET
fnp-5347	224	41	control	control	NOUN
fnp-5347	224	42	group	group	NOUN
fnp-5347	224	43	of	of	ADP
fnp-5347	224	44	26	26	NUM
fnp-5347	224	45	patients	patient	NOUN
fnp-5347	224	46	with	with	ADP
fnp-5347	224	47	non	non	ADJ
fnp-5347	224	48	-	-	ADJ
fnp-5347	224	49	enc	enc	NOUN
fnp-5347	224	50	related	relate	VERB
fnp-5347	224	51	tle	tle	NOUN
fnp-5347	224	52	,	,	PUNCT
fnp-5347	224	53	and	and	CCONJ
fnp-5347	224	54	more	more	ADV
fnp-5347	224	55	frequent	frequent	ADJ
fnp-5347	224	56	psychiatric	psychiatric	ADJ
fnp-5347	224	57	comorbidity	comorbidity	NOUN
fnp-5347	224	58	.	.	PUNCT
fnp-5347	225	1	figure	figure	NOUN
fnp-5347	225	2	5	5	NUM
fnp-5347	225	3	:	:	PUNCT
fnp-5347	225	4	intraoperative	intraoperative	ADJ
fnp-5347	225	5	snapshot	snapshot	ADJ
fnp-5347	225	6	demonstrating	demonstrate	VERB
fnp-5347	225	7	multiple	multiple	ADJ
fnp-5347	225	8	encephaloceles	encephalocele	NOUN
fnp-5347	225	9	in	in	ADP
fnp-5347	225	10	the	the	DET
fnp-5347	225	11	human	human	ADJ
fnp-5347	225	12	temporal	temporal	ADJ
fnp-5347	225	13	lobe	lobe	ADJ
fnp-5347	225	14	figure	figure	NOUN
fnp-5347	225	15	5	5	NUM
fnp-5347	225	16	.	.	PUNCT
fnp-5347	226	1	the	the	DET
fnp-5347	226	2	intraoperative	intraoperative	ADJ
fnp-5347	226	3	vision	vision	PROPN
fnp-5347	226	4	angle	angle	NOUN
fnp-5347	226	5	is	be	AUX
fnp-5347	226	6	directed	direct	VERB
fnp-5347	226	7	towards	towards	ADP
fnp-5347	226	8	the	the	DET
fnp-5347	226	9	basis	basis	NOUN
fnp-5347	226	10	of	of	ADP
fnp-5347	226	11	the	the	DET
fnp-5347	226	12	temporal	temporal	ADJ
fnp-5347	226	13	pole	pole	NOUN
fnp-5347	226	14	in	in	ADP
fnp-5347	226	15	a	a	DET
fnp-5347	226	16	23	23	NUM
fnp-5347	226	17	-	-	PUNCT
fnp-5347	226	18	year	year	NOUN
fnp-5347	226	19	old	old	ADJ
fnp-5347	226	20	patient	patient	NOUN
fnp-5347	226	21	with	with	ADP
fnp-5347	226	22	left	left	ADJ
fnp-5347	226	23	tle	tle	NOUN
fnp-5347	226	24	.	.	PUNCT
fnp-5347	227	1	there	there	PRON
fnp-5347	227	2	were	be	VERB
fnp-5347	227	3	several	several	ADJ
fnp-5347	227	4	larger	large	ADJ
fnp-5347	227	5	and	and	CCONJ
fnp-5347	227	6	smaller	small	ADJ
fnp-5347	227	7	holes	hole	NOUN
fnp-5347	227	8	in	in	ADP
fnp-5347	227	9	the	the	DET
fnp-5347	227	10	skull	skull	NOUN
fnp-5347	227	11	bone	bone	NOUN
fnp-5347	227	12	as	as	SCONJ
fnp-5347	227	13	indicated	indicate	VERB
fnp-5347	227	14	by	by	ADP
fnp-5347	227	15	the	the	DET
fnp-5347	227	16	arrows	arrow	NOUN
fnp-5347	227	17	,	,	PUNCT
fnp-5347	227	18	some	some	PRON
fnp-5347	227	19	of	of	ADP
fnp-5347	227	20	which	which	PRON
fnp-5347	227	21	were	be	AUX
fnp-5347	227	22	too	too	ADV
fnp-5347	227	23	small	small	ADJ
fnp-5347	227	24	to	to	PART
fnp-5347	227	25	be	be	AUX
fnp-5347	227	26	preoperatively	preoperatively	ADV
fnp-5347	227	27	detected	detect	VERB
fnp-5347	227	28	by	by	ADP
fnp-5347	227	29	mri	mri	PROPN
fnp-5347	227	30	.	.	PUNCT
fnp-5347	228	1	all	all	DET
fnp-5347	228	2	clefts	cleft	NOUN
fnp-5347	228	3	were	be	AUX
fnp-5347	228	4	occupied	occupy	VERB
fnp-5347	228	5	by	by	ADP
fnp-5347	228	6	cortical	cortical	ADJ
fnp-5347	228	7	brain	brain	NOUN
fnp-5347	228	8	tissue	tissue	NOUN
fnp-5347	228	9	protrusions	protrusion	NOUN
fnp-5347	228	10	.	.	PUNCT
fnp-5347	229	1	the	the	DET
fnp-5347	229	2	exact	exact	ADJ
fnp-5347	229	3	histopathology	histopathology	NOUN
fnp-5347	229	4	and/or	and/or	CCONJ
fnp-5347	229	5	genetic	genetic	ADJ
fnp-5347	229	6	nature	nature	NOUN
fnp-5347	229	7	of	of	ADP
fnp-5347	229	8	these	these	DET
fnp-5347	229	9	encephaloceles	encephalocele	NOUN
fnp-5347	229	10	need	need	VERB
fnp-5347	229	11	further	further	ADJ
fnp-5347	229	12	clarification	clarification	NOUN
fnp-5347	229	13	.	.	PUNCT
fnp-5347	230	1	image	image	NOUN
fnp-5347	230	2	not	not	PART
fnp-5347	230	3	previously	previously	ADV
fnp-5347	230	4	published	publish	VERB
fnp-5347	230	5	and	and	CCONJ
fnp-5347	230	6	kindly	kindly	ADV
fnp-5347	230	7	provided	provide	VERB
fnp-5347	230	8	prof	prof	NOUN
fnp-5347	230	9	.	.	PUNCT
fnp-5347	231	1	s.	s.	PROPN
fnp-5347	231	2	brander	brander	PROPN
fnp-5347	231	3	,	,	PUNCT
fnp-5347	231	4	neurosurgery	neurosurgery	NOUN
fnp-5347	231	5	dept	dept	NOUN
fnp-5347	231	6	.	.	PUNCT
fnp-5347	232	1	at	at	ADP
fnp-5347	232	2	klinikum	klinikum	NOUN
fnp-5347	232	3	fürth	fürth	NOUN
fnp-5347	232	4	,	,	PUNCT
fnp-5347	232	5	germany	germany	PROPN
fnp-5347	232	6	.	.	PUNCT
fnp-5347	233	1	topic	topic	NOUN
fnp-5347	233	2	6	6	NUM
fnp-5347	233	3	:	:	PUNCT
fnp-5347	233	4	what	what	PRON
fnp-5347	233	5	did	do	AUX
fnp-5347	233	6	we	we	PRON
fnp-5347	233	7	learn	learn	VERB
fnp-5347	233	8	in	in	ADP
fnp-5347	233	9	2022	2022	NUM
fnp-5347	233	10	and	and	CCONJ
fnp-5347	233	11	2023	2023	NUM
fnp-5347	233	12	about	about	ADP
fnp-5347	233	13	leat	leat	NOUN
fnp-5347	233	14	patients	patient	NOUN
fnp-5347	233	15	suffering	suffer	VERB
fnp-5347	233	16	from	from	ADP
fnp-5347	233	17	low	low	ADJ
fnp-5347	233	18	-	-	PUNCT
fnp-5347	233	19	grade	grade	NOUN
fnp-5347	233	20	epilepsy	epilepsy	NOUN
fnp-5347	233	21	-	-	PUNCT
fnp-5347	233	22	associated	associate	VERB
fnp-5347	233	23	brain	brain	NOUN
fnp-5347	233	24	tumors	tumor	NOUN
fnp-5347	233	25	(	(	PUNCT
fnp-5347	233	26	leat	leat	NOUN
fnp-5347	233	27	)	)	PUNCT
fnp-5347	233	28	have	have	AUX
fnp-5347	233	29	a	a	DET
fnp-5347	233	30	high	high	ADJ
fnp-5347	233	31	propensity	propensity	NOUN
fnp-5347	233	32	to	to	PART
fnp-5347	233	33	become	become	VERB
fnp-5347	233	34	seizure	seizure	NOUN
fnp-5347	233	35	and	and	CCONJ
fnp-5347	233	36	drug	drug	NOUN
fnp-5347	233	37	free	free	ADJ
fnp-5347	233	38	after	after	ADP
fnp-5347	233	39	epilepsy	epilepsy	NOUN
fnp-5347	233	40	surgery	surgery	NOUN
fnp-5347	233	41	[	[	X
fnp-5347	233	42	28	28	NUM
fnp-5347	233	43	]	]	PUNCT
fnp-5347	233	44	.	.	PUNCT
fnp-5347	234	1	this	this	PRON
fnp-5347	234	2	is	be	AUX
fnp-5347	234	3	a	a	DET
fnp-5347	234	4	promising	promising	ADJ
fnp-5347	234	5	observation	observation	NOUN
fnp-5347	234	6	factoring	factoring	NOUN
fnp-5347	234	7	into	into	ADP
fnp-5347	234	8	every	every	DET
fnp-5347	234	9	day	day	NOUN
fnp-5347	234	10	's	's	PART
fnp-5347	234	11	patient	patient	ADJ
fnp-5347	234	12	management	management	NOUN
fnp-5347	234	13	and	and	CCONJ
fnp-5347	234	14	counseling	counseling	NOUN
fnp-5347	234	15	.	.	PUNCT
fnp-5347	235	1	the	the	DET
fnp-5347	235	2	question	question	NOUN
fnp-5347	235	3	remains	remain	VERB
fnp-5347	235	4	,	,	PUNCT
fnp-5347	235	5	however	however	ADV
fnp-5347	235	6	,	,	PUNCT
fnp-5347	235	7	why	why	SCONJ
fnp-5347	235	8	up	up	ADP
fnp-5347	235	9	to	to	PART
fnp-5347	235	10	30	30	NUM
fnp-5347	235	11	 	 	SPACE
fnp-5347	235	12	%	%	NOUN
fnp-5347	235	13	of	of	ADP
fnp-5347	235	14	patients	patient	NOUN
fnp-5347	235	15	with	with	ADP
fnp-5347	235	16	leat	leat	NOUN
fnp-5347	235	17	do	do	AUX
fnp-5347	235	18	not	not	PART
fnp-5347	235	19	achieve	achieve	VERB
fnp-5347	235	20	sufficient	sufficient	ADJ
fnp-5347	235	21	seizure	seizure	NOUN
fnp-5347	235	22	control	control	NOUN
fnp-5347	235	23	postsurgically	postsurgically	ADV
fnp-5347	235	24	.	.	PUNCT
fnp-5347	236	1	unfortunately	unfortunately	ADV
fnp-5347	236	2	,	,	PUNCT
fnp-5347	236	3	this	this	DET
fnp-5347	236	4	measure	measure	NOUN
fnp-5347	236	5	is	be	AUX
fnp-5347	236	6	not	not	PART
fnp-5347	236	7	recognized	recognize	VERB
fnp-5347	236	8	in	in	ADP
fnp-5347	236	9	the	the	PRON
fnp-5347	236	10	who	who	PRON
fnp-5347	236	11	brain	brain	VERB
fnp-5347	236	12	tumor	tumor	NOUN
fnp-5347	236	13	classification	classification	NOUN
fnp-5347	236	14	scheme	scheme	NOUN
fnp-5347	236	15	and	and	CCONJ
fnp-5347	236	16	does	do	VERB
fnp-5347	236	17	,	,	PUNCT
fnp-5347	236	18	therefore	therefore	ADV
fnp-5347	236	19	,	,	PUNCT
fnp-5347	236	20	not	not	PART
fnp-5347	236	21	play	play	VERB
fnp-5347	236	22	a	a	DET
fnp-5347	236	23	role	role	NOUN
fnp-5347	236	24	in	in	ADP
fnp-5347	236	25	our	our	PRON
fnp-5347	236	26	current	current	ADJ
fnp-5347	236	27	neurooncology	neurooncology	NOUN
fnp-5347	236	28	-	-	PUNCT
fnp-5347	236	29	focused	focus	VERB
fnp-5347	236	30	literature	literature	NOUN
fnp-5347	236	31	of	of	ADP
fnp-5347	236	32	low	low	ADJ
fnp-5347	236	33	-	-	PUNCT
fnp-5347	236	34	grade	grade	NOUN
fnp-5347	236	35	brain	brain	NOUN
fnp-5347	236	36	tumors	tumor	NOUN
fnp-5347	236	37	.	.	PUNCT
fnp-5347	237	1	this	this	PRON
fnp-5347	237	2	contrasts	contrast	VERB
fnp-5347	237	3	a	a	DET
fnp-5347	237	4	recently	recently	ADV
fnp-5347	237	5	published	publish	VERB
fnp-5347	237	6	work	work	NOUN
fnp-5347	237	7	from	from	ADP
fnp-5347	237	8	hoffmann	hoffmann	PROPN
fnp-5347	237	9	and	and	CCONJ
fnp-5347	237	10	coworker	coworker	NOUN
fnp-5347	237	11	presenting	present	VERB
fnp-5347	237	12	their	their	PRON
fnp-5347	237	13	series	series	NOUN
fnp-5347	237	14	of	of	ADP
fnp-5347	237	15	72	72	NUM
fnp-5347	237	16	leat	leat	NOUN
fnp-5347	237	17	samples	sample	NOUN
fnp-5347	237	18	submitted	submit	VERB
fnp-5347	237	19	to	to	ADP
fnp-5347	237	20	whole	whole	ADJ
fnp-5347	237	21	exome	exome	NOUN
fnp-5347	237	22	sequencing	sequence	VERB
fnp-5347	237	23	[	[	X
fnp-5347	237	24	21	21	NUM
fnp-5347	237	25	]	]	PUNCT
fnp-5347	237	26	.	.	PUNCT
fnp-5347	238	1	the	the	DET
fnp-5347	238	2	same	same	ADJ
fnp-5347	238	3	patients	patient	NOUN
fnp-5347	238	4	were	be	AUX
fnp-5347	238	5	presented	present	VERB
fnp-5347	238	6	also	also	ADV
fnp-5347	238	7	in	in	ADP
fnp-5347	238	8	the	the	DET
fnp-5347	238	9	work	work	NOUN
fnp-5347	238	10	of	of	ADP
fnp-5347	238	11	lópez	lópez	NOUN
fnp-5347	238	12	-	-	PUNCT
fnp-5347	238	13	rivera	rivera	PROPN
fnp-5347	238	14	described	describe	VERB
fnp-5347	238	15	above	above	ADV
fnp-5347	238	16	(	(	PUNCT
fnp-5347	238	17	see	see	VERB
fnp-5347	238	18	topic	topic	NOUN
fnp-5347	238	19	#	#	SYM
fnp-5347	238	20	2	2	NUM
fnp-5347	238	21	)	)	PUNCT
fnp-5347	238	22	.	.	PUNCT
fnp-5347	239	1	there	there	PRON
fnp-5347	239	2	were	be	VERB
fnp-5347	239	3	eight	eight	NUM
fnp-5347	239	4	patient	patient	ADJ
fnp-5347	239	5	samples	sample	NOUN
fnp-5347	239	6	,	,	PUNCT
fnp-5347	239	7	in	in	ADP
fnp-5347	239	8	which	which	PRON
fnp-5347	239	9	the	the	DET
fnp-5347	239	10	aforementioned	aforementioned	ADJ
fnp-5347	239	11	ptpn11	ptpn11	NOUN
fnp-5347	239	12	gene	gene	NOUN
fnp-5347	239	13	was	be	AUX
fnp-5347	239	14	altered	alter	VERB
fnp-5347	239	15	,	,	PUNCT
fnp-5347	239	16	mostly	mostly	ADV
fnp-5347	239	17	by	by	ADP
fnp-5347	239	18	a	a	DET
fnp-5347	239	19	gain	gain	NOUN
fnp-5347	239	20	of	of	ADP
fnp-5347	239	21	the	the	DET
fnp-5347	239	22	long	long	ADJ
fnp-5347	239	23	arm	arm	NOUN
fnp-5347	239	24	of	of	ADP
fnp-5347	239	25	chromosome	chromosome	NOUN
fnp-5347	239	26	12	12	NUM
fnp-5347	239	27	.	.	PUNCT
fnp-5347	240	1	these	these	DET
fnp-5347	240	2	eight	eight	NUM
fnp-5347	240	3	patients	patient	NOUN
fnp-5347	240	4	also	also	ADV
fnp-5347	240	5	showed	show	VERB
fnp-5347	240	6	chromosomal	chromosomal	ADJ
fnp-5347	240	7	gains	gain	NOUN
fnp-5347	240	8	affecting	affect	VERB
fnp-5347	240	9	other	other	ADJ
fnp-5347	240	10	genes	gene	NOUN
fnp-5347	240	11	of	of	ADP
fnp-5347	240	12	the	the	DET
fnp-5347	240	13	map	map	NOUN
fnp-5347	240	14	-	-	PUNCT
fnp-5347	240	15	kinase	kinase	NOUN
fnp-5347	240	16	pathway	pathway	NOUN
fnp-5347	240	17	,	,	PUNCT
fnp-5347	240	18	e.g.	e.g.	ADV
fnp-5347	240	19	,	,	PUNCT
fnp-5347	240	20	shoc2	shoc2	NOUN
fnp-5347	240	21	,	,	PUNCT
fnp-5347	240	22	braf	braf	NOUN
fnp-5347	240	23	,	,	PUNCT
fnp-5347	240	24	kras	kras	PROPN
fnp-5347	240	25	,	,	PUNCT
fnp-5347	240	26	nf1	nf1	NOUN
fnp-5347	240	27	or	or	CCONJ
fnp-5347	240	28	fgfr4	fgfr4	PROPN
fnp-5347	240	29	,	,	PUNCT
fnp-5347	240	30	representing	represent	VERB
fnp-5347	240	31	a	a	DET
fnp-5347	240	32	much	much	ADV
fnp-5347	240	33	more	more	ADV
fnp-5347	240	34	complex	complex	ADJ
fnp-5347	240	35	genotype	genotype	NOUN
fnp-5347	240	36	than	than	SCONJ
fnp-5347	240	37	usually	usually	ADV
fnp-5347	240	38	seen	see	VERB
fnp-5347	240	39	in	in	ADP
fnp-5347	240	40	the	the	DET
fnp-5347	240	41	group	group	NOUN
fnp-5347	240	42	of	of	ADP
fnp-5347	240	43	gg	gg	PROPN
fnp-5347	240	44	.	.	PUNCT
fnp-5347	241	1	another	another	DET
fnp-5347	241	2	seven	seven	NUM
fnp-5347	241	3	patients	patient	NOUN
fnp-5347	241	4	showed	show	VERB
fnp-5347	241	5	a	a	DET
fnp-5347	241	6	similarly	similarly	ADV
fnp-5347	241	7	complex	complex	ADJ
fnp-5347	241	8	genotype	genotype	NOUN
fnp-5347	241	9	including	include	VERB
fnp-5347	241	10	several	several	ADJ
fnp-5347	241	11	genes	gene	NOUN
fnp-5347	241	12	of	of	ADP
fnp-5347	241	13	the	the	DET
fnp-5347	241	14	map	map	NOUN
fnp-5347	241	15	-	-	PUNCT
fnp-5347	241	16	kinase	kinase	NOUN
fnp-5347	241	17	and	and	CCONJ
fnp-5347	241	18	mtor	mtor	NOUN
fnp-5347	241	19	signaling	signal	VERB
fnp-5347	241	20	pathway	pathway	NOUN
fnp-5347	241	21	(	(	PUNCT
fnp-5347	241	22	figure	figure	NOUN
fnp-5347	241	23	6	6	NUM
fnp-5347	241	24	)	)	PUNCT
fnp-5347	241	25	.	.	PUNCT
fnp-5347	242	1	compared	compare	VERB
fnp-5347	242	2	to	to	ADP
fnp-5347	242	3	their	their	PRON
fnp-5347	242	4	group	group	NOUN
fnp-5347	242	5	of	of	ADP
fnp-5347	242	6	29	29	NUM
fnp-5347	242	7	patients	patient	NOUN
fnp-5347	242	8	with	with	ADP
fnp-5347	242	9	a	a	DET
fnp-5347	242	10	gg	gg	NOUN
fnp-5347	242	11	and	and	CCONJ
fnp-5347	242	12	a	a	DET
fnp-5347	242	13	braf	braf	NOUN
fnp-5347	242	14	v600e	v600e	NOUN
fnp-5347	242	15	mutation	mutation	NOUN
fnp-5347	242	16	,	,	PUNCT
fnp-5347	242	17	the	the	DET
fnp-5347	242	18	group	group	NOUN
fnp-5347	242	19	of	of	ADP
fnp-5347	242	20	gg	gg	PROPN
fnp-5347	242	21	with	with	ADP
fnp-5347	242	22	a	a	DET
fnp-5347	242	23	complex	complex	ADJ
fnp-5347	242	24	genotype	genotype	NOUN
fnp-5347	242	25	had	have	VERB
fnp-5347	242	26	a	a	DET
fnp-5347	242	27	much	much	ADV
fnp-5347	242	28	lower	low	ADJ
fnp-5347	242	29	seizure	seizure	NOUN
fnp-5347	242	30	control	control	NOUN
fnp-5347	242	31	two	two	NUM
fnp-5347	242	32	years	year	NOUN
fnp-5347	242	33	after	after	ADP
fnp-5347	242	34	surgery	surgery	NOUN
fnp-5347	242	35	(	(	PUNCT
fnp-5347	242	36	38	38	NUM
fnp-5347	242	37	 	 	SPACE
fnp-5347	242	38	%	%	NOUN
fnp-5347	242	39	)	)	PUNCT
fnp-5347	242	40	.	.	PUNCT
fnp-5347	243	1	this	this	PRON
fnp-5347	243	2	contrasted	contrast	VERB
fnp-5347	243	3	the	the	DET
fnp-5347	243	4	85	85	NUM
fnp-5347	243	5	 	 	SPACE
fnp-5347	243	6	%	%	NOUN
fnp-5347	243	7	of	of	ADP
fnp-5347	243	8	successful	successful	ADJ
fnp-5347	243	9	postsurgical	postsurgical	ADJ
fnp-5347	243	10	seizure	seizure	NOUN
fnp-5347	243	11	control	control	NOUN
fnp-5347	243	12	in	in	ADP
fnp-5347	243	13	the	the	DET
fnp-5347	243	14	braf	braf	NOUN
fnp-5347	243	15	altered	alter	VERB
fnp-5347	243	16	group	group	NOUN
fnp-5347	243	17	of	of	ADP
fnp-5347	243	18	gg	gg	PROPN
fnp-5347	243	19	.	.	PUNCT
fnp-5347	244	1	histopathology	histopathology	NOUN
fnp-5347	244	2	analysis	analysis	NOUN
fnp-5347	244	3	of	of	ADP
fnp-5347	244	4	this	this	DET
fnp-5347	244	5	cohort	cohort	NOUN
fnp-5347	244	6	revealed	reveal	VERB
fnp-5347	244	7	additional	additional	ADJ
fnp-5347	244	8	features	feature	NOUN
fnp-5347	244	9	of	of	ADP
fnp-5347	244	10	what	what	PRON
fnp-5347	244	11	the	the	DET
fnp-5347	244	12	authors	author	NOUN
fnp-5347	244	13	describe	describe	VERB
fnp-5347	244	14	as	as	ADP
fnp-5347	244	15	atypical	atypical	ADJ
fnp-5347	244	16	features	feature	NOUN
fnp-5347	244	17	in	in	ADP
fnp-5347	244	18	gg	gg	PROPN
fnp-5347	244	19	(	(	PUNCT
fnp-5347	244	20	analogue	analogue	NOUN
fnp-5347	244	21	who	who	PRON
fnp-5347	244	22	cns	cns	VERB
fnp-5347	244	23	grade	grade	NOUN
fnp-5347	244	24	2	2	NUM
fnp-5347	244	25	)	)	PUNCT
fnp-5347	244	26	,	,	PUNCT
fnp-5347	244	27	e.g.	e.g.	ADV
fnp-5347	244	28	,	,	PUNCT
fnp-5347	244	29	subarachnoidal	subarachnoidal	ADJ
fnp-5347	244	30	tumor	tumor	NOUN
fnp-5347	244	31	spread	spread	VERB
fnp-5347	244	32	of	of	ADP
fnp-5347	244	33	predominantly	predominantly	ADV
fnp-5347	244	34	astroglial	astroglial	ADJ
fnp-5347	244	35	and	and	CCONJ
fnp-5347	244	36	dysplastic	dysplastic	ADJ
fnp-5347	244	37	neuronal	neuronal	ADJ
fnp-5347	244	38	phenotypes	phenotype	NOUN
fnp-5347	244	39	,	,	PUNCT
fnp-5347	244	40	as	as	ADV
fnp-5347	244	41	well	well	ADV
fnp-5347	244	42	as	as	ADP
fnp-5347	244	43	a	a	DET
fnp-5347	244	44	consistent	consistent	ADJ
fnp-5347	244	45	combination	combination	NOUN
fnp-5347	244	46	of	of	ADP
fnp-5347	244	47	cd34	cd34	PROPN
fnp-5347	244	48	and	and	CCONJ
fnp-5347	244	49	p16	p16	NOUN
fnp-5347	244	50	immunoreactivity	immunoreactivity	NOUN
fnp-5347	244	51	.	.	PUNCT
fnp-5347	245	1	finally	finally	ADV
fnp-5347	245	2	,	,	PUNCT
fnp-5347	245	3	a	a	DET
fnp-5347	245	4	new	new	ADJ
fnp-5347	245	5	unsupervised	unsupervised	ADJ
fnp-5347	245	6	dna	dna	PROPN
fnp-5347	245	7	methylation	methylation	NOUN
fnp-5347	245	8	cluster	cluster	NOUN
fnp-5347	245	9	analysis	analysis	NOUN
fnp-5347	245	10	was	be	AUX
fnp-5347	245	11	presented	present	VERB
fnp-5347	245	12	including	include	VERB
fnp-5347	245	13	more	more	ADJ
fnp-5347	245	14	tumor	tumor	NOUN
fnp-5347	245	15	samples	sample	NOUN
fnp-5347	245	16	from	from	ADP
fnp-5347	245	17	previously	previously	ADV
fnp-5347	245	18	published	publish	VERB
fnp-5347	245	19	cohorts	cohort	NOUN
fnp-5347	245	20	readily	readily	ADV
fnp-5347	245	21	separating	separate	VERB
fnp-5347	245	22	between	between	ADP
fnp-5347	245	23	gg	gg	PROPN
fnp-5347	245	24	,	,	PUNCT
fnp-5347	245	25	dysembryoplastic	dysembryoplastic	ADJ
fnp-5347	245	26	neuroepithelial	neuroepithelial	ADJ
fnp-5347	245	27	tumors	tumor	NOUN
fnp-5347	245	28	(	(	PUNCT
fnp-5347	245	29	dnt	dnt	PROPN
fnp-5347	245	30	)	)	PUNCT
fnp-5347	245	31	,	,	PUNCT
fnp-5347	245	32	low	low	ADJ
fnp-5347	245	33	-	-	PUNCT
fnp-5347	245	34	grade	grade	NOUN
fnp-5347	245	35	glioma	glioma	NOUN
fnp-5347	245	36	myb	myb	NOUN
fnp-5347	245	37	altered	alter	VERB
fnp-5347	245	38	,	,	PUNCT
fnp-5347	245	39	and	and	CCONJ
fnp-5347	245	40	pleomorphic	pleomorphic	ADJ
fnp-5347	245	41	xanthoastrocytoma	xanthoastrocytoma	NOUN
fnp-5347	245	42	(	(	PUNCT
fnp-5347	245	43	pxa	pxa	NOUN
fnp-5347	245	44	)	)	PUNCT
fnp-5347	245	45	.	.	PUNCT
fnp-5347	246	1	there	there	PRON
fnp-5347	246	2	was	be	VERB
fnp-5347	246	3	a	a	DET
fnp-5347	246	4	fifth	fifth	ADJ
fnp-5347	246	5	cluster	cluster	NOUN
fnp-5347	246	6	,	,	PUNCT
fnp-5347	246	7	however	however	ADV
fnp-5347	246	8	,	,	PUNCT
fnp-5347	246	9	including	include	VERB
fnp-5347	246	10	all	all	PRON
fnp-5347	246	11	of	of	ADP
fnp-5347	246	12	the	the	DET
fnp-5347	246	13	ptpn11	ptpn11	NOUN
fnp-5347	246	14	altered	alter	VERB
fnp-5347	246	15	gg	gg	NOUN
fnp-5347	246	16	and	and	CCONJ
fnp-5347	246	17	even	even	ADV
fnp-5347	246	18	more	more	ADJ
fnp-5347	246	19	tumor	tumor	NOUN
fnp-5347	246	20	samples	sample	NOUN
fnp-5347	246	21	,	,	PUNCT
fnp-5347	246	22	some	some	PRON
fnp-5347	246	23	of	of	ADP
fnp-5347	246	24	which	which	PRON
fnp-5347	246	25	also	also	ADV
fnp-5347	246	26	had	have	VERB
fnp-5347	246	27	an	an	DET
fnp-5347	246	28	adverse	adverse	ADJ
fnp-5347	246	29	postsurgical	postsurgical	ADJ
fnp-5347	246	30	outcome	outcome	NOUN
fnp-5347	246	31	(	(	PUNCT
fnp-5347	246	32	one	one	NUM
fnp-5347	246	33	patient	patient	NOUN
fnp-5347	246	34	died	die	VERB
fnp-5347	246	35	from	from	ADP
fnp-5347	246	36	sudep	sudep	NOUN
fnp-5347	246	37	as	as	SCONJ
fnp-5347	246	38	seizures	seizure	NOUN
fnp-5347	246	39	could	could	AUX
fnp-5347	246	40	not	not	PART
fnp-5347	246	41	be	be	AUX
fnp-5347	246	42	controlled	control	VERB
fnp-5347	246	43	)	)	PUNCT
fnp-5347	246	44	.	.	PUNCT
fnp-5347	247	1	figure	figure	VERB
fnp-5347	247	2	6	6	NUM
fnp-5347	247	3	:	:	PUNCT
fnp-5347	247	4	oncoplot	oncoplot	NOUN
fnp-5347	247	5	of	of	ADP
fnp-5347	247	6	wes	wes	PROPN
fnp-5347	247	7	and	and	CCONJ
fnp-5347	247	8	cnv	cnv	PROPN
fnp-5347	247	9	detection	detection	NOUN
fnp-5347	247	10	in	in	ADP
fnp-5347	247	11	ganglioglioma	ganglioglioma	NOUN
fnp-5347	247	12	with	with	ADP
fnp-5347	247	13	clinically	clinically	ADV
fnp-5347	247	14	adverse	adverse	ADJ
fnp-5347	247	15	outcome	outcome	NOUN
fnp-5347	247	16	figure	figure	NOUN
fnp-5347	247	17	6	6	NUM
fnp-5347	247	18	.	.	PUNCT
fnp-5347	248	1	columns	column	NOUN
fnp-5347	248	2	1	1	NUM
fnp-5347	248	3	-	-	SYM
fnp-5347	248	4	44	44	NUM
fnp-5347	248	5	represent	represent	VERB
fnp-5347	248	6	patient	patient	NOUN
fnp-5347	248	7	samples	sample	NOUN
fnp-5347	248	8	submitted	submit	VERB
fnp-5347	248	9	to	to	ADP
fnp-5347	248	10	wes	wes	PROPN
fnp-5347	248	11	.	.	PUNCT
fnp-5347	249	1	these	these	DET
fnp-5347	249	2	data	datum	NOUN
fnp-5347	249	3	were	be	AUX
fnp-5347	249	4	intentionally	intentionally	ADV
fnp-5347	249	5	classified	classify	VERB
fnp-5347	249	6	into	into	ADP
fnp-5347	249	7	three	three	NUM
fnp-5347	249	8	groups	group	NOUN
fnp-5347	249	9	of	of	ADP
fnp-5347	249	10	patients	patient	NOUN
fnp-5347	249	11	:	:	PUNCT
fnp-5347	249	12	gg	gg	NOUN
fnp-5347	249	13	with	with	ADP
fnp-5347	249	14	complex	complex	ADJ
fnp-5347	249	15	genetic	genetic	ADJ
fnp-5347	249	16	variants	variant	NOUN
fnp-5347	249	17	(	(	PUNCT
fnp-5347	249	18	cases	case	NOUN
fnp-5347	249	19	1	1	NUM
fnp-5347	249	20	-	-	SYM
fnp-5347	249	21	15	15	NUM
fnp-5347	249	22	)	)	PUNCT
fnp-5347	249	23	,	,	PUNCT
fnp-5347	249	24	gg	gg	NOUN
fnp-5347	249	25	with	with	ADP
fnp-5347	249	26	non	non	ADJ
fnp-5347	249	27	-	-	ADJ
fnp-5347	249	28	complex	complex	ADJ
fnp-5347	249	29	genetic	genetic	ADJ
fnp-5347	249	30	variants	variant	NOUN
fnp-5347	249	31	(	(	PUNCT
fnp-5347	249	32	cases	case	NOUN
fnp-5347	249	33	16	16	NUM
fnp-5347	249	34	-	-	SYM
fnp-5347	249	35	44	44	NUM
fnp-5347	249	36	)	)	PUNCT
fnp-5347	249	37	,	,	PUNCT
fnp-5347	249	38	and	and	CCONJ
fnp-5347	249	39	gg	gg	VERB
fnp-5347	249	40	without	without	ADP
fnp-5347	249	41	any	any	DET
fnp-5347	249	42	detected	detect	VERB
fnp-5347	249	43	genetic	genetic	ADJ
fnp-5347	249	44	variants	variant	NOUN
fnp-5347	249	45	(	(	PUNCT
fnp-5347	249	46	cases	case	NOUN
fnp-5347	249	47	45	45	NUM
fnp-5347	249	48	-	-	SYM
fnp-5347	249	49	72	72	NUM
fnp-5347	249	50	,	,	PUNCT
fnp-5347	249	51	not	not	PART
fnp-5347	249	52	shown	show	VERB
fnp-5347	249	53	)	)	PUNCT
fnp-5347	249	54	.	.	PUNCT
fnp-5347	250	1	diagnosis	diagnosis	NOUN
fnp-5347	250	2	:	:	PUNCT
fnp-5347	250	3	histopathology	histopathology	NOUN
fnp-5347	250	4	review	review	NOUN
fnp-5347	250	5	confirmed	confirm	VERB
fnp-5347	250	6	the	the	DET
fnp-5347	250	7	diagnosis	diagnosis	NOUN
fnp-5347	250	8	of	of	ADP
fnp-5347	250	9	ganglioglioma	ganglioglioma	ADJ
fnp-5347	250	10	(	(	PUNCT
fnp-5347	250	11	green	green	ADJ
fnp-5347	250	12	tiles	tile	NOUN
fnp-5347	250	13	)	)	PUNCT
fnp-5347	250	14	in	in	ADP
fnp-5347	250	15	43	43	NUM
fnp-5347	250	16	cases	case	NOUN
fnp-5347	250	17	.	.	PUNCT
fnp-5347	251	1	lack	lack	NOUN
fnp-5347	251	2	of	of	ADP
fnp-5347	251	3	seizure	seizure	NOUN
fnp-5347	251	4	freedom	freedom	NOUN
fnp-5347	251	5	(	(	PUNCT
fnp-5347	251	6	red	red	ADJ
fnp-5347	251	7	tiles	tile	NOUN
fnp-5347	251	8	)	)	PUNCT
fnp-5347	251	9	was	be	AUX
fnp-5347	251	10	explicable	explicable	ADJ
fnp-5347	251	11	by	by	ADP
fnp-5347	251	12	incomplete	incomplete	ADJ
fnp-5347	251	13	resection	resection	NOUN
fnp-5347	251	14	only	only	ADV
fnp-5347	251	15	in	in	ADP
fnp-5347	251	16	cases	case	NOUN
fnp-5347	251	17	#	#	SYM
fnp-5347	251	18	9	9	NUM
fnp-5347	251	19	,	,	PUNCT
fnp-5347	251	20	#	#	SYM
fnp-5347	251	21	42	42	NUM
fnp-5347	251	22	,	,	PUNCT
fnp-5347	251	23	and	and	CCONJ
fnp-5347	251	24	#	#	SYM
fnp-5347	251	25	43	43	NUM
fnp-5347	251	26	(	(	PUNCT
fnp-5347	251	27	greyish	greyish	ADJ
fnp-5347	251	28	tiles	tile	NOUN
fnp-5347	251	29	)	)	PUNCT
fnp-5347	251	30	.	.	PUNCT
fnp-5347	252	1	outcome	outcome	NOUN
fnp-5347	252	2	data	datum	NOUN
fnp-5347	252	3	was	be	AUX
fnp-5347	252	4	missing	miss	VERB
fnp-5347	252	5	in	in	ADP
fnp-5347	252	6	cases	case	NOUN
fnp-5347	252	7	#	#	SYM
fnp-5347	252	8	15	15	NUM
fnp-5347	252	9	and	and	CCONJ
fnp-5347	252	10	#	#	SYM
fnp-5347	252	11	18	18	NUM
fnp-5347	252	12	(	(	PUNCT
fnp-5347	252	13	white	white	ADJ
fnp-5347	252	14	tiles	tile	NOUN
fnp-5347	252	15	)	)	PUNCT
fnp-5347	252	16	.	.	PUNCT
fnp-5347	253	1	figure	figure	NOUN
fnp-5347	253	2	collected	collect	VERB
fnp-5347	253	3	from	from	ADP
fnp-5347	253	4	open	open	ADJ
fnp-5347	253	5	-	-	PUNCT
fnp-5347	253	6	access	access	NOUN
fnp-5347	253	7	paper	paper	NOUN
fnp-5347	253	8	published	publish	VERB
fnp-5347	253	9	under	under	ADP
fnp-5347	253	10	a	a	DET
fnp-5347	253	11	creative	creative	ADJ
fnp-5347	253	12	commons	common	NOUN
fnp-5347	253	13	license	license	NOUN
fnp-5347	253	14	,	,	PUNCT
fnp-5347	253	15	with	with	ADP
fnp-5347	253	16	permission	permission	NOUN
fnp-5347	253	17	from	from	ADP
fnp-5347	253	18	the	the	DET
fnp-5347	253	19	authors	author	NOUN
fnp-5347	253	20	.	.	PUNCT
fnp-5347	254	1	these	these	DET
fnp-5347	254	2	results	result	NOUN
fnp-5347	254	3	prompted	prompt	VERB
fnp-5347	254	4	the	the	DET
fnp-5347	254	5	authors	author	NOUN
fnp-5347	254	6	to	to	PART
fnp-5347	254	7	suggest	suggest	VERB
fnp-5347	254	8	that	that	SCONJ
fnp-5347	254	9	the	the	DET
fnp-5347	254	10	who	who	PRON
fnp-5347	254	11	panel	panel	NOUN
fnp-5347	254	12	may	may	AUX
fnp-5347	254	13	use	use	VERB
fnp-5347	254	14	a	a	DET
fnp-5347	254	15	different	different	ADJ
fnp-5347	254	16	strategy	strategy	NOUN
fnp-5347	254	17	when	when	SCONJ
fnp-5347	254	18	classifying	classify	VERB
fnp-5347	254	19	leat	leat	NOUN
fnp-5347	254	20	,	,	PUNCT
fnp-5347	254	21	at	at	ADP
fnp-5347	254	22	least	least	ADJ
fnp-5347	254	23	reconsidering	reconsider	VERB
fnp-5347	254	24	a	a	DET
fnp-5347	254	25	grading	grade	VERB
fnp-5347	254	26	scale	scale	NOUN
fnp-5347	254	27	which	which	PRON
fnp-5347	254	28	re	re	NOUN
fnp-5347	254	29	-	-	NOUN
fnp-5347	254	30	introduces	introduce	NOUN
fnp-5347	254	31	who	who	PRON
fnp-5347	254	32	cns	cns	VERB
fnp-5347	254	33	grade	grade	NOUN
fnp-5347	254	34	2	2	NUM
fnp-5347	254	35	.	.	PUNCT
fnp-5347	255	1	as	as	ADP
fnp-5347	255	2	a	a	DET
fnp-5347	255	3	reminder	reminder	NOUN
fnp-5347	255	4	,	,	PUNCT
fnp-5347	255	5	previous	previous	ADJ
fnp-5347	255	6	editions	edition	NOUN
fnp-5347	255	7	of	of	ADP
fnp-5347	255	8	the	the	PRON
fnp-5347	255	9	who	who	PRON
fnp-5347	255	10	brain	brain	VERB
fnp-5347	255	11	tumor	tumor	NOUN
fnp-5347	255	12	classification	classification	NOUN
fnp-5347	255	13	included	include	VERB
fnp-5347	255	14	even	even	ADV
fnp-5347	255	15	anaplastic	anaplastic	ADJ
fnp-5347	255	16	variants	variant	NOUN
fnp-5347	255	17	of	of	ADP
fnp-5347	255	18	gg	gg	PROPN
fnp-5347	255	19	.	.	PUNCT
fnp-5347	256	1	along	along	ADP
fnp-5347	256	2	these	these	DET
fnp-5347	256	3	lines	line	NOUN
fnp-5347	256	4	,	,	PUNCT
fnp-5347	256	5	reinhard	reinhard	NOUN
fnp-5347	256	6	and	and	CCONJ
fnp-5347	256	7	coworkers	coworker	NOUN
fnp-5347	256	8	recently	recently	ADV
fnp-5347	256	9	published	publish	VERB
fnp-5347	256	10	their	their	PRON
fnp-5347	256	11	study	study	NOUN
fnp-5347	256	12	addressing	address	VERB
fnp-5347	256	13	an	an	DET
fnp-5347	256	14	internationally	internationally	ADV
fnp-5347	256	15	collected	collect	VERB
fnp-5347	256	16	cohort	cohort	NOUN
fnp-5347	256	17	of	of	ADP
fnp-5347	256	18	54	54	NUM
fnp-5347	256	19	anaplastic	anaplastic	ADJ
fnp-5347	256	20	ganglioglioma	ganglioglioma	NOUN
fnp-5347	256	21	,	,	PUNCT
fnp-5347	256	22	often	often	ADV
fnp-5347	256	23	including	include	VERB
fnp-5347	256	24	epilepsy	epilepsy	NOUN
fnp-5347	256	25	,	,	PUNCT
fnp-5347	256	26	tumor	tumor	NOUN
fnp-5347	256	27	relapse	relapse	NOUN
fnp-5347	256	28	and	and	CCONJ
fnp-5347	256	29	second	second	ADJ
fnp-5347	256	30	surgeries	surgery	NOUN
fnp-5347	256	31	in	in	ADP
fnp-5347	256	32	the	the	DET
fnp-5347	256	33	patient	patient	NOUN
fnp-5347	256	34	's	's	PART
fnp-5347	256	35	histories	history	NOUN
fnp-5347	256	36	,	,	PUNCT
fnp-5347	256	37	by	by	ADP
fnp-5347	256	38	using	use	VERB
fnp-5347	256	39	the	the	DET
fnp-5347	256	40	existing	exist	VERB
fnp-5347	256	41	heidelberg	heidelberg	NOUN
fnp-5347	256	42	dna	dna	PROPN
fnp-5347	256	43	methylation	methylation	NOUN
fnp-5347	256	44	classifier	classifier	NOUN
fnp-5347	256	45	[	[	X
fnp-5347	256	46	35	35	NUM
fnp-5347	256	47	]	]	PUNCT
fnp-5347	256	48	.	.	PUNCT
fnp-5347	257	1	the	the	DET
fnp-5347	257	2	majority	majority	NOUN
fnp-5347	257	3	of	of	ADP
fnp-5347	257	4	tumors	tumor	NOUN
fnp-5347	257	5	designated	designate	VERB
fnp-5347	257	6	as	as	ADP
fnp-5347	257	7	anaplastic	anaplastic	ADJ
fnp-5347	257	8	gangliogliomas	ganglioglioma	NOUN
fnp-5347	257	9	in	in	ADP
fnp-5347	257	10	the	the	DET
fnp-5347	257	11	original	original	ADJ
fnp-5347	257	12	histopathology	histopathology	NOUN
fnp-5347	257	13	report	report	NOUN
fnp-5347	257	14	resolved	resolve	VERB
fnp-5347	257	15	into	into	ADP
fnp-5347	257	16	other	other	ADJ
fnp-5347	257	17	who	who	PRON
fnp-5347	257	18	diagnoses	diagnose	VERB
fnp-5347	257	19	,	,	PUNCT
fnp-5347	257	20	most	most	ADV
fnp-5347	257	21	commonly	commonly	ADV
fnp-5347	257	22	pxa	pxa	NOUN
fnp-5347	257	23	(	(	PUNCT
fnp-5347	257	24	30	30	NUM
fnp-5347	257	25	 	 	SPACE
fnp-5347	257	26	%	%	NOUN
fnp-5347	257	27	)	)	PUNCT
fnp-5347	257	28	and	and	CCONJ
fnp-5347	257	29	glioblastoma	glioblastoma	NOUN
fnp-5347	257	30	,	,	PUNCT
fnp-5347	257	31	idh	idh	PROPN
fnp-5347	257	32	wildtype	wildtype	NOUN
fnp-5347	257	33	(	(	PUNCT
fnp-5347	257	34	20	20	NUM
fnp-5347	257	35	 	 	SPACE
fnp-5347	257	36	%	%	NOUN
fnp-5347	257	37	)	)	PUNCT
fnp-5347	257	38	.	.	PUNCT
fnp-5347	258	1	only	only	ADV
fnp-5347	258	2	ten	ten	NUM
fnp-5347	258	3	of	of	ADP
fnp-5347	258	4	their	their	PRON
fnp-5347	258	5	tumor	tumor	NOUN
fnp-5347	258	6	samples	sample	NOUN
fnp-5347	258	7	were	be	AUX
fnp-5347	258	8	not	not	PART
fnp-5347	258	9	assignable	assignable	ADJ
fnp-5347	258	10	to	to	ADP
fnp-5347	258	11	a	a	DET
fnp-5347	258	12	cns	cns	NOUN
fnp-5347	258	13	who	who	PRON
fnp-5347	258	14	diagnosis	diagnosis	VERB
fnp-5347	258	15	.	.	PUNCT
fnp-5347	259	1	it	it	PRON
fnp-5347	259	2	remains	remain	VERB
fnp-5347	259	3	to	to	PART
fnp-5347	259	4	be	be	AUX
fnp-5347	259	5	shown	show	VERB
fnp-5347	259	6	,	,	PUNCT
fnp-5347	259	7	however	however	ADV
fnp-5347	259	8	,	,	PUNCT
fnp-5347	259	9	if	if	SCONJ
fnp-5347	259	10	atypic	atypic	NOUN
fnp-5347	259	11	or	or	CCONJ
fnp-5347	259	12	anaplastic	anaplastic	ADJ
fnp-5347	259	13	ganglioglioma	ganglioglioma	NOUN
fnp-5347	259	14	do	do	AUX
fnp-5347	259	15	not	not	PART
fnp-5347	259	16	exist	exist	VERB
fnp-5347	259	17	at	at	ADV
fnp-5347	259	18	all	all	ADV
fnp-5347	259	19	as	as	ADP
fnp-5347	259	20	a	a	DET
fnp-5347	259	21	category	category	NOUN
fnp-5347	259	22	defined	define	VERB
fnp-5347	259	23	also	also	ADV
fnp-5347	259	24	by	by	ADP
fnp-5347	259	25	dna	dna	PROPN
fnp-5347	259	26	methylation	methylation	NOUN
fnp-5347	259	27	.	.	PUNCT
fnp-5347	260	1	the	the	DET
fnp-5347	260	2	work	work	NOUN
fnp-5347	260	3	of	of	ADP
fnp-5347	260	4	hoffmann	hoffmann	PROPN
fnp-5347	260	5	et	et	PROPN
fnp-5347	260	6	al	al	PROPN
fnp-5347	260	7	.	.	PROPN
fnp-5347	260	8	approved	approve	VERB
fnp-5347	260	9	such	such	DET
fnp-5347	260	10	an	an	DET
fnp-5347	260	11	atypic	atypic	ADJ
fnp-5347	260	12	category	category	NOUN
fnp-5347	260	13	,	,	PUNCT
fnp-5347	260	14	but	but	CCONJ
fnp-5347	260	15	using	use	VERB
fnp-5347	260	16	a	a	DET
fnp-5347	260	17	different	different	ADJ
fnp-5347	260	18	bioinformatic	bioinformatic	ADJ
fnp-5347	260	19	programming	programming	NOUN
fnp-5347	260	20	pipeline	pipeline	NOUN
fnp-5347	260	21	[	[	X
fnp-5347	260	22	21	21	NUM
fnp-5347	260	23	]	]	PUNCT
fnp-5347	260	24	.	.	PUNCT
fnp-5347	261	1	it	it	PRON
fnp-5347	261	2	is	be	AUX
fnp-5347	261	3	the	the	DET
fnp-5347	261	4	availability	availability	NOUN
fnp-5347	261	5	of	of	ADP
fnp-5347	261	6	enough	enough	ADJ
fnp-5347	261	7	and	and	CCONJ
fnp-5347	261	8	clinically	clinically	ADV
fnp-5347	261	9	well	well	ADV
fnp-5347	261	10	annotated	annotate	VERB
fnp-5347	261	11	tumor	tumor	NOUN
fnp-5347	261	12	samples	sample	NOUN
fnp-5347	261	13	covering	cover	VERB
fnp-5347	261	14	the	the	DET
fnp-5347	261	15	entire	entire	ADJ
fnp-5347	261	16	landscape	landscape	NOUN
fnp-5347	261	17	of	of	ADP
fnp-5347	261	18	leat	leat	NOUN
fnp-5347	261	19	that	that	PRON
fnp-5347	261	20	will	will	AUX
fnp-5347	261	21	make	make	VERB
fnp-5347	261	22	the	the	DET
fnp-5347	261	23	difference	difference	NOUN
fnp-5347	261	24	.	.	PUNCT
fnp-5347	262	1	the	the	DET
fnp-5347	262	2	issue	issue	NOUN
fnp-5347	262	3	of	of	ADP
fnp-5347	262	4	a	a	DET
fnp-5347	262	5	lower	low	ADJ
fnp-5347	262	6	tumor	tumor	NOUN
fnp-5347	262	7	cell	cell	NOUN
fnp-5347	262	8	content	content	NOUN
fnp-5347	262	9	in	in	ADP
fnp-5347	262	10	leat	leat	NOUN
fnp-5347	262	11	represents	represent	VERB
fnp-5347	262	12	an	an	DET
fnp-5347	262	13	additional	additional	ADJ
fnp-5347	262	14	challenge	challenge	NOUN
fnp-5347	262	15	to	to	PART
fnp-5347	262	16	be	be	AUX
fnp-5347	262	17	also	also	ADV
fnp-5347	262	18	addressed	address	VERB
fnp-5347	262	19	in	in	ADP
fnp-5347	262	20	any	any	DET
fnp-5347	262	21	dna	dna	PROPN
fnp-5347	262	22	methylation	methylation	NOUN
fnp-5347	262	23	brain	brain	NOUN
fnp-5347	262	24	tumor	tumor	NOUN
fnp-5347	262	25	classifier	classifier	NOUN
fnp-5347	262	26	.	.	PUNCT
fnp-5347	263	1	these	these	DET
fnp-5347	263	2	conflicting	conflicting	ADJ
fnp-5347	263	3	data	datum	NOUN
fnp-5347	263	4	may	may	AUX
fnp-5347	263	5	also	also	ADV
fnp-5347	263	6	pave	pave	VERB
fnp-5347	263	7	the	the	DET
fnp-5347	263	8	way	way	NOUN
fnp-5347	263	9	towards	towards	ADP
fnp-5347	263	10	new	new	ADJ
fnp-5347	263	11	approaches	approach	NOUN
fnp-5347	263	12	to	to	PART
fnp-5347	263	13	classify	classify	VERB
fnp-5347	263	14	brain	brain	NOUN
fnp-5347	263	15	tumors	tumor	NOUN
fnp-5347	263	16	,	,	PUNCT
fnp-5347	263	17	e.g.	e.g.	ADV
fnp-5347	263	18	,	,	PUNCT
fnp-5347	263	19	using	use	VERB
fnp-5347	263	20	the	the	DET
fnp-5347	263	21	real	real	ADJ
fnp-5347	263	22	-	-	PUNCT
fnp-5347	263	23	time	time	NOUN
fnp-5347	263	24	,	,	PUNCT
fnp-5347	263	25	direct	direct	ADJ
fnp-5347	263	26	sequencing	sequencing	NOUN
fnp-5347	263	27	technology	technology	NOUN
fnp-5347	264	1	[	[	X
fnp-5347	264	2	42	42	NUM
fnp-5347	264	3	]	]	PUNCT
fnp-5347	264	4	,	,	PUNCT
fnp-5347	264	5	and	and	CCONJ
fnp-5347	264	6	that	that	SCONJ
fnp-5347	264	7	a	a	DET
fnp-5347	264	8	single	single	ADJ
fnp-5347	264	9	histopathology	histopathology	NOUN
fnp-5347	264	10	consultant	consultant	NOUN
fnp-5347	264	11	may	may	AUX
fnp-5347	264	12	need	need	VERB
fnp-5347	264	13	to	to	PART
fnp-5347	264	14	apply	apply	VERB
fnp-5347	264	15	different	different	ADJ
fnp-5347	264	16	systems	system	NOUN
fnp-5347	264	17	to	to	PART
fnp-5347	264	18	obtain	obtain	VERB
fnp-5347	264	19	a	a	DET
fnp-5347	264	20	sound	sound	ADJ
fnp-5347	264	21	picture	picture	NOUN
fnp-5347	264	22	of	of	ADP
fnp-5347	264	23	the	the	DET
fnp-5347	264	24	underlying	underlie	VERB
fnp-5347	264	25	tumor	tumor	NOUN
fnp-5347	264	26	diagnosis	diagnosis	NOUN
fnp-5347	264	27	.	.	PUNCT
fnp-5347	265	1	that	that	SCONJ
fnp-5347	265	2	clinical	clinical	ADJ
fnp-5347	265	3	considerations	consideration	NOUN
fnp-5347	265	4	play	play	VERB
fnp-5347	265	5	a	a	DET
fnp-5347	265	6	major	major	ADJ
fnp-5347	265	7	role	role	NOUN
fnp-5347	265	8	in	in	ADP
fnp-5347	265	9	leat	leat	NOUN
fnp-5347	265	10	and	and	CCONJ
fnp-5347	265	11	that	that	SCONJ
fnp-5347	265	12	individual	individual	ADJ
fnp-5347	265	13	approaches	approach	NOUN
fnp-5347	265	14	in	in	ADP
fnp-5347	265	15	developing	develop	VERB
fnp-5347	265	16	dna	dna	PROPN
fnp-5347	265	17	methylation	methylation	NOUN
fnp-5347	265	18	classifier	classifier	NOUN
fnp-5347	265	19	can	can	AUX
fnp-5347	265	20	also	also	ADV
fnp-5347	265	21	be	be	AUX
fnp-5347	265	22	concluded	conclude	VERB
fnp-5347	265	23	from	from	ADP
fnp-5347	265	24	a	a	DET
fnp-5347	265	25	paper	paper	NOUN
fnp-5347	265	26	of	of	ADP
fnp-5347	265	27	stone	stone	NOUN
fnp-5347	265	28	and	and	CCONJ
fnp-5347	265	29	coworkers	coworker	NOUN
fnp-5347	266	1	[	[	X
fnp-5347	266	2	40	40	NUM
fnp-5347	266	3	]	]	PUNCT
fnp-5347	266	4	.	.	PUNCT
fnp-5347	267	1	they	they	PRON
fnp-5347	267	2	asked	ask	VERB
fnp-5347	267	3	the	the	DET
fnp-5347	267	4	question	question	NOUN
fnp-5347	267	5	if	if	SCONJ
fnp-5347	267	6	dna	dna	PROPN
fnp-5347	267	7	methylation	methylation	NOUN
fnp-5347	267	8	is	be	AUX
fnp-5347	267	9	helpful	helpful	ADJ
fnp-5347	267	10	to	to	PART
fnp-5347	267	11	synergize	synergize	VERB
fnp-5347	267	12	the	the	DET
fnp-5347	267	13	classification	classification	NOUN
fnp-5347	267	14	of	of	ADP
fnp-5347	267	15	leat	leat	NOUN
fnp-5347	267	16	into	into	ADP
fnp-5347	267	17	histopathology	histopathology	NOUN
fnp-5347	267	18	and	and	CCONJ
fnp-5347	267	19	neuroimaging	neuroimage	VERB
fnp-5347	267	20	similar	similar	ADJ
fnp-5347	267	21	subgroups	subgroup	NOUN
fnp-5347	267	22	and	and	CCONJ
fnp-5347	267	23	constructed	construct	VERB
fnp-5347	267	24	a	a	DET
fnp-5347	267	25	methylation	methylation	NOUN
fnp-5347	267	26	-	-	PUNCT
fnp-5347	267	27	based	base	VERB
fnp-5347	267	28	support	support	NOUN
fnp-5347	267	29	vector	vector	NOUN
fnp-5347	267	30	machine	machine	NOUN
fnp-5347	267	31	model	model	NOUN
fnp-5347	267	32	for	for	ADP
fnp-5347	267	33	their	their	PRON
fnp-5347	267	34	prediction	prediction	NOUN
fnp-5347	267	35	.	.	PUNCT
fnp-5347	268	1	they	they	PRON
fnp-5347	268	2	extended	extend	VERB
fnp-5347	268	3	a	a	DET
fnp-5347	268	4	previously	previously	ADV
fnp-5347	268	5	published	publish	VERB
fnp-5347	268	6	series	series	NOUN
fnp-5347	268	7	now	now	ADV
fnp-5347	268	8	including	include	VERB
fnp-5347	268	9	83	83	NUM
fnp-5347	268	10	leat	leat	NOUN
fnp-5347	268	11	samples	sample	NOUN
fnp-5347	268	12	and	and	CCONJ
fnp-5347	268	13	comprising	comprise	VERB
fnp-5347	268	14	glio	glio	ADJ
fnp-5347	268	15	-	-	PUNCT
fnp-5347	268	16	neuronal	neuronal	ADJ
fnp-5347	268	17	tumors	tumor	NOUN
fnp-5347	268	18	of	of	ADP
fnp-5347	268	19	two	two	NUM
fnp-5347	268	20	major	major	ADJ
fnp-5347	268	21	phenotypes	phenotype	NOUN
fnp-5347	268	22	,	,	PUNCT
fnp-5347	268	23	i.e.	i.e.	X
fnp-5347	268	24	,	,	PUNCT
fnp-5347	268	25	gg	gg	NOUN
fnp-5347	268	26	and	and	CCONJ
fnp-5347	268	27	dnt	dnt	VERB
fnp-5347	268	28	[	[	X
fnp-5347	268	29	39	39	NUM
fnp-5347	268	30	]	]	PUNCT
fnp-5347	268	31	.	.	PUNCT
fnp-5347	269	1	these	these	DET
fnp-5347	269	2	tumor	tumor	NOUN
fnp-5347	269	3	entities	entity	NOUN
fnp-5347	269	4	indeed	indeed	ADV
fnp-5347	269	5	segregated	segregate	VERB
fnp-5347	269	6	into	into	ADP
fnp-5347	269	7	two	two	NUM
fnp-5347	269	8	groups	group	NOUN
fnp-5347	269	9	.	.	PUNCT
fnp-5347	270	1	at	at	ADP
fnp-5347	270	2	the	the	DET
fnp-5347	270	3	histopathological	histopathological	ADJ
fnp-5347	270	4	level	level	NOUN
fnp-5347	270	5	,	,	PUNCT
fnp-5347	270	6	prominent	prominent	ADJ
fnp-5347	270	7	astrocytic	astrocytic	ADJ
fnp-5347	270	8	or	or	CCONJ
fnp-5347	270	9	oligodendrocyte	oligodendrocyte	ADJ
fnp-5347	270	10	-	-	PUNCT
fnp-5347	270	11	like	like	ADJ
fnp-5347	270	12	components	component	NOUN
fnp-5347	270	13	,	,	PUNCT
fnp-5347	270	14	dysplastic	dysplastic	ADJ
fnp-5347	270	15	neurons	neuron	NOUN
fnp-5347	270	16	or	or	CCONJ
fnp-5347	270	17	a	a	DET
fnp-5347	270	18	specific	specific	ADJ
fnp-5347	270	19	glioneuronal	glioneuronal	ADJ
fnp-5347	270	20	element	element	NOUN
fnp-5347	270	21	were	be	AUX
fnp-5347	270	22	important	important	ADJ
fnp-5347	270	23	discriminators	discriminator	NOUN
fnp-5347	270	24	between	between	ADP
fnp-5347	270	25	both	both	DET
fnp-5347	270	26	groups	group	NOUN
fnp-5347	270	27	.	.	PUNCT
fnp-5347	271	1	at	at	ADP
fnp-5347	271	2	the	the	DET
fnp-5347	271	3	neuroradiological	neuroradiological	ADJ
fnp-5347	271	4	level	level	NOUN
fnp-5347	271	5	,	,	PUNCT
fnp-5347	271	6	the	the	DET
fnp-5347	271	7	location	location	NOUN
fnp-5347	271	8	,	,	PUNCT
fnp-5347	271	9	margin	margin	NOUN
fnp-5347	271	10	definition	definition	NOUN
fnp-5347	271	11	,	,	PUNCT
fnp-5347	271	12	enhancement	enhancement	NOUN
fnp-5347	271	13	and	and	CCONJ
fnp-5347	271	14	t2	t2	NOUN
fnp-5347	271	15	flair	flair	NOUN
fnp-5347	271	16	-	-	PUNCT
fnp-5347	271	17	rim	rim	NOUN
fnp-5347	271	18	sign	sign	NOUN
fnp-5347	271	19	were	be	AUX
fnp-5347	271	20	successful	successful	ADJ
fnp-5347	271	21	discriminators	discriminator	NOUN
fnp-5347	271	22	.	.	PUNCT
fnp-5347	272	1	in	in	ADP
fnp-5347	272	2	a	a	DET
fnp-5347	272	3	validation	validation	NOUN
fnp-5347	272	4	round	round	ADP
fnp-5347	272	5	their	their	PRON
fnp-5347	272	6	ai	ai	NOUN
fnp-5347	272	7	-	-	PUNCT
fnp-5347	272	8	based	base	VERB
fnp-5347	272	9	algorithm	algorithm	NOUN
fnp-5347	272	10	classified	classify	VERB
fnp-5347	272	11	22/23	22/23	NUM
fnp-5347	272	12	samples	sample	NOUN
fnp-5347	272	13	correctly	correctly	ADV
fnp-5347	272	14	.	.	PUNCT
fnp-5347	273	1	the	the	DET
fnp-5347	273	2	authors	author	NOUN
fnp-5347	273	3	concluded	conclude	VERB
fnp-5347	273	4	the	the	DET
fnp-5347	273	5	importance	importance	NOUN
fnp-5347	273	6	and	and	CCONJ
fnp-5347	273	7	superiority	superiority	NOUN
fnp-5347	273	8	of	of	ADP
fnp-5347	273	9	an	an	DET
fnp-5347	273	10	integrated	integrate	VERB
fnp-5347	273	11	diagnostic	diagnostic	ADJ
fnp-5347	273	12	approach	approach	NOUN
fnp-5347	273	13	using	use	VERB
fnp-5347	273	14	histopathology	histopathology	NOUN
fnp-5347	273	15	,	,	PUNCT
fnp-5347	273	16	molecular	molecular	ADJ
fnp-5347	273	17	data	datum	NOUN
fnp-5347	273	18	but	but	CCONJ
fnp-5347	273	19	also	also	ADV
fnp-5347	273	20	clinical	clinical	ADJ
fnp-5347	273	21	information	information	NOUN
fnp-5347	273	22	as	as	SCONJ
fnp-5347	273	23	our	our	PRON
fnp-5347	273	24	current	current	ADJ
fnp-5347	273	25	diagnostic	diagnostic	ADJ
fnp-5347	273	26	criteria	criterion	NOUN
fnp-5347	273	27	inadequately	inadequately	ADV
fnp-5347	273	28	reflect	reflect	VERB
fnp-5347	273	29	glioneuronal	glioneuronal	ADJ
fnp-5347	273	30	tumor	tumor	NOUN
fnp-5347	273	31	biology	biology	NOUN
fnp-5347	273	32	and	and	CCONJ
fnp-5347	273	33	leave	leave	VERB
fnp-5347	273	34	a	a	DET
fnp-5347	273	35	proportion	proportion	NOUN
fnp-5347	273	36	unresolvable	unresolvable	ADJ
fnp-5347	273	37	.	.	PUNCT
fnp-5347	274	1	these	these	DET
fnp-5347	274	2	recent	recent	ADJ
fnp-5347	274	3	papers	paper	NOUN
fnp-5347	274	4	continue	continue	VERB
fnp-5347	274	5	to	to	PART
fnp-5347	274	6	pose	pose	VERB
fnp-5347	274	7	questions	question	NOUN
fnp-5347	274	8	how	how	SCONJ
fnp-5347	274	9	to	to	PART
fnp-5347	274	10	reliably	reliably	ADV
fnp-5347	274	11	classify	classify	VERB
fnp-5347	274	12	and	and	CCONJ
fnp-5347	274	13	grade	grade	NOUN
fnp-5347	274	14	leat	leat	NOUN
fnp-5347	274	15	,	,	PUNCT
fnp-5347	274	16	and	and	CCONJ
fnp-5347	274	17	agree	agree	VERB
fnp-5347	274	18	on	on	ADP
fnp-5347	274	19	the	the	DET
fnp-5347	274	20	terminology	terminology	NOUN
fnp-5347	274	21	use	use	NOUN
fnp-5347	274	22	.	.	PUNCT
fnp-5347	275	1	continued	continue	VERB
fnp-5347	275	2	disagreement	disagreement	NOUN
fnp-5347	275	3	will	will	AUX
fnp-5347	275	4	affect	affect	VERB
fnp-5347	275	5	any	any	DET
fnp-5347	275	6	interpretation	interpretation	NOUN
fnp-5347	275	7	of	of	ADP
fnp-5347	275	8	published	publish	VERB
fnp-5347	275	9	research	research	NOUN
fnp-5347	275	10	and	and	CCONJ
fnp-5347	275	11	also	also	ADV
fnp-5347	275	12	obstructs	obstruct	VERB
fnp-5347	275	13	a	a	DET
fnp-5347	275	14	better	well	ADJ
fnp-5347	275	15	prediction	prediction	NOUN
fnp-5347	275	16	of	of	ADP
fnp-5347	275	17	their	their	PRON
fnp-5347	275	18	clinical	clinical	ADJ
fnp-5347	275	19	behavior	behavior	NOUN
fnp-5347	275	20	beyond	beyond	ADP
fnp-5347	275	21	being	be	AUX
fnp-5347	275	22	regarded	regard	VERB
fnp-5347	275	23	as	as	ADP
fnp-5347	275	24	benign	benign	ADJ
fnp-5347	275	25	who	who	PRON
fnp-5347	275	26	cns	cns	VERB
fnp-5347	275	27	grade	grade	NOUN
fnp-5347	275	28	1	1	NUM
fnp-5347	275	29	.	.	PUNCT
fnp-5347	275	30	topic	topic	NOUN
fnp-5347	275	31	7	7	NUM
fnp-5347	275	32	:	:	PUNCT
fnp-5347	275	33	tauopathies	tauopathie	NOUN
fnp-5347	275	34	in	in	ADP
fnp-5347	275	35	mesial	mesial	ADJ
fnp-5347	275	36	temporal	temporal	ADJ
fnp-5347	275	37	lobe	lobe	NOUN
fnp-5347	275	38	epilepsy	epilepsy	NOUN
fnp-5347	275	39	there	there	PRON
fnp-5347	275	40	is	be	AUX
fnp-5347	275	41	increasing	increase	VERB
fnp-5347	275	42	research	research	NOUN
fnp-5347	275	43	interest	interest	NOUN
fnp-5347	275	44	in	in	ADP
fnp-5347	275	45	tauopathies	tauopathie	NOUN
fnp-5347	275	46	related	relate	VERB
fnp-5347	275	47	to	to	ADP
fnp-5347	275	48	temporal	temporal	ADJ
fnp-5347	275	49	lobe	lobe	NOUN
fnp-5347	275	50	epilepsy	epilepsy	NOUN
fnp-5347	275	51	.	.	PUNCT
fnp-5347	276	1	based	base	VERB
fnp-5347	276	2	on	on	ADP
fnp-5347	276	3	the	the	DET
fnp-5347	276	4	original	original	ADJ
fnp-5347	276	5	observations	observation	NOUN
fnp-5347	276	6	of	of	ADP
fnp-5347	276	7	abnormal	abnormal	ADJ
fnp-5347	276	8	tau	tau	PROPN
fnp-5347	276	9	phosphorylation	phosphorylation	NOUN
fnp-5347	276	10	in	in	ADP
fnp-5347	276	11	drug	drug	NOUN
fnp-5347	276	12	-	-	PUNCT
fnp-5347	276	13	resistant	resistant	ADJ
fnp-5347	276	14	epilepsy	epilepsy	NOUN
fnp-5347	276	15	[	[	X
fnp-5347	276	16	48	48	NUM
fnp-5347	276	17	]	]	PUNCT
fnp-5347	276	18	that	that	PRON
fnp-5347	276	19	aggregates	aggregate	VERB
fnp-5347	276	20	into	into	ADP
fnp-5347	276	21	neuropil	neuropil	ADJ
fnp-5347	276	22	threads	thread	NOUN
fnp-5347	276	23	(	(	PUNCT
fnp-5347	276	24	nt	not	PART
fnp-5347	276	25	)	)	PUNCT
fnp-5347	276	26	or	or	CCONJ
fnp-5347	276	27	neurofibrillary	neurofibrillary	ADJ
fnp-5347	276	28	tangles	tangle	NOUN
fnp-5347	276	29	(	(	PUNCT
fnp-5347	276	30	nft	nft	PROPN
fnp-5347	276	31	)	)	PUNCT
fnp-5347	276	32	in	in	ADP
fnp-5347	276	33	brain	brain	NOUN
fnp-5347	276	34	biopsies	biopsy	NOUN
fnp-5347	276	35	surgically	surgically	ADV
fnp-5347	276	36	resected	resect	VERB
fnp-5347	276	37	from	from	ADP
fnp-5347	276	38	patients	patient	NOUN
fnp-5347	276	39	with	with	ADP
fnp-5347	276	40	drug	drug	NOUN
fnp-5347	276	41	-	-	PUNCT
fnp-5347	276	42	resistant	resistant	ADJ
fnp-5347	276	43	epilepsies	epilepsy	NOUN
fnp-5347	276	44	,	,	PUNCT
fnp-5347	276	45	there	there	PRON
fnp-5347	276	46	is	be	VERB
fnp-5347	276	47	an	an	DET
fnp-5347	276	48	ongoing	ongoing	ADJ
fnp-5347	276	49	discussion	discussion	NOUN
fnp-5347	276	50	about	about	ADP
fnp-5347	276	51	precocious	precocious	ADJ
fnp-5347	276	52	aging	aging	NOUN
fnp-5347	276	53	in	in	ADP
fnp-5347	276	54	tle	tle	ADJ
fnp-5347	276	55	patients	patient	NOUN
fnp-5347	276	56	as	as	ADP
fnp-5347	276	57	a	a	DET
fnp-5347	276	58	result	result	NOUN
fnp-5347	276	59	from	from	ADP
fnp-5347	276	60	similar	similar	ADJ
fnp-5347	276	61	pathomechanisms	pathomechanism	NOUN
fnp-5347	276	62	observed	observe	VERB
fnp-5347	276	63	in	in	ADP
fnp-5347	276	64	alzheimer	alzheimer	PROPN
fnp-5347	276	65	's	's	PART
fnp-5347	276	66	disease	disease	NOUN
fnp-5347	276	67	.	.	PUNCT
fnp-5347	277	1	this	this	DET
fnp-5347	277	2	claim	claim	NOUN
fnp-5347	277	3	was	be	AUX
fnp-5347	277	4	not	not	PART
fnp-5347	277	5	only	only	ADV
fnp-5347	277	6	spectacular	spectacular	ADJ
fnp-5347	277	7	at	at	ADP
fnp-5347	277	8	that	that	DET
fnp-5347	277	9	time	time	NOUN
fnp-5347	277	10	but	but	CCONJ
fnp-5347	277	11	may	may	AUX
fnp-5347	277	12	bridge	bridge	VERB
fnp-5347	277	13	the	the	DET
fnp-5347	277	14	open	open	ADJ
fnp-5347	277	15	question	question	NOUN
fnp-5347	277	16	of	of	ADP
fnp-5347	277	17	ongoing	ongoing	ADJ
fnp-5347	277	18	and	and	CCONJ
fnp-5347	277	19	aggravating	aggravating	ADJ
fnp-5347	277	20	memory	memory	NOUN
fnp-5347	277	21	decline	decline	NOUN
fnp-5347	277	22	in	in	ADP
fnp-5347	277	23	drug	drug	NOUN
fnp-5347	277	24	-	-	PUNCT
fnp-5347	277	25	resistant	resistant	ADJ
fnp-5347	277	26	tle	tle	NOUN
fnp-5347	277	27	patients	patient	NOUN
fnp-5347	277	28	.	.	PUNCT
fnp-5347	278	1	however	however	ADV
fnp-5347	278	2	,	,	PUNCT
fnp-5347	278	3	available	available	ADJ
fnp-5347	278	4	research	research	NOUN
fnp-5347	278	5	data	datum	NOUN
fnp-5347	278	6	does	do	AUX
fnp-5347	278	7	not	not	PART
fnp-5347	278	8	fully	fully	ADV
fnp-5347	278	9	support	support	VERB
fnp-5347	278	10	the	the	DET
fnp-5347	278	11	hypothesis	hypothesis	NOUN
fnp-5347	278	12	anymore	anymore	ADV
fnp-5347	278	13	as	as	SCONJ
fnp-5347	278	14	will	will	AUX
fnp-5347	278	15	be	be	AUX
fnp-5347	278	16	shown	show	VERB
fnp-5347	278	17	in	in	ADP
fnp-5347	278	18	a	a	DET
fnp-5347	278	19	small	small	ADJ
fnp-5347	278	20	compilation	compilation	NOUN
fnp-5347	278	21	of	of	ADP
fnp-5347	278	22	three	three	NUM
fnp-5347	278	23	recently	recently	ADV
fnp-5347	278	24	published	publish	VERB
fnp-5347	278	25	papers	paper	NOUN
fnp-5347	278	26	.	.	PUNCT
fnp-5347	279	1	aroor	aroor	PROPN
fnp-5347	279	2	and	and	CCONJ
fnp-5347	279	3	coworkers	coworker	NOUN
fnp-5347	279	4	addressed	address	VERB
fnp-5347	279	5	the	the	DET
fnp-5347	279	6	possibility	possibility	NOUN
fnp-5347	279	7	that	that	SCONJ
fnp-5347	279	8	cognitive	cognitive	ADJ
fnp-5347	279	9	decline	decline	NOUN
fnp-5347	279	10	in	in	ADP
fnp-5347	279	11	epilepsy	epilepsy	NOUN
fnp-5347	279	12	may	may	AUX
fnp-5347	279	13	be	be	AUX
fnp-5347	279	14	associated	associate	VERB
fnp-5347	279	15	with	with	ADP
fnp-5347	279	16	mechanisms	mechanism	NOUN
fnp-5347	279	17	typical	typical	ADJ
fnp-5347	279	18	of	of	ADP
fnp-5347	279	19	alzheimer	alzheimer	PROPN
fnp-5347	279	20	's	's	PART
fnp-5347	279	21	disease	disease	NOUN
fnp-5347	279	22	(	(	PUNCT
fnp-5347	279	23	ad	ad	NOUN
fnp-5347	279	24	)	)	PUNCT
fnp-5347	280	1	[	[	X
fnp-5347	280	2	3	3	NUM
fnp-5347	280	3	]	]	PUNCT
fnp-5347	280	4	.	.	PUNCT
fnp-5347	281	1	they	they	PRON
fnp-5347	281	2	determined	determine	VERB
fnp-5347	281	3	the	the	DET
fnp-5347	281	4	abundance	abundance	NOUN
fnp-5347	281	5	of	of	ADP
fnp-5347	281	6	phospho	phospho	NOUN
fnp-5347	281	7	-	-	PUNCT
fnp-5347	281	8	tau	tau	NOUN
fnp-5347	281	9	and	and	CCONJ
fnp-5347	281	10	aβ	aβ	NOUN
fnp-5347	281	11	proteins	protein	NOUN
fnp-5347	281	12	in	in	ADP
fnp-5347	281	13	association	association	NOUN
fnp-5347	281	14	with	with	ADP
fnp-5347	281	15	cognitive	cognitive	ADJ
fnp-5347	281	16	function	function	NOUN
fnp-5347	281	17	in	in	ADP
fnp-5347	281	18	12	12	NUM
fnp-5347	281	19	cases	case	NOUN
fnp-5347	281	20	of	of	ADP
fnp-5347	281	21	drug	drug	NOUN
fnp-5347	281	22	-	-	PUNCT
fnp-5347	281	23	resistant	resistant	ADJ
fnp-5347	281	24	epilepsy	epilepsy	NOUN
fnp-5347	281	25	.	.	PUNCT
fnp-5347	282	1	indeed	indeed	ADV
fnp-5347	282	2	,	,	PUNCT
fnp-5347	282	3	they	they	PRON
fnp-5347	282	4	could	could	AUX
fnp-5347	282	5	observe	observe	VERB
fnp-5347	282	6	a	a	DET
fnp-5347	282	7	robust	robust	ADJ
fnp-5347	282	8	presence	presence	NOUN
fnp-5347	282	9	of	of	ADP
fnp-5347	282	10	tauphospho	tauphospho	ADV
fnp-5347	282	11	-	-	PUNCT
fnp-5347	282	12	related	relate	VERB
fnp-5347	282	13	nt	not	PART
fnp-5347	282	14	(	(	PUNCT
fnp-5347	282	15	ser202	ser202	PROPN
fnp-5347	282	16	/	/	SYM
fnp-5347	282	17	thr205	thr205	PROPN
fnp-5347	282	18	)	)	PUNCT
fnp-5347	282	19	and	and	CCONJ
fnp-5347	282	20	nft	nft	PROPN
fnp-5347	282	21	pathology	pathology	PROPN
fnp-5347	282	22	,	,	PUNCT
fnp-5347	282	23	as	as	ADV
fnp-5347	282	24	well	well	ADV
fnp-5347	282	25	as	as	ADP
fnp-5347	282	26	aβ	aβ	DET
fnp-5347	282	27	deposits	deposit	NOUN
fnp-5347	282	28	,	,	PUNCT
fnp-5347	282	29	and	and	CCONJ
fnp-5347	282	30	phosphos6	phosphos6	NOUN
fnp-5347	282	31	(	(	PUNCT
fnp-5347	282	32	phosphorylation	phosphorylation	NOUN
fnp-5347	282	33	of	of	ADP
fnp-5347	282	34	s6	s6	PROPN
fnp-5347	282	35	at	at	ADP
fnp-5347	282	36	ser240/244	ser240/244	PROPN
fnp-5347	282	37	or	or	CCONJ
fnp-5347	282	38	ser235/236	ser235/236	PROPN
fnp-5347	282	39	indicating	indicate	VERB
fnp-5347	282	40	an	an	DET
fnp-5347	282	41	activation	activation	NOUN
fnp-5347	282	42	of	of	ADP
fnp-5347	282	43	the	the	DET
fnp-5347	282	44	mtor	mtor	NOUN
fnp-5347	282	45	complex	complex	NOUN
fnp-5347	282	46	)	)	PUNCT
fnp-5347	282	47	in	in	ADP
fnp-5347	282	48	the	the	DET
fnp-5347	282	49	epileptic	epileptic	ADJ
fnp-5347	282	50	samples	sample	NOUN
fnp-5347	282	51	.	.	PUNCT
fnp-5347	283	1	they	they	PRON
fnp-5347	283	2	found	find	VERB
fnp-5347	283	3	no	no	DET
fnp-5347	283	4	significant	significant	ADJ
fnp-5347	283	5	correlation	correlation	NOUN
fnp-5347	283	6	,	,	PUNCT
fnp-5347	283	7	however	however	ADV
fnp-5347	283	8	,	,	PUNCT
fnp-5347	283	9	between	between	ADP
fnp-5347	283	10	tauphospho	tauphospho	PROPN
fnp-5347	283	11	(	(	PUNCT
fnp-5347	283	12	thr205	thr205	PROPN
fnp-5347	283	13	;	;	PUNCT
fnp-5347	283	14	thr181	thr181	PROPN
fnp-5347	283	15	)	)	PUNCT
fnp-5347	283	16	,	,	PUNCT
fnp-5347	283	17	aβ	aβ	NOUN
fnp-5347	283	18	,	,	PUNCT
fnp-5347	283	19	or	or	CCONJ
fnp-5347	283	20	mtor	mtor	PROPN
fnp-5347	283	21	markers	marker	NOUN
fnp-5347	283	22	with	with	ADP
fnp-5347	283	23	cognitive	cognitive	ADJ
fnp-5347	283	24	scores	score	NOUN
fnp-5347	283	25	.	.	PUNCT
fnp-5347	284	1	these	these	DET
fnp-5347	284	2	findings	finding	NOUN
fnp-5347	284	3	still	still	ADV
fnp-5347	284	4	support	support	VERB
fnp-5347	284	5	the	the	DET
fnp-5347	284	6	existence	existence	NOUN
fnp-5347	284	7	of	of	ADP
fnp-5347	284	8	hyperphosphorylated	hyperphosphorylated	ADJ
fnp-5347	284	9	tau	tau	PROPN
fnp-5347	284	10	protein	protein	NOUN
fnp-5347	284	11	and	and	CCONJ
fnp-5347	284	12	aβ	aβ	DET
fnp-5347	284	13	deposits	deposit	NOUN
fnp-5347	284	14	in	in	ADP
fnp-5347	284	15	patients	patient	NOUN
fnp-5347	284	16	with	with	ADP
fnp-5347	284	17	drug	drug	NOUN
fnp-5347	284	18	-	-	PUNCT
fnp-5347	284	19	refractory	refractory	NOUN
fnp-5347	284	20	tle	tle	NOUN
fnp-5347	284	21	,	,	PUNCT
fnp-5347	284	22	but	but	CCONJ
fnp-5347	284	23	their	their	PRON
fnp-5347	284	24	relation	relation	NOUN
fnp-5347	284	25	to	to	ADP
fnp-5347	284	26	cognitive	cognitive	ADJ
fnp-5347	284	27	decline	decline	NOUN
fnp-5347	284	28	remains	remain	VERB
fnp-5347	284	29	uncertain	uncertain	ADJ
fnp-5347	284	30	and	and	CCONJ
fnp-5347	284	31	requires	require	VERB
fnp-5347	284	32	further	further	ADJ
fnp-5347	284	33	investigation	investigation	NOUN
fnp-5347	284	34	.	.	PUNCT
fnp-5347	285	1	concepcion	concepcion	NOUN
fnp-5347	285	2	and	and	CCONJ
fnp-5347	285	3	coworkers	coworker	NOUN
fnp-5347	285	4	studied	study	VERB
fnp-5347	285	5	the	the	DET
fnp-5347	285	6	progressive	progressive	ADJ
fnp-5347	285	7	dysregulation	dysregulation	NOUN
fnp-5347	285	8	of	of	ADP
fnp-5347	285	9	tau	tau	PROPN
fnp-5347	285	10	phosphorylation	phosphorylation	NOUN
fnp-5347	285	11	in	in	ADP
fnp-5347	285	12	a	a	DET
fnp-5347	285	13	rat	rat	NOUN
fnp-5347	285	14	pilocarpine	pilocarpine	NOUN
fnp-5347	285	15	status	status	NOUN
fnp-5347	285	16	epilepticus	epilepticus	NOUN
fnp-5347	285	17	(	(	PUNCT
fnp-5347	285	18	se	se	ADJ
fnp-5347	285	19	)	)	PUNCT
fnp-5347	285	20	model	model	NOUN
fnp-5347	285	21	of	of	ADP
fnp-5347	285	22	tle	tle	NOUN
fnp-5347	285	23	[	[	X
fnp-5347	285	24	14	14	NUM
fnp-5347	285	25	]	]	PUNCT
fnp-5347	285	26	.	.	PUNCT
fnp-5347	286	1	they	they	PRON
fnp-5347	286	2	measured	measure	VERB
fnp-5347	286	3	tau	tau	PROPN
fnp-5347	286	4	expression	expression	NOUN
fnp-5347	286	5	at	at	ADP
fnp-5347	286	6	two	two	NUM
fnp-5347	286	7	months	month	NOUN
fnp-5347	286	8	and	and	CCONJ
fnp-5347	286	9	four	four	NUM
fnp-5347	286	10	months	month	NOUN
fnp-5347	286	11	after	after	ADP
fnp-5347	286	12	se	se	X
fnp-5347	286	13	.	.	PUNCT
fnp-5347	287	1	total	total	PROPN
fnp-5347	287	2	tau	tau	PROPN
fnp-5347	287	3	levels	level	NOUN
fnp-5347	287	4	were	be	AUX
fnp-5347	287	5	modestly	modestly	ADV
fnp-5347	287	6	reduced	reduce	VERB
fnp-5347	287	7	compared	compare	VERB
fnp-5347	287	8	to	to	ADP
fnp-5347	287	9	naïve	naïve	ADJ
fnp-5347	287	10	controls	control	NOUN
fnp-5347	287	11	at	at	ADP
fnp-5347	287	12	two	two	NUM
fnp-5347	287	13	months	month	NOUN
fnp-5347	287	14	post	post	ADJ
fnp-5347	287	15	-	-	ADJ
fnp-5347	287	16	se	se	ADJ
fnp-5347	287	17	,	,	PUNCT
fnp-5347	287	18	but	but	CCONJ
fnp-5347	287	19	there	there	PRON
fnp-5347	287	20	was	be	VERB
fnp-5347	287	21	no	no	DET
fnp-5347	287	22	significant	significant	ADJ
fnp-5347	287	23	reduction	reduction	NOUN
fnp-5347	287	24	in	in	ADP
fnp-5347	287	25	s202	s202	PROPN
fnp-5347	287	26	/	/	SYM
fnp-5347	287	27	t205	t205	PROPN
fnp-5347	287	28	phosphorylation	phosphorylation	NOUN
fnp-5347	287	29	.	.	PUNCT
fnp-5347	288	1	in	in	ADP
fnp-5347	288	2	the	the	DET
fnp-5347	288	3	whole	whole	ADJ
fnp-5347	288	4	hippocampal	hippocampal	ADJ
fnp-5347	288	5	formation	formation	NOUN
fnp-5347	288	6	from	from	ADP
fnp-5347	288	7	four	four	NUM
fnp-5347	288	8	month	month	NOUN
fnp-5347	288	9	post	post	ADJ
fnp-5347	288	10	-	-	ADJ
fnp-5347	288	11	se	se	ADJ
fnp-5347	288	12	rats	rat	NOUN
fnp-5347	288	13	,	,	PUNCT
fnp-5347	288	14	total	total	ADJ
fnp-5347	288	15	tau	tau	PROPN
fnp-5347	288	16	expression	expression	NOUN
fnp-5347	288	17	had	have	AUX
fnp-5347	288	18	reverted	revert	VERB
fnp-5347	288	19	to	to	ADP
fnp-5347	288	20	normal	normal	ADJ
fnp-5347	288	21	,	,	PUNCT
fnp-5347	288	22	but	but	CCONJ
fnp-5347	288	23	there	there	PRON
fnp-5347	288	24	was	be	VERB
fnp-5347	288	25	a	a	DET
fnp-5347	288	26	significant	significant	ADJ
fnp-5347	288	27	reduction	reduction	NOUN
fnp-5347	288	28	in	in	ADP
fnp-5347	288	29	ca1	ca1	PROPN
fnp-5347	288	30	and	and	CCONJ
fnp-5347	288	31	ca3	ca3	NOUN
fnp-5347	288	32	for	for	ADP
fnp-5347	288	33	s202	s202	PROPN
fnp-5347	288	34	/	/	SYM
fnp-5347	288	35	t205	t205	PROPN
fnp-5347	288	36	tau	tau	NOUN
fnp-5347	288	37	phosphorylation	phosphorylation	NOUN
fnp-5347	288	38	.	.	PUNCT
fnp-5347	289	1	no	no	DET
fnp-5347	289	2	change	change	NOUN
fnp-5347	289	3	in	in	ADP
fnp-5347	289	4	phosphorylation	phosphorylation	NOUN
fnp-5347	289	5	was	be	AUX
fnp-5347	289	6	seen	see	VERB
fnp-5347	289	7	at	at	ADP
fnp-5347	289	8	the	the	DET
fnp-5347	289	9	t181	t181	PROPN
fnp-5347	289	10	and	and	CCONJ
fnp-5347	289	11	t231	t231	PROPN
fnp-5347	289	12	tau	tau	PROPN
fnp-5347	289	13	loci	locus	NOUN
fnp-5347	289	14	.	.	PUNCT
fnp-5347	290	1	in	in	ADP
fnp-5347	290	2	somatosensory	somatosensory	NOUN
fnp-5347	290	3	cortex	cortex	NOUN
fnp-5347	290	4	,	,	PUNCT
fnp-5347	290	5	outside	outside	ADP
fnp-5347	290	6	of	of	ADP
fnp-5347	290	7	the	the	DET
fnp-5347	290	8	seizure	seizure	NOUN
fnp-5347	290	9	onset	onset	NOUN
fnp-5347	290	10	zone	zone	NOUN
fnp-5347	290	11	,	,	PUNCT
fnp-5347	290	12	no	no	DET
fnp-5347	290	13	changes	change	NOUN
fnp-5347	290	14	in	in	ADP
fnp-5347	290	15	tau	tau	PROPN
fnp-5347	290	16	expression	expression	NOUN
fnp-5347	290	17	or	or	CCONJ
fnp-5347	290	18	phosphorylation	phosphorylation	NOUN
fnp-5347	290	19	were	be	AUX
fnp-5347	290	20	seen	see	VERB
fnp-5347	290	21	at	at	ADP
fnp-5347	290	22	the	the	DET
fnp-5347	290	23	later	later	ADJ
fnp-5347	290	24	time	time	NOUN
fnp-5347	290	25	point	point	NOUN
fnp-5347	290	26	.	.	PUNCT
fnp-5347	291	1	the	the	DET
fnp-5347	291	2	authors	author	NOUN
fnp-5347	291	3	concluded	conclude	VERB
fnp-5347	291	4	that	that	SCONJ
fnp-5347	291	5	total	total	ADJ
fnp-5347	291	6	tau	tau	PROPN
fnp-5347	291	7	expression	expression	NOUN
fnp-5347	291	8	and	and	CCONJ
fnp-5347	291	9	phosphorylation	phosphorylation	NOUN
fnp-5347	291	10	did	do	AUX
fnp-5347	291	11	not	not	PART
fnp-5347	291	12	show	show	VERB
fnp-5347	291	13	hyperphosphorylation	hyperphosphorylation	NOUN
fnp-5347	291	14	at	at	ADP
fnp-5347	291	15	the	the	DET
fnp-5347	291	16	three	three	NUM
fnp-5347	291	17	ad	ad	NOUN
fnp-5347	291	18	canonical	canonical	NOUN
fnp-5347	291	19	tau	tau	PROPN
fnp-5347	291	20	loci	locus	NOUN
fnp-5347	291	21	tested	test	VERB
fnp-5347	291	22	in	in	ADP
fnp-5347	291	23	their	their	PRON
fnp-5347	291	24	animal	animal	NOUN
fnp-5347	291	25	model	model	NOUN
fnp-5347	291	26	of	of	ADP
fnp-5347	291	27	tle	tle	PROPN
fnp-5347	291	28	.	.	PUNCT
fnp-5347	292	1	instead	instead	ADV
fnp-5347	292	2	,	,	PUNCT
fnp-5347	292	3	the	the	DET
fnp-5347	292	4	s202	s202	PROPN
fnp-5347	292	5	/	/	SYM
fnp-5347	292	6	t205	t205	PROPN
fnp-5347	292	7	locus	locus	NOUN
fnp-5347	292	8	showed	show	VERB
fnp-5347	292	9	progressive	progressive	ADJ
fnp-5347	292	10	dephosphorylation	dephosphorylation	NOUN
fnp-5347	292	11	.	.	PUNCT
fnp-5347	293	1	this	this	PRON
fnp-5347	293	2	suggested	suggest	VERB
fnp-5347	293	3	that	that	SCONJ
fnp-5347	293	4	changes	change	NOUN
fnp-5347	293	5	in	in	ADP
fnp-5347	293	6	tau	tau	PROPN
fnp-5347	293	7	expression	expression	NOUN
fnp-5347	293	8	may	may	AUX
fnp-5347	293	9	play	play	VERB
fnp-5347	293	10	a	a	DET
fnp-5347	293	11	different	different	ADJ
fnp-5347	293	12	role	role	NOUN
fnp-5347	293	13	in	in	ADP
fnp-5347	293	14	tle	tle	NOUN
fnp-5347	293	15	than	than	ADP
fnp-5347	293	16	in	in	ADP
fnp-5347	293	17	ad	ad	NOUN
fnp-5347	293	18	.	.	PUNCT
fnp-5347	294	1	further	furth	ADJ
fnp-5347	294	2	studies	study	NOUN
fnp-5347	294	3	are	be	AUX
fnp-5347	294	4	needed	need	VERB
fnp-5347	294	5	,	,	PUNCT
fnp-5347	294	6	therefore	therefore	ADV
fnp-5347	294	7	,	,	PUNCT
fnp-5347	294	8	to	to	PART
fnp-5347	294	9	understand	understand	VERB
fnp-5347	294	10	how	how	SCONJ
fnp-5347	294	11	such	such	ADJ
fnp-5347	294	12	tau	tau	PROPN
fnp-5347	294	13	changes	change	NOUN
fnp-5347	294	14	may	may	AUX
fnp-5347	294	15	impact	impact	VERB
fnp-5347	294	16	neuronal	neuronal	ADJ
fnp-5347	294	17	excitability	excitability	NOUN
fnp-5347	294	18	in	in	ADP
fnp-5347	294	19	chronic	chronic	ADJ
fnp-5347	294	20	epilepsy	epilepsy	NOUN
fnp-5347	294	21	.	.	PUNCT
fnp-5347	295	1	witt	witt	PROPN
fnp-5347	295	2	and	and	CCONJ
fnp-5347	295	3	coworkers	coworker	NOUN
fnp-5347	295	4	approached	approach	VERB
fnp-5347	295	5	this	this	DET
fnp-5347	295	6	interesting	interesting	ADJ
fnp-5347	295	7	topic	topic	NOUN
fnp-5347	295	8	from	from	ADP
fnp-5347	295	9	a	a	DET
fnp-5347	295	10	neuropsychology	neuropsychology	NOUN
fnp-5347	295	11	standpoint	standpoint	NOUN
fnp-5347	295	12	claiming	claim	VERB
fnp-5347	295	13	that	that	SCONJ
fnp-5347	295	14	the	the	DET
fnp-5347	295	15	etiology	etiology	NOUN
fnp-5347	295	16	of	of	ADP
fnp-5347	295	17	cognitive	cognitive	ADJ
fnp-5347	295	18	deficits	deficit	NOUN
fnp-5347	295	19	in	in	ADP
fnp-5347	295	20	epilepsy	epilepsy	NOUN
fnp-5347	295	21	is	be	AUX
fnp-5347	295	22	really	really	ADV
fnp-5347	295	23	multifactorial	multifactorial	ADJ
fnp-5347	295	24	,	,	PUNCT
fnp-5347	295	25	the	the	DET
fnp-5347	295	26	neuropathology	neuropathology	NOUN
fnp-5347	295	27	of	of	ADP
fnp-5347	295	28	mtle	mtle	NOUN
fnp-5347	295	29	rather	rather	ADV
fnp-5347	295	30	multifaceted	multifaceted	ADJ
fnp-5347	295	31	and	and	CCONJ
fnp-5347	295	32	beyond	beyond	ADP
fnp-5347	295	33	that	that	PRON
fnp-5347	295	34	of	of	ADP
fnp-5347	295	35	justifying	justify	VERB
fnp-5347	295	36	the	the	DET
fnp-5347	295	37	study	study	NOUN
fnp-5347	295	38	of	of	ADP
fnp-5347	295	39	hyperphosphorylated	hyperphosphorylated	ADJ
fnp-5347	295	40	tau	tau	PROPN
fnp-5347	296	1	[	[	X
fnp-5347	296	2	46	46	NUM
fnp-5347	296	3	]	]	PUNCT
fnp-5347	296	4	.	.	PUNCT
fnp-5347	297	1	indeed	indeed	ADV
fnp-5347	297	2	,	,	PUNCT
fnp-5347	297	3	the	the	DET
fnp-5347	297	4	bidirectionality	bidirectionality	NOUN
fnp-5347	297	5	between	between	ADP
fnp-5347	297	6	epilepsy	epilepsy	NOUN
fnp-5347	297	7	and	and	CCONJ
fnp-5347	297	8	dementia	dementia	NOUN
fnp-5347	297	9	is	be	AUX
fnp-5347	297	10	of	of	ADP
fnp-5347	297	11	high	high	ADJ
fnp-5347	297	12	interest	interest	NOUN
fnp-5347	297	13	,	,	PUNCT
fnp-5347	297	14	also	also	ADV
fnp-5347	297	15	from	from	ADP
fnp-5347	297	16	the	the	DET
fnp-5347	297	17	epileptological	epileptological	ADJ
fnp-5347	297	18	perspective	perspective	NOUN
fnp-5347	297	19	.	.	PUNCT
fnp-5347	298	1	however	however	ADV
fnp-5347	298	2	,	,	PUNCT
fnp-5347	298	3	there	there	PRON
fnp-5347	298	4	are	be	VERB
fnp-5347	298	5	many	many	ADJ
fnp-5347	298	6	etiologies	etiology	NOUN
fnp-5347	298	7	in	in	ADP
fnp-5347	298	8	tle	tle	NOUN
fnp-5347	298	9	that	that	PRON
fnp-5347	298	10	were	be	AUX
fnp-5347	298	11	associated	associate	VERB
fnp-5347	298	12	with	with	ADP
fnp-5347	298	13	cognitive	cognitive	ADJ
fnp-5347	298	14	decline	decline	NOUN
fnp-5347	298	15	in	in	ADP
fnp-5347	298	16	epilepsy	epilepsy	NOUN
fnp-5347	298	17	,	,	PUNCT
fnp-5347	298	18	as	as	SCONJ
fnp-5347	298	19	histopathology	histopathology	NOUN
fnp-5347	298	20	findings	finding	NOUN
fnp-5347	298	21	in	in	ADP
fnp-5347	298	22	mtle	mtle	NOUN
fnp-5347	298	23	samples	sample	NOUN
fnp-5347	298	24	reported	report	VERB
fnp-5347	298	25	hippocampal	hippocampal	ADJ
fnp-5347	298	26	sclerosis	sclerosis	NOUN
fnp-5347	298	27	,	,	PUNCT
fnp-5347	298	28	dysplastic	dysplastic	ADJ
fnp-5347	298	29	lesions	lesion	NOUN
fnp-5347	298	30	,	,	PUNCT
fnp-5347	298	31	and	and	CCONJ
fnp-5347	298	32	neurodevelopmental	neurodevelopmental	ADJ
fnp-5347	298	33	neoplasm	neoplasm	NOUN
fnp-5347	298	34	as	as	ADP
fnp-5347	298	35	major	major	ADJ
fnp-5347	298	36	disease	disease	NOUN
fnp-5347	298	37	categories	category	NOUN
fnp-5347	298	38	.	.	PUNCT
fnp-5347	299	1	last	last	ADJ
fnp-5347	299	2	but	but	CCONJ
fnp-5347	299	3	not	not	PART
fnp-5347	299	4	least	least	ADJ
fnp-5347	299	5	,	,	PUNCT
fnp-5347	299	6	anti	anti	ADJ
fnp-5347	299	7	-	-	ADJ
fnp-5347	299	8	seizure	seizure	ADJ
fnp-5347	299	9	medication	medication	NOUN
fnp-5347	299	10	can	can	AUX
fnp-5347	299	11	also	also	ADV
fnp-5347	299	12	have	have	VERB
fnp-5347	299	13	adverse	adverse	ADJ
fnp-5347	299	14	effects	effect	NOUN
fnp-5347	299	15	on	on	ADP
fnp-5347	299	16	cognition	cognition	NOUN
fnp-5347	299	17	.	.	PUNCT
fnp-5347	300	1	these	these	DET
fnp-5347	300	2	authors	author	NOUN
fnp-5347	300	3	concluded	conclude	VERB
fnp-5347	300	4	that	that	SCONJ
fnp-5347	300	5	the	the	DET
fnp-5347	300	6	neuropsychology	neuropsychology	NOUN
fnp-5347	300	7	and	and	CCONJ
fnp-5347	300	8	neuropathology	neuropathology	NOUN
fnp-5347	300	9	of	of	ADP
fnp-5347	300	10	mtle	mtle	NOUN
fnp-5347	300	11	is	be	AUX
fnp-5347	300	12	actually	actually	ADV
fnp-5347	300	13	more	more	ADV
fnp-5347	300	14	complex	complex	ADJ
fnp-5347	300	15	than	than	SCONJ
fnp-5347	300	16	recently	recently	ADV
fnp-5347	300	17	postulated	postulate	VERB
fnp-5347	300	18	[	[	X
fnp-5347	300	19	49	49	NUM
fnp-5347	300	20	]	]	PUNCT
fnp-5347	300	21	.	.	PUNCT
fnp-5347	301	1	the	the	DET
fnp-5347	301	2	suggested	suggest	VERB
fnp-5347	301	3	model	model	NOUN
fnp-5347	301	4	that	that	SCONJ
fnp-5347	301	5	ad	ad	NOUN
fnp-5347	301	6	-	-	PUNCT
fnp-5347	301	7	tle	tle	NOUN
fnp-5347	301	8	represent	represent	VERB
fnp-5347	301	9	a	a	DET
fnp-5347	301	10	specific	specific	ADJ
fnp-5347	301	11	disease	disease	NOUN
fnp-5347	301	12	subtype	subtype	NOUN
fnp-5347	301	13	needs	need	VERB
fnp-5347	301	14	further	further	ADJ
fnp-5347	301	15	validation	validation	NOUN
fnp-5347	301	16	to	to	PART
fnp-5347	301	17	confirm	confirm	VERB
fnp-5347	301	18	the	the	DET
fnp-5347	301	19	role	role	NOUN
fnp-5347	301	20	of	of	ADP
fnp-5347	301	21	hyperphosphorylated	hyperphosphorylated	ADJ
fnp-5347	301	22	tau	tau	PROPN
fnp-5347	301	23	in	in	ADP
fnp-5347	301	24	epilepsy	epilepsy	NOUN
fnp-5347	301	25	patients	patient	NOUN
fnp-5347	301	26	with	with	ADP
fnp-5347	301	27	and	and	CCONJ
fnp-5347	301	28	without	without	ADP
fnp-5347	301	29	ad	ad	NOUN
fnp-5347	301	30	considering	consider	VERB
fnp-5347	301	31	age	age	NOUN
fnp-5347	301	32	and	and	CCONJ
fnp-5347	301	33	age	age	NOUN
fnp-5347	301	34	at	at	ADP
fnp-5347	301	35	epilepsy	epilepsy	NOUN
fnp-5347	301	36	onset	onset	NOUN
fnp-5347	301	37	as	as	ADP
fnp-5347	301	38	potential	potential	ADJ
fnp-5347	301	39	moderator	moderator	NOUN
fnp-5347	301	40	variables	variable	NOUN
fnp-5347	301	41	.	.	PUNCT
fnp-5347	302	1	topic	topic	NOUN
fnp-5347	302	2	8	8	NUM
fnp-5347	302	3	:	:	PUNCT
fnp-5347	302	4	'	'	PUNCT
fnp-5347	302	5	hippocampal	hippocampal	ADJ
fnp-5347	302	6	innate	innate	ADJ
fnp-5347	302	7	inflammatory	inflammatory	ADJ
fnp-5347	302	8	gliosis	gliosis	NOUN
fnp-5347	302	9	only	only	ADV
fnp-5347	302	10	'	'	PUNCT
fnp-5347	302	11	in	in	ADP
fnp-5347	302	12	pharmacoresistant	pharmacoresistant	NOUN
fnp-5347	302	13	tle	tle	NOUN
fnp-5347	302	14	hippocampal	hippocampal	ADJ
fnp-5347	302	15	sclerosis	sclerosis	NOUN
fnp-5347	302	16	(	(	PUNCT
fnp-5347	302	17	hs	hs	X
fnp-5347	302	18	)	)	PUNCT
fnp-5347	302	19	remains	remain	VERB
fnp-5347	302	20	the	the	DET
fnp-5347	302	21	most	most	ADV
fnp-5347	302	22	common	common	ADJ
fnp-5347	302	23	structural	structural	ADJ
fnp-5347	302	24	brain	brain	NOUN
fnp-5347	302	25	lesion	lesion	NOUN
fnp-5347	302	26	of	of	ADP
fnp-5347	302	27	all	all	DET
fnp-5347	302	28	focal	focal	ADJ
fnp-5347	302	29	epilepsies	epilepsy	NOUN
fnp-5347	302	30	and	and	CCONJ
fnp-5347	302	31	is	be	AUX
fnp-5347	302	32	the	the	DET
fnp-5347	302	33	hallmark	hallmark	NOUN
fnp-5347	302	34	of	of	ADP
fnp-5347	302	35	temporal	temporal	ADJ
fnp-5347	302	36	lobe	lobe	NOUN
fnp-5347	302	37	epilepsy	epilepsy	NOUN
fnp-5347	302	38	(	(	PUNCT
fnp-5347	302	39	tle	tle	ADJ
fnp-5347	302	40	)	)	PUNCT
fnp-5347	302	41	.	.	PUNCT
fnp-5347	303	1	histopathology	histopathology	NOUN
fnp-5347	303	2	patterns	pattern	NOUN
fnp-5347	303	3	vary	vary	VERB
fnp-5347	303	4	,	,	PUNCT
fnp-5347	303	5	however	however	ADV
fnp-5347	303	6	,	,	PUNCT
fnp-5347	303	7	in	in	ADP
fnp-5347	303	8	this	this	DET
fnp-5347	303	9	cohort	cohort	NOUN
fnp-5347	303	10	of	of	ADP
fnp-5347	303	11	affected	affect	VERB
fnp-5347	303	12	individuals	individual	NOUN
fnp-5347	303	13	and	and	CCONJ
fnp-5347	303	14	the	the	DET
fnp-5347	303	15	ilae	ilae	NOUN
fnp-5347	303	16	has	have	AUX
fnp-5347	303	17	developed	develop	VERB
fnp-5347	303	18	a	a	DET
fnp-5347	303	19	3	3	NUM
fnp-5347	303	20	-	-	PUNCT
fnp-5347	303	21	tiered	tiere	VERB
fnp-5347	303	22	classification	classification	NOUN
fnp-5347	303	23	scheme	scheme	NOUN
fnp-5347	303	24	based	base	VERB
fnp-5347	303	25	on	on	ADP
fnp-5347	303	26	the	the	DET
fnp-5347	303	27	pattern	pattern	NOUN
fnp-5347	303	28	of	of	ADP
fnp-5347	303	29	segmental	segmental	ADJ
fnp-5347	303	30	neuronal	neuronal	ADJ
fnp-5347	303	31	cell	cell	NOUN
fnp-5347	303	32	loss	loss	NOUN
fnp-5347	303	33	in	in	ADP
fnp-5347	303	34	the	the	DET
fnp-5347	303	35	ca	ca	NOUN
fnp-5347	303	36	regions	region	NOUN
fnp-5347	303	37	[	[	X
fnp-5347	303	38	11	11	NUM
fnp-5347	303	39	]	]	PUNCT
fnp-5347	303	40	.	.	PUNCT
fnp-5347	304	1	there	there	PRON
fnp-5347	304	2	has	have	AUX
fnp-5347	304	3	always	always	ADV
fnp-5347	304	4	been	be	AUX
fnp-5347	304	5	a	a	DET
fnp-5347	304	6	fourth	fourth	ADJ
fnp-5347	304	7	category	category	NOUN
fnp-5347	304	8	of	of	ADP
fnp-5347	304	9	'	'	PUNCT
fnp-5347	304	10	no	no	PRON
fnp-5347	304	11	-	-	PUNCT
fnp-5347	304	12	hs	hs	ADJ
fnp-5347	304	13	,	,	PUNCT
fnp-5347	304	14	gliosis	gliosis	NOUN
fnp-5347	304	15	only	only	ADV
fnp-5347	304	16	'	'	PUNCT
fnp-5347	304	17	,	,	PUNCT
fnp-5347	304	18	however	however	ADV
fnp-5347	304	19	.	.	PUNCT
fnp-5347	305	1	this	this	DET
fnp-5347	305	2	category	category	NOUN
fnp-5347	305	3	represented	represent	VERB
fnp-5347	305	4	almost	almost	ADV
fnp-5347	305	5	20	20	NUM
fnp-5347	305	6	 	 	SPACE
fnp-5347	305	7	%	%	NOUN
fnp-5347	305	8	of	of	ADP
fnp-5347	305	9	the	the	DET
fnp-5347	305	10	entire	entire	ADJ
fnp-5347	305	11	cohort	cohort	NOUN
fnp-5347	305	12	of	of	ADP
fnp-5347	305	13	tle	tle	NOUN
fnp-5347	305	14	patients	patient	NOUN
fnp-5347	305	15	with	with	ADP
fnp-5347	305	16	surgical	surgical	ADJ
fnp-5347	305	17	resection	resection	NOUN
fnp-5347	305	18	of	of	ADP
fnp-5347	305	19	the	the	DET
fnp-5347	305	20	hippocampus	hippocampus	NOUN
fnp-5347	305	21	and	and	CCONJ
fnp-5347	305	22	clinical	clinical	ADJ
fnp-5347	305	23	histories	history	NOUN
fnp-5347	305	24	were	be	AUX
fnp-5347	305	25	described	describe	VERB
fnp-5347	305	26	as	as	ADP
fnp-5347	305	27	slightly	slightly	ADV
fnp-5347	305	28	different	different	ADJ
fnp-5347	305	29	from	from	ADP
fnp-5347	305	30	the	the	DET
fnp-5347	305	31	hs	hs	PROPN
fnp-5347	305	32	cohort	cohort	PROPN
fnp-5347	305	33	,	,	PUNCT
fnp-5347	305	34	i.e.	i.e.	X
fnp-5347	305	35	later	later	ADV
fnp-5347	305	36	seizure	seizure	NOUN
fnp-5347	305	37	onset	onset	NOUN
fnp-5347	305	38	and	and	CCONJ
fnp-5347	305	39	later	later	ADV
fnp-5347	305	40	age	age	NOUN
fnp-5347	305	41	at	at	ADP
fnp-5347	305	42	surgery	surgery	NOUN
fnp-5347	305	43	,	,	PUNCT
fnp-5347	305	44	respectively	respectively	ADV
fnp-5347	305	45	.	.	PUNCT
fnp-5347	306	1	grote	grote	NOUN
fnp-5347	306	2	and	and	CCONJ
fnp-5347	306	3	coworkers	coworker	NOUN
fnp-5347	306	4	have	have	AUX
fnp-5347	306	5	addressed	address	VERB
fnp-5347	306	6	this	this	DET
fnp-5347	306	7	challenging	challenging	ADJ
fnp-5347	306	8	category	category	NOUN
fnp-5347	306	9	of	of	ADP
fnp-5347	306	10	'	'	PUNCT
fnp-5347	306	11	no	no	PRON
fnp-5347	306	12	-	-	PUNCT
fnp-5347	306	13	hs	hs	ADJ
fnp-5347	306	14	,	,	PUNCT
fnp-5347	306	15	gliosis	gliosis	NOUN
fnp-5347	306	16	only	only	ADV
fnp-5347	306	17	'	'	PUNCT
fnp-5347	306	18	with	with	ADP
fnp-5347	306	19	a	a	DET
fnp-5347	306	20	comprehensive	comprehensive	ADJ
fnp-5347	306	21	and	and	CCONJ
fnp-5347	306	22	innovative	innovative	ADJ
fnp-5347	306	23	clinico	clinico	NOUN
fnp-5347	306	24	-	-	PUNCT
fnp-5347	306	25	pathological	pathological	ADJ
fnp-5347	306	26	and	and	CCONJ
fnp-5347	306	27	molecular	molecular	ADJ
fnp-5347	306	28	study	study	NOUN
fnp-5347	306	29	design	design	NOUN
fnp-5347	306	30	[	[	X
fnp-5347	306	31	19	19	NUM
fnp-5347	306	32	]	]	PUNCT
fnp-5347	306	33	.	.	PUNCT
fnp-5347	307	1	they	they	PRON
fnp-5347	307	2	reviewed	review	VERB
fnp-5347	307	3	a	a	DET
fnp-5347	307	4	cohort	cohort	NOUN
fnp-5347	307	5	of	of	ADP
fnp-5347	307	6	627	627	NUM
fnp-5347	307	7	patients	patient	NOUN
fnp-5347	307	8	with	with	ADP
fnp-5347	307	9	drug	drug	NOUN
fnp-5347	307	10	-	-	PUNCT
fnp-5347	307	11	resistant	resistant	ADJ
fnp-5347	307	12	tle	tle	NOUN
fnp-5347	307	13	submitted	submit	VERB
fnp-5347	307	14	to	to	ADP
fnp-5347	307	15	hippocampal	hippocampal	ADJ
fnp-5347	307	16	resection	resection	NOUN
fnp-5347	307	17	.	.	PUNCT
fnp-5347	308	1	seventy	seventy	NUM
fnp-5347	308	2	samples	sample	NOUN
fnp-5347	308	3	showed	show	VERB
fnp-5347	308	4	'	'	PUNCT
fnp-5347	308	5	no	no	DET
fnp-5347	308	6	-	-	PUNCT
fnp-5347	308	7	hs	hs	ADJ
fnp-5347	308	8	,	,	PUNCT
fnp-5347	308	9	gliosis	gliosis	NOUN
fnp-5347	308	10	only	only	ADV
fnp-5347	308	11	'	'	PUNCT
fnp-5347	308	12	at	at	ADP
fnp-5347	308	13	the	the	DET
fnp-5347	308	14	histopathology	histopathology	NOUN
fnp-5347	308	15	examination	examination	NOUN
fnp-5347	308	16	(	(	PUNCT
fnp-5347	308	17	11	11	NUM
fnp-5347	308	18	 	 	SPACE
fnp-5347	308	19	%	%	NOUN
fnp-5347	308	20	)	)	PUNCT
fnp-5347	308	21	.	.	PUNCT
fnp-5347	309	1	indeed	indeed	ADV
fnp-5347	309	2	,	,	PUNCT
fnp-5347	309	3	a	a	DET
fnp-5347	309	4	careful	careful	ADJ
fnp-5347	309	5	review	review	NOUN
fnp-5347	309	6	of	of	ADP
fnp-5347	309	7	the	the	DET
fnp-5347	309	8	clinical	clinical	ADJ
fnp-5347	309	9	charts	chart	NOUN
fnp-5347	309	10	confirmed	confirm	VERB
fnp-5347	309	11	a	a	DET
fnp-5347	309	12	significantly	significantly	ADV
fnp-5347	309	13	later	later	ADJ
fnp-5347	309	14	onset	onset	NOUN
fnp-5347	309	15	of	of	ADP
fnp-5347	309	16	seizures	seizure	NOUN
fnp-5347	309	17	when	when	SCONJ
fnp-5347	309	18	compared	compare	VERB
fnp-5347	309	19	to	to	ADP
fnp-5347	309	20	hs	hs	PROPN
fnp-5347	309	21	(	(	PUNCT
fnp-5347	309	22	16.3	16.3	NUM
fnp-5347	309	23	vs.	vs.	ADP
fnp-5347	309	24	12.2	12.2	NUM
fnp-5347	309	25	years	year	NOUN
fnp-5347	309	26	,	,	PUNCT
fnp-5347	309	27	p	p	X
fnp-5347	309	28	 	 	SPACE
fnp-5347	309	29	<	<	NOUN
fnp-5347	309	30	 	 	SPACE
fnp-5347	309	31	0.005	0.005	NUM
fnp-5347	309	32	)	)	PUNCT
fnp-5347	309	33	,	,	PUNCT
fnp-5347	309	34	and	and	CCONJ
fnp-5347	309	35	a	a	DET
fnp-5347	309	36	significantly	significantly	ADV
fnp-5347	309	37	worse	bad	ADJ
fnp-5347	309	38	rate	rate	NOUN
fnp-5347	309	39	of	of	ADP
fnp-5347	309	40	seizure	seizure	NOUN
fnp-5347	309	41	freedom	freedom	NOUN
fnp-5347	309	42	after	after	ADP
fnp-5347	309	43	surgery	surgery	NOUN
fnp-5347	309	44	(	(	PUNCT
fnp-5347	309	45	43	43	NUM
fnp-5347	309	46	 	 	SPACE
fnp-5347	309	47	%	%	NOUN
fnp-5347	309	48	vs.	vs.	ADP
fnp-5347	309	49	68	68	NUM
fnp-5347	309	50	 	 	SPACE
fnp-5347	309	51	%	%	NOUN
fnp-5347	309	52	,	,	PUNCT
fnp-5347	309	53	p	p	X
fnp-5347	309	54	 	 	SPACE
fnp-5347	309	55	=	=	NOUN
fnp-5347	309	56	 	 	SPACE
fnp-5347	309	57	0.0001	0.0001	NUM
fnp-5347	309	58	)	)	PUNCT
fnp-5347	309	59	.	.	PUNCT
fnp-5347	310	1	more	more	ADV
fnp-5347	310	2	interestingly	interestingly	ADV
fnp-5347	310	3	,	,	PUNCT
fnp-5347	310	4	however	however	ADV
fnp-5347	310	5	,	,	PUNCT
fnp-5347	310	6	was	be	AUX
fnp-5347	310	7	their	their	PRON
fnp-5347	310	8	rna	rna	NOUN
fnp-5347	310	9	sequencing	sequence	VERB
fnp-5347	310	10	analysis	analysis	NOUN
fnp-5347	310	11	comparing	compare	VERB
fnp-5347	310	12	no	no	PRON
fnp-5347	310	13	-	-	PUNCT
fnp-5347	310	14	hs	hs	PROPN
fnp-5347	310	15	vs.	vs.	X
fnp-5347	310	16	hs	hs	PROPN
fnp-5347	310	17	samples	sample	NOUN
fnp-5347	310	18	,	,	PUNCT
fnp-5347	310	19	which	which	PRON
fnp-5347	310	20	revealed	reveal	VERB
fnp-5347	310	21	a	a	DET
fnp-5347	310	22	distinct	distinct	ADJ
fnp-5347	310	23	transcriptional	transcriptional	NOUN
fnp-5347	310	24	program	program	NOUN
fnp-5347	310	25	visible	visible	ADJ
fnp-5347	310	26	only	only	ADV
fnp-5347	310	27	in	in	ADP
fnp-5347	310	28	the	the	DET
fnp-5347	310	29	no	no	DET
fnp-5347	310	30	-	-	PUNCT
fnp-5347	310	31	hs	hs	PROPN
fnp-5347	310	32	group	group	NOUN
fnp-5347	310	33	and	and	CCONJ
fnp-5347	310	34	which	which	PRON
fnp-5347	310	35	suggested	suggest	VERB
fnp-5347	310	36	an	an	DET
fnp-5347	310	37	innate	innate	ADJ
fnp-5347	310	38	inflammatory	inflammatory	ADJ
fnp-5347	310	39	response	response	NOUN
fnp-5347	310	40	of	of	ADP
fnp-5347	310	41	reactive	reactive	ADJ
fnp-5347	310	42	astrocytes	astrocyte	NOUN
fnp-5347	310	43	.	.	PUNCT
fnp-5347	311	1	notwithstanding	notwithstanding	ADP
fnp-5347	311	2	,	,	PUNCT
fnp-5347	311	3	reactive	reactive	ADJ
fnp-5347	311	4	astrocytes	astrocyte	NOUN
fnp-5347	311	5	are	be	AUX
fnp-5347	311	6	the	the	DET
fnp-5347	311	7	cellular	cellular	ADJ
fnp-5347	311	8	correlate	correlate	NOUN
fnp-5347	311	9	of	of	ADP
fnp-5347	311	10	'	'	PUNCT
fnp-5347	311	11	gliosis	gliosis	NOUN
fnp-5347	311	12	only	only	ADV
fnp-5347	311	13	'	'	PUNCT
fnp-5347	311	14	,	,	PUNCT
fnp-5347	311	15	histopathologically	histopathologically	ADV
fnp-5347	311	16	characterized	characterize	VERB
fnp-5347	311	17	by	by	ADP
fnp-5347	311	18	a	a	DET
fnp-5347	311	19	diffuse	diffuse	ADJ
fnp-5347	311	20	astrogliosis	astrogliosis	NOUN
fnp-5347	311	21	pattern	pattern	NOUN
fnp-5347	311	22	lacking	lack	VERB
fnp-5347	311	23	restricted	restrict	VERB
fnp-5347	311	24	segmental	segmental	ADJ
fnp-5347	311	25	focality	focality	NOUN
fnp-5347	311	26	and	and	CCONJ
fnp-5347	311	27	which	which	PRON
fnp-5347	311	28	is	be	AUX
fnp-5347	311	29	,	,	PUNCT
fnp-5347	311	30	therefore	therefore	ADV
fnp-5347	311	31	,	,	PUNCT
fnp-5347	311	32	poorly	poorly	ADV
fnp-5347	311	33	controllable	controllable	ADJ
fnp-5347	311	34	by	by	ADP
fnp-5347	311	35	surgery	surgery	NOUN
fnp-5347	311	36	.	.	PUNCT
fnp-5347	312	1	poorer	poor	ADJ
fnp-5347	312	2	postsurgical	postsurgical	ADJ
fnp-5347	312	3	outcome	outcome	NOUN
fnp-5347	312	4	in	in	ADP
fnp-5347	312	5	this	this	DET
fnp-5347	312	6	cohort	cohort	NOUN
fnp-5347	312	7	should	should	AUX
fnp-5347	312	8	alert	alert	VERB
fnp-5347	312	9	any	any	DET
fnp-5347	312	10	physician	physician	NOUN
fnp-5347	312	11	,	,	PUNCT
fnp-5347	312	12	therefore	therefore	ADV
fnp-5347	312	13	,	,	PUNCT
fnp-5347	312	14	when	when	SCONJ
fnp-5347	312	15	red	red	ADJ
fnp-5347	312	16	flags	flag	NOUN
fnp-5347	312	17	occur	occur	VERB
fnp-5347	312	18	during	during	ADP
fnp-5347	312	19	the	the	DET
fnp-5347	312	20	presurgical	presurgical	ADJ
fnp-5347	312	21	evaluation	evaluation	NOUN
fnp-5347	312	22	,	,	PUNCT
fnp-5347	312	23	e.g.	e.g.	ADV
fnp-5347	312	24	,	,	PUNCT
fnp-5347	312	25	clinical	clinical	ADJ
fnp-5347	312	26	and	and	CCONJ
fnp-5347	312	27	demographic	demographic	ADJ
fnp-5347	312	28	features	feature	NOUN
fnp-5347	312	29	such	such	ADJ
fnp-5347	312	30	as	as	ADP
fnp-5347	312	31	later	later	ADJ
fnp-5347	312	32	disease	disease	NOUN
fnp-5347	312	33	onset	onset	VERB
fnp-5347	312	34	,	,	PUNCT
fnp-5347	312	35	negative	negative	ADJ
fnp-5347	312	36	mri	mri	NOUN
fnp-5347	312	37	findings	finding	NOUN
fnp-5347	312	38	or	or	CCONJ
fnp-5347	312	39	bilateral	bilateral	ADJ
fnp-5347	312	40	epileptogenicity	epileptogenicity	NOUN
fnp-5347	312	41	patterns	pattern	NOUN
fnp-5347	312	42	(	(	PUNCT
fnp-5347	312	43	figure	figure	NOUN
fnp-5347	312	44	7	7	NUM
fnp-5347	312	45	)	)	PUNCT
fnp-5347	312	46	.	.	PUNCT
fnp-5347	313	1	a	a	DET
fnp-5347	313	2	more	more	ADV
fnp-5347	313	3	adequate	adequate	ADJ
fnp-5347	313	4	treatment	treatment	NOUN
fnp-5347	313	5	algorithm	algorithm	NOUN
fnp-5347	313	6	should	should	AUX
fnp-5347	313	7	rather	rather	ADV
fnp-5347	313	8	address	address	VERB
fnp-5347	313	9	the	the	DET
fnp-5347	313	10	innate	innate	ADJ
fnp-5347	313	11	inflammatory	inflammatory	ADJ
fnp-5347	313	12	tissue	tissue	NOUN
fnp-5347	313	13	response	response	NOUN
fnp-5347	313	14	,	,	PUNCT
fnp-5347	313	15	but	but	CCONJ
fnp-5347	313	16	these	these	PRON
fnp-5347	313	17	may	may	AUX
fnp-5347	313	18	not	not	PART
fnp-5347	313	19	be	be	AUX
fnp-5347	313	20	readily	readily	ADV
fnp-5347	313	21	available	available	ADJ
fnp-5347	313	22	yet	yet	ADV
fnp-5347	313	23	.	.	PUNCT
fnp-5347	314	1	however	however	ADV
fnp-5347	314	2	,	,	PUNCT
fnp-5347	314	3	the	the	DET
fnp-5347	314	4	same	same	ADJ
fnp-5347	314	5	group	group	NOUN
fnp-5347	314	6	has	have	AUX
fnp-5347	314	7	published	publish	VERB
fnp-5347	314	8	their	their	PRON
fnp-5347	314	9	results	result	NOUN
fnp-5347	314	10	of	of	ADP
fnp-5347	314	11	fingolimod	fingolimod	ADJ
fnp-5347	314	12	treatment	treatment	NOUN
fnp-5347	314	13	in	in	ADP
fnp-5347	314	14	an	an	DET
fnp-5347	314	15	experimental	experimental	ADJ
fnp-5347	314	16	tle	tle	NOUN
fnp-5347	314	17	model	model	NOUN
fnp-5347	314	18	targeting	target	VERB
fnp-5347	314	19	the	the	DET
fnp-5347	314	20	innate	innate	ADJ
fnp-5347	314	21	inflammatory	inflammatory	ADJ
fnp-5347	314	22	gliosis	gliosis	NOUN
fnp-5347	314	23	in	in	ADP
fnp-5347	314	24	2019	2019	NUM
fnp-5347	314	25	[	[	SYM
fnp-5347	314	26	34	34	NUM
fnp-5347	314	27	]	]	PUNCT
fnp-5347	314	28	.	.	PUNCT
fnp-5347	315	1	fingolimod	fingolimod	PROPN
fnp-5347	315	2	targets	target	NOUN
fnp-5347	315	3	sphingosine	sphingosine	NOUN
fnp-5347	315	4	-	-	PUNCT
fnp-5347	315	5	phosphate	phosphate	NOUN
fnp-5347	315	6	receptors	receptor	NOUN
fnp-5347	315	7	(	(	PUNCT
fnp-5347	315	8	s1prs	s1prs	NUM
fnp-5347	315	9	)	)	PUNCT
fnp-5347	315	10	and	and	CCONJ
fnp-5347	315	11	revealed	reveal	VERB
fnp-5347	315	12	robust	robust	ADJ
fnp-5347	315	13	anti	anti	ADJ
fnp-5347	315	14	-	-	ADJ
fnp-5347	315	15	convulsive	convulsive	ADJ
fnp-5347	315	16	activity	activity	NOUN
fnp-5347	315	17	in	in	ADP
fnp-5347	315	18	kainate	kainate	NOUN
fnp-5347	315	19	-	-	PUNCT
fnp-5347	315	20	induced	induce	VERB
fnp-5347	315	21	se	se	ADJ
fnp-5347	315	22	mice	mouse	NOUN
fnp-5347	315	23	.	.	PUNCT
fnp-5347	316	1	in	in	ADP
fnp-5347	316	2	addition	addition	NOUN
fnp-5347	316	3	,	,	PUNCT
fnp-5347	316	4	it	it	PRON
fnp-5347	316	5	had	have	VERB
fnp-5347	316	6	neuroprotective	neuroprotective	ADJ
fnp-5347	316	7	and	and	CCONJ
fnp-5347	316	8	anti	anti	ADJ
fnp-5347	316	9	-	-	ADJ
fnp-5347	316	10	gliotic	gliotic	ADJ
fnp-5347	316	11	effects	effect	NOUN
fnp-5347	316	12	and	and	CCONJ
fnp-5347	316	13	reduced	reduce	VERB
fnp-5347	316	14	cytotoxic	cytotoxic	ADJ
fnp-5347	316	15	t	t	NOUN
fnp-5347	316	16	cell	cell	NOUN
fnp-5347	316	17	infiltrates	infiltrate	NOUN
fnp-5347	316	18	suggesting	suggest	VERB
fnp-5347	316	19	repurposing	repurpose	VERB
fnp-5347	316	20	of	of	ADP
fnp-5347	316	21	fingolimod	fingolimod	NOUN
fnp-5347	316	22	(	(	PUNCT
fnp-5347	316	23	previously	previously	ADV
fnp-5347	316	24	known	know	VERB
fnp-5347	316	25	as	as	ADP
fnp-5347	316	26	suitable	suitable	ADJ
fnp-5347	316	27	drug	drug	NOUN
fnp-5347	316	28	in	in	ADP
fnp-5347	316	29	multiple	multiple	ADJ
fnp-5347	316	30	sclerosis	sclerosis	NOUN
fnp-5347	316	31	treatment	treatment	NOUN
fnp-5347	316	32	)	)	PUNCT
fnp-5347	316	33	as	as	ADP
fnp-5347	316	34	novel	novel	ADJ
fnp-5347	316	35	therapeutic	therapeutic	ADJ
fnp-5347	316	36	option	option	NOUN
fnp-5347	316	37	in	in	ADP
fnp-5347	316	38	focal	focal	ADJ
fnp-5347	316	39	epilepsies	epilepsy	NOUN
fnp-5347	316	40	.	.	PUNCT
fnp-5347	317	1	it	it	PRON
fnp-5347	317	2	is	be	AUX
fnp-5347	317	3	hoped	hope	VERB
fnp-5347	317	4	,	,	PUNCT
fnp-5347	317	5	therefore	therefore	ADV
fnp-5347	317	6	,	,	PUNCT
fnp-5347	317	7	that	that	SCONJ
fnp-5347	317	8	patients	patient	NOUN
fnp-5347	317	9	with	with	ADP
fnp-5347	317	10	no	no	PRON
fnp-5347	317	11	-	-	PUNCT
fnp-5347	317	12	hs	hs	PROPN
fnp-5347	317	13	can	can	AUX
fnp-5347	317	14	be	be	AUX
fnp-5347	317	15	identified	identify	VERB
fnp-5347	317	16	early	early	ADV
fnp-5347	317	17	on	on	ADV
fnp-5347	317	18	during	during	ADP
fnp-5347	317	19	the	the	DET
fnp-5347	317	20	presurgical	presurgical	ADJ
fnp-5347	317	21	evaluation	evaluation	NOUN
fnp-5347	317	22	phase	phase	NOUN
fnp-5347	317	23	to	to	PART
fnp-5347	317	24	carefully	carefully	ADV
fnp-5347	317	25	consider	consider	VERB
fnp-5347	317	26	all	all	DET
fnp-5347	317	27	therapeutic	therapeutic	ADJ
fnp-5347	317	28	options	option	NOUN
fnp-5347	317	29	.	.	PUNCT
fnp-5347	318	1	figure	figure	VERB
fnp-5347	318	2	7	7	NUM
fnp-5347	318	3	:	:	PUNCT
fnp-5347	318	4	graphical	graphical	ADJ
fnp-5347	318	5	summary	summary	NOUN
fnp-5347	318	6	of	of	ADP
fnp-5347	318	7	the	the	DET
fnp-5347	318	8	differences	difference	NOUN
fnp-5347	318	9	between	between	ADP
fnp-5347	318	10	hippocampal	hippocampal	ADJ
fnp-5347	318	11	sclerosis	sclerosis	NOUN
fnp-5347	318	12	and	and	CCONJ
fnp-5347	318	13	innate	innate	VERB
fnp-5347	318	14	inflammatory	inflammatory	ADJ
fnp-5347	318	15	'	'	PUNCT
fnp-5347	318	16	gliosis	gliosis	NOUN
fnp-5347	318	17	only	only	ADV
fnp-5347	318	18	'	'	PUNCT
fnp-5347	318	19	(	(	PUNCT
fnp-5347	318	20	i²go	i²go	NOUN
fnp-5347	318	21	)	)	PUNCT
fnp-5347	318	22	figure	figure	NOUN
fnp-5347	318	23	7	7	NUM
fnp-5347	318	24	.	.	PUNCT
fnp-5347	319	1	the	the	DET
fnp-5347	319	2	authors	author	NOUN
fnp-5347	319	3	claim	claim	VERB
fnp-5347	319	4	that	that	SCONJ
fnp-5347	319	5	i²go	i²go	NOUN
fnp-5347	319	6	constitutes	constitute	VERB
fnp-5347	319	7	a	a	DET
fnp-5347	319	8	distinct	distinct	ADJ
fnp-5347	319	9	mtle	mtle	NOUN
fnp-5347	319	10	syndrome	syndrome	NOUN
fnp-5347	319	11	with	with	ADP
fnp-5347	319	12	characteristic	characteristic	ADJ
fnp-5347	319	13	clinical	clinical	ADJ
fnp-5347	319	14	and	and	CCONJ
fnp-5347	319	15	pathological	pathological	ADJ
fnp-5347	319	16	features	feature	NOUN
fnp-5347	319	17	.	.	PUNCT
fnp-5347	320	1	i²go	i²go	X
fnp-5347	320	2	is	be	AUX
fnp-5347	320	3	less	less	ADV
fnp-5347	320	4	amenable	amenable	ADJ
fnp-5347	320	5	by	by	ADP
fnp-5347	320	6	surgery	surgery	NOUN
fnp-5347	320	7	and	and	CCONJ
fnp-5347	320	8	bears	bear	VERB
fnp-5347	320	9	a	a	DET
fnp-5347	320	10	greater	great	ADJ
fnp-5347	320	11	hazard	hazard	NOUN
fnp-5347	320	12	for	for	ADP
fnp-5347	320	13	postoperative	postoperative	ADJ
fnp-5347	320	14	neuropsychological	neuropsychological	ADJ
fnp-5347	320	15	deterioration	deterioration	NOUN
fnp-5347	320	16	.	.	PUNCT
fnp-5347	321	1	'	'	PUNCT
fnp-5347	321	2	gliosis	gliosis	NOUN
fnp-5347	321	3	only	only	ADV
fnp-5347	321	4	'	'	PUNCT
fnp-5347	321	5	is	be	AUX
fnp-5347	321	6	the	the	DET
fnp-5347	321	7	neuropathological	neuropathological	ADJ
fnp-5347	321	8	hallmark	hallmark	NOUN
fnp-5347	321	9	of	of	ADP
fnp-5347	321	10	i²go	i²go	PUNCT
fnp-5347	321	11	and	and	CCONJ
fnp-5347	321	12	shows	show	VERB
fnp-5347	321	13	a	a	DET
fnp-5347	321	14	unique	unique	ADJ
fnp-5347	321	15	transcriptional	transcriptional	NOUN
fnp-5347	321	16	signature	signature	NOUN
fnp-5347	321	17	marked	mark	VERB
fnp-5347	321	18	by	by	ADP
fnp-5347	321	19	an	an	DET
fnp-5347	321	20	astrocyte	astrocyte	NOUN
fnp-5347	321	21	-	-	PUNCT
fnp-5347	321	22	mediated	mediate	VERB
fnp-5347	321	23	chronic	chronic	ADJ
fnp-5347	321	24	inflammation	inflammation	NOUN
fnp-5347	321	25	pattern	pattern	NOUN
fnp-5347	321	26	.	.	PUNCT
fnp-5347	322	1	figure	figure	NOUN
fnp-5347	322	2	collected	collect	VERB
fnp-5347	322	3	from	from	ADP
fnp-5347	322	4	open	open	ADJ
fnp-5347	322	5	-	-	PUNCT
fnp-5347	322	6	access	access	NOUN
fnp-5347	322	7	paper	paper	NOUN
fnp-5347	322	8	published	publish	VERB
fnp-5347	322	9	under	under	ADP
fnp-5347	322	10	a	a	DET
fnp-5347	322	11	creative	creative	ADJ
fnp-5347	322	12	commons	common	NOUN
fnp-5347	322	13	license	license	NOUN
fnp-5347	322	14	,	,	PUNCT
fnp-5347	322	15	with	with	ADP
fnp-5347	322	16	permission	permission	NOUN
fnp-5347	322	17	from	from	ADP
fnp-5347	322	18	the	the	DET
fnp-5347	322	19	authors	author	NOUN
fnp-5347	322	20	.	.	PUNCT
fnp-5347	323	1	topic	topic	NOUN
fnp-5347	323	2	9	9	NUM
fnp-5347	323	3	:	:	PUNCT
fnp-5347	323	4	altered	alter	VERB
fnp-5347	323	5	adult	adult	NOUN
fnp-5347	323	6	neurogenesis	neurogenesis	NOUN
fnp-5347	323	7	and	and	CCONJ
fnp-5347	323	8	gliogenesis	gliogenesis	NOUN
fnp-5347	323	9	in	in	ADP
fnp-5347	323	10	patients	patient	NOUN
fnp-5347	323	11	with	with	ADP
fnp-5347	323	12	mesial	mesial	ADJ
fnp-5347	323	13	tle	tle	NOUN
fnp-5347	323	14	the	the	DET
fnp-5347	323	15	impact	impact	NOUN
fnp-5347	323	16	of	of	ADP
fnp-5347	323	17	gliogenesis	gliogenesis	NOUN
fnp-5347	323	18	and	and	CCONJ
fnp-5347	323	19	reactive	reactive	ADJ
fnp-5347	323	20	gliosis	gliosis	NOUN
fnp-5347	323	21	in	in	ADP
fnp-5347	323	22	epileptogenic	epileptogenic	ADJ
fnp-5347	323	23	human	human	ADJ
fnp-5347	323	24	tissue	tissue	NOUN
fnp-5347	323	25	has	have	AUX
fnp-5347	323	26	also	also	ADV
fnp-5347	323	27	been	be	AUX
fnp-5347	323	28	addressed	address	VERB
fnp-5347	323	29	in	in	ADP
fnp-5347	323	30	a	a	DET
fnp-5347	323	31	seminal	seminal	ADJ
fnp-5347	323	32	paper	paper	NOUN
fnp-5347	323	33	published	publish	VERB
fnp-5347	323	34	by	by	ADP
fnp-5347	323	35	ammothumkandy	ammothumkandy	NOUN
fnp-5347	323	36	and	and	CCONJ
fnp-5347	323	37	coworkers	coworker	NOUN
fnp-5347	323	38	[	[	X
fnp-5347	323	39	2	2	NUM
fnp-5347	323	40	]	]	PUNCT
fnp-5347	323	41	.	.	PUNCT
fnp-5347	324	1	they	they	PRON
fnp-5347	324	2	used	use	VERB
fnp-5347	324	3	immunofluorescence	immunofluorescence	NOUN
fnp-5347	324	4	microscopy	microscopy	NOUN
fnp-5347	324	5	in	in	ADP
fnp-5347	324	6	human	human	ADJ
fnp-5347	324	7	surgical	surgical	ADJ
fnp-5347	324	8	hippocampus	hippocampus	NOUN
fnp-5347	324	9	obtained	obtain	VERB
fnp-5347	324	10	from	from	ADP
fnp-5347	324	11	19	19	NUM
fnp-5347	324	12	mtle	mtle	NOUN
fnp-5347	324	13	patients	patient	NOUN
fnp-5347	324	14	,	,	PUNCT
fnp-5347	324	15	performed	perform	VERB
fnp-5347	324	16	neuronal	neuronal	ADJ
fnp-5347	324	17	stem	stem	NOUN
fnp-5347	324	18	-	-	PUNCT
fnp-5347	324	19	cell	cell	NOUN
fnp-5347	324	20	cultures	culture	NOUN
fnp-5347	324	21	and	and	CCONJ
fnp-5347	324	22	multi	multi	ADJ
fnp-5347	324	23	-	-	ADJ
fnp-5347	324	24	electrode	electrode	ADJ
fnp-5347	324	25	array	array	NOUN
fnp-5347	324	26	recordings	recording	NOUN
fnp-5347	324	27	of	of	ADP
fnp-5347	324	28	ex	ex	PRON
fnp-5347	324	29	vivo	vivo	NOUN
fnp-5347	324	30	hippocampal	hippocampal	ADJ
fnp-5347	324	31	slices	slice	NOUN
fnp-5347	324	32	to	to	PART
fnp-5347	324	33	address	address	VERB
fnp-5347	324	34	the	the	DET
fnp-5347	324	35	hitherto	hitherto	NOUN
fnp-5347	324	36	open	open	ADJ
fnp-5347	324	37	question	question	NOUN
fnp-5347	324	38	if	if	SCONJ
fnp-5347	324	39	and	and	CCONJ
fnp-5347	324	40	how	how	SCONJ
fnp-5347	324	41	aberrant	aberrant	ADJ
fnp-5347	324	42	neurogenesis	neurogenesis	NOUN
fnp-5347	324	43	and	and	CCONJ
fnp-5347	324	44	gliogenesis	gliogenesis	NOUN
fnp-5347	324	45	play	play	VERB
fnp-5347	324	46	a	a	DET
fnp-5347	324	47	role	role	NOUN
fnp-5347	324	48	in	in	ADP
fnp-5347	324	49	seizure	seizure	NOUN
fnp-5347	324	50	initiation	initiation	NOUN
fnp-5347	324	51	and	and	CCONJ
fnp-5347	324	52	progression	progression	NOUN
fnp-5347	324	53	.	.	PUNCT
fnp-5347	325	1	this	this	PRON
fnp-5347	325	2	has	have	AUX
fnp-5347	325	3	been	be	AUX
fnp-5347	325	4	repetitively	repetitively	ADV
fnp-5347	325	5	reported	report	VERB
fnp-5347	325	6	in	in	ADP
fnp-5347	325	7	rodent	rodent	ADJ
fnp-5347	325	8	animal	animal	NOUN
fnp-5347	325	9	models	model	NOUN
fnp-5347	325	10	but	but	CCONJ
fnp-5347	325	11	needs	need	VERB
fnp-5347	325	12	further	further	ADJ
fnp-5347	325	13	confirmation	confirmation	NOUN
fnp-5347	325	14	in	in	ADP
fnp-5347	325	15	the	the	DET
fnp-5347	325	16	human	human	ADJ
fnp-5347	325	17	disease	disease	NOUN
fnp-5347	325	18	condition	condition	NOUN
fnp-5347	325	19	.	.	PUNCT
fnp-5347	326	1	as	as	SCONJ
fnp-5347	326	2	reported	report	VERB
fnp-5347	326	3	in	in	ADP
fnp-5347	326	4	previous	previous	ADJ
fnp-5347	326	5	studies	study	NOUN
fnp-5347	326	6	(	(	PUNCT
fnp-5347	326	7	see	see	VERB
fnp-5347	326	8	below	below	ADV
fnp-5347	326	9	)	)	PUNCT
fnp-5347	326	10	,	,	PUNCT
fnp-5347	326	11	the	the	DET
fnp-5347	326	12	authors	author	NOUN
fnp-5347	326	13	confirmed	confirm	VERB
fnp-5347	326	14	a	a	DET
fnp-5347	326	15	decline	decline	NOUN
fnp-5347	326	16	of	of	ADP
fnp-5347	326	17	neurogenesis	neurogenesis	NOUN
fnp-5347	326	18	in	in	ADP
fnp-5347	326	19	tle	tle	NOUN
fnp-5347	326	20	patients	patient	NOUN
fnp-5347	326	21	when	when	SCONJ
fnp-5347	326	22	their	their	PRON
fnp-5347	326	23	disease	disease	NOUN
fnp-5347	326	24	had	have	VERB
fnp-5347	326	25	a	a	DET
fnp-5347	326	26	longer	long	ADJ
fnp-5347	326	27	duration	duration	NOUN
fnp-5347	326	28	.	.	PUNCT
fnp-5347	327	1	these	these	DET
fnp-5347	327	2	data	datum	NOUN
fnp-5347	327	3	were	be	AUX
fnp-5347	327	4	obtained	obtain	VERB
fnp-5347	327	5	from	from	ADP
fnp-5347	327	6	fixed	fix	VERB
fnp-5347	327	7	tissue	tissue	NOUN
fnp-5347	327	8	specimens	specimen	NOUN
fnp-5347	327	9	as	as	ADV
fnp-5347	327	10	well	well	ADV
fnp-5347	327	11	as	as	ADP
fnp-5347	327	12	in	in	ADP
fnp-5347	327	13	vitro	vitro	X
fnp-5347	327	14	from	from	ADP
fnp-5347	327	15	neural	neural	ADJ
fnp-5347	327	16	stem	stem	NOUN
fnp-5347	327	17	cell	cell	NOUN
fnp-5347	327	18	cultures	culture	NOUN
fnp-5347	327	19	.	.	PUNCT
fnp-5347	328	1	colocalization	colocalization	NOUN
fnp-5347	328	2	of	of	ADP
fnp-5347	328	3	dcx+	dcx+	PROPN
fnp-5347	328	4	and	and	CCONJ
fnp-5347	328	5	prox1	prox1	NOUN
fnp-5347	328	6	+	+	CCONJ
fnp-5347	328	7	immunoreactivity	immunoreactivity	NOUN
fnp-5347	328	8	was	be	AUX
fnp-5347	328	9	used	use	VERB
fnp-5347	328	10	to	to	PART
fnp-5347	328	11	recognize	recognize	VERB
fnp-5347	328	12	immature	immature	ADJ
fnp-5347	328	13	dentate	dentate	ADJ
fnp-5347	328	14	granule	granule	NOUN
fnp-5347	328	15	cells	cell	NOUN
fnp-5347	328	16	and	and	CCONJ
fnp-5347	328	17	by	by	ADP
fnp-5347	328	18	comparing	compare	VERB
fnp-5347	328	19	biopsy	biopsy	ADJ
fnp-5347	328	20	tissue	tissue	NOUN
fnp-5347	328	21	with	with	ADP
fnp-5347	328	22	age	age	NOUN
fnp-5347	328	23	-	-	PUNCT
fnp-5347	328	24	matched	match	VERB
fnp-5347	328	25	postmortem	postmortem	NOUN
fnp-5347	328	26	controls	control	NOUN
fnp-5347	328	27	.	.	PUNCT
fnp-5347	329	1	in	in	ADP
fnp-5347	329	2	contrast	contrast	NOUN
fnp-5347	329	3	,	,	PUNCT
fnp-5347	329	4	gliogenesis	gliogenesis	PRON
fnp-5347	329	5	remained	remain	VERB
fnp-5347	329	6	persistently	persistently	ADV
fnp-5347	329	7	high	high	ADJ
fnp-5347	329	8	even	even	ADV
fnp-5347	329	9	in	in	ADP
fnp-5347	329	10	the	the	DET
fnp-5347	329	11	chronic	chronic	ADJ
fnp-5347	329	12	epileptic	epileptic	ADJ
fnp-5347	329	13	condition	condition	NOUN
fnp-5347	329	14	.	.	PUNCT
fnp-5347	330	1	immature	immature	ADJ
fnp-5347	330	2	astroglia	astroglia	PROPN
fnp-5347	330	3	were	be	AUX
fnp-5347	330	4	characterized	characterize	VERB
fnp-5347	330	5	by	by	ADP
fnp-5347	330	6	dcx+/prox1and	dcx+/prox1and	NOUN
fnp-5347	330	7	gfap+	gfap+	PROPN
fnp-5347	330	8	immunoreactivity	immunoreactivity	NOUN
fnp-5347	330	9	compared	compare	VERB
fnp-5347	330	10	to	to	ADP
fnp-5347	330	11	their	their	PRON
fnp-5347	330	12	mature	mature	ADJ
fnp-5347	330	13	counterpart	counterpart	NOUN
fnp-5347	330	14	being	be	AUX
fnp-5347	330	15	only	only	ADV
fnp-5347	330	16	gfap+	gfap+	ADV
fnp-5347	330	17	immunoreactive	immunoreactive	ADJ
fnp-5347	330	18	.	.	PUNCT
fnp-5347	331	1	400	400	NUM
fnp-5347	331	2	 	 	SPACE
fnp-5347	331	3	µm	µm	ADP
fnp-5347	331	4	thick	thick	ADJ
fnp-5347	331	5	slices	slice	NOUN
fnp-5347	331	6	of	of	ADP
fnp-5347	331	7	the	the	DET
fnp-5347	331	8	human	human	ADJ
fnp-5347	331	9	hippocampus	hippocampus	NOUN
fnp-5347	331	10	were	be	AUX
fnp-5347	331	11	then	then	ADV
fnp-5347	331	12	used	use	VERB
fnp-5347	331	13	for	for	ADP
fnp-5347	331	14	multi	multi	ADJ
fnp-5347	331	15	-	-	ADJ
fnp-5347	331	16	electrode	electrode	ADJ
fnp-5347	331	17	array	array	NOUN
fnp-5347	331	18	recordings	recording	NOUN
fnp-5347	331	19	followed	follow	VERB
fnp-5347	331	20	by	by	ADP
fnp-5347	331	21	immunofluorescence	immunofluorescence	NOUN
fnp-5347	331	22	stainings	staining	NOUN
fnp-5347	331	23	of	of	ADP
fnp-5347	331	24	the	the	DET
fnp-5347	331	25	aforementioned	aforementioned	ADJ
fnp-5347	331	26	cell	cell	NOUN
fnp-5347	331	27	marker	marker	NOUN
fnp-5347	331	28	sets	set	NOUN
fnp-5347	331	29	.	.	PUNCT
fnp-5347	332	1	based	base	VERB
fnp-5347	332	2	on	on	ADP
fnp-5347	332	3	these	these	DET
fnp-5347	332	4	findings	finding	NOUN
fnp-5347	332	5	they	they	PRON
fnp-5347	332	6	classified	classify	VERB
fnp-5347	332	7	tissue	tissue	NOUN
fnp-5347	332	8	regions	region	NOUN
fnp-5347	332	9	as	as	ADP
fnp-5347	332	10	active	active	ADJ
fnp-5347	332	11	or	or	CCONJ
fnp-5347	332	12	non	non	ADJ
fnp-5347	332	13	-	-	ADJ
fnp-5347	332	14	active	active	ADJ
fnp-5347	332	15	.	.	PUNCT
fnp-5347	333	1	neurogenesis	neurogenesis	NOUN
fnp-5347	333	2	was	be	AUX
fnp-5347	333	3	convincingly	convincingly	ADV
fnp-5347	333	4	proven	prove	VERB
fnp-5347	333	5	only	only	ADV
fnp-5347	333	6	in	in	ADP
fnp-5347	333	7	neurophysiologically	neurophysiologically	ADV
fnp-5347	333	8	non	non	ADJ
fnp-5347	333	9	-	-	ADJ
fnp-5347	333	10	active	active	ADJ
fnp-5347	333	11	tissues	tissue	NOUN
fnp-5347	333	12	but	but	CCONJ
fnp-5347	333	13	not	not	PART
fnp-5347	333	14	in	in	ADP
fnp-5347	333	15	tissue	tissue	NOUN
fnp-5347	333	16	with	with	ADP
fnp-5347	333	17	epileptiform	epileptiform	NOUN
fnp-5347	333	18	activity	activity	NOUN
fnp-5347	333	19	.	.	PUNCT
fnp-5347	334	1	they	they	PRON
fnp-5347	334	2	concluded	conclude	VERB
fnp-5347	334	3	from	from	ADP
fnp-5347	334	4	this	this	DET
fnp-5347	334	5	set	set	NOUN
fnp-5347	334	6	of	of	ADP
fnp-5347	334	7	experiments	experiment	NOUN
fnp-5347	334	8	that	that	SCONJ
fnp-5347	334	9	newborn	newborn	ADJ
fnp-5347	334	10	neurons	neuron	NOUN
fnp-5347	334	11	do	do	AUX
fnp-5347	334	12	not	not	PART
fnp-5347	334	13	contribute	contribute	VERB
fnp-5347	334	14	to	to	ADP
fnp-5347	334	15	epileptiform	epileptiform	NOUN
fnp-5347	334	16	activity	activity	NOUN
fnp-5347	334	17	at	at	ADP
fnp-5347	334	18	chronic	chronic	ADJ
fnp-5347	334	19	stages	stage	NOUN
fnp-5347	334	20	of	of	ADP
fnp-5347	334	21	mtle	mtle	NOUN
fnp-5347	334	22	,	,	PUNCT
fnp-5347	334	23	which	which	PRON
fnp-5347	334	24	was	be	AUX
fnp-5347	334	25	further	far	ADV
fnp-5347	334	26	corroborated	corroborate	VERB
fnp-5347	334	27	by	by	ADP
fnp-5347	334	28	low	low	ADJ
fnp-5347	334	29	levels	level	NOUN
fnp-5347	334	30	of	of	ADP
fnp-5347	334	31	immediate	immediate	ADJ
fnp-5347	334	32	early	early	ADJ
fnp-5347	334	33	gene	gene	NOUN
fnp-5347	334	34	expression	expression	NOUN
fnp-5347	334	35	in	in	ADP
fnp-5347	334	36	immature	immature	ADJ
fnp-5347	334	37	neurons	neuron	NOUN
fnp-5347	334	38	.	.	PUNCT
fnp-5347	335	1	this	this	DET
fnp-5347	335	2	situation	situation	NOUN
fnp-5347	335	3	was	be	AUX
fnp-5347	335	4	different	different	ADJ
fnp-5347	335	5	when	when	SCONJ
fnp-5347	335	6	looking	look	VERB
fnp-5347	335	7	at	at	ADP
fnp-5347	335	8	immature	immature	ADJ
fnp-5347	335	9	astroglia	astroglia	NOUN
fnp-5347	335	10	,	,	PUNCT
fnp-5347	335	11	which	which	PRON
fnp-5347	335	12	were	be	AUX
fnp-5347	335	13	present	present	ADJ
fnp-5347	335	14	in	in	ADP
fnp-5347	335	15	all	all	DET
fnp-5347	335	16	mtle	mtle	NOUN
fnp-5347	335	17	cases	case	NOUN
fnp-5347	335	18	,	,	PUNCT
fnp-5347	335	19	but	but	CCONJ
fnp-5347	335	20	their	their	PRON
fnp-5347	335	21	location	location	NOUN
fnp-5347	335	22	and	and	CCONJ
fnp-5347	335	23	activity	activity	NOUN
fnp-5347	335	24	was	be	AUX
fnp-5347	335	25	very	very	ADV
fnp-5347	335	26	much	much	ADV
fnp-5347	335	27	associated	associate	VERB
fnp-5347	335	28	with	with	ADP
fnp-5347	335	29	epileptiform	epileptiform	NOUN
fnp-5347	335	30	activity	activity	NOUN
fnp-5347	335	31	.	.	PUNCT
fnp-5347	336	1	specifically	specifically	ADV
fnp-5347	336	2	,	,	PUNCT
fnp-5347	336	3	their	their	PRON
fnp-5347	336	4	results	result	NOUN
fnp-5347	336	5	indicated	indicate	VERB
fnp-5347	336	6	that	that	SCONJ
fnp-5347	336	7	immature	immature	ADJ
fnp-5347	336	8	astrocytes	astrocyte	NOUN
fnp-5347	336	9	can	can	AUX
fnp-5347	336	10	migrate	migrate	VERB
fnp-5347	336	11	towards	towards	ADP
fnp-5347	336	12	neuronal	neuronal	ADJ
fnp-5347	336	13	activity	activity	NOUN
fnp-5347	336	14	,	,	PUNCT
fnp-5347	336	15	e.g.	e.g.	ADV
fnp-5347	336	16	,	,	PUNCT
fnp-5347	336	17	the	the	DET
fnp-5347	336	18	hilus	hilus	ADJ
fnp-5347	336	19	,	,	PUNCT
fnp-5347	336	20	or	or	CCONJ
fnp-5347	336	21	directly	directly	ADV
fnp-5347	336	22	contribute	contribute	VERB
fnp-5347	336	23	to	to	ADP
fnp-5347	336	24	generating	generate	VERB
fnp-5347	336	25	seizures	seizure	NOUN
fnp-5347	336	26	.	.	PUNCT
fnp-5347	337	1	their	their	PRON
fnp-5347	337	2	results	result	NOUN
fnp-5347	337	3	suggest	suggest	VERB
fnp-5347	337	4	an	an	DET
fnp-5347	337	5	intriguing	intriguing	ADJ
fnp-5347	337	6	hypothesis	hypothesis	NOUN
fnp-5347	337	7	that	that	PRON
fnp-5347	337	8	immature	immature	ADJ
fnp-5347	337	9	astroglia	astroglia	NOUN
fnp-5347	337	10	play	play	VERB
fnp-5347	337	11	a	a	DET
fnp-5347	337	12	role	role	NOUN
fnp-5347	337	13	as	as	ADP
fnp-5347	337	14	'	'	PUNCT
fnp-5347	337	15	lossy	lossy	ADJ
fnp-5347	337	16	capacitor	capacitor	NOUN
fnp-5347	337	17	'	'	PUNCT
fnp-5347	337	18	in	in	ADP
fnp-5347	337	19	initiating	initiate	VERB
fnp-5347	337	20	coordinated	coordinated	ADJ
fnp-5347	337	21	epileptiform	epileptiform	NOUN
fnp-5347	337	22	activity	activity	NOUN
fnp-5347	337	23	.	.	PUNCT
fnp-5347	338	1	astrocytes	astrocyte	NOUN
fnp-5347	338	2	would	would	AUX
fnp-5347	338	3	usually	usually	ADV
fnp-5347	338	4	prevent	prevent	VERB
fnp-5347	338	5	excessive	excessive	ADJ
fnp-5347	338	6	neurotransmission	neurotransmission	NOUN
fnp-5347	338	7	and	and	CCONJ
fnp-5347	338	8	limit	limit	VERB
fnp-5347	338	9	neuronal	neuronal	ADJ
fnp-5347	338	10	hyperactivity	hyperactivity	NOUN
fnp-5347	338	11	by	by	ADP
fnp-5347	338	12	soaking	soak	VERB
fnp-5347	338	13	calcium	calcium	NOUN
fnp-5347	338	14	intracellularly	intracellularly	ADV
fnp-5347	338	15	and	and	CCONJ
fnp-5347	338	16	then	then	ADV
fnp-5347	338	17	activate	activate	VERB
fnp-5347	338	18	inhibitory	inhibitory	ADJ
fnp-5347	338	19	gabaergic	gabaergic	ADJ
fnp-5347	338	20	interneurons	interneuron	NOUN
fnp-5347	338	21	[	[	X
fnp-5347	338	22	15	15	NUM
fnp-5347	338	23	,	,	PUNCT
fnp-5347	338	24	32	32	NUM
fnp-5347	338	25	]	]	PUNCT
fnp-5347	338	26	.	.	PUNCT
fnp-5347	339	1	once	once	ADV
fnp-5347	339	2	immature	immature	ADJ
fnp-5347	339	3	astroglia	astroglia	NOUN
fnp-5347	339	4	are	be	AUX
fnp-5347	339	5	unable	unable	ADJ
fnp-5347	339	6	to	to	PART
fnp-5347	339	7	maintain	maintain	VERB
fnp-5347	339	8	extracellular	extracellular	ADJ
fnp-5347	339	9	ionic	ionic	ADJ
fnp-5347	339	10	homeostasis	homeostasis	NOUN
fnp-5347	339	11	,	,	PUNCT
fnp-5347	339	12	functional	functional	ADJ
fnp-5347	339	13	alterations	alteration	NOUN
fnp-5347	339	14	in	in	ADP
fnp-5347	339	15	their	their	PRON
fnp-5347	339	16	activity	activity	NOUN
fnp-5347	339	17	lead	lead	NOUN
fnp-5347	339	18	to	to	ADP
fnp-5347	339	19	aberrant	aberrant	ADJ
fnp-5347	339	20	modulation	modulation	NOUN
fnp-5347	339	21	of	of	ADP
fnp-5347	339	22	the	the	DET
fnp-5347	339	23	network	network	NOUN
fnp-5347	339	24	.	.	PUNCT
fnp-5347	340	1	as	as	SCONJ
fnp-5347	340	2	mentioned	mention	VERB
fnp-5347	340	3	in	in	ADP
fnp-5347	340	4	the	the	DET
fnp-5347	340	5	chapter	chapter	NOUN
fnp-5347	340	6	above	above	ADV
fnp-5347	340	7	,	,	PUNCT
fnp-5347	340	8	these	these	DET
fnp-5347	340	9	results	result	NOUN
fnp-5347	340	10	offer	offer	VERB
fnp-5347	340	11	a	a	DET
fnp-5347	340	12	new	new	ADJ
fnp-5347	340	13	avenue	avenue	NOUN
fnp-5347	340	14	in	in	ADP
fnp-5347	340	15	rather	rather	ADV
fnp-5347	340	16	targeting	target	VERB
fnp-5347	340	17	reactive	reactive	ADJ
fnp-5347	340	18	astroglia	astroglia	NOUN
fnp-5347	340	19	,	,	PUNCT
fnp-5347	340	20	e.g.	e.g.	ADV
fnp-5347	340	21	,	,	PUNCT
fnp-5347	340	22	immature	immature	ADJ
fnp-5347	340	23	astroglia	astroglia	PROPN
fnp-5347	340	24	as	as	SCONJ
fnp-5347	340	25	described	describe	VERB
fnp-5347	340	26	by	by	ADP
fnp-5347	340	27	ammothumkandy	ammothumkandy	NOUN
fnp-5347	340	28	or	or	CCONJ
fnp-5347	340	29	those	those	PRON
fnp-5347	340	30	described	describe	VERB
fnp-5347	340	31	above	above	ADV
fnp-5347	340	32	as	as	ADP
fnp-5347	340	33	reactive	reactive	ADJ
fnp-5347	340	34	astroglia	astroglia	ADV
fnp-5347	340	35	with	with	ADP
fnp-5347	340	36	an	an	DET
fnp-5347	340	37	innate	innate	ADJ
fnp-5347	340	38	inflammatory	inflammatory	ADJ
fnp-5347	340	39	response	response	NOUN
fnp-5347	340	40	.	.	PUNCT
fnp-5347	341	1	it	it	PRON
fnp-5347	341	2	needs	need	VERB
fnp-5347	341	3	to	to	PART
fnp-5347	341	4	be	be	AUX
fnp-5347	341	5	shown	show	VERB
fnp-5347	341	6	,	,	PUNCT
fnp-5347	341	7	however	however	ADV
fnp-5347	341	8	,	,	PUNCT
fnp-5347	341	9	if	if	SCONJ
fnp-5347	341	10	these	these	DET
fnp-5347	341	11	astroglial	astroglial	ADJ
fnp-5347	341	12	populations	population	NOUN
fnp-5347	341	13	are	be	AUX
fnp-5347	341	14	similar	similar	ADJ
fnp-5347	341	15	to	to	ADP
fnp-5347	341	16	each	each	DET
fnp-5347	341	17	other	other	ADJ
fnp-5347	341	18	or	or	CCONJ
fnp-5347	341	19	present	present	VERB
fnp-5347	341	20	a	a	DET
fnp-5347	341	21	new	new	ADJ
fnp-5347	341	22	cell	cell	NOUN
fnp-5347	341	23	type	type	NOUN
fnp-5347	341	24	specific	specific	ADJ
fnp-5347	341	25	to	to	ADP
fnp-5347	341	26	the	the	DET
fnp-5347	341	27	disease	disease	NOUN
fnp-5347	341	28	condition	condition	NOUN
fnp-5347	341	29	.	.	PUNCT
fnp-5347	342	1	topic	topic	NOUN
fnp-5347	342	2	10	10	NUM
fnp-5347	342	3	:	:	PUNCT
fnp-5347	342	4	autoimmune	autoimmune	ADJ
fnp-5347	342	5	encephalitis	encephalitis	NOUN
fnp-5347	342	6	and	and	CCONJ
fnp-5347	342	7	norse	norse	PROPN
fnp-5347	342	8	in	in	ADP
fnp-5347	342	9	my	my	PRON
fnp-5347	342	10	final	final	ADJ
fnp-5347	342	11	chapter	chapter	NOUN
fnp-5347	342	12	,	,	PUNCT
fnp-5347	342	13	i	i	PRON
fnp-5347	342	14	would	would	AUX
fnp-5347	342	15	like	like	VERB
fnp-5347	342	16	to	to	PART
fnp-5347	342	17	highlight	highlight	VERB
fnp-5347	342	18	a	a	DET
fnp-5347	342	19	paper	paper	NOUN
fnp-5347	342	20	addressing	address	VERB
fnp-5347	342	21	the	the	DET
fnp-5347	342	22	impact	impact	NOUN
fnp-5347	342	23	of	of	ADP
fnp-5347	342	24	autoimmunity	autoimmunity	NOUN
fnp-5347	342	25	to	to	ADP
fnp-5347	342	26	the	the	DET
fnp-5347	342	27	pathogenesis	pathogenesis	NOUN
fnp-5347	342	28	of	of	ADP
fnp-5347	342	29	tle	tle	PROPN
fnp-5347	342	30	.	.	PUNCT
fnp-5347	343	1	tle	tle	PROPN
fnp-5347	343	2	is	be	AUX
fnp-5347	343	3	one	one	NUM
fnp-5347	343	4	of	of	ADP
fnp-5347	343	5	the	the	DET
fnp-5347	343	6	syndromes	syndrome	NOUN
fnp-5347	343	7	linked	link	VERB
fnp-5347	343	8	to	to	ADP
fnp-5347	343	9	autoantibodies	autoantibody	NOUN
fnp-5347	343	10	,	,	PUNCT
fnp-5347	343	11	such	such	ADJ
fnp-5347	343	12	as	as	ADP
fnp-5347	343	13	anti	anti	ADJ
fnp-5347	343	14	-	-	ADJ
fnp-5347	343	15	n	n	CCONJ
fnp-5347	343	16	-	-	PUNCT
fnp-5347	343	17	methyl	methyl	NOUN
fnp-5347	343	18	-	-	PUNCT
fnp-5347	343	19	d	d	NOUN
fnp-5347	343	20	-	-	NOUN
fnp-5347	343	21	aspartate	aspartate	NOUN
fnp-5347	343	22	(	(	PUNCT
fnp-5347	343	23	nmda	nmda	ADJ
fnp-5347	343	24	)	)	PUNCT
fnp-5347	343	25	,	,	PUNCT
fnp-5347	343	26	anti	anti	ADJ
fnp-5347	343	27	-	-	ADJ
fnp-5347	343	28	leucine	leucine	ADJ
fnp-5347	343	29	-	-	PUNCT
fnp-5347	343	30	rich	rich	ADJ
fnp-5347	343	31	glioma	glioma	NOUN
fnp-5347	343	32	-	-	PUNCT
fnp-5347	343	33	inactivated	inactivate	VERB
fnp-5347	343	34	protein	protein	NOUN
fnp-5347	343	35	1	1	NUM
fnp-5347	343	36	(	(	PUNCT
fnp-5347	343	37	gli1	gli1	NOUN
fnp-5347	343	38	)	)	PUNCT
fnp-5347	343	39	,	,	PUNCT
fnp-5347	343	40	or	or	CCONJ
fnp-5347	343	41	glutamic	glutamic	ADJ
fnp-5347	343	42	acid	acid	NOUN
fnp-5347	343	43	decarboxylase	decarboxylase	PROPN
fnp-5347	343	44	(	(	PUNCT
fnp-5347	343	45	gad	gad	PROPN
fnp-5347	343	46	)	)	PUNCT
fnp-5347	343	47	.	.	PUNCT
fnp-5347	344	1	tröscher	tröscher	PROPN
fnp-5347	344	2	and	and	CCONJ
fnp-5347	344	3	coworker	coworker	NOUN
fnp-5347	344	4	specifically	specifically	ADV
fnp-5347	344	5	addressed	address	VERB
fnp-5347	344	6	the	the	DET
fnp-5347	344	7	latter	latter	ADJ
fnp-5347	344	8	syndrome	syndrome	NOUN
fnp-5347	344	9	of	of	ADP
fnp-5347	344	10	gad	gad	PROPN
fnp-5347	344	11	-	-	PUNCT
fnp-5347	344	12	tle	tle	ADJ
fnp-5347	344	13	,	,	PUNCT
fnp-5347	344	14	in	in	ADP
fnp-5347	344	15	which	which	PRON
fnp-5347	344	16	the	the	DET
fnp-5347	344	17	immunopathogenesis	immunopathogenesis	NOUN
fnp-5347	344	18	remains	remain	VERB
fnp-5347	344	19	enigmatic	enigmatic	ADJ
fnp-5347	344	20	[	[	X
fnp-5347	344	21	41	41	NUM
fnp-5347	344	22	]	]	PUNCT
fnp-5347	344	23	.	.	PUNCT
fnp-5347	345	1	they	they	PRON
fnp-5347	345	2	reviewed	review	VERB
fnp-5347	345	3	imaging	imaging	NOUN
fnp-5347	345	4	,	,	PUNCT
fnp-5347	345	5	serum	serum	NOUN
fnp-5347	345	6	and	and	CCONJ
fnp-5347	345	7	cerebral	cerebral	ADJ
fnp-5347	345	8	spinal	spinal	ADJ
fnp-5347	345	9	fluid	fluid	NOUN
fnp-5347	345	10	analysis	analysis	NOUN
fnp-5347	345	11	and	and	CCONJ
fnp-5347	345	12	brain	brain	NOUN
fnp-5347	345	13	tissue	tissue	NOUN
fnp-5347	345	14	in	in	ADP
fnp-5347	345	15	a	a	DET
fnp-5347	345	16	consecutive	consecutive	ADJ
fnp-5347	345	17	series	series	NOUN
fnp-5347	345	18	of	of	ADP
fnp-5347	345	19	15	15	NUM
fnp-5347	345	20	patients	patient	NOUN
fnp-5347	345	21	with	with	ADP
fnp-5347	345	22	gad	gad	PROPN
fnp-5347	345	23	-	-	PUNCT
fnp-5347	345	24	tle	tle	ADJ
fnp-5347	345	25	,	,	PUNCT
fnp-5347	345	26	including	include	VERB
fnp-5347	345	27	immunohistochemistry	immunohistochemistry	NOUN
fnp-5347	345	28	,	,	PUNCT
fnp-5347	345	29	multiplex	multiplex	NOUN
fnp-5347	345	30	fluorescent	fluorescent	NOUN
fnp-5347	345	31	microscopy	microscopy	NOUN
fnp-5347	345	32	and	and	CCONJ
fnp-5347	345	33	transcriptomic	transcriptomic	ADJ
fnp-5347	345	34	analysis	analysis	NOUN
fnp-5347	345	35	for	for	ADP
fnp-5347	345	36	inflammatory	inflammatory	ADJ
fnp-5347	345	37	mediators	mediator	NOUN
fnp-5347	345	38	and	and	CCONJ
fnp-5347	345	39	neuronal	neuronal	ADJ
fnp-5347	345	40	degeneration	degeneration	NOUN
fnp-5347	345	41	.	.	PUNCT
fnp-5347	346	1	in	in	ADP
fnp-5347	346	2	nine	nine	NUM
fnp-5347	346	3	of	of	ADP
fnp-5347	346	4	their	their	PRON
fnp-5347	346	5	patients	patient	NOUN
fnp-5347	346	6	,	,	PUNCT
fnp-5347	346	7	they	they	PRON
fnp-5347	346	8	observed	observe	VERB
fnp-5347	346	9	medio	medio	ADJ
fnp-5347	346	10	-	-	ADJ
fnp-5347	346	11	temporal	temporal	ADJ
fnp-5347	346	12	swelling	swelling	NOUN
fnp-5347	346	13	and	and	CCONJ
fnp-5347	346	14	t2	t2	NOUN
fnp-5347	346	15	signal	signal	NOUN
fnp-5347	346	16	increase	increase	NOUN
fnp-5347	346	17	within	within	ADP
fnp-5347	346	18	the	the	DET
fnp-5347	346	19	first	first	ADJ
fnp-5347	346	20	6	6	NUM
fnp-5347	346	21	years	year	NOUN
fnp-5347	346	22	after	after	ADP
fnp-5347	346	23	the	the	DET
fnp-5347	346	24	onset	onset	NOUN
fnp-5347	346	25	of	of	ADP
fnp-5347	346	26	symptoms	symptom	NOUN
fnp-5347	346	27	,	,	PUNCT
fnp-5347	346	28	and	and	CCONJ
fnp-5347	346	29	all	all	DET
fnp-5347	346	30	developed	developed	ADJ
fnp-5347	346	31	unilateral	unilateral	ADJ
fnp-5347	346	32	or	or	CCONJ
fnp-5347	346	33	bilateral	bilateral	ADJ
fnp-5347	346	34	hippocampal	hippocampal	ADJ
fnp-5347	346	35	sclerosis	sclerosis	NOUN
fnp-5347	346	36	.	.	PUNCT
fnp-5347	347	1	early	early	ADJ
fnp-5347	347	2	csf	csf	ADJ
fnp-5347	347	3	analysis	analysis	NOUN
fnp-5347	347	4	<	<	X
fnp-5347	347	5	 	 	SPACE
fnp-5347	347	6	6	6	NUM
fnp-5347	347	7	years	year	NOUN
fnp-5347	347	8	after	after	SCONJ
fnp-5347	347	9	onset	onset	NOUN
fnp-5347	347	10	revealed	reveal	VERB
fnp-5347	347	11	intrathecal	intrathecal	ADJ
fnp-5347	347	12	synthesis	synthesis	NOUN
fnp-5347	347	13	of	of	ADP
fnp-5347	347	14	iggs	igg	NOUN
fnp-5347	347	15	.	.	PUNCT
fnp-5347	348	1	there	there	PRON
fnp-5347	348	2	were	be	VERB
fnp-5347	348	3	also	also	ADV
fnp-5347	348	4	high	high	ADJ
fnp-5347	348	5	numbers	number	NOUN
fnp-5347	348	6	of	of	ADP
fnp-5347	348	7	plasma	plasma	NOUN
fnp-5347	348	8	cells	cell	NOUN
fnp-5347	348	9	in	in	ADP
fnp-5347	348	10	surgical	surgical	ADJ
fnp-5347	348	11	brain	brain	NOUN
fnp-5347	348	12	tissue	tissue	NOUN
fnp-5347	348	13	but	but	CCONJ
fnp-5347	348	14	no	no	DET
fnp-5347	348	15	evidence	evidence	NOUN
fnp-5347	348	16	for	for	ADP
fnp-5347	348	17	complement	complement	NOUN
fnp-5347	348	18	-	-	PUNCT
fnp-5347	348	19	mediated	mediate	VERB
fnp-5347	348	20	tissue	tissue	NOUN
fnp-5347	348	21	damage	damage	NOUN
fnp-5347	348	22	.	.	PUNCT
fnp-5347	349	1	in	in	ADP
fnp-5347	349	2	contrast	contrast	NOUN
fnp-5347	349	3	,	,	PUNCT
fnp-5347	349	4	there	there	PRON
fnp-5347	349	5	was	be	VERB
fnp-5347	349	6	a	a	DET
fnp-5347	349	7	dense	dense	ADJ
fnp-5347	349	8	infiltration	infiltration	NOUN
fnp-5347	349	9	of	of	ADP
fnp-5347	349	10	cd8	cd8	PROPN
fnp-5347	349	11	+	+	PROPN
fnp-5347	349	12	cytotoxic	cytotoxic	ADJ
fnp-5347	349	13	t	t	NOUN
fnp-5347	349	14	cells	cell	NOUN
fnp-5347	349	15	,	,	PUNCT
fnp-5347	349	16	some	some	PRON
fnp-5347	349	17	of	of	ADP
fnp-5347	349	18	which	which	PRON
fnp-5347	349	19	had	have	VERB
fnp-5347	349	20	a	a	DET
fnp-5347	349	21	specific	specific	ADJ
fnp-5347	349	22	resident	resident	NOUN
fnp-5347	349	23	memory	memory	NOUN
fnp-5347	349	24	t	t	PROPN
fnp-5347	349	25	cell	cell	NOUN
fnp-5347	349	26	phenotype	phenotype	NOUN
fnp-5347	349	27	.	.	PUNCT
fnp-5347	350	1	cytotoxic	cytotoxic	ADJ
fnp-5347	350	2	granzyme	granzyme	NOUN
fnp-5347	350	3	b	b	NOUN
fnp-5347	350	4	-	-	PUNCT
fnp-5347	350	5	positive	positive	ADJ
fnp-5347	350	6	t	t	NOUN
fnp-5347	350	7	cells	cell	NOUN
fnp-5347	350	8	attached	attach	VERB
fnp-5347	350	9	to	to	ADP
fnp-5347	350	10	neurons	neuron	NOUN
fnp-5347	350	11	were	be	AUX
fnp-5347	350	12	also	also	ADV
fnp-5347	350	13	recognized	recognize	VERB
fnp-5347	350	14	at	at	ADP
fnp-5347	350	15	the	the	DET
fnp-5347	350	16	microscopic	microscopic	ADJ
fnp-5347	350	17	level	level	NOUN
fnp-5347	350	18	.	.	PUNCT
fnp-5347	351	1	their	their	PRON
fnp-5347	351	2	data	datum	NOUN
fnp-5347	351	3	convincingly	convincingly	ADV
fnp-5347	351	4	showed	show	VERB
fnp-5347	351	5	that	that	SCONJ
fnp-5347	351	6	patients	patient	NOUN
fnp-5347	351	7	with	with	ADP
fnp-5347	351	8	gad	gad	NOUN
fnp-5347	351	9	-	-	PUNCT
fnp-5347	351	10	tle	tle	NOUN
fnp-5347	351	11	go	go	VERB
fnp-5347	351	12	through	through	ADP
fnp-5347	351	13	an	an	DET
fnp-5347	351	14	early	early	ADJ
fnp-5347	351	15	encephalitic	encephalitic	ADJ
fnp-5347	351	16	stage	stage	NOUN
fnp-5347	351	17	(	(	PUNCT
fnp-5347	351	18	<	<	X
fnp-5347	351	19	 	 	SPACE
fnp-5347	351	20	6	6	NUM
fnp-5347	351	21	years	year	NOUN
fnp-5347	351	22	)	)	PUNCT
fnp-5347	351	23	with	with	ADP
fnp-5347	351	24	cd8	cd8	PROPN
fnp-5347	351	25	+	+	PROPN
fnp-5347	351	26	cytotoxic	cytotoxic	ADJ
fnp-5347	351	27	t	t	NOUN
fnp-5347	351	28	lymphocytes	lymphocyte	NOUN
fnp-5347	351	29	mediated	mediate	VERB
fnp-5347	351	30	,	,	PUNCT
fnp-5347	351	31	antigen	antigen	NOUN
fnp-5347	351	32	-	-	PUNCT
fnp-5347	351	33	driven	drive	VERB
fnp-5347	351	34	neuronal	neuronal	ADJ
fnp-5347	351	35	cell	cell	NOUN
fnp-5347	351	36	loss	loss	NOUN
fnp-5347	351	37	but	but	CCONJ
fnp-5347	351	38	without	without	ADP
fnp-5347	351	39	signs	sign	NOUN
fnp-5347	351	40	of	of	ADP
fnp-5347	351	41	complement	complement	NOUN
fnp-5347	351	42	-	-	PUNCT
fnp-5347	351	43	mediated	mediate	VERB
fnp-5347	351	44	cell	cell	NOUN
fnp-5347	351	45	death	death	NOUN
fnp-5347	351	46	.	.	PUNCT
fnp-5347	352	1	subsequently	subsequently	ADV
fnp-5347	352	2	,	,	PUNCT
fnp-5347	352	3	patients	patient	NOUN
fnp-5347	352	4	enter	enter	VERB
fnp-5347	352	5	an	an	DET
fnp-5347	352	6	apparently	apparently	ADV
fnp-5347	352	7	immunological	immunological	ADJ
fnp-5347	352	8	inactive	inactive	ADJ
fnp-5347	352	9	or	or	CCONJ
fnp-5347	352	10	low	low	ADJ
fnp-5347	352	11	-	-	PUNCT
fnp-5347	352	12	active	active	ADJ
fnp-5347	352	13	stage	stage	NOUN
fnp-5347	352	14	with	with	ADP
fnp-5347	352	15	ongoing	ongoing	ADJ
fnp-5347	352	16	seizures	seizure	NOUN
fnp-5347	352	17	,	,	PUNCT
fnp-5347	352	18	probably	probably	ADV
fnp-5347	352	19	caused	cause	VERB
fnp-5347	352	20	by	by	ADP
fnp-5347	352	21	the	the	DET
fnp-5347	352	22	structural	structural	ADJ
fnp-5347	352	23	damage	damage	NOUN
fnp-5347	352	24	to	to	ADP
fnp-5347	352	25	the	the	DET
fnp-5347	352	26	temporal	temporal	ADJ
fnp-5347	352	27	lobe	lobe	NOUN
fnp-5347	352	28	.	.	PUNCT
fnp-5347	353	1	the	the	DET
fnp-5347	353	2	observation	observation	NOUN
fnp-5347	353	3	of	of	ADP
fnp-5347	353	4	such	such	DET
fnp-5347	353	5	an	an	DET
fnp-5347	353	6	early	early	ADJ
fnp-5347	353	7	stage	stage	NOUN
fnp-5347	353	8	of	of	ADP
fnp-5347	353	9	tissue	tissue	NOUN
fnp-5347	353	10	damage	damage	NOUN
fnp-5347	353	11	is	be	AUX
fnp-5347	353	12	clinically	clinically	ADV
fnp-5347	353	13	most	most	ADV
fnp-5347	353	14	helpful	helpful	ADJ
fnp-5347	353	15	to	to	PART
fnp-5347	353	16	understand	understand	VERB
fnp-5347	353	17	why	why	SCONJ
fnp-5347	353	18	immunotherapies	immunotherapy	NOUN
fnp-5347	353	19	usually	usually	ADV
fnp-5347	353	20	do	do	AUX
fnp-5347	353	21	not	not	PART
fnp-5347	353	22	lead	lead	VERB
fnp-5347	353	23	to	to	PART
fnp-5347	353	24	seizure	seizure	VERB
fnp-5347	353	25	freedom	freedom	NOUN
fnp-5347	353	26	.	.	PUNCT
fnp-5347	354	1	a	a	DET
fnp-5347	354	2	review	review	NOUN
fnp-5347	354	3	from	from	ADP
fnp-5347	354	4	bien	bien	PROPN
fnp-5347	354	5	and	and	CCONJ
fnp-5347	354	6	bauer	bauer	PROPN
fnp-5347	354	7	further	far	ADV
fnp-5347	354	8	highlighted	highlight	VERB
fnp-5347	354	9	what	what	PRON
fnp-5347	354	10	neuropathology	neuropathology	NOUN
fnp-5347	354	11	teaches	teach	VERB
fnp-5347	354	12	us	we	PRON
fnp-5347	354	13	about	about	ADP
fnp-5347	354	14	autoimmune	autoimmune	ADJ
fnp-5347	354	15	encephalitis	encephalitis	NOUN
fnp-5347	354	16	,	,	PUNCT
fnp-5347	354	17	e.g.	e.g.	ADV
fnp-5347	354	18	,	,	PUNCT
fnp-5347	354	19	nmda	nmda	ADJ
fnp-5347	354	20	and	and	CCONJ
fnp-5347	354	21	gli1	gli1	NOUN
fnp-5347	354	22	,	,	PUNCT
fnp-5347	354	23	autoimmune	autoimmune	ADJ
fnp-5347	354	24	associated	associate	VERB
fnp-5347	354	25	epilepsies	epilepsy	NOUN
fnp-5347	354	26	including	include	VERB
fnp-5347	354	27	rasmussen	rasmussen	PROPN
fnp-5347	354	28	,	,	PUNCT
fnp-5347	354	29	paraneoplastic	paraneoplastic	ADJ
fnp-5347	354	30	or	or	CCONJ
fnp-5347	354	31	gad	gad	NOUN
fnp-5347	354	32	-	-	PUNCT
fnp-5347	354	33	tle	tle	NOUN
fnp-5347	354	34	[	[	X
fnp-5347	354	35	8	8	NUM
fnp-5347	354	36	]	]	PUNCT
fnp-5347	354	37	.	.	PUNCT
fnp-5347	355	1	the	the	DET
fnp-5347	355	2	authors	author	NOUN
fnp-5347	355	3	argue	argue	VERB
fnp-5347	355	4	in	in	ADP
fnp-5347	355	5	favor	favor	NOUN
fnp-5347	355	6	of	of	ADP
fnp-5347	355	7	a	a	DET
fnp-5347	355	8	research	research	NOUN
fnp-5347	355	9	-	-	PUNCT
fnp-5347	355	10	driven	drive	VERB
fnp-5347	355	11	neuropathology	neuropathology	NOUN
fnp-5347	355	12	approach	approach	NOUN
fnp-5347	355	13	to	to	PART
fnp-5347	355	14	better	well	ADV
fnp-5347	355	15	understand	understand	VERB
fnp-5347	355	16	these	these	DET
fnp-5347	355	17	diseases	disease	NOUN
fnp-5347	355	18	.	.	PUNCT
fnp-5347	356	1	it	it	PRON
fnp-5347	356	2	is	be	AUX
fnp-5347	356	3	so	so	ADV
fnp-5347	356	4	important	important	ADJ
fnp-5347	356	5	to	to	PART
fnp-5347	356	6	receive	receive	VERB
fnp-5347	356	7	morphological	morphological	ADJ
fnp-5347	356	8	as	as	ADV
fnp-5347	356	9	well	well	ADV
fnp-5347	356	10	as	as	ADP
fnp-5347	356	11	temporal	temporal	ADJ
fnp-5347	356	12	information	information	NOUN
fnp-5347	356	13	over	over	ADP
fnp-5347	356	14	disease	disease	NOUN
fnp-5347	356	15	periods	period	NOUN
fnp-5347	356	16	,	,	PUNCT
fnp-5347	356	17	and	and	CCONJ
fnp-5347	356	18	which	which	PRON
fnp-5347	356	19	can	can	AUX
fnp-5347	356	20	best	well	ADV
fnp-5347	356	21	be	be	AUX
fnp-5347	356	22	acquired	acquire	VERB
fnp-5347	356	23	by	by	ADP
fnp-5347	356	24	studying	study	VERB
fnp-5347	356	25	the	the	DET
fnp-5347	356	26	affected	affected	ADJ
fnp-5347	356	27	brain	brain	NOUN
fnp-5347	356	28	tissue	tissue	NOUN
fnp-5347	356	29	.	.	PUNCT
fnp-5347	357	1	molecular	molecular	ADJ
fnp-5347	357	2	technique	technique	NOUN
fnp-5347	357	3	will	will	AUX
fnp-5347	357	4	then	then	ADV
fnp-5347	357	5	broaden	broaden	VERB
fnp-5347	357	6	and	and	CCONJ
fnp-5347	357	7	support	support	VERB
fnp-5347	357	8	these	these	DET
fnp-5347	357	9	data	datum	NOUN
fnp-5347	357	10	.	.	PUNCT
fnp-5347	358	1	last	last	ADJ
fnp-5347	358	2	but	but	CCONJ
fnp-5347	358	3	not	not	PART
fnp-5347	358	4	least	least	ADJ
fnp-5347	358	5	is	be	AUX
fnp-5347	358	6	a	a	DET
fnp-5347	358	7	comprehensive	comprehensive	ADJ
fnp-5347	358	8	neuropathology	neuropathology	NOUN
fnp-5347	358	9	description	description	NOUN
fnp-5347	358	10	of	of	ADP
fnp-5347	358	11	new	new	ADJ
fnp-5347	358	12	-	-	PUNCT
fnp-5347	358	13	onset	onset	NOUN
fnp-5347	358	14	refractory	refractory	NOUN
fnp-5347	358	15	status	status	NOUN
fnp-5347	358	16	epilepticus	epilepticus	NOUN
fnp-5347	358	17	(	(	PUNCT
fnp-5347	358	18	norse	norse	PROPN
fnp-5347	358	19	)	)	PUNCT
fnp-5347	358	20	,	,	PUNCT
fnp-5347	358	21	including	include	VERB
fnp-5347	358	22	its	its	PRON
fnp-5347	358	23	subtype	subtype	NOUN
fnp-5347	358	24	with	with	ADP
fnp-5347	358	25	a	a	DET
fnp-5347	358	26	preceding	precede	VERB
fnp-5347	358	27	febrile	febrile	NOUN
fnp-5347	358	28	illness	illness	NOUN
fnp-5347	358	29	also	also	ADV
fnp-5347	358	30	known	know	VERB
fnp-5347	358	31	as	as	ADP
fnp-5347	358	32	fires	fire	NOUN
fnp-5347	358	33	(	(	PUNCT
fnp-5347	358	34	febrile	febrile	NOUN
fnp-5347	358	35	infection	infection	NOUN
fnp-5347	358	36	-	-	PUNCT
fnp-5347	358	37	related	relate	VERB
fnp-5347	358	38	epilepsy	epilepsy	NOUN
fnp-5347	358	39	syndrome	syndrome	NOUN
fnp-5347	358	40	)	)	PUNCT
fnp-5347	358	41	.	.	PUNCT
fnp-5347	359	1	these	these	DET
fnp-5347	359	2	conditions	condition	NOUN
fnp-5347	359	3	represent	represent	VERB
fnp-5347	359	4	a	a	DET
fnp-5347	359	5	most	most	ADV
fnp-5347	359	6	severe	severe	ADJ
fnp-5347	359	7	emergency	emergency	NOUN
fnp-5347	359	8	condition	condition	NOUN
fnp-5347	359	9	in	in	ADP
fnp-5347	359	10	epileptology	epileptology	NOUN
fnp-5347	359	11	,	,	PUNCT
fnp-5347	359	12	e.g.	e.g.	ADV
fnp-5347	359	13	status	status	NOUN
fnp-5347	359	14	epilepticus	epilepticus	NOUN
fnp-5347	359	15	(	(	PUNCT
fnp-5347	359	16	se	se	ADJ
fnp-5347	359	17	)	)	PUNCT
fnp-5347	359	18	.	.	PUNCT
fnp-5347	360	1	indeed	indeed	ADV
fnp-5347	360	2	,	,	PUNCT
fnp-5347	360	3	the	the	DET
fnp-5347	360	4	prognosis	prognosis	NOUN
fnp-5347	360	5	of	of	ADP
fnp-5347	360	6	norse	norse	PROPN
fnp-5347	360	7	has	have	VERB
fnp-5347	360	8	a	a	DET
fnp-5347	360	9	high	high	ADJ
fnp-5347	360	10	rate	rate	NOUN
fnp-5347	360	11	of	of	ADP
fnp-5347	360	12	mortality	mortality	NOUN
fnp-5347	360	13	.	.	PUNCT
fnp-5347	361	1	as	as	ADP
fnp-5347	361	2	a	a	DET
fnp-5347	361	3	matter	matter	NOUN
fnp-5347	361	4	of	of	ADP
fnp-5347	361	5	fact	fact	NOUN
fnp-5347	361	6	,	,	PUNCT
fnp-5347	361	7	most	most	ADJ
fnp-5347	361	8	cases	case	NOUN
fnp-5347	361	9	of	of	ADP
fnp-5347	361	10	norse	norse	PROPN
fnp-5347	361	11	remain	remain	VERB
fnp-5347	361	12	inexplicable	inexplicable	ADJ
fnp-5347	361	13	despite	despite	SCONJ
fnp-5347	361	14	extensive	extensive	ADJ
fnp-5347	361	15	clinical	clinical	ADJ
fnp-5347	361	16	evaluations	evaluation	NOUN
fnp-5347	361	17	,	,	PUNCT
fnp-5347	361	18	eeg	eeg	PROPN
fnp-5347	361	19	studies	study	NOUN
fnp-5347	361	20	,	,	PUNCT
fnp-5347	361	21	neuroimaging	neuroimaging	NOUN
fnp-5347	361	22	and	and	CCONJ
fnp-5347	361	23	laboratory	laboratory	NOUN
fnp-5347	361	24	testing	testing	NOUN
fnp-5347	361	25	.	.	PUNCT
fnp-5347	362	1	as	as	SCONJ
fnp-5347	362	2	mentioned	mention	VERB
fnp-5347	362	3	above	above	ADV
fnp-5347	362	4	,	,	PUNCT
fnp-5347	362	5	neuropathology	neuropathology	NOUN
fnp-5347	362	6	evaluations	evaluation	NOUN
fnp-5347	362	7	conducted	conduct	VERB
fnp-5347	362	8	in	in	ADP
fnp-5347	362	9	biopsies	biopsy	NOUN
fnp-5347	362	10	or	or	CCONJ
fnp-5347	362	11	autopsy	autopsy	ADJ
fnp-5347	362	12	tissue	tissue	NOUN
fnp-5347	362	13	are	be	AUX
fnp-5347	362	14	helpful	helpful	ADJ
fnp-5347	362	15	,	,	PUNCT
fnp-5347	362	16	therefore	therefore	ADV
fnp-5347	362	17	,	,	PUNCT
fnp-5347	362	18	to	to	PART
fnp-5347	362	19	better	well	ADV
fnp-5347	362	20	identify	identify	VERB
fnp-5347	362	21	an	an	DET
fnp-5347	362	22	etiology	etiology	NOUN
fnp-5347	362	23	in	in	ADP
fnp-5347	362	24	norse	norse	NOUN
fnp-5347	362	25	or	or	CCONJ
fnp-5347	362	26	fires	fire	NOUN
fnp-5347	362	27	.	.	PUNCT
fnp-5347	363	1	hanin	hanin	NOUN
fnp-5347	363	2	and	and	CCONJ
fnp-5347	363	3	coworkers	coworker	NOUN
fnp-5347	363	4	collected	collect	VERB
fnp-5347	363	5	published	publish	VERB
fnp-5347	363	6	data	datum	NOUN
fnp-5347	363	7	from	from	ADP
fnp-5347	363	8	64	64	NUM
fnp-5347	363	9	cases	case	NOUN
fnp-5347	363	10	of	of	ADP
fnp-5347	363	11	norse	norse	NOUN
fnp-5347	363	12	and	and	CCONJ
fnp-5347	363	13	fires	fire	NOUN
fnp-5347	363	14	,	,	PUNCT
fnp-5347	363	15	including	include	VERB
fnp-5347	363	16	66	66	NUM
fnp-5347	363	17	neuropathology	neuropathology	NOUN
fnp-5347	363	18	tissue	tissue	NOUN
fnp-5347	363	19	samples	sample	NOUN
fnp-5347	363	20	:	:	PUNCT
fnp-5347	363	21	37	37	NUM
fnp-5347	363	22	biopsies	biopsy	NOUN
fnp-5347	363	23	,	,	PUNCT
fnp-5347	363	24	18	18	NUM
fnp-5347	363	25	autopsies	autopsy	NOUN
fnp-5347	363	26	,	,	PUNCT
fnp-5347	363	27	7	7	NUM
fnp-5347	363	28	epilepsy	epilepsy	NOUN
fnp-5347	363	29	surgery	surgery	NOUN
fnp-5347	363	30	samples	sample	NOUN
fnp-5347	363	31	,	,	PUNCT
fnp-5347	363	32	4	4	NUM
fnp-5347	363	33	not	not	PART
fnp-5347	363	34	otherwise	otherwise	ADV
fnp-5347	363	35	specified	specify	VERB
fnp-5347	363	36	[	[	X
fnp-5347	363	37	20	20	NUM
fnp-5347	363	38	]	]	PUNCT
fnp-5347	363	39	.	.	PUNCT
fnp-5347	364	1	in	in	ADP
fnp-5347	364	2	general	general	ADJ
fnp-5347	364	3	,	,	PUNCT
fnp-5347	364	4	se	se	PROPN
fnp-5347	364	5	associated	associated	PROPN
fnp-5347	364	6	neuropathology	neuropathology	NOUN
fnp-5347	364	7	findings	finding	NOUN
fnp-5347	364	8	include	include	VERB
fnp-5347	364	9	neuronal	neuronal	ADJ
fnp-5347	364	10	cell	cell	NOUN
fnp-5347	364	11	loss	loss	NOUN
fnp-5347	364	12	in	in	ADP
fnp-5347	364	13	the	the	DET
fnp-5347	364	14	hippocampus	hippocampus	NOUN
fnp-5347	364	15	,	,	PUNCT
fnp-5347	364	16	cerebellum	cerebellum	NOUN
fnp-5347	364	17	and	and	CCONJ
fnp-5347	364	18	thalamus	thalamus	NOUN
fnp-5347	364	19	associated	associate	VERB
fnp-5347	364	20	with	with	ADP
fnp-5347	364	21	reactive	reactive	ADJ
fnp-5347	364	22	gliosis	gliosis	NOUN
fnp-5347	364	23	and	and	CCONJ
fnp-5347	364	24	often	often	ADV
fnp-5347	364	25	also	also	ADV
fnp-5347	364	26	microglial	microglial	ADJ
fnp-5347	364	27	activation	activation	NOUN
fnp-5347	364	28	.	.	PUNCT
fnp-5347	365	1	same	same	ADJ
fnp-5347	365	2	findings	finding	NOUN
fnp-5347	365	3	can	can	AUX
fnp-5347	365	4	be	be	AUX
fnp-5347	365	5	observed	observe	VERB
fnp-5347	365	6	in	in	ADP
fnp-5347	365	7	norse	norse	NOUN
fnp-5347	365	8	and	and	CCONJ
fnp-5347	365	9	fires	fire	NOUN
fnp-5347	365	10	,	,	PUNCT
fnp-5347	365	11	with	with	ADP
fnp-5347	365	12	the	the	DET
fnp-5347	365	13	addition	addition	NOUN
fnp-5347	365	14	of	of	ADP
fnp-5347	365	15	perivascular	perivascular	ADJ
fnp-5347	365	16	t	t	PROPN
fnp-5347	365	17	-	-	PUNCT
fnp-5347	365	18	cell	cell	NOUN
fnp-5347	365	19	infiltration	infiltration	NOUN
fnp-5347	365	20	in	in	ADP
fnp-5347	365	21	a	a	DET
fnp-5347	365	22	number	number	NOUN
fnp-5347	365	23	of	of	ADP
fnp-5347	365	24	cases	case	NOUN
fnp-5347	365	25	.	.	PUNCT
fnp-5347	366	1	these	these	DET
fnp-5347	366	2	lymphocytic	lymphocytic	ADJ
fnp-5347	366	3	infiltrates	infiltrate	NOUN
fnp-5347	366	4	are	be	AUX
fnp-5347	366	5	similar	similar	ADJ
fnp-5347	366	6	to	to	ADP
fnp-5347	366	7	those	those	PRON
fnp-5347	366	8	described	describe	VERB
fnp-5347	366	9	above	above	ADV
fnp-5347	366	10	,	,	PUNCT
fnp-5347	366	11	mainly	mainly	ADV
fnp-5347	366	12	being	be	AUX
fnp-5347	366	13	cytotoxic	cytotoxic	ADJ
fnp-5347	366	14	t	t	NOUN
fnp-5347	366	15	cells	cell	NOUN
fnp-5347	366	16	.	.	PUNCT
fnp-5347	367	1	they	they	PRON
fnp-5347	367	2	have	have	AUX
fnp-5347	367	3	been	be	AUX
fnp-5347	367	4	confirmed	confirm	VERB
fnp-5347	367	5	by	by	ADP
fnp-5347	367	6	the	the	DET
fnp-5347	367	7	neuropathological	neuropathological	ADJ
fnp-5347	367	8	examination	examination	NOUN
fnp-5347	367	9	in	in	ADP
fnp-5347	367	10	16	16	NUM
fnp-5347	367	11	 	 	SPACE
fnp-5347	367	12	%	%	NOUN
fnp-5347	367	13	of	of	ADP
fnp-5347	367	14	published	publish	VERB
fnp-5347	367	15	cases	case	NOUN
fnp-5347	367	16	and	and	CCONJ
fnp-5347	367	17	helped	help	VERB
fnp-5347	367	18	to	to	PART
fnp-5347	367	19	solve	solve	VERB
fnp-5347	367	20	the	the	DET
fnp-5347	367	21	etiology	etiology	NOUN
fnp-5347	367	22	.	.	PUNCT
fnp-5347	368	1	these	these	DET
fnp-5347	368	2	histopathology	histopathology	NOUN
fnp-5347	368	3	findings	finding	NOUN
fnp-5347	368	4	also	also	ADV
fnp-5347	368	5	triggered	trigger	VERB
fnp-5347	368	6	a	a	DET
fnp-5347	368	7	different	different	ADJ
fnp-5347	368	8	therapeutic	therapeutic	ADJ
fnp-5347	368	9	approach	approach	NOUN
fnp-5347	368	10	,	,	PUNCT
fnp-5347	368	11	including	include	VERB
fnp-5347	368	12	a	a	DET
fnp-5347	368	13	high	high	ADJ
fnp-5347	368	14	dose	dose	NOUN
fnp-5347	368	15	pulse	pulse	NOUN
fnp-5347	368	16	of	of	ADP
fnp-5347	368	17	steroids	steroid	NOUN
fnp-5347	368	18	or	or	CCONJ
fnp-5347	368	19	even	even	ADV
fnp-5347	368	20	tacrolimus	tacrolimus	NOUN
fnp-5347	368	21	,	,	PUNCT
fnp-5347	368	22	although	although	SCONJ
fnp-5347	368	23	this	this	DET
fnp-5347	368	24	treatment	treatment	NOUN
fnp-5347	368	25	had	have	AUX
fnp-5347	368	26	not	not	PART
fnp-5347	368	27	resolved	resolve	VERB
fnp-5347	368	28	the	the	DET
fnp-5347	368	29	symptoms	symptom	NOUN
fnp-5347	368	30	.	.	PUNCT
fnp-5347	369	1	meanwhile	meanwhile	ADV
fnp-5347	369	2	,	,	PUNCT
fnp-5347	369	3	autoimmune	autoimmune	ADJ
fnp-5347	369	4	encephalitis	encephalitis	NOUN
fnp-5347	369	5	has	have	AUX
fnp-5347	369	6	been	be	AUX
fnp-5347	369	7	identified	identify	VERB
fnp-5347	369	8	as	as	ADP
fnp-5347	369	9	most	most	ADJ
fnp-5347	369	10	frequent	frequent	ADJ
fnp-5347	369	11	cause	cause	NOUN
fnp-5347	369	12	of	of	ADP
fnp-5347	369	13	norse	norse	NOUN
fnp-5347	369	14	and	and	CCONJ
fnp-5347	369	15	fires	fire	NOUN
fnp-5347	369	16	,	,	PUNCT
fnp-5347	369	17	and	and	CCONJ
fnp-5347	369	18	which	which	PRON
fnp-5347	369	19	call	call	VERB
fnp-5347	369	20	for	for	ADP
fnp-5347	369	21	more	more	ADJ
fnp-5347	369	22	studies	study	NOUN
fnp-5347	369	23	to	to	PART
fnp-5347	369	24	better	well	ADV
fnp-5347	369	25	identify	identify	VERB
fnp-5347	369	26	the	the	DET
fnp-5347	369	27	molecular	molecular	ADJ
fnp-5347	369	28	target	target	NOUN
fnp-5347	369	29	for	for	ADP
fnp-5347	369	30	a	a	DET
fnp-5347	369	31	successful	successful	ADJ
fnp-5347	369	32	therapy	therapy	NOUN
fnp-5347	369	33	.	.	PUNCT
fnp-5347	370	1	thus	thus	ADV
fnp-5347	370	2	,	,	PUNCT
fnp-5347	370	3	this	this	DET
fnp-5347	370	4	series	series	NOUN
fnp-5347	370	5	of	of	ADP
fnp-5347	370	6	recent	recent	ADJ
fnp-5347	370	7	papers	paper	NOUN
fnp-5347	370	8	highlighted	highlight	VERB
fnp-5347	370	9	the	the	DET
fnp-5347	370	10	ongoing	ongoing	ADJ
fnp-5347	370	11	research	research	NOUN
fnp-5347	370	12	interest	interest	NOUN
fnp-5347	370	13	and	and	CCONJ
fnp-5347	370	14	which	which	PRON
fnp-5347	370	15	hopefully	hopefully	ADV
fnp-5347	370	16	will	will	AUX
fnp-5347	370	17	help	help	VERB
fnp-5347	370	18	to	to	PART
fnp-5347	370	19	develop	develop	VERB
fnp-5347	370	20	rational	rational	ADJ
fnp-5347	370	21	therapeutic	therapeutic	ADJ
fnp-5347	370	22	options	option	NOUN
fnp-5347	370	23	in	in	ADP
fnp-5347	370	24	the	the	DET
fnp-5347	370	25	near	near	ADJ
fnp-5347	370	26	future	future	NOUN
fnp-5347	370	27	.	.	PUNCT
fnp-5347	371	1	references	reference	NOUN
fnp-5347	371	2	1	1	NUM
fnp-5347	371	3	.	.	PUNCT
fnp-5347	372	1	aledo	aledo	NOUN
fnp-5347	372	2	-	-	PUNCT
fnp-5347	372	3	serrano	serrano	PROPN
fnp-5347	372	4	a	a	X
fnp-5347	372	5	,	,	PUNCT
fnp-5347	372	6	toledano	toledano	PROPN
fnp-5347	372	7	r	r	NOUN
fnp-5347	372	8	,	,	PUNCT
fnp-5347	372	9	garcia	garcia	PROPN
fnp-5347	372	10	-	-	PUNCT
fnp-5347	372	11	morales	morales	PROPN
fnp-5347	372	12	i	i	PRON
fnp-5347	372	13	,	,	PUNCT
fnp-5347	372	14	budke	budke	PROPN
fnp-5347	372	15	m	m	PROPN
fnp-5347	372	16	,	,	PUNCT
fnp-5347	372	17	beltran	beltran	PROPN
fnp-5347	372	18	-	-	PUNCT
fnp-5347	372	19	corbellini	corbellini	PROPN
fnp-5347	372	20	a	a	PRON
fnp-5347	372	21	,	,	PUNCT
fnp-5347	372	22	blumcke	blumcke	PROPN
fnp-5347	372	23	i	i	PROPN
fnp-5347	372	24	,	,	PUNCT
fnp-5347	372	25	coras	coras	PROPN
fnp-5347	372	26	r	r	PROPN
fnp-5347	372	27	,	,	PUNCT
fnp-5347	372	28	gil	gil	PROPN
fnp-5347	372	29	-	-	PROPN
fnp-5347	372	30	nagel	nagel	PROPN
fnp-5347	372	31	a	a	X
fnp-5347	372	32	(	(	PUNCT
fnp-5347	372	33	2022	2022	NUM
fnp-5347	372	34	)	)	PUNCT
fnp-5347	372	35	d	d	X
fnp-5347	372	36	-	-	PUNCT
fnp-5347	372	37	galactose	galactose	ADJ
fnp-5347	372	38	supplementation	supplementation	NOUN
fnp-5347	372	39	for	for	ADP
fnp-5347	372	40	the	the	DET
fnp-5347	372	41	treatment	treatment	NOUN
fnp-5347	372	42	of	of	ADP
fnp-5347	372	43	patients	patient	NOUN
fnp-5347	372	44	with	with	ADP
fnp-5347	372	45	mild	mild	ADJ
fnp-5347	372	46	malformation	malformation	NOUN
fnp-5347	372	47	of	of	ADP
fnp-5347	372	48	cortical	cortical	ADJ
fnp-5347	372	49	development	development	NOUN
fnp-5347	372	50	with	with	ADP
fnp-5347	372	51	oligodendroglial	oligodendroglial	ADJ
fnp-5347	372	52	hyperplasia	hyperplasia	NOUN
fnp-5347	372	53	in	in	ADP
fnp-5347	372	54	epilepsy	epilepsy	NOUN
fnp-5347	372	55	(	(	PUNCT
fnp-5347	372	56	moghe	moghe	NOUN
fnp-5347	372	57	):	):	PUNCT
fnp-5347	372	58	an	an	DET
fnp-5347	372	59	interim	interim	ADJ
fnp-5347	372	60	analysis	analysis	NOUN
fnp-5347	372	61	of	of	ADP
fnp-5347	372	62	a	a	DET
fnp-5347	372	63	proof	proof	NOUN
fnp-5347	372	64	-	-	PUNCT
fnp-5347	372	65	of	of	ADP
fnp-5347	372	66	-	-	PUNCT
fnp-5347	372	67	concept	concept	NOUN
fnp-5347	372	68	trial	trial	NOUN
fnp-5347	372	69	.	.	PUNCT
fnp-5347	373	1	epilepsia	epilepsia	NOUN
fnp-5347	373	2	63	63	NUM
fnp-5347	373	3	:	:	PUNCT
fnp-5347	373	4	22	22	NUM
fnp-5347	373	5	-	-	SYM
fnp-5347	373	6	23	23	NUM
fnp-5347	373	7	2	2	NUM
fnp-5347	373	8	.	.	PUNCT
fnp-5347	373	9	ammothumkandy	ammothumkandy	PROPN
fnp-5347	373	10	a	a	PROPN
fnp-5347	373	11	,	,	PUNCT
fnp-5347	373	12	ravina	ravina	PROPN
fnp-5347	373	13	k	k	PROPN
fnp-5347	373	14	,	,	PUNCT
fnp-5347	373	15	wolseley	wolseley	PROPN
fnp-5347	373	16	v	v	PROPN
fnp-5347	373	17	,	,	PUNCT
fnp-5347	373	18	tartt	tartt	NOUN
fnp-5347	373	19	an	an	PROPN
fnp-5347	373	20	,	,	PUNCT
fnp-5347	373	21	yu	yu	PROPN
fnp-5347	373	22	pn	pn	PROPN
fnp-5347	373	23	,	,	PUNCT
fnp-5347	373	24	corona	corona	PROPN
fnp-5347	373	25	l	l	PROPN
fnp-5347	373	26	,	,	PUNCT
fnp-5347	373	27	zhang	zhang	PROPN
fnp-5347	373	28	n	n	SYM
fnp-5347	373	29	,	,	PUNCT
fnp-5347	373	30	nune	nune	PROPN
fnp-5347	373	31	g	g	PROPN
fnp-5347	373	32	,	,	PUNCT
fnp-5347	373	33	kalayjian	kalayjian	ADJ
fnp-5347	373	34	l	l	NOUN
fnp-5347	373	35	,	,	PUNCT
fnp-5347	373	36	mann	mann	PROPN
fnp-5347	373	37	jj	jj	PROPN
fnp-5347	373	38	et	et	PROPN
fnp-5347	373	39	al	al	PROPN
fnp-5347	373	40	(	(	PUNCT
fnp-5347	373	41	2022	2022	NUM
fnp-5347	373	42	)	)	PUNCT
fnp-5347	373	43	altered	alter	VERB
fnp-5347	373	44	adult	adult	NOUN
fnp-5347	373	45	neurogenesis	neurogenesis	NOUN
fnp-5347	373	46	and	and	CCONJ
fnp-5347	373	47	gliogenesis	gliogenesis	NOUN
fnp-5347	373	48	in	in	ADP
fnp-5347	373	49	patients	patient	NOUN
fnp-5347	373	50	with	with	ADP
fnp-5347	373	51	mesial	mesial	ADJ
fnp-5347	373	52	temporal	temporal	ADJ
fnp-5347	373	53	lobe	lobe	NOUN
fnp-5347	373	54	epilepsy	epilepsy	NOUN
fnp-5347	373	55	.	.	PUNCT
fnp-5347	374	1	nat	nat	PROPN
fnp-5347	374	2	neurosci	neurosci	PROPN
fnp-5347	374	3	25	25	NUM
fnp-5347	374	4	:	:	PUNCT
fnp-5347	374	5	493	493	NUM
fnp-5347	374	6	-	-	SYM
fnp-5347	374	7	503	503	NUM
fnp-5347	374	8	.	.	PUNCT
fnp-5347	375	1	https://doi.org/10.1038/s41593-022-01044-2	https://doi.org/10.1038/s41593-022-01044-2	NUM
fnp-5347	375	2	3	3	NUM
fnp-5347	375	3	.	.	PUNCT
fnp-5347	375	4	aroor	aroor	PROPN
fnp-5347	376	1	a	a	DET
fnp-5347	376	2	,	,	PUNCT
fnp-5347	376	3	nguyen	nguyen	NOUN
fnp-5347	376	4	p	p	X
fnp-5347	376	5	,	,	PUNCT
fnp-5347	376	6	li	li	PROPN
fnp-5347	376	7	y	y	PROPN
fnp-5347	376	8	,	,	PUNCT
fnp-5347	376	9	das	das	PROPN
fnp-5347	376	10	r	r	PROPN
fnp-5347	376	11	,	,	PUNCT
fnp-5347	376	12	lugo	lugo	PROPN
fnp-5347	376	13	jn	jn	PROPN
fnp-5347	376	14	,	,	PUNCT
fnp-5347	376	15	brewster	brewster	PROPN
fnp-5347	376	16	al	al	PROPN
fnp-5347	376	17	(	(	PUNCT
fnp-5347	376	18	2023	2023	NUM
fnp-5347	376	19	)	)	PUNCT
fnp-5347	376	20	assessment	assessment	NOUN
fnp-5347	376	21	of	of	ADP
fnp-5347	376	22	tau	tau	PROPN
fnp-5347	376	23	phosphorylation	phosphorylation	NOUN
fnp-5347	376	24	and	and	CCONJ
fnp-5347	376	25	beta	beta	NOUN
fnp-5347	376	26	-	-	PUNCT
fnp-5347	376	27	amyloid	amyloid	NOUN
fnp-5347	376	28	pathology	pathology	NOUN
fnp-5347	376	29	in	in	ADP
fnp-5347	376	30	human	human	ADJ
fnp-5347	376	31	drug	drug	NOUN
fnp-5347	376	32	-	-	PUNCT
fnp-5347	376	33	resistant	resistant	ADJ
fnp-5347	376	34	epilepsy	epilepsy	NOUN
fnp-5347	376	35	.	.	PUNCT
fnp-5347	377	1	epilepsia	epilepsia	NOUN
fnp-5347	377	2	open	open	ADJ
fnp-5347	377	3	8	8	NUM
fnp-5347	377	4	:	:	SYM
fnp-5347	377	5	609	609	NUM
fnp-5347	377	6	-	-	SYM
fnp-5347	377	7	622	622	NUM
fnp-5347	377	8	.	.	PUNCT
fnp-5347	378	1	https://doi.org/10.1002/epi4.12744	https://doi.org/10.1002/epi4.12744	PROPN
fnp-5347	378	2	4	4	NUM
fnp-5347	378	3	.	.	PUNCT
fnp-5347	378	4	atli	atli	PROPN
fnp-5347	379	1	b	b	PROPN
fnp-5347	379	2	,	,	PUNCT
fnp-5347	379	3	rath	rath	PROPN
fnp-5347	379	4	s	s	PROPN
fnp-5347	379	5	,	,	PUNCT
fnp-5347	379	6	burtscher	burtscher	PROPN
fnp-5347	379	7	j	j	PROPN
fnp-5347	379	8	,	,	PUNCT
fnp-5347	379	9	hainfellner	hainfellner	PROPN
fnp-5347	379	10	ja	ja	PROPN
fnp-5347	379	11	,	,	PUNCT
fnp-5347	379	12	hametner	hametner	PROPN
fnp-5347	379	13	s	s	PART
fnp-5347	379	14	(	(	PUNCT
fnp-5347	379	15	2022	2022	NUM
fnp-5347	379	16	)	)	PUNCT
fnp-5347	379	17	frontal	frontal	ADJ
fnp-5347	379	18	intradiploic	intradiploic	ADJ
fnp-5347	379	19	encephalocele	encephalocele	PROPN
fnp-5347	379	20	in	in	ADP
fnp-5347	379	21	a	a	DET
fnp-5347	379	22	44	44	NUM
fnp-5347	379	23	-	-	PUNCT
fnp-5347	379	24	year	year	NOUN
fnp-5347	379	25	-	-	PUNCT
fnp-5347	379	26	old	old	ADJ
fnp-5347	379	27	male	male	ADJ
fnp-5347	379	28	patient	patient	NOUN
fnp-5347	379	29	:	:	PUNCT
fnp-5347	379	30	illustrative	illustrative	ADJ
fnp-5347	379	31	case	case	NOUN
fnp-5347	379	32	.	.	PUNCT
fnp-5347	380	1	j	j	PROPN
fnp-5347	380	2	neurosurg	neurosurg	PROPN
fnp-5347	380	3	case	case	NOUN
fnp-5347	380	4	lessons	lesson	VERB
fnp-5347	380	5	4	4	NUM
fnp-5347	380	6	:	:	PUNCT
fnp-5347	380	7	.	.	PUNCT
fnp-5347	381	1	https://doi.org/10.3171/case2270	https://doi.org/10.3171/case2270	PROPN
fnp-5347	381	2	5	5	NUM
fnp-5347	381	3	.	.	PUNCT
fnp-5347	381	4	baldassari	baldassari	PROPN
fnp-5347	381	5	s	s	PROPN
fnp-5347	381	6	,	,	PUNCT
fnp-5347	381	7	ribierre	ribierre	PROPN
fnp-5347	381	8	t	t	PROPN
fnp-5347	381	9	,	,	PUNCT
fnp-5347	381	10	marsan	marsan	PROPN
fnp-5347	381	11	e	e	PROPN
fnp-5347	381	12	,	,	PUNCT
fnp-5347	381	13	adle	adle	ADJ
fnp-5347	381	14	-	-	PUNCT
fnp-5347	381	15	biassette	biassette	PROPN
fnp-5347	381	16	h	h	NOUN
fnp-5347	381	17	,	,	PUNCT
fnp-5347	381	18	ferrand	ferrand	NOUN
fnp-5347	381	19	-	-	PUNCT
fnp-5347	381	20	sorbets	sorbet	NOUN
fnp-5347	381	21	s	s	NOUN
fnp-5347	381	22	,	,	PUNCT
fnp-5347	381	23	bulteau	bulteau	NOUN
fnp-5347	381	24	c	c	NOUN
fnp-5347	381	25	,	,	PUNCT
fnp-5347	381	26	dorison	dorison	NOUN
fnp-5347	381	27	n	n	CCONJ
fnp-5347	381	28	,	,	PUNCT
fnp-5347	381	29	fohlen	fohlen	VERB
fnp-5347	381	30	m	m	PROPN
fnp-5347	381	31	,	,	PUNCT
fnp-5347	381	32	polivka	polivka	PROPN
fnp-5347	381	33	m	m	PROPN
fnp-5347	381	34	,	,	PUNCT
fnp-5347	381	35	weckhuysen	weckhuysen	PROPN
fnp-5347	381	36	s	s	PROPN
fnp-5347	381	37	et	et	PROPN
fnp-5347	381	38	al	al	PROPN
fnp-5347	381	39	(	(	PUNCT
fnp-5347	381	40	2019	2019	NUM
fnp-5347	381	41	)	)	PUNCT
fnp-5347	381	42	dissecting	dissect	VERB
fnp-5347	381	43	the	the	DET
fnp-5347	381	44	genetic	genetic	ADJ
fnp-5347	381	45	basis	basis	NOUN
fnp-5347	381	46	of	of	ADP
fnp-5347	381	47	focal	focal	ADJ
fnp-5347	381	48	cortical	cortical	ADJ
fnp-5347	381	49	dysplasia	dysplasia	NOUN
fnp-5347	381	50	:	:	PUNCT
fnp-5347	381	51	a	a	DET
fnp-5347	381	52	large	large	ADJ
fnp-5347	381	53	cohort	cohort	NOUN
fnp-5347	381	54	study	study	NOUN
fnp-5347	381	55	.	.	PUNCT
fnp-5347	382	1	acta	acta	PROPN
fnp-5347	382	2	neuropathol	neuropathol	PROPN
fnp-5347	382	3	138	138	NUM
fnp-5347	382	4	:	:	PUNCT
fnp-5347	382	5	885	885	NUM
fnp-5347	382	6	-	-	SYM
fnp-5347	382	7	900	900	NUM
fnp-5347	382	8	.	.	PUNCT
fnp-5347	383	1	https://doi.org/10.1007/s00401-019-02061-5	https://doi.org/10.1007/s00401-019-02061-5	NUM
fnp-5347	384	1	6	6	NUM
fnp-5347	384	2	.	.	PUNCT
fnp-5347	385	1	barba	barba	PROPN
fnp-5347	385	2	c	c	X
fnp-5347	385	3	,	,	PUNCT
fnp-5347	385	4	blumcke	blumcke	PROPN
fnp-5347	385	5	i	i	PROPN
fnp-5347	385	6	,	,	PUNCT
fnp-5347	385	7	winawer	winawer	PROPN
fnp-5347	385	8	mr	mr	PROPN
fnp-5347	385	9	,	,	PUNCT
fnp-5347	385	10	hartlieb	hartlieb	PROPN
fnp-5347	385	11	t	t	PROPN
fnp-5347	385	12	,	,	PUNCT
fnp-5347	385	13	kang	kang	PROPN
fnp-5347	385	14	hc	hc	PROPN
fnp-5347	385	15	,	,	PUNCT
fnp-5347	385	16	grisotto	grisotto	PROPN
fnp-5347	385	17	l	l	NOUN
fnp-5347	385	18	,	,	PUNCT
fnp-5347	385	19	chipaux	chipaux	PROPN
fnp-5347	385	20	m	m	PROPN
fnp-5347	385	21	,	,	PUNCT
fnp-5347	385	22	bien	bien	PROPN
fnp-5347	385	23	cg	cg	PROPN
fnp-5347	385	24	,	,	PUNCT
fnp-5347	385	25	hermanovska	hermanovska	NOUN
fnp-5347	385	26	b	b	PROPN
fnp-5347	385	27	,	,	PUNCT
fnp-5347	385	28	porter	porter	NOUN
fnp-5347	385	29	be	be	AUX
fnp-5347	385	30	et	et	PROPN
fnp-5347	385	31	al	al	PROPN
fnp-5347	385	32	(	(	PUNCT
fnp-5347	385	33	2023	2023	NUM
fnp-5347	385	34	)	)	PUNCT
fnp-5347	385	35	clinical	clinical	ADJ
fnp-5347	385	36	features	feature	NOUN
fnp-5347	385	37	,	,	PUNCT
fnp-5347	385	38	neuropathology	neuropathology	NOUN
fnp-5347	385	39	,	,	PUNCT
fnp-5347	385	40	and	and	CCONJ
fnp-5347	385	41	surgical	surgical	ADJ
fnp-5347	385	42	outcome	outcome	NOUN
fnp-5347	385	43	in	in	ADP
fnp-5347	385	44	patients	patient	NOUN
fnp-5347	385	45	with	with	ADP
fnp-5347	385	46	refractory	refractory	NOUN
fnp-5347	385	47	epilepsy	epilepsy	NOUN
fnp-5347	385	48	and	and	CCONJ
fnp-5347	385	49	brain	brain	NOUN
fnp-5347	385	50	somatic	somatic	ADJ
fnp-5347	385	51	variants	variant	NOUN
fnp-5347	385	52	in	in	ADP
fnp-5347	385	53	the	the	DET
fnp-5347	385	54	slc35a2	slc35a2	NOUN
fnp-5347	385	55	gene	gene	NOUN
fnp-5347	385	56	.	.	PUNCT
fnp-5347	386	1	neurology	neurology	NOUN
fnp-5347	386	2	100	100	NUM
fnp-5347	386	3	:	:	PUNCT
fnp-5347	386	4	e528	e528	PROPN
fnp-5347	386	5	-	-	PUNCT
fnp-5347	386	6	e542	e542	PROPN
fnp-5347	386	7	.	.	PUNCT
fnp-5347	387	1	https://doi.org/10.1212/wnl.0000000000201471	https://doi.org/10.1212/wnl.0000000000201471	PROPN
fnp-5347	387	2	7	7	NUM
fnp-5347	387	3	.	.	PUNCT
fnp-5347	387	4	bedrosian	bedrosian	PROPN
fnp-5347	387	5	ta	ta	PROPN
fnp-5347	387	6	,	,	PUNCT
fnp-5347	387	7	miller	miller	PROPN
fnp-5347	387	8	ke	ke	PROPN
fnp-5347	387	9	,	,	PUNCT
fnp-5347	387	10	grischow	grischow	INTJ
fnp-5347	387	11	oe	oe	PROPN
fnp-5347	387	12	,	,	PUNCT
fnp-5347	387	13	schieffer	schieffer	PROPN
fnp-5347	387	14	km	km	PROPN
fnp-5347	387	15	,	,	PUNCT
fnp-5347	387	16	lahaye	lahaye	PROPN
fnp-5347	387	17	s	s	PROPN
fnp-5347	387	18	,	,	PUNCT
fnp-5347	387	19	yoon	yoon	PROPN
fnp-5347	387	20	h	h	PROPN
fnp-5347	387	21	,	,	PUNCT
fnp-5347	387	22	miller	miller	PROPN
fnp-5347	387	23	ar	ar	PROPN
fnp-5347	387	24	,	,	PUNCT
fnp-5347	387	25	navarro	navarro	PROPN
fnp-5347	387	26	j	j	PROPN
fnp-5347	387	27	,	,	PUNCT
fnp-5347	387	28	westfall	westfall	PROPN
fnp-5347	387	29	j	j	PROPN
fnp-5347	387	30	,	,	PUNCT
fnp-5347	387	31	leraas	leraas	NOUN
fnp-5347	387	32	k	k	PROPN
fnp-5347	387	33	et	et	PROPN
fnp-5347	387	34	al	al	PROPN
fnp-5347	387	35	(	(	PUNCT
fnp-5347	387	36	2022	2022	NUM
fnp-5347	387	37	)	)	PUNCT
fnp-5347	387	38	detection	detection	NOUN
fnp-5347	387	39	of	of	ADP
fnp-5347	387	40	brain	brain	NOUN
fnp-5347	387	41	somatic	somatic	ADJ
fnp-5347	387	42	variation	variation	NOUN
fnp-5347	387	43	in	in	ADP
fnp-5347	387	44	epilepsy	epilepsy	NOUN
fnp-5347	387	45	-	-	PUNCT
fnp-5347	387	46	associated	associate	VERB
fnp-5347	387	47	developmental	developmental	ADJ
fnp-5347	387	48	lesions	lesion	NOUN
fnp-5347	387	49	.	.	PUNCT
fnp-5347	388	1	epilepsia	epilepsia	NOUN
fnp-5347	388	2	63	63	NUM
fnp-5347	388	3	:	:	PUNCT
fnp-5347	388	4	1981	1981	NUM
fnp-5347	388	5	-	-	SYM
fnp-5347	388	6	1997	1997	NUM
fnp-5347	388	7	.	.	PUNCT
fnp-5347	389	1	https://doi.org/10.1111/epi.17323	https://doi.org/10.1111/epi.17323	PROPN
fnp-5347	389	2	8	8	NUM
fnp-5347	389	3	.	.	PUNCT
fnp-5347	389	4	bien	bien	PROPN
fnp-5347	389	5	cg	cg	PROPN
fnp-5347	389	6	,	,	PUNCT
fnp-5347	389	7	bauer	bauer	PROPN
fnp-5347	389	8	j	j	PROPN
fnp-5347	389	9	(	(	PUNCT
fnp-5347	389	10	2023	2023	NUM
fnp-5347	389	11	)	)	PUNCT
fnp-5347	389	12	what	what	PRON
fnp-5347	389	13	neuropathology	neuropathology	NOUN
fnp-5347	389	14	teaches	teach	VERB
fnp-5347	389	15	us	we	PRON
fnp-5347	389	16	about	about	ADP
fnp-5347	389	17	autoimmune	autoimmune	ADJ
fnp-5347	389	18	encephalitides	encephalitis	NOUN
fnp-5347	389	19	,	,	PUNCT
fnp-5347	389	20	autoimmune	autoimmune	ADJ
fnp-5347	389	21	epilepsies	epilepsy	NOUN
fnp-5347	389	22	,	,	PUNCT
fnp-5347	389	23	and	and	CCONJ
fnp-5347	389	24	encephalomyelitides	encephalomyelitide	NOUN
fnp-5347	389	25	.	.	PUNCT
fnp-5347	390	1	clin	clin	PROPN
fnp-5347	390	2	neuropathol	neuropathol	PROPN
fnp-5347	390	3	42	42	NUM
fnp-5347	390	4	:	:	PUNCT
fnp-5347	390	5	87	87	NUM
fnp-5347	390	6	-	-	SYM
fnp-5347	390	7	92	92	NUM
fnp-5347	390	8	.	.	PUNCT
fnp-5347	391	1	https://doi.org/10.5414/np301536	https://doi.org/10.5414/np301536	NOUN
fnp-5347	391	2	9	9	NUM
fnp-5347	391	3	.	.	PUNCT
fnp-5347	392	1	blumcke	blumcke	NOUN
fnp-5347	392	2	i	i	PRON
fnp-5347	392	3	(	(	PUNCT
fnp-5347	392	4	2022	2022	NUM
fnp-5347	392	5	)	)	PUNCT
fnp-5347	392	6	neuropathology	neuropathology	NOUN
fnp-5347	392	7	and	and	CCONJ
fnp-5347	392	8	epilepsy	epilepsy	ADJ
fnp-5347	392	9	surgery	surgery	NOUN
fnp-5347	392	10	:	:	PUNCT
fnp-5347	392	11	2022	2022	NUM
fnp-5347	392	12	update	update	NOUN
fnp-5347	392	13	.	.	PUNCT
fnp-5347	393	1	free	free	ADJ
fnp-5347	393	2	neuropathology	neuropathology	NOUN
fnp-5347	393	3	3	3	NUM
fnp-5347	393	4	:	:	SYM
fnp-5347	393	5	1	1	NUM
fnp-5347	393	6	-	-	SYM
fnp-5347	393	7	17	17	NUM
fnp-5347	393	8	.	.	PUNCT
fnp-5347	394	1	https://doi.org/doi.org/10.17879/freeneuropathology-2022-3813	https://doi.org/doi.org/10.17879/freeneuropathology-2022-3813	PROPN
fnp-5347	394	2	10	10	NUM
fnp-5347	394	3	.	.	PUNCT
fnp-5347	395	1	blumcke	blumcke	PROPN
fnp-5347	395	2	i	i	PROPN
fnp-5347	395	3	,	,	PUNCT
fnp-5347	395	4	coras	coras	PROPN
fnp-5347	395	5	r	r	PROPN
fnp-5347	395	6	,	,	PUNCT
fnp-5347	395	7	busch	busch	PROPN
fnp-5347	395	8	rm	rm	PROPN
fnp-5347	395	9	,	,	PUNCT
fnp-5347	395	10	morita	morita	PROPN
fnp-5347	395	11	-	-	PUNCT
fnp-5347	395	12	sherman	sherman	PROPN
fnp-5347	395	13	m	m	PROPN
fnp-5347	395	14	,	,	PUNCT
fnp-5347	395	15	lal	lal	PROPN
fnp-5347	395	16	d	d	PROPN
fnp-5347	395	17	,	,	PUNCT
fnp-5347	395	18	prayson	prayson	NOUN
fnp-5347	395	19	r	r	NOUN
fnp-5347	395	20	,	,	PUNCT
fnp-5347	395	21	cendes	cende	NOUN
fnp-5347	395	22	f	f	PROPN
fnp-5347	395	23	,	,	PUNCT
fnp-5347	395	24	lopes	lope	NOUN
fnp-5347	395	25	-	-	PUNCT
fnp-5347	395	26	cendes	cende	VERB
fnp-5347	395	27	i	i	PROPN
fnp-5347	395	28	,	,	PUNCT
fnp-5347	395	29	rogerio	rogerio	PROPN
fnp-5347	395	30	f	f	PROPN
fnp-5347	395	31	,	,	PUNCT
fnp-5347	395	32	almeida	almeida	PROPN
fnp-5347	395	33	vs	vs	ADP
fnp-5347	395	34	et	et	PROPN
fnp-5347	395	35	al	al	PROPN
fnp-5347	395	36	(	(	PUNCT
fnp-5347	395	37	2021	2021	NUM
fnp-5347	395	38	)	)	PUNCT
fnp-5347	395	39	toward	toward	ADP
fnp-5347	395	40	a	a	DET
fnp-5347	395	41	better	well	ADJ
fnp-5347	395	42	definition	definition	NOUN
fnp-5347	395	43	of	of	ADP
fnp-5347	395	44	focal	focal	ADJ
fnp-5347	395	45	cortical	cortical	ADJ
fnp-5347	395	46	dysplasia	dysplasia	NOUN
fnp-5347	395	47	:	:	PUNCT
fnp-5347	395	48	an	an	DET
fnp-5347	395	49	iterative	iterative	NOUN
fnp-5347	395	50	histopathological	histopathological	ADJ
fnp-5347	395	51	and	and	CCONJ
fnp-5347	395	52	genetic	genetic	ADJ
fnp-5347	395	53	agreement	agreement	NOUN
fnp-5347	395	54	trial	trial	NOUN
fnp-5347	395	55	.	.	PUNCT
fnp-5347	396	1	epilepsia	epilepsia	NOUN
fnp-5347	396	2	62	62	NUM
fnp-5347	396	3	:	:	PUNCT
fnp-5347	396	4	1416	1416	NUM
fnp-5347	396	5	-	-	SYM
fnp-5347	396	6	1428	1428	NUM
fnp-5347	396	7	.	.	PUNCT
fnp-5347	397	1	https://doi.org/10.1111/epi.16899	https://doi.org/10.1111/epi.16899	NOUN
fnp-5347	397	2	11	11	NUM
fnp-5347	397	3	.	.	PUNCT
fnp-5347	398	1	blumcke	blumcke	PROPN
fnp-5347	398	2	i	i	PROPN
fnp-5347	398	3	,	,	PUNCT
fnp-5347	398	4	thom	thom	PROPN
fnp-5347	398	5	m	m	PROPN
fnp-5347	398	6	,	,	PUNCT
fnp-5347	398	7	aronica	aronica	PROPN
fnp-5347	398	8	e	e	PROPN
fnp-5347	398	9	,	,	PUNCT
fnp-5347	398	10	armstrong	armstrong	PROPN
fnp-5347	398	11	dd	dd	PROPN
fnp-5347	398	12	,	,	PUNCT
fnp-5347	398	13	bartolomei	bartolomei	PROPN
fnp-5347	398	14	f	f	PROPN
fnp-5347	398	15	,	,	PUNCT
fnp-5347	398	16	bernasconi	bernasconi	PROPN
fnp-5347	398	17	a	a	PRON
fnp-5347	398	18	,	,	PUNCT
fnp-5347	398	19	bernasconi	bernasconi	PROPN
fnp-5347	398	20	n	n	CCONJ
fnp-5347	398	21	,	,	PUNCT
fnp-5347	398	22	bien	bien	PROPN
fnp-5347	398	23	cg	cg	PROPN
fnp-5347	398	24	,	,	PUNCT
fnp-5347	398	25	cendes	cende	VERB
fnp-5347	398	26	f	f	PROPN
fnp-5347	398	27	,	,	PUNCT
fnp-5347	398	28	coras	coras	PROPN
fnp-5347	398	29	r	r	PROPN
fnp-5347	398	30	et	et	PROPN
fnp-5347	398	31	al	al	PROPN
fnp-5347	398	32	(	(	PUNCT
fnp-5347	398	33	2013	2013	NUM
fnp-5347	398	34	)	)	PUNCT
fnp-5347	398	35	international	international	ADJ
fnp-5347	398	36	consensus	consensus	NOUN
fnp-5347	398	37	classification	classification	NOUN
fnp-5347	398	38	of	of	ADP
fnp-5347	398	39	hippocampal	hippocampal	ADJ
fnp-5347	398	40	sclerosis	sclerosis	NOUN
fnp-5347	398	41	in	in	ADP
fnp-5347	398	42	temporal	temporal	ADJ
fnp-5347	398	43	lobe	lobe	ADJ
fnp-5347	398	44	epilepsy	epilepsy	NOUN
fnp-5347	398	45	:	:	PUNCT
fnp-5347	398	46	a	a	DET
fnp-5347	398	47	task	task	NOUN
fnp-5347	398	48	force	force	NOUN
fnp-5347	398	49	report	report	NOUN
fnp-5347	398	50	from	from	ADP
fnp-5347	398	51	the	the	DET
fnp-5347	398	52	ilae	ilae	NOUN
fnp-5347	398	53	commission	commission	NOUN
fnp-5347	398	54	on	on	ADP
fnp-5347	398	55	diagnostic	diagnostic	ADJ
fnp-5347	398	56	methods	method	NOUN
fnp-5347	398	57	.	.	PUNCT
fnp-5347	399	1	epilepsia	epilepsia	NOUN
fnp-5347	399	2	54	54	NUM
fnp-5347	399	3	:	:	PUNCT
fnp-5347	399	4	1315	1315	NUM
fnp-5347	399	5	-	-	SYM
fnp-5347	399	6	1329	1329	NUM
fnp-5347	399	7	.	.	PUNCT
fnp-5347	400	1	https://doi.org/10.1111/epi.12220	https://doi.org/10.1111/epi.12220	ADP
fnp-5347	400	2	12	12	NUM
fnp-5347	400	3	.	.	PUNCT
fnp-5347	401	1	bonduelle	bonduelle	PROPN
fnp-5347	401	2	t	t	PROPN
fnp-5347	401	3	,	,	PUNCT
fnp-5347	401	4	hartlieb	hartlieb	PROPN
fnp-5347	401	5	t	t	PROPN
fnp-5347	401	6	,	,	PUNCT
fnp-5347	401	7	baldassari	baldassari	PROPN
fnp-5347	401	8	s	s	PROPN
fnp-5347	401	9	,	,	PUNCT
fnp-5347	401	10	sim	sim	ADJ
fnp-5347	401	11	ns	ns	ADJ
fnp-5347	401	12	,	,	PUNCT
fnp-5347	401	13	kim	kim	PROPN
fnp-5347	401	14	sh	sh	PROPN
fnp-5347	401	15	,	,	PUNCT
fnp-5347	401	16	kang	kang	PROPN
fnp-5347	401	17	hc	hc	PROPN
fnp-5347	401	18	,	,	PUNCT
fnp-5347	401	19	kobow	kobow	VERB
fnp-5347	401	20	k	k	PROPN
fnp-5347	401	21	,	,	PUNCT
fnp-5347	401	22	coras	coras	PROPN
fnp-5347	401	23	r	r	PROPN
fnp-5347	401	24	,	,	PUNCT
fnp-5347	401	25	chipaux	chipaux	NOUN
fnp-5347	401	26	m	m	PROPN
fnp-5347	401	27	,	,	PUNCT
fnp-5347	401	28	dorfmuller	dorfmuller	NOUN
fnp-5347	401	29	g	g	PROPN
fnp-5347	401	30	et	et	PROPN
fnp-5347	401	31	al	al	PROPN
fnp-5347	401	32	(	(	PUNCT
fnp-5347	401	33	2021	2021	NUM
fnp-5347	401	34	)	)	PUNCT
fnp-5347	401	35	frequent	frequent	ADJ
fnp-5347	401	36	slc35a2	slc35a2	NOUN
fnp-5347	401	37	brain	brain	NOUN
fnp-5347	401	38	mosaicism	mosaicism	NOUN
fnp-5347	401	39	in	in	ADP
fnp-5347	401	40	mild	mild	ADJ
fnp-5347	401	41	malformation	malformation	NOUN
fnp-5347	401	42	of	of	ADP
fnp-5347	401	43	cortical	cortical	ADJ
fnp-5347	401	44	development	development	NOUN
fnp-5347	401	45	with	with	ADP
fnp-5347	401	46	oligodendroglial	oligodendroglial	ADJ
fnp-5347	401	47	hyperplasia	hyperplasia	NOUN
fnp-5347	401	48	in	in	ADP
fnp-5347	401	49	epilepsy	epilepsy	NOUN
fnp-5347	401	50	(	(	PUNCT
fnp-5347	401	51	moghe	moghe	NOUN
fnp-5347	401	52	)	)	PUNCT
fnp-5347	401	53	.	.	PUNCT
fnp-5347	402	1	acta	acta	PROPN
fnp-5347	402	2	neuropathol	neuropathol	PROPN
fnp-5347	402	3	commun	commun	PROPN
fnp-5347	402	4	9	9	NUM
fnp-5347	402	5	:	:	SYM
fnp-5347	402	6	3	3	NUM
fnp-5347	402	7	.	.	X
fnp-5347	402	8	https://doi.org/10.1186/s40478-020-01085-3	https://doi.org/10.1186/s40478-020-01085-3	NOUN
fnp-5347	402	9	13	13	NUM
fnp-5347	402	10	.	.	PUNCT
fnp-5347	403	1	chung	chung	PROPN
fnp-5347	403	2	c	c	PROPN
fnp-5347	403	3	,	,	PUNCT
fnp-5347	403	4	yang	yang	PROPN
fnp-5347	403	5	x	x	PROPN
fnp-5347	403	6	,	,	PUNCT
fnp-5347	403	7	bae	bae	PROPN
fnp-5347	403	8	t	t	PROPN
fnp-5347	403	9	,	,	PUNCT
fnp-5347	403	10	vong	vong	PROPN
fnp-5347	403	11	ki	ki	PROPN
fnp-5347	403	12	,	,	PUNCT
fnp-5347	403	13	mittal	mittal	PROPN
fnp-5347	403	14	s	s	PROPN
fnp-5347	403	15	,	,	PUNCT
fnp-5347	403	16	donkels	donkel	NOUN
fnp-5347	403	17	c	c	PROPN
fnp-5347	403	18	,	,	PUNCT
fnp-5347	403	19	westley	westley	PROPN
fnp-5347	403	20	phillips	phillips	PROPN
fnp-5347	403	21	h	h	PROPN
fnp-5347	403	22	,	,	PUNCT
fnp-5347	403	23	li	li	PROPN
fnp-5347	403	24	z	z	PROPN
fnp-5347	403	25	,	,	PUNCT
fnp-5347	403	26	marsh	marsh	PROPN
fnp-5347	403	27	apl	apl	PROPN
fnp-5347	403	28	,	,	PUNCT
fnp-5347	403	29	breuss	breuss	NOUN
fnp-5347	403	30	mw	mw	VERB
fnp-5347	403	31	et	et	PROPN
fnp-5347	403	32	al	al	PROPN
fnp-5347	403	33	(	(	PUNCT
fnp-5347	403	34	2023	2023	NUM
fnp-5347	403	35	)	)	PUNCT
fnp-5347	403	36	comprehensive	comprehensive	ADJ
fnp-5347	403	37	multi	multi	ADJ
fnp-5347	403	38	-	-	ADJ
fnp-5347	403	39	omic	omic	ADJ
fnp-5347	403	40	profiling	profiling	NOUN
fnp-5347	403	41	of	of	ADP
fnp-5347	403	42	somatic	somatic	ADJ
fnp-5347	403	43	mutations	mutation	NOUN
fnp-5347	403	44	in	in	ADP
fnp-5347	403	45	malformations	malformation	NOUN
fnp-5347	403	46	of	of	ADP
fnp-5347	403	47	cortical	cortical	ADJ
fnp-5347	403	48	development	development	NOUN
fnp-5347	403	49	.	.	PUNCT
fnp-5347	404	1	nat	nat	PROPN
fnp-5347	404	2	genet	genet	PROPN
fnp-5347	404	3	55	55	NUM
fnp-5347	404	4	:	:	PUNCT
fnp-5347	404	5	209	209	NUM
fnp-5347	404	6	-	-	SYM
fnp-5347	404	7	220	220	NUM
fnp-5347	404	8	.	.	PUNCT
fnp-5347	404	9	https://doi.org/10.1038/s41588-022-01276-9	https://doi.org/10.1038/s41588-022-01276-9	PROPN
fnp-5347	404	10	14	14	NUM
fnp-5347	404	11	.	.	PUNCT
fnp-5347	405	1	concepcion	concepcion	PROPN
fnp-5347	405	2	fa	fa	PROPN
fnp-5347	405	3	,	,	PUNCT
fnp-5347	405	4	ekstrom	ekstrom	ADP
fnp-5347	405	5	na	na	PROPN
fnp-5347	405	6	,	,	PUNCT
fnp-5347	405	7	khan	khan	PROPN
fnp-5347	405	8	mn	mn	PROPN
fnp-5347	405	9	,	,	PUNCT
fnp-5347	405	10	estes	este	NOUN
fnp-5347	405	11	oo	oo	ADV
fnp-5347	405	12	,	,	PUNCT
fnp-5347	405	13	poolos	poolos	X
fnp-5347	405	14	np	np	INTJ
fnp-5347	405	15	(	(	PUNCT
fnp-5347	405	16	2023	2023	NUM
fnp-5347	405	17	)	)	PUNCT
fnp-5347	405	18	progressive	progressive	ADJ
fnp-5347	405	19	dysregulation	dysregulation	NOUN
fnp-5347	405	20	of	of	ADP
fnp-5347	405	21	tau	tau	PROPN
fnp-5347	405	22	phosphorylation	phosphorylation	NOUN
fnp-5347	405	23	in	in	ADP
fnp-5347	405	24	an	an	DET
fnp-5347	405	25	animal	animal	NOUN
fnp-5347	405	26	model	model	NOUN
fnp-5347	405	27	of	of	ADP
fnp-5347	405	28	temporal	temporal	ADJ
fnp-5347	405	29	lobe	lobe	ADJ
fnp-5347	405	30	epilepsy	epilepsy	NOUN
fnp-5347	405	31	.	.	PUNCT
fnp-5347	406	1	neuroscience	neuroscience	NOUN
fnp-5347	406	2	522	522	NUM
fnp-5347	406	3	:	:	PUNCT
fnp-5347	406	4	42	42	NUM
fnp-5347	406	5	-	-	SYM
fnp-5347	406	6	56	56	NUM
fnp-5347	406	7	.	.	PUNCT
fnp-5347	407	1	https://doi.org/10.1016/j.neuroscience.2023.04.020	https://doi.org/10.1016/j.neuroscience.2023.04.020	NOUN
fnp-5347	407	2	15	15	NUM
fnp-5347	407	3	.	.	PUNCT
fnp-5347	408	1	deemyad	deemyad	PROPN
fnp-5347	408	2	t	t	PROPN
fnp-5347	408	3	,	,	PUNCT
fnp-5347	408	4	luthi	luthi	PROPN
fnp-5347	408	5	j	j	PROPN
fnp-5347	408	6	,	,	PUNCT
fnp-5347	408	7	spruston	spruston	PROPN
fnp-5347	408	8	n	n	CCONJ
fnp-5347	408	9	(	(	PUNCT
fnp-5347	408	10	2018	2018	NUM
fnp-5347	408	11	)	)	PUNCT
fnp-5347	408	12	astrocytes	astrocyte	NOUN
fnp-5347	408	13	integrate	integrate	VERB
fnp-5347	408	14	and	and	CCONJ
fnp-5347	408	15	drive	drive	VERB
fnp-5347	408	16	action	action	NOUN
fnp-5347	408	17	potential	potential	NOUN
fnp-5347	408	18	firing	firing	NOUN
fnp-5347	408	19	in	in	ADP
fnp-5347	408	20	inhibitory	inhibitory	ADJ
fnp-5347	408	21	subnetworks	subnetwork	NOUN
fnp-5347	408	22	.	.	PUNCT
fnp-5347	409	1	nat	nat	PROPN
fnp-5347	409	2	commun	commun	PROPN
fnp-5347	409	3	9	9	NUM
fnp-5347	409	4	:	:	SYM
fnp-5347	409	5	4336	4336	NUM
fnp-5347	409	6	.	.	PUNCT
fnp-5347	410	1	https://doi.org/10.1038/s41467-018-06338-3	https://doi.org/10.1038/s41467-018-06338-3	PROPN
fnp-5347	410	2	16	16	NUM
fnp-5347	410	3	.	.	PUNCT
fnp-5347	410	4	di	di	PROPN
fnp-5347	410	5	giacomo	giacomo	PROPN
fnp-5347	410	6	r	r	PROPN
fnp-5347	410	7	,	,	PUNCT
fnp-5347	410	8	burini	burini	NOUN
fnp-5347	410	9	a	a	NOUN
fnp-5347	410	10	,	,	PUNCT
fnp-5347	410	11	visani	visani	PROPN
fnp-5347	410	12	e	e	NOUN
fnp-5347	410	13	,	,	PUNCT
fnp-5347	410	14	doniselli	doniselli	PROPN
fnp-5347	410	15	fm	fm	PROPN
fnp-5347	410	16	,	,	PUNCT
fnp-5347	410	17	cuccarini	cuccarini	VERB
fnp-5347	410	18	v	v	NOUN
fnp-5347	410	19	,	,	PUNCT
fnp-5347	410	20	garbelli	garbelli	ADJ
fnp-5347	410	21	r	r	NOUN
fnp-5347	410	22	,	,	PUNCT
fnp-5347	410	23	marucci	marucci	NOUN
fnp-5347	410	24	g	g	PROPN
fnp-5347	410	25	,	,	PUNCT
fnp-5347	410	26	de	de	PROPN
fnp-5347	410	27	santis	santis	PROPN
fnp-5347	410	28	d	d	PROPN
fnp-5347	410	29	,	,	PUNCT
fnp-5347	410	30	didato	didato	NOUN
fnp-5347	410	31	g	g	NOUN
fnp-5347	410	32	,	,	PUNCT
fnp-5347	410	33	deleo	deleo	VERB
fnp-5347	410	34	f	f	PROPN
fnp-5347	410	35	et	et	PROPN
fnp-5347	410	36	al	al	PROPN
fnp-5347	410	37	(	(	PUNCT
fnp-5347	410	38	2023	2023	NUM
fnp-5347	410	39	)	)	PUNCT
fnp-5347	410	40	distinctive	distinctive	ADJ
fnp-5347	410	41	electro	electro	NOUN
fnp-5347	410	42	-	-	PUNCT
fnp-5347	410	43	clinical	clinical	ADJ
fnp-5347	410	44	,	,	PUNCT
fnp-5347	410	45	neuroimaging	neuroimaging	NOUN
fnp-5347	410	46	and	and	CCONJ
fnp-5347	410	47	histopathological	histopathological	ADJ
fnp-5347	410	48	features	feature	NOUN
fnp-5347	410	49	of	of	ADP
fnp-5347	410	50	temporal	temporal	ADJ
fnp-5347	410	51	encephaloceles	encephalocele	NOUN
fnp-5347	410	52	associated	associate	VERB
fnp-5347	410	53	to	to	ADP
fnp-5347	410	54	epilepsy	epilepsy	NOUN
fnp-5347	410	55	.	.	PUNCT
fnp-5347	411	1	neurol	neurol	PROPN
fnp-5347	411	2	sci	sci	PROPN
fnp-5347	411	3	44	44	NUM
fnp-5347	411	4	:	:	PUNCT
fnp-5347	411	5	4451	4451	NUM
fnp-5347	411	6	-	-	SYM
fnp-5347	411	7	4463	4463	NUM
fnp-5347	411	8	.	.	PUNCT
fnp-5347	412	1	https://doi.org/10.1007/s10072-023-06939-x	https://doi.org/10.1007/s10072-023-06939-x	PROPN
fnp-5347	412	2	17	17	NUM
fnp-5347	412	3	.	.	PUNCT
fnp-5347	413	1	eriksson	eriksson	PROPN
fnp-5347	413	2	mh	mh	PROPN
fnp-5347	413	3	,	,	PUNCT
fnp-5347	413	4	ripart	ripart	PROPN
fnp-5347	413	5	m	m	PROPN
fnp-5347	413	6	,	,	PUNCT
fnp-5347	413	7	piper	piper	PROPN
fnp-5347	413	8	rj	rj	PROPN
fnp-5347	413	9	,	,	PUNCT
fnp-5347	413	10	moeller	moeller	PROPN
fnp-5347	413	11	f	f	PROPN
fnp-5347	413	12	,	,	PUNCT
fnp-5347	413	13	das	das	PROPN
fnp-5347	413	14	kb	kb	PROPN
fnp-5347	413	15	,	,	PUNCT
fnp-5347	413	16	eltze	eltze	PROPN
fnp-5347	413	17	c	c	AUX
fnp-5347	413	18	,	,	PUNCT
fnp-5347	413	19	cooray	cooray	VERB
fnp-5347	413	20	g	g	NOUN
fnp-5347	413	21	,	,	PUNCT
fnp-5347	413	22	booth	booth	PROPN
fnp-5347	413	23	j	j	PROPN
fnp-5347	413	24	,	,	PUNCT
fnp-5347	413	25	whitaker	whitaker	PROPN
fnp-5347	413	26	kj	kj	PROPN
fnp-5347	413	27	,	,	PUNCT
fnp-5347	413	28	chari	chari	PROPN
fnp-5347	413	29	a	a	X
fnp-5347	413	30	et	et	NOUN
fnp-5347	413	31	al	al	PROPN
fnp-5347	413	32	(	(	PUNCT
fnp-5347	413	33	2023	2023	NUM
fnp-5347	413	34	)	)	PUNCT
fnp-5347	413	35	predicting	predict	VERB
fnp-5347	413	36	seizure	seizure	NOUN
fnp-5347	413	37	outcome	outcome	NOUN
fnp-5347	413	38	after	after	ADP
fnp-5347	413	39	epilepsy	epilepsy	NOUN
fnp-5347	413	40	surgery	surgery	NOUN
fnp-5347	413	41	:	:	PUNCT
fnp-5347	413	42	do	do	AUX
fnp-5347	413	43	we	we	PRON
fnp-5347	413	44	need	need	VERB
fnp-5347	413	45	more	more	ADJ
fnp-5347	413	46	complex	complex	ADJ
fnp-5347	413	47	models	model	NOUN
fnp-5347	413	48	,	,	PUNCT
fnp-5347	413	49	larger	large	ADJ
fnp-5347	413	50	samples	sample	NOUN
fnp-5347	413	51	,	,	PUNCT
fnp-5347	413	52	or	or	CCONJ
fnp-5347	413	53	better	well	ADJ
fnp-5347	413	54	data	datum	NOUN
fnp-5347	413	55	?	?	PUNCT
fnp-5347	414	1	epilepsia	epilepsia	NOUN
fnp-5347	414	2	64	64	NUM
fnp-5347	414	3	:	:	PUNCT
fnp-5347	414	4	2014	2014	NUM
fnp-5347	414	5	-	-	SYM
fnp-5347	414	6	2026	2026	NUM
fnp-5347	414	7	.	.	PUNCT
fnp-5347	415	1	https://doi.org/10.1111/epi.17637	https://doi.org/10.1111/epi.17637	NOUN
fnp-5347	415	2	18	18	NUM
fnp-5347	415	3	.	.	PUNCT
fnp-5347	415	4	garganis	garganis	PROPN
fnp-5347	415	5	k	k	PROPN
fnp-5347	415	6	,	,	PUNCT
fnp-5347	415	7	gkiatis	gkiatis	PROPN
fnp-5347	415	8	k	k	PROPN
fnp-5347	415	9	,	,	PUNCT
fnp-5347	415	10	maletic	maletic	PROPN
fnp-5347	415	11	j	j	PROPN
fnp-5347	415	12	,	,	PUNCT
fnp-5347	415	13	harushukuri	harushukuri	PROPN
fnp-5347	415	14	j	j	PROPN
fnp-5347	415	15	,	,	PUNCT
fnp-5347	415	16	kondylidis	kondylidis	PROPN
fnp-5347	415	17	n	n	CCONJ
fnp-5347	415	18	,	,	PUNCT
fnp-5347	415	19	dinopoulos	dinopoulos	PROPN
fnp-5347	415	20	a	a	PRON
fnp-5347	415	21	,	,	PUNCT
fnp-5347	415	22	vorgia	vorgia	NOUN
fnp-5347	415	23	p	p	NOUN
fnp-5347	415	24	,	,	PUNCT
fnp-5347	415	25	coras	coras	PROPN
fnp-5347	415	26	r	r	PROPN
fnp-5347	415	27	,	,	PUNCT
fnp-5347	415	28	bluemcke	bluemcke	PROPN
fnp-5347	415	29	i	i	PROPN
fnp-5347	415	30	,	,	PUNCT
fnp-5347	415	31	zountsas	zountsas	PROPN
fnp-5347	415	32	b	b	PROPN
fnp-5347	415	33	(	(	PUNCT
fnp-5347	415	34	2023	2023	NUM
fnp-5347	415	35	)	)	PUNCT
fnp-5347	415	36	frontal	frontal	ADJ
fnp-5347	415	37	lobe	lobe	NOUN
fnp-5347	415	38	epilepsy	epilepsy	NOUN
fnp-5347	415	39	and	and	CCONJ
fnp-5347	415	40	mild	mild	ADJ
fnp-5347	415	41	malformation	malformation	NOUN
fnp-5347	415	42	with	with	ADP
fnp-5347	415	43	oligodendroglial	oligodendroglial	ADJ
fnp-5347	415	44	hyperplasia	hyperplasia	NOUN
fnp-5347	415	45	:	:	PUNCT
fnp-5347	415	46	further	further	ADJ
fnp-5347	415	47	observations	observation	NOUN
fnp-5347	415	48	on	on	ADP
fnp-5347	415	49	electroclinical	electroclinical	ADJ
fnp-5347	415	50	and	and	CCONJ
fnp-5347	415	51	imaging	imaging	NOUN
fnp-5347	415	52	phenotypes	phenotype	NOUN
fnp-5347	415	53	,	,	PUNCT
fnp-5347	415	54	and	and	CCONJ
fnp-5347	415	55	surgical	surgical	ADJ
fnp-5347	415	56	perspectives	perspective	NOUN
fnp-5347	415	57	.	.	PUNCT
fnp-5347	416	1	epileptic	epileptic	ADJ
fnp-5347	416	2	disorders	disorder	NOUN
fnp-5347	416	3	25	25	NUM
fnp-5347	416	4	:	:	PUNCT
fnp-5347	416	5	343	343	NUM
fnp-5347	416	6	-	-	SYM
fnp-5347	416	7	359	359	NUM
fnp-5347	416	8	.	.	PUNCT
fnp-5347	417	1	https://doi.org/10.1002/epd2.20062	https://doi.org/10.1002/epd2.20062	PRON
fnp-5347	417	2	19	19	NUM
fnp-5347	417	3	.	.	PUNCT
fnp-5347	418	1	grote	grote	VERB
fnp-5347	418	2	a	a	PRON
fnp-5347	418	3	,	,	PUNCT
fnp-5347	418	4	heiland	heiland	PROPN
fnp-5347	418	5	dh	dh	PROPN
fnp-5347	418	6	,	,	PUNCT
fnp-5347	418	7	taube	taube	PROPN
fnp-5347	418	8	j	j	PROPN
fnp-5347	418	9	,	,	PUNCT
fnp-5347	418	10	helmstaedter	helmstaedter	PROPN
fnp-5347	418	11	c	c	NOUN
fnp-5347	418	12	,	,	PUNCT
fnp-5347	418	13	ravi	ravi	PROPN
fnp-5347	418	14	vm	vm	PROPN
fnp-5347	418	15	,	,	PUNCT
fnp-5347	418	16	will	will	AUX
fnp-5347	418	17	p	p	NOUN
fnp-5347	418	18	,	,	PUNCT
fnp-5347	418	19	hattingen	hattingen	PROPN
fnp-5347	418	20	e	e	PROPN
fnp-5347	418	21	,	,	PUNCT
fnp-5347	418	22	schure	schure	PROPN
fnp-5347	418	23	jr	jr	PROPN
fnp-5347	418	24	,	,	PUNCT
fnp-5347	418	25	witt	witt	PROPN
fnp-5347	418	26	ja	ja	PROPN
fnp-5347	418	27	,	,	PUNCT
fnp-5347	418	28	reimers	reimer	VERB
fnp-5347	418	29	a	a	DET
fnp-5347	418	30	et	et	NOUN
fnp-5347	418	31	al	al	PROPN
fnp-5347	418	32	(	(	PUNCT
fnp-5347	418	33	2023	2023	NUM
fnp-5347	418	34	)	)	PUNCT
fnp-5347	418	35	'	'	PUNCT
fnp-5347	418	36	hippocampal	hippocampal	ADJ
fnp-5347	418	37	innate	innate	ADJ
fnp-5347	418	38	inflammatory	inflammatory	ADJ
fnp-5347	418	39	gliosis	gliosis	NOUN
fnp-5347	418	40	only	only	ADV
fnp-5347	418	41	'	'	PUNCT
fnp-5347	418	42	in	in	ADP
fnp-5347	418	43	pharmacoresistant	pharmacoresistant	ADJ
fnp-5347	418	44	temporal	temporal	ADJ
fnp-5347	418	45	lobe	lobe	ADJ
fnp-5347	418	46	epilepsy	epilepsy	NOUN
fnp-5347	418	47	.	.	PUNCT
fnp-5347	419	1	brain	brain	NOUN
fnp-5347	419	2	146	146	NUM
fnp-5347	419	3	:	:	PUNCT
fnp-5347	419	4	549	549	NUM
fnp-5347	419	5	-	-	SYM
fnp-5347	419	6	560	560	NUM
fnp-5347	419	7	.	.	PUNCT
fnp-5347	419	8	https://doi.org/10.1093/brain/awac293	https://doi.org/10.1093/brain/awac293	NOUN
fnp-5347	419	9	20	20	NUM
fnp-5347	419	10	.	.	PUNCT
fnp-5347	420	1	hanin	hanin	PROPN
fnp-5347	420	2	a	a	PRON
fnp-5347	420	3	,	,	PUNCT
fnp-5347	420	4	cespedes	cespedes	PROPN
fnp-5347	420	5	j	j	PROPN
fnp-5347	420	6	,	,	PUNCT
fnp-5347	420	7	huttner	huttner	X
fnp-5347	420	8	a	a	NOUN
fnp-5347	420	9	,	,	PUNCT
fnp-5347	420	10	strelnikov	strelnikov	NOUN
fnp-5347	420	11	d	d	NOUN
fnp-5347	420	12	,	,	PUNCT
fnp-5347	420	13	gopaul	gopaul	PROPN
fnp-5347	420	14	m	m	PROPN
fnp-5347	420	15	,	,	PUNCT
fnp-5347	420	16	distasio	distasio	PROPN
fnp-5347	420	17	m	m	PROPN
fnp-5347	420	18	,	,	PUNCT
fnp-5347	420	19	vezzani	vezzani	PROPN
fnp-5347	420	20	a	a	PRON
fnp-5347	420	21	,	,	PUNCT
fnp-5347	420	22	hirsch	hirsch	PROPN
fnp-5347	420	23	lj	lj	PROPN
fnp-5347	420	24	,	,	PUNCT
fnp-5347	420	25	aronica	aronica	PROPN
fnp-5347	420	26	e	e	PROPN
fnp-5347	420	27	(	(	PUNCT
fnp-5347	420	28	2023	2023	NUM
fnp-5347	420	29	)	)	PUNCT
fnp-5347	420	30	neuropathology	neuropathology	NOUN
fnp-5347	420	31	of	of	ADP
fnp-5347	420	32	new	new	ADJ
fnp-5347	420	33	-	-	PUNCT
fnp-5347	420	34	onset	onset	NOUN
fnp-5347	420	35	refractory	refractory	NOUN
fnp-5347	420	36	status	status	NOUN
fnp-5347	420	37	epilepticus	epilepticus	NOUN
fnp-5347	420	38	(	(	PUNCT
fnp-5347	420	39	norse	norse	PROPN
fnp-5347	420	40	)	)	PUNCT
fnp-5347	420	41	.	.	PUNCT
fnp-5347	421	1	j	j	PROPN
fnp-5347	421	2	neurol	neurol	NOUN
fnp-5347	421	3	270	270	NUM
fnp-5347	421	4	:	:	PUNCT
fnp-5347	421	5	3688	3688	NUM
fnp-5347	421	6	-	-	SYM
fnp-5347	421	7	3702	3702	NUM
fnp-5347	421	8	.	.	PUNCT
fnp-5347	422	1	https://doi.org/10.1007/s00415-023-11726-x	https://doi.org/10.1007/s00415-023-11726-x	PROPN
fnp-5347	422	2	21	21	NUM
fnp-5347	422	3	.	.	PUNCT
fnp-5347	423	1	hoffmann	hoffmann	PROPN
fnp-5347	423	2	l	l	PROPN
fnp-5347	423	3	,	,	PUNCT
fnp-5347	423	4	coras	coras	PROPN
fnp-5347	423	5	r	r	PROPN
fnp-5347	423	6	,	,	PUNCT
fnp-5347	423	7	kobow	kobow	VERB
fnp-5347	423	8	k	k	PROPN
fnp-5347	423	9	,	,	PUNCT
fnp-5347	423	10	lópez	lópez	PROPN
fnp-5347	423	11	-	-	PUNCT
fnp-5347	423	12	rivera	rivera	PROPN
fnp-5347	423	13	ja	ja	PROPN
fnp-5347	423	14	,	,	PUNCT
fnp-5347	423	15	lal	lal	PROPN
fnp-5347	424	1	d	d	PROPN
fnp-5347	424	2	,	,	PUNCT
fnp-5347	424	3	leu	leu	PROPN
fnp-5347	424	4	c	c	PROPN
fnp-5347	424	5	,	,	PUNCT
fnp-5347	424	6	najm	najm	ADJ
fnp-5347	424	7	i	i	PROPN
fnp-5347	424	8	,	,	PUNCT
fnp-5347	424	9	nürnberg	nürnberg	PROPN
fnp-5347	424	10	p	p	PROPN
fnp-5347	424	11	,	,	PUNCT
fnp-5347	424	12	herms	herms	PROPN
fnp-5347	424	13	j	j	PROPN
fnp-5347	424	14	,	,	PUNCT
fnp-5347	424	15	harter	harter	PROPN
fnp-5347	424	16	pn	pn	PROPN
fnp-5347	424	17	et	et	PROPN
fnp-5347	424	18	al	al	PROPN
fnp-5347	424	19	(	(	PUNCT
fnp-5347	424	20	2023	2023	NUM
fnp-5347	424	21	)	)	PUNCT
fnp-5347	424	22	ganglioglioma	ganglioglioma	NOUN
fnp-5347	424	23	with	with	ADP
fnp-5347	424	24	adverse	adverse	ADJ
fnp-5347	424	25	clinical	clinical	ADJ
fnp-5347	424	26	outcome	outcome	NOUN
fnp-5347	424	27	and	and	CCONJ
fnp-5347	424	28	atypical	atypical	ADJ
fnp-5347	424	29	histopathological	histopathological	ADJ
fnp-5347	424	30	features	feature	NOUN
fnp-5347	424	31	were	be	AUX
fnp-5347	424	32	defined	define	VERB
fnp-5347	424	33	by	by	ADP
fnp-5347	424	34	alterations	alteration	NOUN
fnp-5347	424	35	in	in	ADP
fnp-5347	424	36	ptpn11	ptpn11	NOUN
fnp-5347	424	37	and	and	CCONJ
fnp-5347	424	38	other	other	ADJ
fnp-5347	424	39	ras-/map	ras-/map	ADJ
fnp-5347	424	40	-	-	PUNCT
fnp-5347	424	41	kinase	kinase	NOUN
fnp-5347	424	42	pathway	pathway	NOUN
fnp-5347	424	43	genes	gene	NOUN
fnp-5347	424	44	(	(	PUNCT
fnp-5347	424	45	vol	vol	NOUN
fnp-5347	424	46	145	145	NUM
fnp-5347	424	47	,	,	PUNCT
fnp-5347	424	48	pg	pg	NOUN
fnp-5347	424	49	815	815	NUM
fnp-5347	424	50	,	,	PUNCT
fnp-5347	424	51	2023	2023	NUM
fnp-5347	424	52	)	)	PUNCT
fnp-5347	424	53	.	.	PUNCT
fnp-5347	425	1	acta	acta	PROPN
fnp-5347	425	2	neuropathologica	neuropathologica	PROPN
fnp-5347	425	3	145	145	NUM
fnp-5347	425	4	:	:	PUNCT
fnp-5347	425	5	851	851	NUM
fnp-5347	425	6	-	-	SYM
fnp-5347	425	7	855	855	NUM
fnp-5347	425	8	.	.	PUNCT
fnp-5347	426	1	https://doi.org/10.1007/s00401-023-02577-x	https://doi.org/10.1007/s00401-023-02577-x	PROPN
fnp-5347	426	2	22	22	NUM
fnp-5347	426	3	.	.	PUNCT
fnp-5347	427	1	holthausen	holthausen	PROPN
fnp-5347	427	2	h	h	PROPN
fnp-5347	427	3	,	,	PUNCT
fnp-5347	427	4	coras	coras	PROPN
fnp-5347	427	5	r	r	PROPN
fnp-5347	427	6	,	,	PUNCT
fnp-5347	427	7	tang	tang	PROPN
fnp-5347	427	8	y	y	PROPN
fnp-5347	427	9	,	,	PUNCT
fnp-5347	427	10	bai	bai	PROPN
fnp-5347	427	11	l	l	PROPN
fnp-5347	427	12	,	,	PUNCT
fnp-5347	427	13	wang	wang	PROPN
fnp-5347	427	14	i	i	PROPN
fnp-5347	427	15	,	,	PUNCT
fnp-5347	427	16	pieper	pieper	PROPN
fnp-5347	427	17	t	t	PROPN
fnp-5347	427	18	,	,	PUNCT
fnp-5347	427	19	kudernatsch	kudernatsch	PROPN
fnp-5347	427	20	m	m	PROPN
fnp-5347	427	21	,	,	PUNCT
fnp-5347	427	22	hartlieb	hartlieb	PROPN
fnp-5347	427	23	t	t	PROPN
fnp-5347	427	24	,	,	PUNCT
fnp-5347	427	25	staudt	staudt	NOUN
fnp-5347	427	26	m	m	PROPN
fnp-5347	427	27	,	,	PUNCT
fnp-5347	427	28	winkler	winkler	NOUN
fnp-5347	427	29	p	p	PROPN
fnp-5347	427	30	et	et	PROPN
fnp-5347	427	31	al	al	PROPN
fnp-5347	427	32	(	(	PUNCT
fnp-5347	427	33	2022	2022	NUM
fnp-5347	427	34	)	)	PUNCT
fnp-5347	427	35	multilobar	multilobar	ADJ
fnp-5347	427	36	unilateral	unilateral	ADJ
fnp-5347	427	37	hypoplasia	hypoplasia	NOUN
fnp-5347	427	38	with	with	ADP
fnp-5347	427	39	emphasis	emphasis	NOUN
fnp-5347	427	40	on	on	ADP
fnp-5347	427	41	the	the	DET
fnp-5347	427	42	posterior	posterior	ADJ
fnp-5347	427	43	quadrant	quadrant	NOUN
fnp-5347	427	44	and	and	CCONJ
fnp-5347	427	45	severe	severe	ADJ
fnp-5347	427	46	epilepsy	epilepsy	NOUN
fnp-5347	427	47	in	in	ADP
fnp-5347	427	48	children	child	NOUN
fnp-5347	427	49	with	with	ADP
fnp-5347	427	50	fcd	fcd	ADJ
fnp-5347	427	51	ilae	ilae	NOUN
fnp-5347	427	52	type	type	NOUN
fnp-5347	427	53	1a	1a	NOUN
fnp-5347	427	54	.	.	PUNCT
fnp-5347	428	1	epilepsia	epilepsia	NOUN
fnp-5347	428	2	63	63	NUM
fnp-5347	428	3	:	:	PUNCT
fnp-5347	428	4	42	42	NUM
fnp-5347	428	5	-	-	SYM
fnp-5347	428	6	60	60	NUM
fnp-5347	428	7	.	.	PUNCT
fnp-5347	429	1	https://doi.org/10.1111/epi.17114	https://doi.org/10.1111/epi.17114	PROPN
fnp-5347	429	2	23	23	NUM
fnp-5347	429	3	.	.	PUNCT
fnp-5347	430	1	honke	honke	PROPN
fnp-5347	430	2	j	j	PROPN
fnp-5347	430	3	,	,	PUNCT
fnp-5347	430	4	hoffmann	hoffmann	PROPN
fnp-5347	430	5	l	l	PROPN
fnp-5347	430	6	,	,	PUNCT
fnp-5347	430	7	coras	coras	PROPN
fnp-5347	430	8	r	r	PROPN
fnp-5347	430	9	,	,	PUNCT
fnp-5347	430	10	kobow	kobow	VERB
fnp-5347	430	11	k	k	PROPN
fnp-5347	430	12	,	,	PUNCT
fnp-5347	430	13	leu	leu	PROPN
fnp-5347	430	14	c	c	PROPN
fnp-5347	430	15	,	,	PUNCT
fnp-5347	430	16	pieper	pieper	PROPN
fnp-5347	430	17	t	t	PROPN
fnp-5347	430	18	,	,	PUNCT
fnp-5347	430	19	hartlieb	hartlieb	PROPN
fnp-5347	430	20	t	t	PROPN
fnp-5347	430	21	,	,	PUNCT
fnp-5347	430	22	bien	bien	PROPN
fnp-5347	430	23	cg	cg	PROPN
fnp-5347	430	24	,	,	PUNCT
fnp-5347	430	25	woermann	woermann	PROPN
fnp-5347	430	26	f	f	PROPN
fnp-5347	430	27	,	,	PUNCT
fnp-5347	430	28	cloppenborg	cloppenborg	PROPN
fnp-5347	430	29	t	t	PROPN
fnp-5347	430	30	et	et	PROPN
fnp-5347	430	31	al	al	PROPN
fnp-5347	430	32	(	(	PUNCT
fnp-5347	430	33	2023	2023	NUM
fnp-5347	430	34	)	)	PUNCT
fnp-5347	430	35	deep	deep	ADJ
fnp-5347	430	36	histopathology	histopathology	NOUN
fnp-5347	430	37	genotype	genotype	NOUN
fnp-5347	430	38	-	-	PUNCT
fnp-5347	430	39	phenotype	phenotype	NOUN
fnp-5347	430	40	analysis	analysis	NOUN
fnp-5347	430	41	of	of	ADP
fnp-5347	430	42	focal	focal	ADJ
fnp-5347	430	43	cortical	cortical	ADJ
fnp-5347	430	44	dysplasia	dysplasia	NOUN
fnp-5347	430	45	type	type	NOUN
fnp-5347	430	46	ii	ii	NOUN
fnp-5347	430	47	differentiates	differentiate	NOUN
fnp-5347	430	48	between	between	ADP
fnp-5347	430	49	the	the	DET
fnp-5347	430	50	gator1	gator1	NOUN
fnp-5347	430	51	-	-	PUNCT
fnp-5347	430	52	altered	alter	VERB
fnp-5347	430	53	autophagocytic	autophagocytic	ADJ
fnp-5347	430	54	subtype	subtype	NOUN
fnp-5347	430	55	iia	iia	NOUN
fnp-5347	430	56	and	and	CCONJ
fnp-5347	430	57	mtor	mtor	NOUN
fnp-5347	430	58	-	-	PUNCT
fnp-5347	430	59	altered	alter	VERB
fnp-5347	430	60	migration	migration	NOUN
fnp-5347	430	61	deficient	deficient	ADJ
fnp-5347	430	62	subtype	subtype	NOUN
fnp-5347	430	63	iib	iib	PROPN
fnp-5347	430	64	.	.	PUNCT
fnp-5347	431	1	acta	acta	PROPN
fnp-5347	431	2	neuropathol	neuropathol	PROPN
fnp-5347	431	3	com	com	PROPN
fnp-5347	431	4	11	11	NUM
fnp-5347	431	5	:	:	PUNCT
fnp-5347	431	6	artn	artn	NOUN
fnp-5347	431	7	179	179	NUM
fnp-5347	431	8	.	.	PUNCT
fnp-5347	432	1	https://doi.org/10.1186/s40478-023-01675-x	https://doi.org/10.1186/s40478-023-01675-x	PROPN
fnp-5347	432	2	24	24	NUM
fnp-5347	432	3	.	.	PUNCT
fnp-5347	433	1	jirsa	jirsa	PROPN
fnp-5347	433	2	v	v	PROPN
fnp-5347	433	3	,	,	PUNCT
fnp-5347	433	4	wang	wang	PROPN
fnp-5347	433	5	h	h	PROPN
fnp-5347	433	6	,	,	PUNCT
fnp-5347	433	7	triebkorn	triebkorn	ADJ
fnp-5347	433	8	p	p	X
fnp-5347	433	9	,	,	PUNCT
fnp-5347	433	10	hashemi	hashemi	PROPN
fnp-5347	433	11	m	m	PROPN
fnp-5347	433	12	,	,	PUNCT
fnp-5347	433	13	jha	jha	PROPN
fnp-5347	433	14	j	j	PROPN
fnp-5347	433	15	,	,	PUNCT
fnp-5347	433	16	gonzalez	gonzalez	PROPN
fnp-5347	433	17	-	-	PUNCT
fnp-5347	433	18	martinez	martinez	PROPN
fnp-5347	433	19	j	j	PROPN
fnp-5347	433	20	,	,	PUNCT
fnp-5347	433	21	guye	guye	PROPN
fnp-5347	433	22	m	m	PROPN
fnp-5347	433	23	,	,	PUNCT
fnp-5347	433	24	makhalova	makhalova	PROPN
fnp-5347	433	25	j	j	PROPN
fnp-5347	433	26	,	,	PUNCT
fnp-5347	433	27	bartolomei	bartolomei	PROPN
fnp-5347	433	28	f	f	PROPN
fnp-5347	433	29	(	(	PUNCT
fnp-5347	433	30	2023	2023	NUM
fnp-5347	433	31	)	)	PUNCT
fnp-5347	433	32	personalised	personalise	VERB
fnp-5347	433	33	virtual	virtual	ADJ
fnp-5347	433	34	brain	brain	NOUN
fnp-5347	433	35	models	model	NOUN
fnp-5347	433	36	in	in	ADP
fnp-5347	433	37	epilepsy	epilepsy	NOUN
fnp-5347	433	38	.	.	PUNCT
fnp-5347	434	1	lancet	lancet	PROPN
fnp-5347	434	2	neurol	neurol	PROPN
fnp-5347	434	3	22	22	NUM
fnp-5347	434	4	:	:	PUNCT
fnp-5347	434	5	443	443	NUM
fnp-5347	434	6	-	-	SYM
fnp-5347	434	7	454	454	NUM
fnp-5347	434	8	.	.	PUNCT
fnp-5347	435	1	https://doi.org/10.1016/s1474-4422(23)00008-x	https://doi.org/10.1016/s1474-4422(23)00008-x	PROPN
fnp-5347	435	2	25	25	NUM
fnp-5347	435	3	.	.	PUNCT
fnp-5347	436	1	kerr	kerr	PROPN
fnp-5347	436	2	wt	wt	PROPN
fnp-5347	436	3	,	,	PUNCT
fnp-5347	436	4	mcfarlane	mcfarlane	PROPN
fnp-5347	436	5	kn	kn	PROPN
fnp-5347	436	6	(	(	PUNCT
fnp-5347	436	7	2023	2023	NUM
fnp-5347	436	8	)	)	PUNCT
fnp-5347	436	9	machine	machine	NOUN
fnp-5347	436	10	learning	learning	NOUN
fnp-5347	436	11	and	and	CCONJ
fnp-5347	436	12	artificial	artificial	ADJ
fnp-5347	436	13	intelligence	intelligence	NOUN
fnp-5347	436	14	applications	application	NOUN
fnp-5347	436	15	to	to	PART
fnp-5347	436	16	epilepsy	epilepsy	VERB
fnp-5347	436	17	:	:	PUNCT
fnp-5347	436	18	a	a	DET
fnp-5347	436	19	review	review	NOUN
fnp-5347	436	20	for	for	ADP
fnp-5347	436	21	the	the	DET
fnp-5347	436	22	practicing	practice	VERB
fnp-5347	436	23	epileptologist	epileptologist	NOUN
fnp-5347	436	24	.	.	PUNCT
fnp-5347	437	1	curr	curr	PROPN
fnp-5347	437	2	neurol	neurol	PROPN
fnp-5347	437	3	neurosci	neurosci	PROPN
fnp-5347	437	4	rep	rep	PROPN
fnp-5347	437	5	23	23	NUM
fnp-5347	437	6	:	:	PUNCT
fnp-5347	437	7	869	869	NUM
fnp-5347	437	8	-	-	SYM
fnp-5347	437	9	879	879	NUM
fnp-5347	437	10	.	.	PUNCT
fnp-5347	438	1	https://doi.org/10.1007/s11910-023-01318-7	https://doi.org/10.1007/s11910-023-01318-7	NUM
fnp-5347	438	2	26	26	NUM
fnp-5347	438	3	.	.	PUNCT
fnp-5347	439	1	khoshkhoo	khoshkhoo	PROPN
fnp-5347	439	2	s	s	PROPN
fnp-5347	439	3	,	,	PUNCT
fnp-5347	439	4	wang	wang	PROPN
fnp-5347	439	5	yl	yl	NOUN
fnp-5347	439	6	,	,	PUNCT
fnp-5347	439	7	chahine	chahine	VERB
fnp-5347	439	8	y	y	PROPN
fnp-5347	439	9	,	,	PUNCT
fnp-5347	439	10	erson	erson	PROPN
fnp-5347	439	11	-	-	PUNCT
fnp-5347	439	12	omay	omay	PROPN
fnp-5347	439	13	ez	ez	PROPN
fnp-5347	439	14	,	,	PUNCT
fnp-5347	439	15	robert	robert	PROPN
fnp-5347	439	16	sm	sm	PROPN
fnp-5347	439	17	,	,	PUNCT
fnp-5347	439	18	kiziltug	kiziltug	PROPN
fnp-5347	439	19	e	e	PROPN
fnp-5347	439	20	,	,	PUNCT
fnp-5347	439	21	damisah	damisah	VERB
fnp-5347	439	22	ec	ec	PROPN
fnp-5347	439	23	,	,	PUNCT
fnp-5347	439	24	nelson	nelson	PROPN
fnp-5347	439	25	-	-	PUNCT
fnp-5347	439	26	williams	williams	PROPN
fnp-5347	439	27	c	c	PROPN
fnp-5347	439	28	,	,	PUNCT
fnp-5347	439	29	zhu	zhu	PROPN
fnp-5347	439	30	gy	gy	PROPN
fnp-5347	439	31	,	,	PUNCT
fnp-5347	439	32	kong	kong	PROPN
fnp-5347	439	33	wn	wn	PROPN
fnp-5347	439	34	et	et	PROPN
fnp-5347	439	35	al	al	PROPN
fnp-5347	439	36	(	(	PUNCT
fnp-5347	439	37	2023	2023	NUM
fnp-5347	439	38	)	)	PUNCT
fnp-5347	439	39	contribution	contribution	NOUN
fnp-5347	439	40	of	of	ADP
fnp-5347	439	41	somatic	somatic	ADJ
fnp-5347	439	42	ras	ras	PROPN
fnp-5347	439	43	/	/	SYM
fnp-5347	439	44	raf	raf	PROPN
fnp-5347	439	45	/	/	SYM
fnp-5347	439	46	mitogen	mitogen	NOUN
fnp-5347	439	47	-	-	PUNCT
fnp-5347	439	48	activated	activate	VERB
fnp-5347	439	49	protein	protein	NOUN
fnp-5347	439	50	kinase	kinase	PROPN
fnp-5347	439	51	variants	variant	NOUN
fnp-5347	439	52	in	in	ADP
fnp-5347	439	53	the	the	DET
fnp-5347	439	54	hippocampus	hippocampus	NOUN
fnp-5347	439	55	in	in	ADP
fnp-5347	439	56	drug	drug	NOUN
fnp-5347	439	57	-	-	PUNCT
fnp-5347	439	58	resistant	resistant	ADJ
fnp-5347	439	59	mesial	mesial	ADJ
fnp-5347	439	60	temporal	temporal	ADJ
fnp-5347	439	61	lobe	lobe	NOUN
fnp-5347	439	62	epilepsy	epilepsy	NOUN
fnp-5347	439	63	.	.	PUNCT
fnp-5347	440	1	jama	jama	PROPN
fnp-5347	440	2	neurology	neurology	NOUN
fnp-5347	440	3	80	80	NUM
fnp-5347	440	4	:	:	PUNCT
fnp-5347	440	5	578	578	NUM
fnp-5347	440	6	-	-	SYM
fnp-5347	440	7	587	587	NUM
fnp-5347	440	8	.	.	PUNCT
fnp-5347	441	1	https://doi.org/10.1001/jamaneurol.2023.0473	https://doi.org/10.1001/jamaneurol.2023.0473	NOUN
fnp-5347	441	2	27	27	NUM
fnp-5347	441	3	.	.	PUNCT
fnp-5347	442	1	kolble	kolble	PROPN
fnp-5347	442	2	k	k	PROPN
fnp-5347	442	3	,	,	PUNCT
fnp-5347	442	4	cross	cross	PROPN
fnp-5347	442	5	jh	jh	PROPN
fnp-5347	442	6	,	,	PUNCT
fnp-5347	442	7	becker	becker	PROPN
fnp-5347	443	1	a	a	PRON
fnp-5347	443	2	,	,	PUNCT
fnp-5347	443	3	blumcke	blumcke	INTJ
fnp-5347	443	4	i	i	PRON
fnp-5347	443	5	(	(	PUNCT
fnp-5347	443	6	2018	2018	NUM
fnp-5347	443	7	)	)	PUNCT
fnp-5347	443	8	a	a	DET
fnp-5347	443	9	web	web	NOUN
fnp-5347	443	10	-	-	PUNCT
fnp-5347	443	11	based	base	VERB
fnp-5347	443	12	diagnostic	diagnostic	ADJ
fnp-5347	443	13	reference	reference	NOUN
fnp-5347	443	14	centre	centre	NOUN
fnp-5347	443	15	for	for	ADP
fnp-5347	443	16	the	the	DET
fnp-5347	443	17	european	european	ADJ
fnp-5347	443	18	reference	reference	NOUN
fnp-5347	443	19	network	network	NOUN
fnp-5347	443	20	"	"	PUNCT
fnp-5347	443	21	epicare	epicare	NOUN
fnp-5347	443	22	"	"	PUNCT
fnp-5347	443	23	:	:	PUNCT
fnp-5347	443	24	recommendations	recommendation	NOUN
fnp-5347	443	25	of	of	ADP
fnp-5347	443	26	the	the	DET
fnp-5347	443	27	eneuropathology	eneuropathology	NOUN
fnp-5347	443	28	working	working	NOUN
fnp-5347	443	29	group	group	NOUN
fnp-5347	443	30	.	.	PUNCT
fnp-5347	444	1	epileptic	epileptic	ADJ
fnp-5347	444	2	disord	disord	NOUN
fnp-5347	444	3	20	20	NUM
fnp-5347	444	4	:	:	PUNCT
fnp-5347	444	5	339	339	NUM
fnp-5347	444	6	-	-	SYM
fnp-5347	444	7	345	345	NUM
fnp-5347	444	8	.	.	PUNCT
fnp-5347	445	1	https://doi.org/10.1684/epd.2018.1002	https://doi.org/10.1684/epd.2018.1002	NOUN
fnp-5347	445	2	28	28	NUM
fnp-5347	445	3	.	.	PUNCT
fnp-5347	446	1	lamberink	lamberink	PROPN
fnp-5347	446	2	hj	hj	PROPN
fnp-5347	446	3	,	,	PUNCT
fnp-5347	446	4	otte	otte	PROPN
fnp-5347	446	5	wm	wm	PROPN
fnp-5347	446	6	,	,	PUNCT
fnp-5347	446	7	blümcke	blümcke	PROPN
fnp-5347	446	8	i	i	PROPN
fnp-5347	446	9	,	,	PUNCT
fnp-5347	446	10	braun	braun	PROPN
fnp-5347	446	11	kpj	kpj	PROPN
fnp-5347	446	12	(	(	PUNCT
fnp-5347	446	13	2020	2020	NUM
fnp-5347	446	14	)	)	PUNCT
fnp-5347	446	15	seizure	seizure	NOUN
fnp-5347	446	16	outcome	outcome	NOUN
fnp-5347	446	17	and	and	CCONJ
fnp-5347	446	18	use	use	NOUN
fnp-5347	446	19	of	of	ADP
fnp-5347	446	20	antiepileptic	antiepileptic	ADJ
fnp-5347	446	21	drugs	drug	NOUN
fnp-5347	446	22	after	after	ADP
fnp-5347	446	23	epilepsy	epilepsy	NOUN
fnp-5347	446	24	surgery	surgery	NOUN
fnp-5347	446	25	according	accord	VERB
fnp-5347	446	26	to	to	ADP
fnp-5347	446	27	histopathological	histopathological	ADJ
fnp-5347	446	28	diagnosis	diagnosis	NOUN
fnp-5347	446	29	:	:	PUNCT
fnp-5347	446	30	a	a	DET
fnp-5347	446	31	retrospective	retrospective	ADJ
fnp-5347	446	32	multicentre	multicentre	NOUN
fnp-5347	446	33	cohort	cohort	NOUN
fnp-5347	446	34	study	study	NOUN
fnp-5347	446	35	.	.	PUNCT
fnp-5347	447	1	lancet	lancet	PROPN
fnp-5347	447	2	neurol	neurol	PROPN
fnp-5347	447	3	19	19	NUM
fnp-5347	447	4	:	:	SYM
fnp-5347	447	5	748	748	NUM
fnp-5347	447	6	-	-	SYM
fnp-5347	447	7	757	757	PROPN
fnp-5347	447	8	.	.	PUNCT
fnp-5347	448	1	https://doi.org/10.1016/s1474-4422(20)30220-9	https://doi.org/10.1016/s1474-4422(20)30220-9	PROPN
fnp-5347	448	2	29	29	NUM
fnp-5347	448	3	.	.	PUNCT
fnp-5347	449	1	lerond	lerond	PROPN
fnp-5347	449	2	j	j	PROPN
fnp-5347	449	3	,	,	PUNCT
fnp-5347	449	4	mathon	mathon	PROPN
fnp-5347	449	5	b	b	PROPN
fnp-5347	449	6	,	,	PUNCT
fnp-5347	449	7	scopin	scopin	PROPN
fnp-5347	449	8	m	m	PROPN
fnp-5347	449	9	,	,	PUNCT
fnp-5347	449	10	nichelli	nichelli	PROPN
fnp-5347	449	11	l	l	PROPN
fnp-5347	449	12	,	,	PUNCT
fnp-5347	449	13	guegan	guegan	PROPN
fnp-5347	449	14	j	j	NOUN
fnp-5347	449	15	,	,	PUNCT
fnp-5347	449	16	bertholle	bertholle	PROPN
fnp-5347	449	17	c	c	PROPN
fnp-5347	449	18	,	,	PUNCT
fnp-5347	449	19	izac	izac	PROPN
fnp-5347	449	20	b	b	PROPN
fnp-5347	449	21	,	,	PUNCT
fnp-5347	449	22	andrieu	andrieu	PROPN
fnp-5347	449	23	m	m	PROPN
fnp-5347	449	24	,	,	PUNCT
fnp-5347	449	25	gareau	gareau	PROPN
fnp-5347	449	26	t	t	PROPN
fnp-5347	449	27	,	,	PUNCT
fnp-5347	449	28	donneger	donneger	PROPN
fnp-5347	449	29	f	f	PROPN
fnp-5347	449	30	et	et	PROPN
fnp-5347	449	31	al	al	PROPN
fnp-5347	449	32	(	(	PUNCT
fnp-5347	449	33	2023	2023	NUM
fnp-5347	449	34	)	)	PUNCT
fnp-5347	449	35	hippocampal	hippocampal	NOUN
fnp-5347	449	36	and	and	CCONJ
fnp-5347	449	37	neocortical	neocortical	ADJ
fnp-5347	449	38	braf	braf	NOUN
fnp-5347	449	39	mutant	mutant	ADJ
fnp-5347	449	40	non	non	ADJ
fnp-5347	449	41	-	-	ADJ
fnp-5347	449	42	expansive	expansive	ADJ
fnp-5347	449	43	lesions	lesion	NOUN
fnp-5347	449	44	in	in	ADP
fnp-5347	449	45	focal	focal	ADJ
fnp-5347	449	46	epilepsies	epilepsy	NOUN
fnp-5347	449	47	.	.	PUNCT
fnp-5347	450	1	neuropathol	neuropathol	NOUN
fnp-5347	450	2	appl	appl	PROPN
fnp-5347	450	3	neurobiol	neurobiol	PROPN
fnp-5347	450	4	49	49	NUM
fnp-5347	450	5	:	:	PUNCT
fnp-5347	450	6	e12937	e12937	NOUN
fnp-5347	450	7	.	.	PUNCT
fnp-5347	451	1	https://doi.org/10.1111/nan.12937	https://doi.org/10.1111/nan.12937	PROPN
fnp-5347	451	2	30	30	NUM
fnp-5347	451	3	.	.	PUNCT
fnp-5347	452	1	lopez	lopez	PROPN
fnp-5347	452	2	-	-	PUNCT
fnp-5347	452	3	rivera	rivera	PROPN
fnp-5347	452	4	ja	ja	PROPN
fnp-5347	452	5	,	,	PUNCT
fnp-5347	452	6	leu	leu	PROPN
fnp-5347	452	7	c	c	PROPN
fnp-5347	452	8	,	,	PUNCT
fnp-5347	452	9	macnee	macnee	PROPN
fnp-5347	452	10	m	m	PROPN
fnp-5347	452	11	,	,	PUNCT
fnp-5347	452	12	khoury	khoury	PROPN
fnp-5347	452	13	j	j	PROPN
fnp-5347	452	14	,	,	PUNCT
fnp-5347	452	15	hoffmann	hoffmann	PROPN
fnp-5347	452	16	l	l	PROPN
fnp-5347	452	17	,	,	PUNCT
fnp-5347	452	18	coras	coras	PROPN
fnp-5347	452	19	r	r	PROPN
fnp-5347	452	20	,	,	PUNCT
fnp-5347	452	21	kobow	kobow	VERB
fnp-5347	452	22	k	k	PROPN
fnp-5347	452	23	,	,	PUNCT
fnp-5347	452	24	bhattarai	bhattarai	ADJ
fnp-5347	452	25	n	n	CCONJ
fnp-5347	452	26	,	,	PUNCT
fnp-5347	452	27	perez	perez	PROPN
fnp-5347	452	28	-	-	PUNCT
fnp-5347	452	29	palma	palma	NOUN
fnp-5347	452	30	e	e	NOUN
fnp-5347	452	31	,	,	PUNCT
fnp-5347	452	32	hamer	hamer	NOUN
fnp-5347	452	33	h	h	NOUN
fnp-5347	452	34	et	et	PROPN
fnp-5347	452	35	al	al	PROPN
fnp-5347	452	36	(	(	PUNCT
fnp-5347	452	37	2022	2022	NUM
fnp-5347	452	38	)	)	PUNCT
fnp-5347	452	39	the	the	DET
fnp-5347	452	40	genomic	genomic	ADJ
fnp-5347	452	41	landscape	landscape	NOUN
fnp-5347	452	42	across	across	ADP
fnp-5347	452	43	474	474	NUM
fnp-5347	452	44	surgically	surgically	ADV
fnp-5347	452	45	accessible	accessible	ADJ
fnp-5347	452	46	epileptogenic	epileptogenic	ADJ
fnp-5347	452	47	human	human	ADJ
fnp-5347	452	48	brain	brain	NOUN
fnp-5347	452	49	lesions	lesion	NOUN
fnp-5347	452	50	.	.	PUNCT
fnp-5347	453	1	brain	brain	NOUN
fnp-5347	453	2	:	:	PUNCT
fnp-5347	453	3	.	.	PUNCT
fnp-5347	454	1	https://doi.org/10.1093/brain/awac376	https://doi.org/10.1093/brain/awac376	PROPN
fnp-5347	454	2	31	31	NUM
fnp-5347	454	3	.	.	PUNCT
fnp-5347	455	1	macdonald	macdonald	PROPN
fnp-5347	455	2	-	-	PUNCT
fnp-5347	455	3	laurs	laurs	PROPN
fnp-5347	455	4	e	e	NOUN
fnp-5347	455	5	,	,	PUNCT
fnp-5347	455	6	warren	warren	PROPN
fnp-5347	455	7	ael	ael	PROPN
fnp-5347	455	8	,	,	PUNCT
fnp-5347	455	9	francis	francis	PROPN
fnp-5347	455	10	p	p	PROPN
fnp-5347	455	11	,	,	PUNCT
fnp-5347	455	12	mandelstam	mandelstam	PROPN
fnp-5347	455	13	sa	sa	PROPN
fnp-5347	455	14	,	,	PUNCT
fnp-5347	455	15	lee	lee	PROPN
fnp-5347	455	16	ws	ws	PROPN
fnp-5347	455	17	,	,	PUNCT
fnp-5347	455	18	coleman	coleman	PROPN
fnp-5347	455	19	m	m	PROPN
fnp-5347	455	20	,	,	PUNCT
fnp-5347	455	21	stephenson	stephenson	PROPN
fnp-5347	455	22	sem	sem	PROPN
fnp-5347	455	23	,	,	PUNCT
fnp-5347	455	24	barton	barton	PROPN
fnp-5347	455	25	s	s	PROPN
fnp-5347	455	26	,	,	PUNCT
fnp-5347	455	27	d'arcy	d'arcy	PROPN
fnp-5347	455	28	c	c	PROPN
fnp-5347	455	29	,	,	PUNCT
fnp-5347	455	30	lockhart	lockhart	PROPN
fnp-5347	455	31	pj	pj	PROPN
fnp-5347	455	32	et	et	PROPN
fnp-5347	455	33	al	al	PROPN
fnp-5347	455	34	(	(	PUNCT
fnp-5347	455	35	2023	2023	NUM
fnp-5347	455	36	)	)	PUNCT
fnp-5347	455	37	the	the	DET
fnp-5347	455	38	clinical	clinical	ADJ
fnp-5347	455	39	,	,	PUNCT
fnp-5347	455	40	imaging	imaging	NOUN
fnp-5347	455	41	,	,	PUNCT
fnp-5347	455	42	pathological	pathological	ADJ
fnp-5347	455	43	and	and	CCONJ
fnp-5347	455	44	genetic	genetic	ADJ
fnp-5347	455	45	landscape	landscape	NOUN
fnp-5347	455	46	of	of	ADP
fnp-5347	455	47	bottom	bottom	ADJ
fnp-5347	455	48	-	-	PUNCT
fnp-5347	455	49	of	of	ADP
fnp-5347	455	50	-	-	PUNCT
fnp-5347	455	51	sulcus	sulcus	NOUN
fnp-5347	455	52	dysplasia	dysplasia	NOUN
fnp-5347	455	53	.	.	PUNCT
fnp-5347	456	1	brain	brain	NOUN
fnp-5347	456	2	:	:	PUNCT
fnp-5347	456	3	.	.	PUNCT
fnp-5347	457	1	https://doi.org/10.1093/brain/awad379	https://doi.org/10.1093/brain/awad379	X
fnp-5347	457	2	32	32	NUM
fnp-5347	457	3	.	.	PUNCT
fnp-5347	458	1	mu	mu	PROPN
fnp-5347	458	2	y	y	PROPN
fnp-5347	458	3	,	,	PUNCT
fnp-5347	458	4	bennett	bennett	PROPN
fnp-5347	458	5	dv	dv	PROPN
fnp-5347	458	6	,	,	PUNCT
fnp-5347	458	7	rubinov	rubinov	PROPN
fnp-5347	458	8	m	m	PROPN
fnp-5347	458	9	,	,	PUNCT
fnp-5347	458	10	narayan	narayan	PROPN
fnp-5347	458	11	s	s	PROPN
fnp-5347	458	12	,	,	PUNCT
fnp-5347	458	13	yang	yang	PROPN
fnp-5347	458	14	ct	ct	PROPN
fnp-5347	458	15	,	,	PUNCT
fnp-5347	458	16	tanimoto	tanimoto	PROPN
fnp-5347	458	17	m	m	PROPN
fnp-5347	458	18	,	,	PUNCT
fnp-5347	458	19	mensh	mensh	PROPN
fnp-5347	458	20	bd	bd	PROPN
fnp-5347	458	21	,	,	PUNCT
fnp-5347	458	22	looger	looger	PROPN
fnp-5347	458	23	ll	ll	PROPN
fnp-5347	458	24	,	,	PUNCT
fnp-5347	458	25	ahrens	ahren	VERB
fnp-5347	458	26	mb	mb	ADP
fnp-5347	458	27	(	(	PUNCT
fnp-5347	458	28	2019	2019	NUM
fnp-5347	458	29	)	)	PUNCT
fnp-5347	458	30	glia	glia	NOUN
fnp-5347	458	31	accumulate	accumulate	VERB
fnp-5347	458	32	evidence	evidence	NOUN
fnp-5347	458	33	that	that	SCONJ
fnp-5347	458	34	actions	action	NOUN
fnp-5347	458	35	are	be	AUX
fnp-5347	458	36	futile	futile	ADJ
fnp-5347	458	37	and	and	CCONJ
fnp-5347	458	38	suppress	suppress	VERB
fnp-5347	458	39	unsuccessful	unsuccessful	ADJ
fnp-5347	458	40	behavior	behavior	NOUN
fnp-5347	458	41	.	.	PUNCT
fnp-5347	459	1	cell	cell	NOUN
fnp-5347	459	2	178	178	NUM
fnp-5347	459	3	:	:	PUNCT
fnp-5347	459	4	27	27	NUM
fnp-5347	459	5	-	-	SYM
fnp-5347	459	6	43	43	NUM
fnp-5347	459	7	e19	e19	NOUN
fnp-5347	459	8	.	.	PUNCT
fnp-5347	460	1	https://doi.org/10.1016/j.cell.2019.05.050	https://doi.org/10.1016/j.cell.2019.05.050	PROPN
fnp-5347	460	2	33	33	NUM
fnp-5347	460	3	.	.	PUNCT
fnp-5347	461	1	najm	najm	PROPN
fnp-5347	461	2	i	i	PROPN
fnp-5347	461	3	,	,	PUNCT
fnp-5347	461	4	lal	lal	PROPN
fnp-5347	461	5	d	d	PROPN
fnp-5347	461	6	,	,	PUNCT
fnp-5347	461	7	vanegas	vanegas	PROPN
fnp-5347	461	8	ma	ma	PROPN
fnp-5347	461	9	,	,	PUNCT
fnp-5347	461	10	cendes	cende	VERB
fnp-5347	461	11	f	f	PROPN
fnp-5347	461	12	,	,	PUNCT
fnp-5347	461	13	lopes	lope	NOUN
fnp-5347	461	14	-	-	PUNCT
fnp-5347	461	15	cendes	cende	VERB
fnp-5347	461	16	i	i	PROPN
fnp-5347	461	17	,	,	PUNCT
fnp-5347	461	18	palmini	palmini	PROPN
fnp-5347	461	19	a	a	PRON
fnp-5347	461	20	,	,	PUNCT
fnp-5347	461	21	paglioli	paglioli	NOUN
fnp-5347	461	22	e	e	NOUN
fnp-5347	461	23	,	,	PUNCT
fnp-5347	461	24	sarnat	sarnat	PROPN
fnp-5347	461	25	hb	hb	PROPN
fnp-5347	461	26	,	,	PUNCT
fnp-5347	461	27	walsh	walsh	PROPN
fnp-5347	461	28	ca	ca	PROPN
fnp-5347	461	29	,	,	PUNCT
fnp-5347	461	30	wiebe	wiebe	PROPN
fnp-5347	461	31	s	s	PROPN
fnp-5347	461	32	et	et	PROPN
fnp-5347	461	33	al	al	PROPN
fnp-5347	461	34	(	(	PUNCT
fnp-5347	461	35	2022	2022	NUM
fnp-5347	461	36	)	)	PUNCT
fnp-5347	461	37	the	the	DET
fnp-5347	461	38	ilae	ilae	NOUN
fnp-5347	461	39	consensus	consensus	NOUN
fnp-5347	461	40	classification	classification	NOUN
fnp-5347	461	41	of	of	ADP
fnp-5347	461	42	focal	focal	ADJ
fnp-5347	461	43	cortical	cortical	ADJ
fnp-5347	461	44	dysplasia	dysplasia	NOUN
fnp-5347	461	45	:	:	PUNCT
fnp-5347	461	46	an	an	DET
fnp-5347	461	47	update	update	NOUN
fnp-5347	461	48	proposed	propose	VERB
fnp-5347	461	49	by	by	ADP
fnp-5347	461	50	an	an	DET
fnp-5347	461	51	ad	ad	X
fnp-5347	461	52	hoc	hoc	X
fnp-5347	461	53	task	task	NOUN
fnp-5347	461	54	force	force	NOUN
fnp-5347	461	55	of	of	ADP
fnp-5347	461	56	the	the	DET
fnp-5347	461	57	ilae	ilae	NOUN
fnp-5347	461	58	diagnostic	diagnostic	ADJ
fnp-5347	461	59	methods	method	NOUN
fnp-5347	461	60	commission	commission	NOUN
fnp-5347	461	61	.	.	PUNCT
fnp-5347	462	1	epilepsia	epilepsia	NOUN
fnp-5347	462	2	63	63	NUM
fnp-5347	462	3	:	:	SYM
fnp-5347	462	4	1899	1899	NUM
fnp-5347	462	5	-	-	SYM
fnp-5347	462	6	1919	1919	NUM
fnp-5347	462	7	.	.	PUNCT
fnp-5347	463	1	https://doi.org/10.1111/epi.17301	https://doi.org/10.1111/epi.17301	NOUN
fnp-5347	463	2	34	34	NUM
fnp-5347	463	3	.	.	PUNCT
fnp-5347	464	1	pitsch	pitsch	PROPN
fnp-5347	464	2	j	j	PROPN
fnp-5347	464	3	,	,	PUNCT
fnp-5347	464	4	kuehn	kuehn	PROPN
fnp-5347	464	5	jc	jc	PROPN
fnp-5347	464	6	,	,	PUNCT
fnp-5347	464	7	gnatkovsky	gnatkovsky	NOUN
fnp-5347	464	8	v	v	PROPN
fnp-5347	464	9	,	,	PUNCT
fnp-5347	464	10	muller	muller	PROPN
fnp-5347	464	11	ja	ja	PROPN
fnp-5347	464	12	,	,	PUNCT
fnp-5347	464	13	van	van	PROPN
fnp-5347	464	14	loo	loo	PROPN
fnp-5347	464	15	kmj	kmj	PROPN
fnp-5347	464	16	,	,	PUNCT
fnp-5347	464	17	de	de	PROPN
fnp-5347	464	18	curtis	curtis	PROPN
fnp-5347	464	19	m	m	PROPN
fnp-5347	464	20	,	,	PUNCT
fnp-5347	464	21	vatter	vatter	PROPN
fnp-5347	464	22	h	h	NOUN
fnp-5347	464	23	,	,	PUNCT
fnp-5347	464	24	schoch	schoch	PROPN
fnp-5347	464	25	s	s	PROPN
fnp-5347	464	26	,	,	PUNCT
fnp-5347	464	27	elger	elger	PROPN
fnp-5347	464	28	ce	ce	PROPN
fnp-5347	464	29	,	,	PUNCT
fnp-5347	464	30	becker	becker	PROPN
fnp-5347	464	31	aj	aj	PROPN
fnp-5347	464	32	(	(	PUNCT
fnp-5347	464	33	2019	2019	NUM
fnp-5347	464	34	)	)	PUNCT
fnp-5347	464	35	anti	anti	ADJ
fnp-5347	464	36	-	-	ADJ
fnp-5347	464	37	epileptogenic	epileptogenic	ADJ
fnp-5347	464	38	and	and	CCONJ
fnp-5347	464	39	anti	anti	ADJ
fnp-5347	464	40	-	-	ADJ
fnp-5347	464	41	convulsive	convulsive	ADJ
fnp-5347	464	42	effects	effect	NOUN
fnp-5347	464	43	of	of	ADP
fnp-5347	464	44	fingolimod	fingolimod	NOUN
fnp-5347	464	45	in	in	ADP
fnp-5347	464	46	experimental	experimental	ADJ
fnp-5347	464	47	temporal	temporal	ADJ
fnp-5347	464	48	lobe	lobe	NOUN
fnp-5347	464	49	epilepsy	epilepsy	NOUN
fnp-5347	464	50	.	.	PUNCT
fnp-5347	465	1	mol	mol	ADP
fnp-5347	465	2	neurobiol	neurobiol	PROPN
fnp-5347	465	3	56	56	NUM
fnp-5347	465	4	:	:	PUNCT
fnp-5347	465	5	1825	1825	NUM
fnp-5347	465	6	-	-	SYM
fnp-5347	465	7	1840	1840	NUM
fnp-5347	465	8	.	.	PUNCT
fnp-5347	466	1	https://doi.org/10.1007/s12035-018-1181-y	https://doi.org/10.1007/s12035-018-1181-y	PROPN
fnp-5347	466	2	35	35	NUM
fnp-5347	466	3	.	.	PUNCT
fnp-5347	467	1	reinhardt	reinhardt	PROPN
fnp-5347	467	2	a	a	PROPN
fnp-5347	467	3	,	,	PUNCT
fnp-5347	467	4	pfister	pfister	PROPN
fnp-5347	467	5	k	k	PROPN
fnp-5347	467	6	,	,	PUNCT
fnp-5347	467	7	schrimpf	schrimpf	NOUN
fnp-5347	467	8	d	d	PROPN
fnp-5347	467	9	,	,	PUNCT
fnp-5347	467	10	stichel	stichel	PROPN
fnp-5347	467	11	d	d	PROPN
fnp-5347	467	12	,	,	PUNCT
fnp-5347	467	13	sahm	sahm	PROPN
fnp-5347	467	14	f	f	PROPN
fnp-5347	467	15	,	,	PUNCT
fnp-5347	467	16	al	al	PROPN
fnp-5347	467	17	.	.	PUNCT
fnp-5347	467	18	e	e	PROPN
fnp-5347	467	19	(	(	PUNCT
fnp-5347	467	20	2022	2022	NUM
fnp-5347	467	21	)	)	PUNCT
fnp-5347	467	22	anaplastic	anaplastic	ADJ
fnp-5347	467	23	ganglioglioma	ganglioglioma	NOUN
fnp-5347	467	24	–	–	PUNCT
fnp-5347	467	25	a	a	DET
fnp-5347	467	26	diagnosis	diagnosis	NOUN
fnp-5347	467	27	comprising	comprise	VERB
fnp-5347	467	28	several	several	ADJ
fnp-5347	467	29	distinct	distinct	ADJ
fnp-5347	467	30	tumour	tumour	NOUN
fnp-5347	467	31	types	type	NOUN
fnp-5347	467	32	.	.	PUNCT
fnp-5347	468	1	neuropathology	neuropathology	NOUN
fnp-5347	468	2	and	and	CCONJ
fnp-5347	468	3	applied	apply	VERB
fnp-5347	468	4	neurobiology	neurobiology	NOUN
fnp-5347	468	5	48	48	NUM
fnp-5347	468	6	(	(	PUNCT
fnp-5347	468	7	7	7	NUM
fnp-5347	468	8	):	):	PUNCT
fnp-5347	468	9	e12847	e12847	NOUN
fnp-5347	468	10	.	.	PUNCT
fnp-5347	469	1	https://doi.org/10.1111/nan.12847	https://doi.org/10.1111/nan.12847	PROPN
fnp-5347	469	2	36	36	NUM
fnp-5347	469	3	.	.	PUNCT
fnp-5347	470	1	ribierre	ribierre	PROPN
fnp-5347	470	2	t	t	PROPN
fnp-5347	470	3	,	,	PUNCT
fnp-5347	470	4	deleuze	deleuze	PROPN
fnp-5347	470	5	c	c	PROPN
fnp-5347	470	6	,	,	PUNCT
fnp-5347	470	7	bacq	bacq	PROPN
fnp-5347	470	8	a	a	NOUN
fnp-5347	470	9	,	,	PUNCT
fnp-5347	470	10	baldassari	baldassari	PROPN
fnp-5347	470	11	s	s	PROPN
fnp-5347	470	12	,	,	PUNCT
fnp-5347	470	13	marsan	marsan	PROPN
fnp-5347	470	14	e	e	PROPN
fnp-5347	470	15	,	,	PUNCT
fnp-5347	470	16	chipaux	chipaux	ADV
fnp-5347	470	17	m	m	PROPN
fnp-5347	470	18	,	,	PUNCT
fnp-5347	470	19	muraca	muraca	PROPN
fnp-5347	470	20	g	g	PROPN
fnp-5347	470	21	,	,	PUNCT
fnp-5347	470	22	roussel	roussel	PROPN
fnp-5347	470	23	d	d	PROPN
fnp-5347	470	24	,	,	PUNCT
fnp-5347	470	25	navarro	navarro	PROPN
fnp-5347	470	26	v	v	PROPN
fnp-5347	470	27	,	,	PUNCT
fnp-5347	470	28	leguern	leguern	ADJ
fnp-5347	470	29	e	e	PROPN
fnp-5347	470	30	et	et	PROPN
fnp-5347	470	31	al	al	PROPN
fnp-5347	470	32	(	(	PUNCT
fnp-5347	470	33	2018	2018	NUM
fnp-5347	470	34	)	)	PUNCT
fnp-5347	470	35	second	second	ADV
fnp-5347	470	36	-	-	PUNCT
fnp-5347	470	37	hit	hit	VERB
fnp-5347	470	38	mosaic	mosaic	ADJ
fnp-5347	470	39	mutation	mutation	NOUN
fnp-5347	470	40	in	in	ADP
fnp-5347	470	41	mtorc1	mtorc1	PROPN
fnp-5347	470	42	repressor	repressor	NOUN
fnp-5347	470	43	depdc5	depdc5	NOUN
fnp-5347	470	44	causes	cause	VERB
fnp-5347	470	45	focal	focal	ADJ
fnp-5347	470	46	cortical	cortical	ADJ
fnp-5347	470	47	dysplasia	dysplasia	NOUN
fnp-5347	470	48	-	-	PUNCT
fnp-5347	470	49	associated	associate	VERB
fnp-5347	470	50	epilepsy	epilepsy	NOUN
fnp-5347	470	51	.	.	PUNCT
fnp-5347	471	1	j	j	PROPN
fnp-5347	471	2	clin	clin	PROPN
fnp-5347	471	3	invest	invest	VERB
fnp-5347	471	4	128	128	NUM
fnp-5347	471	5	:	:	SYM
fnp-5347	471	6	2452	2452	NUM
fnp-5347	471	7	-	-	SYM
fnp-5347	471	8	2458	2458	NUM
fnp-5347	471	9	.	.	PUNCT
fnp-5347	472	1	https://doi.org/10.1172/jci99384	https://doi.org/10.1172/jci99384	PROPN
fnp-5347	472	2	37	37	NUM
fnp-5347	472	3	.	.	PUNCT
fnp-5347	473	1	schurr	schurr	PROPN
fnp-5347	473	2	j	j	PROPN
fnp-5347	473	3	,	,	PUNCT
fnp-5347	473	4	coras	coras	PROPN
fnp-5347	473	5	r	r	PROPN
fnp-5347	473	6	,	,	PUNCT
fnp-5347	473	7	rossler	rossler	PROPN
fnp-5347	473	8	k	k	PROPN
fnp-5347	473	9	,	,	PUNCT
fnp-5347	473	10	pieper	pieper	PROPN
fnp-5347	473	11	t	t	PROPN
fnp-5347	473	12	,	,	PUNCT
fnp-5347	473	13	kudernatsch	kudernatsch	PROPN
fnp-5347	473	14	m	m	PROPN
fnp-5347	473	15	,	,	PUNCT
fnp-5347	473	16	holthausen	holthausen	NOUN
fnp-5347	473	17	h	h	PROPN
fnp-5347	473	18	,	,	PUNCT
fnp-5347	473	19	winkler	winkler	NOUN
fnp-5347	473	20	p	p	NOUN
fnp-5347	473	21	,	,	PUNCT
fnp-5347	473	22	woermann	woermann	PROPN
fnp-5347	473	23	f	f	PROPN
fnp-5347	473	24	,	,	PUNCT
fnp-5347	473	25	bien	bien	PROPN
fnp-5347	473	26	cg	cg	PROPN
fnp-5347	473	27	,	,	PUNCT
fnp-5347	473	28	polster	polster	PROPN
fnp-5347	473	29	t	t	PROPN
fnp-5347	473	30	et	et	PROPN
fnp-5347	473	31	al	al	PROPN
fnp-5347	473	32	(	(	PUNCT
fnp-5347	473	33	2017	2017	NUM
fnp-5347	473	34	)	)	PUNCT
fnp-5347	473	35	mild	mild	ADJ
fnp-5347	473	36	malformation	malformation	NOUN
fnp-5347	473	37	of	of	ADP
fnp-5347	473	38	cortical	cortical	ADJ
fnp-5347	473	39	development	development	NOUN
fnp-5347	473	40	with	with	ADP
fnp-5347	473	41	oligodendroglial	oligodendroglial	ADJ
fnp-5347	473	42	hyperplasia	hyperplasia	NOUN
fnp-5347	473	43	in	in	ADP
fnp-5347	473	44	frontal	frontal	ADJ
fnp-5347	473	45	lobe	lobe	NOUN
fnp-5347	473	46	epilepsy	epilepsy	NOUN
fnp-5347	473	47	:	:	PUNCT
fnp-5347	473	48	a	a	DET
fnp-5347	473	49	new	new	ADJ
fnp-5347	473	50	clinico	clinico	ADJ
fnp-5347	473	51	-	-	PUNCT
fnp-5347	473	52	pathological	pathological	ADJ
fnp-5347	473	53	entity	entity	NOUN
fnp-5347	473	54	.	.	PUNCT
fnp-5347	474	1	brain	brain	NOUN
fnp-5347	474	2	pathol	pathol	NOUN
fnp-5347	474	3	27	27	NUM
fnp-5347	474	4	:	:	SYM
fnp-5347	474	5	26	26	NUM
fnp-5347	474	6	-	-	SYM
fnp-5347	474	7	35	35	NUM
fnp-5347	474	8	.	.	PUNCT
fnp-5347	475	1	https://doi.org/10.1111/bpa.12347	https://doi.org/10.1111/bpa.12347	ADJ
fnp-5347	475	2	38	38	NUM
fnp-5347	475	3	.	.	PUNCT
fnp-5347	476	1	sim	sim	ADJ
fnp-5347	476	2	ns	ns	ADJ
fnp-5347	476	3	,	,	PUNCT
fnp-5347	476	4	seo	seo	NOUN
fnp-5347	476	5	y	y	PROPN
fnp-5347	476	6	,	,	PUNCT
fnp-5347	476	7	lim	lim	PROPN
fnp-5347	476	8	js	js	PROPN
fnp-5347	476	9	,	,	PUNCT
fnp-5347	476	10	kim	kim	PROPN
fnp-5347	476	11	wk	wk	PROPN
fnp-5347	476	12	,	,	PUNCT
fnp-5347	476	13	son	son	NOUN
fnp-5347	476	14	h	h	PROPN
fnp-5347	476	15	,	,	PUNCT
fnp-5347	476	16	kim	kim	PROPN
fnp-5347	476	17	hd	hd	PROPN
fnp-5347	476	18	,	,	PUNCT
fnp-5347	476	19	kim	kim	PROPN
fnp-5347	476	20	s	s	PROPN
fnp-5347	476	21	,	,	PUNCT
fnp-5347	476	22	an	an	DET
fnp-5347	476	23	hj	hj	PROPN
fnp-5347	476	24	,	,	PUNCT
fnp-5347	476	25	kang	kang	PROPN
fnp-5347	476	26	hc	hc	PROPN
fnp-5347	476	27	,	,	PUNCT
fnp-5347	476	28	kim	kim	PROPN
fnp-5347	476	29	sh	sh	INTJ
fnp-5347	476	30	et	et	PROPN
fnp-5347	476	31	al	al	PROPN
fnp-5347	476	32	(	(	PUNCT
fnp-5347	476	33	2018	2018	NUM
fnp-5347	476	34	)	)	PUNCT
fnp-5347	476	35	brain	brain	NOUN
fnp-5347	476	36	somatic	somatic	ADJ
fnp-5347	476	37	mutations	mutation	NOUN
fnp-5347	476	38	in	in	ADP
fnp-5347	476	39	slc35a2	slc35a2	NOUN
fnp-5347	476	40	cause	cause	VERB
fnp-5347	476	41	intractable	intractable	ADJ
fnp-5347	476	42	epilepsy	epilepsy	NOUN
fnp-5347	476	43	with	with	ADP
fnp-5347	476	44	aberrant	aberrant	ADJ
fnp-5347	476	45	n	n	CCONJ
fnp-5347	476	46	-	-	PUNCT
fnp-5347	476	47	glycosylation	glycosylation	NOUN
fnp-5347	476	48	.	.	PUNCT
fnp-5347	477	1	neurol	neurol	PROPN
fnp-5347	477	2	genet	genet	PROPN
fnp-5347	477	3	4	4	NUM
fnp-5347	477	4	:	:	PUNCT
fnp-5347	477	5	e294	e294	NUM
fnp-5347	477	6	.	.	PUNCT
fnp-5347	478	1	https://doi.org/10.1212/nxg.0000000000000294	https://doi.org/10.1212/nxg.0000000000000294	NOUN
fnp-5347	478	2	39	39	NUM
fnp-5347	478	3	.	.	PUNCT
fnp-5347	479	1	stone	stone	NOUN
fnp-5347	479	2	tj	tj	PROPN
fnp-5347	479	3	,	,	PUNCT
fnp-5347	479	4	keeley	keeley	PROPN
fnp-5347	479	5	a	a	PROPN
fnp-5347	479	6	,	,	PUNCT
fnp-5347	479	7	virasami	virasami	NOUN
fnp-5347	479	8	a	a	NOUN
fnp-5347	479	9	,	,	PUNCT
fnp-5347	479	10	harkness	harkness	PROPN
fnp-5347	479	11	w	w	PROPN
fnp-5347	479	12	,	,	PUNCT
fnp-5347	479	13	tisdall	tisdall	PROPN
fnp-5347	479	14	m	m	PROPN
fnp-5347	479	15	,	,	PUNCT
fnp-5347	479	16	izquierdo	izquierdo	PROPN
fnp-5347	479	17	delgado	delgado	VERB
fnp-5347	479	18	e	e	X
fnp-5347	479	19	,	,	PUNCT
fnp-5347	479	20	gutteridge	gutteridge	VERB
fnp-5347	479	21	a	a	PRON
fnp-5347	479	22	,	,	PUNCT
fnp-5347	479	23	brooks	brooks	PROPN
fnp-5347	479	24	t	t	PROPN
fnp-5347	479	25	,	,	PUNCT
fnp-5347	479	26	kristiansen	kristiansen	NOUN
fnp-5347	479	27	m	m	PROPN
fnp-5347	479	28	,	,	PUNCT
fnp-5347	479	29	chalker	chalker	PROPN
fnp-5347	479	30	j	j	PROPN
fnp-5347	479	31	et	et	PROPN
fnp-5347	479	32	al	al	PROPN
fnp-5347	479	33	(	(	PUNCT
fnp-5347	479	34	2018	2018	NUM
fnp-5347	479	35	)	)	PUNCT
fnp-5347	479	36	comprehensive	comprehensive	ADJ
fnp-5347	479	37	molecular	molecular	ADJ
fnp-5347	479	38	characterisation	characterisation	NOUN
fnp-5347	479	39	of	of	ADP
fnp-5347	479	40	epilepsy	epilepsy	NOUN
fnp-5347	479	41	-	-	PUNCT
fnp-5347	479	42	associated	associate	VERB
fnp-5347	479	43	glioneuronal	glioneuronal	ADJ
fnp-5347	479	44	tumours	tumour	NOUN
fnp-5347	479	45	.	.	PUNCT
fnp-5347	480	1	acta	acta	PROPN
fnp-5347	480	2	neuropathol	neuropathol	PROPN
fnp-5347	480	3	135	135	NUM
fnp-5347	480	4	:	:	PUNCT
fnp-5347	480	5	115	115	NUM
fnp-5347	480	6	-	-	SYM
fnp-5347	480	7	129	129	NUM
fnp-5347	480	8	.	.	PUNCT
fnp-5347	481	1	https://doi.org/10.1007/s00401-017-1773-z	https://doi.org/10.1007/s00401-017-1773-z	NOUN
fnp-5347	481	2	40	40	NUM
fnp-5347	481	3	.	.	PUNCT
fnp-5347	482	1	stone	stone	NOUN
fnp-5347	482	2	tj	tj	PROPN
fnp-5347	482	3	,	,	PUNCT
fnp-5347	482	4	mankad	mankad	NOUN
fnp-5347	483	1	k	k	PROPN
fnp-5347	483	2	,	,	PUNCT
fnp-5347	483	3	tan	tan	PROPN
fnp-5347	483	4	ap	ap	PROPN
fnp-5347	483	5	,	,	PUNCT
fnp-5347	483	6	jan	jan	PROPN
fnp-5347	483	7	w	w	PROPN
fnp-5347	483	8	,	,	PUNCT
fnp-5347	483	9	pickles	pickle	NOUN
fnp-5347	483	10	jc	jc	PROPN
fnp-5347	483	11	,	,	PUNCT
fnp-5347	483	12	gogou	gogou	PROPN
fnp-5347	483	13	m	m	PROPN
fnp-5347	483	14	,	,	PUNCT
fnp-5347	483	15	chalker	chalker	PROPN
fnp-5347	483	16	j	j	PROPN
fnp-5347	483	17	,	,	PUNCT
fnp-5347	483	18	slodkowska	slodkowska	PROPN
fnp-5347	483	19	i	i	PROPN
fnp-5347	483	20	,	,	PUNCT
fnp-5347	483	21	pang	pang	NOUN
fnp-5347	483	22	e	e	NOUN
fnp-5347	483	23	,	,	PUNCT
fnp-5347	483	24	kristiansen	kristiansen	VERB
fnp-5347	483	25	m	m	VERB
fnp-5347	483	26	et	et	NOUN
fnp-5347	483	27	al	al	PROPN
fnp-5347	483	28	(	(	PUNCT
fnp-5347	483	29	2023	2023	NUM
fnp-5347	483	30	)	)	PUNCT
fnp-5347	483	31	dna	dna	PROPN
fnp-5347	483	32	methylation	methylation	NOUN
fnp-5347	483	33	-	-	PUNCT
fnp-5347	483	34	based	base	VERB
fnp-5347	483	35	classification	classification	NOUN
fnp-5347	483	36	of	of	ADP
fnp-5347	483	37	glioneuronal	glioneuronal	ADJ
fnp-5347	483	38	tumours	tumours	PROPN
fnp-5347	483	39	synergises	synergise	VERB
fnp-5347	483	40	with	with	ADP
fnp-5347	483	41	histology	histology	NOUN
fnp-5347	483	42	and	and	CCONJ
fnp-5347	483	43	radiology	radiology	NOUN
fnp-5347	483	44	to	to	PART
fnp-5347	483	45	refine	refine	VERB
fnp-5347	483	46	accurate	accurate	ADJ
fnp-5347	483	47	molecular	molecular	ADJ
fnp-5347	483	48	stratification	stratification	NOUN
fnp-5347	483	49	.	.	PUNCT
fnp-5347	484	1	neuropathol	neuropathol	NOUN
fnp-5347	484	2	appl	appl	PROPN
fnp-5347	484	3	neurobiol	neurobiol	PROPN
fnp-5347	484	4	49	49	NUM
fnp-5347	484	5	:	:	PUNCT
fnp-5347	484	6	e12894	e12894	PROPN
fnp-5347	484	7	.	.	PUNCT
fnp-5347	485	1	https://doi.org/10.1111/nan.12894	https://doi.org/10.1111/nan.12894	PROPN
fnp-5347	485	2	41	41	NUM
fnp-5347	485	3	.	.	PUNCT
fnp-5347	486	1	tröscher	tröscher	PROPN
fnp-5347	486	2	ar	ar	PROPN
fnp-5347	486	3	,	,	PUNCT
fnp-5347	486	4	mair	mair	PROPN
fnp-5347	486	5	km	km	PROPN
fnp-5347	486	6	,	,	PUNCT
fnp-5347	486	7	de	de	PROPN
fnp-5347	486	8	juan	juan	PROPN
fnp-5347	486	9	lv	lv	PROPN
fnp-5347	486	10	,	,	PUNCT
fnp-5347	486	11	köck	köck	ADJ
fnp-5347	486	12	u	u	NOUN
fnp-5347	486	13	,	,	PUNCT
fnp-5347	486	14	steinmaurer	steinmaurer	ADP
fnp-5347	486	15	a	a	PRON
fnp-5347	486	16	,	,	PUNCT
fnp-5347	486	17	baier	baier	PROPN
fnp-5347	486	18	h	h	PROPN
fnp-5347	486	19	,	,	PUNCT
fnp-5347	486	20	becker	becker	PROPN
fnp-5347	486	21	a	a	PRON
fnp-5347	486	22	,	,	PUNCT
fnp-5347	486	23	blümcke	blümcke	PROPN
fnp-5347	486	24	i	i	PRON
fnp-5347	486	25	,	,	PUNCT
fnp-5347	486	26	finzel	finzel	PROPN
fnp-5347	486	27	m	m	NOUN
fnp-5347	486	28	,	,	PUNCT
fnp-5347	486	29	geis	geis	PROPN
fnp-5347	486	30	c	c	PROPN
fnp-5347	486	31	et	et	PROPN
fnp-5347	486	32	al	al	PROPN
fnp-5347	486	33	(	(	PUNCT
fnp-5347	486	34	2023	2023	NUM
fnp-5347	486	35	)	)	PUNCT
fnp-5347	486	36	temporal	temporal	ADJ
fnp-5347	486	37	lobe	lobe	NOUN
fnp-5347	486	38	epilepsy	epilepsy	NOUN
fnp-5347	486	39	with	with	ADP
fnp-5347	486	40	gad	gad	PROPN
fnp-5347	486	41	antibodies	antibodie	VERB
fnp-5347	486	42	:	:	PUNCT
fnp-5347	487	1	neurons	neuron	NOUN
fnp-5347	487	2	killed	kill	VERB
fnp-5347	487	3	by	by	ADP
fnp-5347	487	4	t	t	PROPN
fnp-5347	487	5	cells	cell	NOUN
fnp-5347	487	6	not	not	PART
fnp-5347	487	7	by	by	ADP
fnp-5347	487	8	complement	complement	NOUN
fnp-5347	487	9	membrane	membrane	NOUN
fnp-5347	487	10	attack	attack	NOUN
fnp-5347	487	11	complex	complex	NOUN
fnp-5347	487	12	.	.	PUNCT
fnp-5347	488	1	brain	brain	NOUN
fnp-5347	488	2	146	146	NUM
fnp-5347	488	3	:	:	SYM
fnp-5347	488	4	1436	1436	NUM
fnp-5347	488	5	-	-	SYM
fnp-5347	488	6	1452	1452	NUM
fnp-5347	488	7	.	.	PUNCT
fnp-5347	489	1	https://doi.org/10.1093/brain/awac404	https://doi.org/10.1093/brain/awac404	PROPN
fnp-5347	489	2	42	42	NUM
fnp-5347	489	3	.	.	PUNCT
fnp-5347	490	1	vermeulen	vermeulen	PROPN
fnp-5347	490	2	c	c	PROPN
fnp-5347	490	3	,	,	PUNCT
fnp-5347	490	4	pages	page	NOUN
fnp-5347	490	5	-	-	PUNCT
fnp-5347	490	6	gallego	gallego	NOUN
fnp-5347	490	7	m	m	PROPN
fnp-5347	490	8	,	,	PUNCT
fnp-5347	490	9	kester	kester	PROPN
fnp-5347	490	10	l	l	PROPN
fnp-5347	490	11	,	,	PUNCT
fnp-5347	490	12	kranendonk	kranendonk	PROPN
fnp-5347	490	13	meg	meg	PROPN
fnp-5347	490	14	,	,	PUNCT
fnp-5347	490	15	wesseling	wessele	VERB
fnp-5347	490	16	p	p	PRON
fnp-5347	490	17	,	,	PUNCT
fnp-5347	490	18	verburg	verburg	NOUN
fnp-5347	490	19	n	n	CCONJ
fnp-5347	490	20	,	,	PUNCT
fnp-5347	490	21	de	de	X
fnp-5347	490	22	witt	witt	PROPN
fnp-5347	490	23	hamer	hamer	PROPN
fnp-5347	490	24	p	p	PROPN
fnp-5347	490	25	,	,	PUNCT
fnp-5347	490	26	kooi	kooi	PROPN
fnp-5347	490	27	ej	ej	PROPN
fnp-5347	490	28	,	,	PUNCT
fnp-5347	490	29	dankmeijer	dankmeijer	NOUN
fnp-5347	490	30	l	l	PROPN
fnp-5347	490	31	,	,	PUNCT
fnp-5347	490	32	van	van	PROPN
fnp-5347	490	33	der	der	PROPN
fnp-5347	490	34	lugt	lugt	PROPN
fnp-5347	490	35	j	j	PROPN
fnp-5347	490	36	et	et	PROPN
fnp-5347	490	37	al	al	PROPN
fnp-5347	490	38	(	(	PUNCT
fnp-5347	490	39	2023	2023	NUM
fnp-5347	490	40	)	)	PUNCT
fnp-5347	490	41	ultra	ultra	ADJ
fnp-5347	490	42	-	-	ADJ
fnp-5347	490	43	fast	fast	ADJ
fnp-5347	490	44	deep	deep	ADV
fnp-5347	490	45	-	-	PUNCT
fnp-5347	490	46	learned	learn	VERB
fnp-5347	490	47	cns	cns	NOUN
fnp-5347	490	48	tumour	tumour	NOUN
fnp-5347	490	49	classification	classification	NOUN
fnp-5347	490	50	during	during	ADP
fnp-5347	490	51	surgery	surgery	NOUN
fnp-5347	490	52	.	.	PUNCT
fnp-5347	491	1	nature	nature	NOUN
fnp-5347	491	2	622	622	NUM
fnp-5347	491	3	:	:	PUNCT
fnp-5347	491	4	842	842	NUM
fnp-5347	491	5	-	-	SYM
fnp-5347	491	6	849	849	NUM
fnp-5347	491	7	.	.	PUNCT
fnp-5347	491	8	https://doi.org/10.1038/s41586-023-06615-2	https://doi.org/10.1038/s41586-023-06615-2	NUM
fnp-5347	491	9	43	43	NUM
fnp-5347	491	10	.	.	PUNCT
fnp-5347	492	1	vorndran	vorndran	PROPN
fnp-5347	492	2	j	j	PROPN
fnp-5347	492	3	,	,	PUNCT
fnp-5347	492	4	neuner	neuner	PROPN
fnp-5347	492	5	c	c	PROPN
fnp-5347	492	6	,	,	PUNCT
fnp-5347	492	7	coras	coras	PROPN
fnp-5347	492	8	r	r	PROPN
fnp-5347	492	9	,	,	PUNCT
fnp-5347	492	10	hoffmann	hoffmann	PROPN
fnp-5347	492	11	l	l	PROPN
fnp-5347	492	12	,	,	PUNCT
fnp-5347	492	13	geffers	geffer	VERB
fnp-5347	492	14	s	s	PRON
fnp-5347	492	15	,	,	PUNCT
fnp-5347	492	16	honke	honke	PROPN
fnp-5347	492	17	j	j	PROPN
fnp-5347	492	18	,	,	PUNCT
fnp-5347	492	19	herms	herms	PROPN
fnp-5347	492	20	j	j	PROPN
fnp-5347	492	21	,	,	PUNCT
fnp-5347	492	22	roeber	roeber	PROPN
fnp-5347	492	23	s	s	PROPN
fnp-5347	492	24	,	,	PUNCT
fnp-5347	492	25	hamer	hamer	NOUN
fnp-5347	492	26	h	h	NOUN
fnp-5347	492	27	,	,	PUNCT
fnp-5347	492	28	brandner	brandner	PROPN
fnp-5347	492	29	s	s	PART
fnp-5347	492	30	et	et	PROPN
fnp-5347	492	31	al	al	PROPN
fnp-5347	492	32	(	(	PUNCT
fnp-5347	492	33	2023	2023	NUM
fnp-5347	492	34	)	)	PUNCT
fnp-5347	492	35	a	a	DET
fnp-5347	492	36	deep	deep	ADJ
fnp-5347	492	37	learning	learning	NOUN
fnp-5347	492	38	-	-	PUNCT
fnp-5347	492	39	based	base	VERB
fnp-5347	492	40	histopathology	histopathology	NOUN
fnp-5347	492	41	classifier	classifier	NOUN
fnp-5347	492	42	for	for	ADP
fnp-5347	492	43	focal	focal	ADJ
fnp-5347	492	44	cortical	cortical	ADJ
fnp-5347	492	45	dysplasia	dysplasia	NOUN
fnp-5347	492	46	.	.	PUNCT
fnp-5347	493	1	neural	neural	ADJ
fnp-5347	493	2	comput	comput	PROPN
fnp-5347	493	3	appl	appl	PROPN
fnp-5347	493	4	35	35	NUM
fnp-5347	493	5	:	:	PUNCT
fnp-5347	493	6	12775	12775	NUM
fnp-5347	493	7	-	-	SYM
fnp-5347	493	8	12792	12792	NUM
fnp-5347	493	9	.	.	PUNCT
fnp-5347	494	1	https://doi.org/10.1007/s00521-023-08364-9	https://doi.org/10.1007/s00521-023-08364-9	NUM
fnp-5347	494	2	44	44	NUM
fnp-5347	494	3	.	.	PUNCT
fnp-5347	495	1	walger	walger	PROPN
fnp-5347	495	2	l	l	PROPN
fnp-5347	495	3	,	,	PUNCT
fnp-5347	495	4	adler	adler	PROPN
fnp-5347	495	5	s	s	PROPN
fnp-5347	495	6	,	,	PUNCT
fnp-5347	495	7	wagstyl	wagstyl	PROPN
fnp-5347	495	8	k	k	PROPN
fnp-5347	495	9	,	,	PUNCT
fnp-5347	495	10	henschel	henschel	PROPN
fnp-5347	495	11	l	l	PROPN
fnp-5347	495	12	,	,	PUNCT
fnp-5347	495	13	david	david	PROPN
fnp-5347	495	14	b	b	PROPN
fnp-5347	495	15	,	,	PUNCT
fnp-5347	495	16	borger	borger	PROPN
fnp-5347	495	17	v	v	PROPN
fnp-5347	495	18	,	,	PUNCT
fnp-5347	495	19	hattingen	hattingen	PROPN
fnp-5347	495	20	e	e	PROPN
fnp-5347	495	21	,	,	PUNCT
fnp-5347	495	22	vatter	vatter	PROPN
fnp-5347	495	23	h	h	PROPN
fnp-5347	495	24	,	,	PUNCT
fnp-5347	495	25	elger	elger	PROPN
fnp-5347	495	26	ce	ce	PROPN
fnp-5347	495	27	,	,	PUNCT
fnp-5347	495	28	baldeweg	baldeweg	VERB
fnp-5347	495	29	t	t	PROPN
fnp-5347	495	30	et	et	NOUN
fnp-5347	495	31	al	al	PROPN
fnp-5347	495	32	(	(	PUNCT
fnp-5347	495	33	2023	2023	NUM
fnp-5347	495	34	)	)	PUNCT
fnp-5347	495	35	artificial	artificial	ADJ
fnp-5347	495	36	intelligence	intelligence	NOUN
fnp-5347	495	37	for	for	ADP
fnp-5347	495	38	the	the	DET
fnp-5347	495	39	detection	detection	NOUN
fnp-5347	495	40	of	of	ADP
fnp-5347	495	41	focal	focal	ADJ
fnp-5347	495	42	cortical	cortical	ADJ
fnp-5347	495	43	dysplasia	dysplasia	NOUN
fnp-5347	495	44	:	:	PUNCT
fnp-5347	495	45	challenges	challenge	NOUN
fnp-5347	495	46	in	in	ADP
fnp-5347	495	47	translating	translate	VERB
fnp-5347	495	48	algorithms	algorithm	NOUN
fnp-5347	495	49	into	into	ADP
fnp-5347	495	50	clinical	clinical	ADJ
fnp-5347	495	51	practice	practice	NOUN
fnp-5347	495	52	.	.	PUNCT
fnp-5347	496	1	epilepsia	epilepsia	NOUN
fnp-5347	496	2	64	64	NUM
fnp-5347	496	3	:	:	PUNCT
fnp-5347	496	4	1093	1093	NUM
fnp-5347	496	5	-	-	SYM
fnp-5347	496	6	1112	1112	NUM
fnp-5347	496	7	.	.	PUNCT
fnp-5347	497	1	https://doi.org/10.1111/epi.17522	https://doi.org/10.1111/epi.17522	PROPN
fnp-5347	497	2	45	45	NUM
fnp-5347	497	3	.	.	PUNCT
fnp-5347	498	1	winawer	winawer	PROPN
fnp-5347	498	2	mr	mr	PROPN
fnp-5347	498	3	,	,	PUNCT
fnp-5347	498	4	griffin	griffin	PROPN
fnp-5347	498	5	ng	ng	PROPN
fnp-5347	498	6	,	,	PUNCT
fnp-5347	498	7	samanamud	samanamud	PROPN
fnp-5347	498	8	j	j	PROPN
fnp-5347	498	9	,	,	PUNCT
fnp-5347	498	10	baugh	baugh	PROPN
fnp-5347	498	11	eh	eh	INTJ
fnp-5347	498	12	,	,	PUNCT
fnp-5347	498	13	rathakrishnan	rathakrishnan	NOUN
fnp-5347	498	14	d	d	PROPN
fnp-5347	498	15	,	,	PUNCT
fnp-5347	498	16	ramalingam	ramalingam	NOUN
fnp-5347	498	17	s	s	PROPN
fnp-5347	498	18	,	,	PUNCT
fnp-5347	498	19	zagzag	zagzag	NOUN
fnp-5347	498	20	d	d	PROPN
fnp-5347	498	21	,	,	PUNCT
fnp-5347	498	22	schevon	schevon	PROPN
fnp-5347	498	23	ca	ca	PROPN
fnp-5347	498	24	,	,	PUNCT
fnp-5347	498	25	dugan	dugan	VERB
fnp-5347	498	26	p	p	PRON
fnp-5347	498	27	,	,	PUNCT
fnp-5347	498	28	hegde	hegde	PROPN
fnp-5347	498	29	m	m	PROPN
fnp-5347	498	30	et	et	NOUN
fnp-5347	498	31	al	al	PROPN
fnp-5347	498	32	(	(	PUNCT
fnp-5347	498	33	2018	2018	NUM
fnp-5347	498	34	)	)	PUNCT
fnp-5347	498	35	somatic	somatic	ADJ
fnp-5347	498	36	slc35a2	slc35a2	NOUN
fnp-5347	498	37	variants	variant	NOUN
fnp-5347	498	38	in	in	ADP
fnp-5347	498	39	the	the	DET
fnp-5347	498	40	brain	brain	NOUN
fnp-5347	498	41	are	be	AUX
fnp-5347	498	42	associated	associate	VERB
fnp-5347	498	43	with	with	ADP
fnp-5347	498	44	intractable	intractable	ADJ
fnp-5347	498	45	neocortical	neocortical	ADJ
fnp-5347	498	46	epilepsy	epilepsy	NOUN
fnp-5347	498	47	.	.	PUNCT
fnp-5347	499	1	ann	ann	PROPN
fnp-5347	499	2	neurol	neurol	PROPN
fnp-5347	499	3	83	83	NUM
fnp-5347	499	4	:	:	SYM
fnp-5347	499	5	1133	1133	NUM
fnp-5347	499	6	-	-	SYM
fnp-5347	499	7	1146	1146	NUM
fnp-5347	499	8	.	.	PUNCT
fnp-5347	500	1	https://doi.org/10.1002/ana.25243	https://doi.org/10.1002/ana.25243	PROPN
fnp-5347	500	2	46	46	NUM
fnp-5347	500	3	.	.	PUNCT
fnp-5347	501	1	witt	witt	PROPN
fnp-5347	501	2	ja	ja	PROPN
fnp-5347	501	3	,	,	PUNCT
fnp-5347	501	4	becker	becker	PROPN
fnp-5347	501	5	aj	aj	PROPN
fnp-5347	501	6	,	,	PUNCT
fnp-5347	501	7	helmstaedter	helmstaedter	PROPN
fnp-5347	501	8	c	c	PROPN
fnp-5347	501	9	(	(	PUNCT
fnp-5347	501	10	2023	2023	NUM
fnp-5347	501	11	)	)	PUNCT
fnp-5347	501	12	the	the	DET
fnp-5347	501	13	multifactorial	multifactorial	ADJ
fnp-5347	501	14	etiology	etiology	NOUN
fnp-5347	501	15	of	of	ADP
fnp-5347	501	16	cognitive	cognitive	ADJ
fnp-5347	501	17	deficits	deficit	NOUN
fnp-5347	501	18	in	in	ADP
fnp-5347	501	19	epilepsy	epilepsy	NOUN
fnp-5347	501	20	and	and	CCONJ
fnp-5347	501	21	the	the	DET
fnp-5347	501	22	neuropathology	neuropathology	NOUN
fnp-5347	501	23	of	of	ADP
fnp-5347	501	24	mesial	mesial	ADJ
fnp-5347	501	25	temporal	temporal	ADJ
fnp-5347	501	26	lobe	lobe	NOUN
fnp-5347	501	27	epilepsy	epilepsy	NOUN
fnp-5347	501	28	beyond	beyond	ADP
fnp-5347	501	29	hyperphosphorylated	hyperphosphorylated	ADJ
fnp-5347	501	30	tau	tau	PROPN
fnp-5347	501	31	.	.	PUNCT
fnp-5347	502	1	alzheimers	alzheimers	PROPN
fnp-5347	502	2	dement	dement	PROPN
fnp-5347	502	3	19	19	NUM
fnp-5347	502	4	:	:	PUNCT
fnp-5347	502	5	3231	3231	NUM
fnp-5347	502	6	-	-	SYM
fnp-5347	502	7	3232	3232	NUM
fnp-5347	502	8	.	.	PUNCT
fnp-5347	503	1	https://doi.org/10.1002/alz.13085	https://doi.org/10.1002/alz.13085	PROPN
fnp-5347	503	2	47	47	NUM
fnp-5347	503	3	.	.	PUNCT
fnp-5347	504	1	witters	witter	NOUN
fnp-5347	504	2	p	p	PROPN
fnp-5347	504	3	,	,	PUNCT
fnp-5347	504	4	tahata	tahata	PROPN
fnp-5347	504	5	s	s	PROPN
fnp-5347	504	6	,	,	PUNCT
fnp-5347	504	7	barone	barone	PROPN
fnp-5347	504	8	r	r	PROPN
fnp-5347	504	9	,	,	PUNCT
fnp-5347	504	10	ounap	ounap	PROPN
fnp-5347	504	11	k	k	NOUN
fnp-5347	504	12	,	,	PUNCT
fnp-5347	504	13	salvarinova	salvarinova	PROPN
fnp-5347	504	14	r	r	X
fnp-5347	504	15	,	,	PUNCT
fnp-5347	504	16	gronborg	gronborg	PROPN
fnp-5347	504	17	s	s	PROPN
fnp-5347	504	18	,	,	PUNCT
fnp-5347	504	19	hoganson	hoganson	PROPN
fnp-5347	504	20	g	g	NOUN
fnp-5347	504	21	,	,	PUNCT
fnp-5347	504	22	scaglia	scaglia	NOUN
fnp-5347	504	23	f	f	PROPN
fnp-5347	504	24	,	,	PUNCT
fnp-5347	504	25	lewis	lewis	PROPN
fnp-5347	504	26	am	am	PROPN
fnp-5347	504	27	,	,	PUNCT
fnp-5347	504	28	mori	mori	PROPN
fnp-5347	504	29	m	m	PROPN
fnp-5347	504	30	et	et	PROPN
fnp-5347	504	31	al	al	PROPN
fnp-5347	504	32	(	(	PUNCT
fnp-5347	504	33	2020	2020	NUM
fnp-5347	504	34	)	)	PUNCT
fnp-5347	504	35	clinical	clinical	ADJ
fnp-5347	504	36	and	and	CCONJ
fnp-5347	504	37	biochemical	biochemical	ADJ
fnp-5347	504	38	improvement	improvement	NOUN
fnp-5347	504	39	with	with	ADP
fnp-5347	504	40	galactose	galactose	ADJ
fnp-5347	504	41	supplementation	supplementation	NOUN
fnp-5347	504	42	in	in	ADP
fnp-5347	504	43	slc35a2	slc35a2	NOUN
fnp-5347	504	44	-	-	PUNCT
fnp-5347	504	45	cdg	cdg	PROPN
fnp-5347	504	46	.	.	PUNCT
fnp-5347	505	1	genet	genet	PROPN
fnp-5347	505	2	med	me	VERB
fnp-5347	505	3	22	22	NUM
fnp-5347	505	4	:	:	PUNCT
fnp-5347	505	5	1102	1102	NUM
fnp-5347	505	6	-	-	SYM
fnp-5347	505	7	1107	1107	NUM
fnp-5347	505	8	.	.	PUNCT
fnp-5347	506	1	https://doi.org/10.1038/s41436-020-0767-8	https://doi.org/10.1038/s41436-020-0767-8	NUM
fnp-5347	506	2	48	48	NUM
fnp-5347	506	3	.	.	PUNCT
fnp-5347	507	1	xi	xi	PROPN
fnp-5347	507	2	zq	zq	PROPN
fnp-5347	507	3	,	,	PUNCT
fnp-5347	507	4	wang	wang	PROPN
fnp-5347	507	5	xf	xf	PROPN
fnp-5347	507	6	,	,	PUNCT
fnp-5347	507	7	shu	shu	PROPN
fnp-5347	507	8	xf	xf	PROPN
fnp-5347	507	9	,	,	PUNCT
fnp-5347	507	10	chen	chen	PROPN
fnp-5347	507	11	gj	gj	PROPN
fnp-5347	507	12	,	,	PUNCT
fnp-5347	507	13	xiao	xiao	PROPN
fnp-5347	507	14	f	f	PROPN
fnp-5347	507	15	,	,	PUNCT
fnp-5347	507	16	sun	sun	PROPN
fnp-5347	507	17	jj	jj	PROPN
fnp-5347	507	18	,	,	PUNCT
fnp-5347	507	19	zhu	zhu	PROPN
fnp-5347	507	20	x	x	SYM
fnp-5347	507	21	(	(	PUNCT
fnp-5347	507	22	2011	2011	NUM
fnp-5347	507	23	)	)	PUNCT
fnp-5347	507	24	is	be	AUX
fnp-5347	507	25	intractable	intractable	ADJ
fnp-5347	507	26	epilepsy	epilepsy	NOUN
fnp-5347	507	27	a	a	DET
fnp-5347	507	28	tauopathy	tauopathy	NOUN
fnp-5347	507	29	?	?	PUNCT
fnp-5347	508	1	med	med	ADJ
fnp-5347	508	2	hypotheses	hypothesis	NOUN
fnp-5347	508	3	76	76	NUM
fnp-5347	508	4	:	:	PUNCT
fnp-5347	508	5	897	897	NUM
fnp-5347	508	6	-	-	SYM
fnp-5347	508	7	900	900	NUM
fnp-5347	508	8	.	.	PUNCT
fnp-5347	509	1	https://doi.org/10.1016/j.mehy.2011.03.003	https://doi.org/10.1016/j.mehy.2011.03.003	NOUN
fnp-5347	509	2	49	49	NUM
fnp-5347	509	3	.	.	PUNCT
fnp-5347	510	1	zawar	zawar	NOUN
fnp-5347	510	2	i	i	PRON
fnp-5347	510	3	,	,	PUNCT
fnp-5347	510	4	kapur	kapur	PROPN
fnp-5347	510	5	j	j	PROPN
fnp-5347	510	6	(	(	PUNCT
fnp-5347	510	7	2023	2023	NUM
fnp-5347	510	8	)	)	PUNCT
fnp-5347	510	9	does	do	AUX
fnp-5347	510	10	alzheimer	alzheimer	PROPN
fnp-5347	510	11	's	's	PART
fnp-5347	510	12	disease	disease	NOUN
fnp-5347	510	13	with	with	ADP
fnp-5347	510	14	mesial	mesial	ADJ
fnp-5347	510	15	temporal	temporal	ADJ
fnp-5347	510	16	lobe	lobe	ADJ
fnp-5347	510	17	epilepsy	epilepsy	NOUN
fnp-5347	510	18	represent	represent	VERB
fnp-5347	510	19	a	a	DET
fnp-5347	510	20	distinct	distinct	ADJ
fnp-5347	510	21	disease	disease	NOUN
fnp-5347	510	22	subtype	subtype	NOUN
fnp-5347	510	23	?	?	PUNCT
fnp-5347	511	1	alzheimers	alzheimer	NOUN
fnp-5347	511	2	dement	dement	PROPN
fnp-5347	511	3	19	19	NUM
fnp-5347	511	4	:	:	SYM
fnp-5347	511	5	2697	2697	NUM
fnp-5347	511	6	-	-	SYM
fnp-5347	511	7	2706	2706	NUM
fnp-5347	511	8	.	.	PUNCT
fnp-5347	512	1	https://doi.org/10.1002/alz.12943	https://doi.org/10.1002/alz.12943	PROPN
fnp-5347	512	2	copyright	copyright	NOUN
fnp-5347	512	3	:	:	PUNCT
fnp-5347	512	4	©	©	PROPN
fnp-5347	512	5	2024	2024	NUM
fnp-5347	512	6	the	the	DET
fnp-5347	512	7	author(s	author(s	NOUN
fnp-5347	512	8	)	)	PUNCT
fnp-5347	512	9	.	.	PUNCT
fnp-5347	513	1	this	this	PRON
fnp-5347	513	2	is	be	AUX
fnp-5347	513	3	an	an	DET
fnp-5347	513	4	open	open	ADJ
fnp-5347	513	5	access	access	NOUN
fnp-5347	513	6	article	article	NOUN
fnp-5347	513	7	distributed	distribute	VERB
fnp-5347	513	8	under	under	ADP
fnp-5347	513	9	the	the	DET
fnp-5347	513	10	terms	term	NOUN
fnp-5347	513	11	of	of	ADP
fnp-5347	513	12	the	the	DET
fnp-5347	513	13	creative	creative	ADJ
fnp-5347	513	14	commons	common	NOUN
fnp-5347	513	15	attribution	attribution	NOUN
fnp-5347	513	16	4.0	4.0	NUM
fnp-5347	513	17	international	international	ADJ
fnp-5347	513	18	license	license	NOUN
fnp-5347	513	19	(	(	PUNCT
fnp-5347	513	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-5347	513	21	)	)	PUNCT
fnp-5347	513	22	,	,	PUNCT
fnp-5347	513	23	which	which	PRON
fnp-5347	513	24	permits	permit	VERB
fnp-5347	513	25	unrestricted	unrestricted	ADJ
fnp-5347	513	26	use	use	NOUN
fnp-5347	513	27	,	,	PUNCT
fnp-5347	513	28	distribution	distribution	NOUN
fnp-5347	513	29	,	,	PUNCT
fnp-5347	513	30	and	and	CCONJ
fnp-5347	513	31	reproduction	reproduction	NOUN
fnp-5347	513	32	in	in	ADP
fnp-5347	513	33	any	any	DET
fnp-5347	513	34	medium	medium	NOUN
fnp-5347	513	35	,	,	PUNCT
fnp-5347	513	36	provided	provide	VERB
fnp-5347	513	37	the	the	DET
fnp-5347	513	38	original	original	ADJ
fnp-5347	513	39	author	author	NOUN
fnp-5347	513	40	and	and	CCONJ
fnp-5347	513	41	source	source	NOUN
fnp-5347	513	42	are	be	AUX
fnp-5347	513	43	credited	credit	VERB
fnp-5347	513	44	,	,	PUNCT
fnp-5347	513	45	a	a	DET
fnp-5347	513	46	link	link	NOUN
fnp-5347	513	47	to	to	ADP
fnp-5347	513	48	the	the	DET
fnp-5347	513	49	creative	creative	ADJ
fnp-5347	513	50	commons	common	NOUN
fnp-5347	513	51	license	license	NOUN
fnp-5347	513	52	is	be	AUX
fnp-5347	513	53	provided	provide	VERB
fnp-5347	513	54	,	,	PUNCT
fnp-5347	513	55	and	and	CCONJ
fnp-5347	513	56	any	any	DET
fnp-5347	513	57	changes	change	NOUN
fnp-5347	513	58	are	be	AUX
fnp-5347	513	59	indicated	indicate	VERB
fnp-5347	513	60	.	.	PUNCT
fnp-5347	514	1	the	the	DET
fnp-5347	514	2	creative	creative	ADJ
fnp-5347	514	3	commons	common	NOUN
fnp-5347	514	4	public	public	ADJ
fnp-5347	514	5	domain	domain	NOUN
fnp-5347	514	6	dedication	dedication	NOUN
fnp-5347	514	7	waiver	waiver	NOUN
fnp-5347	514	8	(	(	PUNCT
fnp-5347	514	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-5347	514	10	)	)	PUNCT
fnp-5347	514	11	applies	apply	VERB
fnp-5347	514	12	to	to	ADP
fnp-5347	514	13	the	the	DET
fnp-5347	514	14	data	datum	NOUN
fnp-5347	514	15	made	make	VERB
fnp-5347	514	16	available	available	ADJ
fnp-5347	514	17	in	in	ADP
fnp-5347	514	18	this	this	DET
fnp-5347	514	19	article	article	NOUN
fnp-5347	514	20	,	,	PUNCT
fnp-5347	514	21	unless	unless	SCONJ
fnp-5347	514	22	otherwise	otherwise	ADV
fnp-5347	514	23	stated	state	VERB
fnp-5347	514	24	.	.	PUNCT